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Thesis Abstract 
Skeletal muscle (SkM) is an extremely abundant and mechano-sensitive tissue, 
demonstrating increases in mass and function following mechanical loading/resistance 
exercise (RE). Over the past 3 decades, there has been considerable progress in the 
development of bioengineered SkM models for elucidating the cellular and molecular 
mechanisms underpinning load-induced SkM adaptation in-vitro. However, the majority 
of studies often employ loading regimes which lack resemblance of intermittent 
eccentric-lengthening contraction experienced during RE in-vivo. As the field of SkM 
epigenetics has only more recently begun to emerge, there is a paucity of data surrounding 
the epigenetic regulation of mechanical loading in bioengineered SkM. The work 
conducted herein therefore intermittently loaded bioengineered fibrin SkM in-vitro to 
determine whether mechanical loading alone recapitulates both the transcriptional and 
epigenetic responses in SkM following loading/RE in-vivo. The initial experiments 
(chapter 3) first characterised the use of a novel bioreactor system (i.e. which has never 
previously been used to bioengineered SkM) for loading bioengineered SkM which 
demonstrated a comparable mechano-transcriptional response of candidate genes that 
were differentially regulated after loading in previous well-characterised bioreactors. In 
order to identify appropriate genes to analyse in response to loading in bioengineered 
SkM, the most frequently regulated genes across both the human transcriptome and 
methylome after acute RE in-vivo were determined in chapter 4. Indeed, extensive 
bioinformatics analysis revealed a number of transcriptionally and epigenetically 
regulated genes in human SkM that were subsequently analysed at the mRNA and DNA 
methylation level following acute mechanical loading in fibrin engineered SkM (chapter 
5). Despite few changes observed in DNA methylation, mechanical loading alone induced 
similar changes in gene expression compared to loading/RE in human and rodent SkM 
 xxiv 
in-vivo. Amongst the array of genes analysed, UBR5 demonstrated the largest increase in 
mRNA expression across all models of loading. Therefore, the final experimental chapter 
of this thesis (chapter 6) wished to elucidate the mechanistic role of UBR5 after 
mechanical loading in human myotubes. Most interestingly, mechanical loading was able 
to rescue the siRNA-induced reduction in UBR5 gene expression, further suggesting a 
pivotal role in load-induced adaptation. 
 
Overall, the present thesis suggests that mechanical loading of C2C12 bioengineered fibrin 
muscle is a useful in-vitro model for investigating the transcriptional response to loading 
in-vivo. Therefore, providing a representative model for investigating the molecular 
mechanisms underpinning load-induce SkM adaptation. However, the application of 
repeated/chronic loading, with or without electrical stimulation may be necessary to 
evoke epigenetic alterations that are comparable to those observed following loading/RE 
in-vivo.  
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CHAPTER 1  
Introduction 
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1! General Introduction 
The experiments undertaken within this thesis were conducted using a self-assembling fibrin 
bioengineered skeletal muscle (SkM) model to investigate whether acute mechanical loading 
alone (i.e. in isolation of a neural input and systemic factors) in-vitro mimics the transcriptional 
and epigenetic responses to resistance exercise (RE) in-vivo. In an attempt to recapitulate the 
morphological and functional characteristics of SkM in-vivo, existing knowledge of native 
SkM development, structure and post-natal growth and regeneration must first be 
acknowledged as myotube formation during cell culture in-vitro somewhat resembles SkM 
development and regeneration in-vivo. Given the main aim of this thesis was to determine the 
acute molecular responses to mechanical loading alone, it is therefore important to also 
consider the key molecular pathways that regulate SkM adaptation following RE in-vivo and 
the common techniques used to explore these mechanisms. Therefore, an introduction into the 
development, structure, and molecular mechanisms of SkM adaptation (i.e. muscle mass and 
function) are described in the introduction of this thesis. However, common methods and 
techniques used for investigating the mechanisms of mechanical loading in-vivo and in-vitro 
are described in the introduction section of chapter 3. Furthermore, the continually evolving 
field of SkM epigenetics and bioengineering will be introduced with a specific focus on DNA 
methylation and the techniques and biomaterials frequently used within SkM bioengineering 
research. 
 
1.1!Skeletal Muscle Embryonic Development 
Since the 1960’s, scientists have attempted to unravel the molecular mechanisms underpinning 
embryonic skeletal muscle (SkM) development to complete formation and regeneration of 
adult muscle (termed myogenesis) with the aim of improving treatment strategies for muscular 
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disorders (both neuromuscular and musculoskeletal disorders characterised by disease of the 
motor neurons and muscle membrane or supporting proteins, affecting muscle regeneration) or 
myopathies (i.e. muscle diseases which directly affect the muscle fibre/contractile apparatus, 
resulting in muscle weakness; Cardamone et al., 2008; Chal & Pourquié, 2017).  
 
Within the embryo of vertebrates, SkM arises from the paraxial mesoderm which separates into 
somites on either side of the neural tube and notochord (Buckingham et al., 2003). Somites are 
further divided into the epaxial and hypaxial dermomyotome which gives rise to the 
musculature of the back and limbs, respectively. Myogenesis within the embryo is regulated 
via a number of key growth and transcription factors (see Figure 1.1). Specifically, 
delamination and migration of myogenic precursor cells (MPCs) from the dermomyotome are 
determined by the expression of the paired box transcription factor, Pax3 and tyrosine kinase 
receptor, c-Met, where genetic deletion of both of these genes in mice prevents delamination 
of cells and subsequent formation of limb musculature (Bladt et al., 1995; Tajbakhsh et al., 
1997). Once cells migrate to the limb bud, expression of the basic helix-loop-helix (bHLH) 
transcription factors, Myf5 and MyoD are upregulated to direct the myogenic lineage whereas 
myogenic regulatory factors (MRFs), myogenin and MRF4, alongside Mef2 determine 
terminal differentiation of myoblasts to myocytes (Buckingham et al., 2003; see Figure 1.1).     
 4 
 
 
 
 
 
 
(NT = neural tube; NC = notochord;  SE = surface ectoderm). Taken from Buckingham et al., 
(2003). 
 
After the transition of myoblasts to myocytes, primary myofibres/myotubes are then formed 
from Pax3+ cells at around embryonic day (E) 10.5-12.5 which express various myosin proteins 
(slow MHC and MLC1; Chal and Pourquié, 2017). The primary fibres act as a scaffold for the 
production of secondary myofibres which occurs at around E14.5-17.5 and is influenced via 
innervation/neural input of the fibres. Here, Pax7+ cells fuse to the primary fibres and begin to 
express fast MHC isoforms (Van Horn & Crow, 1989). A number of these Pax7 expressing 
cells form the population of resident stem cells (termed satellite cells) which are critical for 
postnatal growth and regeneration (see section 1.3).  
Figure 1.1. Embryonic SkM development 
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1.2!Postnatal Growth and Regeneration  
1.2.1! The Roles of Satellite Cells in Skeletal Muscle Growth, Repair and 
Regeneration 
SkM fibres contain large quantities of myonuclei, ranging between 44 and 116 myonuclei/mm 
of muscle fibre (Tseng et al., 1994). Interestingly, myofibre number is predetermined during 
gestation and therefore, hyperplasia (new fibre formation) is not thought to increase postnatally 
under physiological conditions (i.e. after exercise). Furthermore, myofibres are terminally 
differentiated as the myonuclei once incorporated into the fibre can no longer undergo mitosis. 
Therefore, maintenance and regeneration of adult muscle is dependent on muscle-specific stem 
cells, termed satellite cells which contribute to approximately ~2.5-6% of total nuclei (Zammit 
et al., 2002). These resident muscle stem cells were first identified under electron microscopy 
in frog tibialis anticus muscle and were coined ‘satellite cells’ based on their peripheral 
location, as they resided between the plasma membrane and basal lamina of the muscle fibre 
(Mauro, 1961). Since this discovery, a plethora of research has attempted to demonstrate the 
importance of satellite cells during postnatal growth and regeneration and to unravel the 
mechanisms which govern these fundamental biological processes.  
 
Despite early research suggesting that muscle regeneration may primarily be attributable to the 
presence of bone marrow-derived mesenchymal stem cells in mice SkM (Ferrari et al., 1998), 
others have shown this was not the case (Sherwood et al. 2004) and that satellite cells are 
indeed the major contributors towards the regeneration of injured SkM (Collins et al., 2005). 
Indeed, Collins and colleagues demonstrated that transplantation of single myofibres (derived 
from TA, EDL and soleus rodent muscles) containing just ~7 satellite cells regenerated >100 
myofibres in injured mouse muscle (Collins et al., 2005). In response to muscle injury, satellite 
cells undergo a series of events which underpin the repair and regeneration process. Indeed, 
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upon damage, satellite cells are first activated (termed myoblasts) where they then migrate to 
the site of injury in order to differentiate and fuse to the damaged portion of the existing muscle 
fibre (Schiaffino, Pierobon Bormioli and Aloisi, 1972, 1976; see Figure 1.2A). Furthermore, a 
subset of these activated satellite cells return to the fibre and quiesce in a process called self-
renewal. This then maintains the satellite cell pool ready for future incorporation in response 
to muscle damage or for routine turnover of myonuclei. The activation of satellite cells is 
governed by the activity of key myogenic regulatory factors (MRF), Myf5 and MyoD 
(Tajbakhsh et al., 1996) whereas migration and differentiation of satellite cells is dependent on 
the MRFs, Myogenin and Myf6 (otherwise known as Mrf4; Brack and Rando, 2012; see Figure 
1.2B). Upon activation, satellite cells undergo asymmetric division whereby cells adopt distinct 
fates to enable simultaneous activation, proliferation and differentiation of myoblasts or they 
undertake the self-renewal program (Zammit et al., 2004). Assymetric cell division has been 
shown to be regulated via signaling of the P38 mitogen-activated protein kinase (MAPK) 
pathway (Troy et al., 2012). Cells committing to differentiation have been shown to coexpress 
Pax7 and MyoD whereas those returning to quiescence to enable self-renewal demonstrate 
downregulation of MyoD. Albeit, Pax7 is still upregulated (Zammit et al., 2004).  
 
The role of satellite cells for inducing SkM muscle hypertrophy in response to mechanical 
loading has however been debated. Work by Rosenblatt and Parry first demonstrated that 
mechanical/functional overload-induced hypertrophy was completely ablated when satellite 
cells of the mouse EDL were lost after exposure to γ-irradiation (Rosenblatt & Parry, 1992). 
Despite the effects of γ-irradiation in blocking DNA synthesis, this technique lacks cellular 
specificity and therefore the reduced hypertrophic response cannot necessarily be extrapolated 
to the loss of just satellite cells. Others therefore used a Pax7- depleted mouse model treated 
with tamoxifen to investigate whether satellite cells are indeed key players for inducing SkM 
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hypertrophy (Mccarthy et al., 2011; Fry et al., 2014; Egner et al., 2016). Interestingly, 
mechanical overload of the plantaris mouse muscle induced a similar hypertrophic response 
(~2-fold) in Pax7- versus wild-type mice (Mccarthy et al., 2011) whilst others failed to 
recapitulate such findings using a similar model as hypertrophy was blunted in Pax7- null mice 
(Egner et al., 2016). Conversely however, the same group later demonstrated that the 
hypertrophic response to mechanical overload could not be maintained after 8 weeks of loading 
whereby muscle growth was blunted in Pax7- mice (Fry et al., 2014). Taken together, research 
to date therefore suggests that satellite cells may not be the key determinant of initial muscle 
growth following mechanical loading/RE, albeit may be integral for maintenance of SkM 
growth and muscle regeneration.  
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Schematic representation of the cascade of events underpinning SkM repair and regeneration 
via the regulation of satellite cells. Taken from Hawke and Garry (2001). 
 
A 
B 
Figure 1.2. SkM repair and regeneration 
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1.3!Skeletal Muscle Structure 
1.3.1! Gross Structure of Skeletal Muscle 
Skeletal muscle (SkM) is the most abundant tissue in the human body with >600 muscles  
making up approximately ~30-40% of total body mass, depending on gender status, with males 
typically possessing larger quantities (Janssen et al., 2000). Typically, SkM is composed of 
~70% water (700 ml/kg SkM) and ~30% solids (300 g/kg SkM), the majority of which is 
protein (~70%; Wackerhage, 2014). The most abundant proteins in SkM are the key 
myofibrillar contractile proteins, the 480 kDa thick myosin (~20-40%) and 42 kDa thin actin 
(~15%) filaments (Carroll et al., 2004). Given SkM is fundamental for movement, 
thermoregulation, posture, metabolism and is the major site for glucose utilisation and disposal 
(~80%; Egan and Zierath, 2012), its detailed structure and function is of paramount importance 
for improvements and maintenance of musculoskeletal health and performance.  
 
SkM connects to bone via connective tissue such as tendons which attaches to either end of the 
muscle, termed the myotendinous junction (MTJ). SkM itself is also surrounded by sheets of 
connective tissue, namely (from the outer to inner layers) the epimysium, perimysium and 
endomysium. The epimysium encloses the entire SkM tissue, whereas the perimysium 
encompasses fascicles which contain bundles of several (~10-100) myofibres (MacLaren and 
Morton, 2011; see Figure 1.3). Finally, the endomysium separates individual myofibres which 
can be ~10-120 µm in diameter and ~20 cm (specifically for the large sartorius muscle; Heron 
and Richmond, 1993). The myofibres comprise the protein dense myofibrils/sarcomeres which 
contain the myosin thick and actin thin filaments, the essential units for muscle contraction 
(see section 1.3.2).   
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Schematic representation of the gross anatomical structure of SkM. Taken from MacLaren and 
Morton (2011). 
 
Figure 1.3. SkM gross anatomical structure 
 11 
1.3.2! Ultra-Structure of Skeletal Muscle 
The myofibrils run adjacent to the entire length of the muscle cells which contain ~2000 
myofibrils per myofibre, depending of the specific muscle (Jones et al., 2004). Importantly, 
the myofibrils contain the contractile proteins, thick myosin and actin, which gives rise to the 
striation appearance of the myofibre (Huxley, 1953). As visualised in Figure 1.4, the 
sarcomeres containing the myosin and actin filaments are precisely organised. Indeed, the light 
isotropic (I) band highlights the area where only actin thin filaments are present. However, the 
dark anisotropic (A) band contains areas where only myosin is present (also known as the H-
zone) or where there is an overlap of actin and myosin filaments (which demonstrates the 
darkest area of the sarcomere; Huxley, 1953; Jones, Round and de Haan, 2004). The H-zone is 
further dissected by the M-line which attaches the thick myosin filaments via the key 
myomesin/myomesin-2  (MacLaren & Morton, 2011). Finally, each sarcomere is separated by 
the Z-disc/line which comprises the essential structural cytoskeleton proteins nebulin, α-actin 
and desmin, and also stabilises myosin filaments via the largest muscle protein, titin which has 
a protein size of ~3700 kDa (Krüger and Linke, 2011; see Figure 1.4).  
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Schematic representation of the sarcomere. Below represents cross-sections of the sarcomere 
containing only actin filaments (left), myosin filaments (middle) and overlap of actin and 
myosin (right). (A = anisotropic/dark band; I = isotropic/light band; H = H-zone; M = M-line; 
Z = Z-disc/line). Taken from Jones, Round and de Haan (2004). 
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Figure 1.4. SkM sarcomere structure  
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1.4! Skeletal Muscle Function 
1.4.1! Skeletal Muscle Contraction  
As described is section 1.3.1 and 1.3.2, it is the well-organised structure of the myosin and 
actin filaments embedded within the myofibril which gives rise to the precise structure of the 
sarcomeres and orchestrate muscular contraction to initiate movement and subsequent force 
production. In order for muscle to contract, a series of events take place. Firstly, a neural signal 
(known as a nerve impulse) is generated from the central nervous system (CNS) which is 
sensed by the muscle via the neuromuscular junction (NMJ). It is here where the 
neurotransmitter acetylcholine (ACh) is released from the neural axons and is received by the 
ACh receptors located on the motor end plate on muscle which ultimately act as voltage-gate 
ion channels to permit influx and efflux of sodium and potassium, respectively (MacLaren & 
Morton, 2011). This results in an overall positive charge and thus depolarizes the plasma 
membrane which triggers the action potential along the transvers tubule (T-tubules) channels 
which initiates excitation-contraction coupling. Once the action potential is sensed by the 
myofibre, Ca2+ is released from the sarcoplasmic reticulum (SR) into the sarcoplasm which 
binds to troponin C on the actin filaments and directs the troponin-tropomycin complex to 
expose the binding sites for the myosin heads to attach, enabling the sarcomere to undergo the 
‘sliding filament mechanism’. This mechanism is underpinned via ATP hydrolysis where the 
products (ATD and Pi) remain bound to myosin heads. Crossbridges are then formed via the 
attachment of myosin to the actin bindings sites, after which Pi is released to enable tilting and 
rotation of the myosin heads which leads to a ‘pulling’ motion, inducing muscular contraction 
and subsequent force production. During muscle contraction, the I band length of the sarcomere 
shortens whilst the A band does not change (MacLaren & Morton, 2011). After completion of 
muscle contraction, there is a reuptake of Ca2+ ions into the SR which is regulated via the 
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activity of the SR Ca2+ ATPase (SERCA), preparing the muscle for future contraction 
(Periasamy and Kalyanasundaram, 2007). 
 
Schematic representation of the cascade of events underpinning SkM contraction. Taken from 
Tortora and Derrickson (2012). 
 
1.5! Key Regulatory Signaling Pathways Associated with Skeletal Muscle Hypertrophy 
and Atrophy  
1.5.1! Positive Regulators of Skeletal Muscle Mass 
The regulation of SkM mass is orchestrated via the synthesis and breakdown of muscle protein 
whereby muscle size increases when protein synthesis (MPS) exceeds protein breakdown rates 
(MPB), and represents a ‘positive’ net protein balance. Conversely, muscle mass is 
compromised when the net protein balance is ‘negative’, represented by greater protein 
breakdown versus protein synthesis rates. Such events are controlled by a number of well-
Figure 1.5. SkM contraction 
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characterised regulatory transcripts/proteins that interact with each other within specific 
cellular and molecular pathways. The most notable positive regulator of MPS/ribosome 
biogenesis (increased cellular capacity to undergo protein translation) and subsequent muscle 
mass is the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway (see 
Figure 1.6). It is important to note however that mTOR is difficult to directly measure given 
its large protein size. Previous researchers have therefore studied the activity of mTOR via 
measuring the activity of upstream regulators, Akt/PKB, and downstream effectors, p70S6K 
and 4E-BP1 (Baar & Esser, 1999; Baar et al., 2000; Bodine et al., 2001b; Drummond et al., 
2009). The first study to demonstrate the importance of mTOR for inducing SkM hypertrophy 
following RE subjected rodent plantar- and dorsiflexor muscles to high frequency (100 Hz) 
chronic electrical stimulation consisting of 10 sets × 6 reps (3 s contractions per rep, each rep 
interspersed with 10 s rest and each set separated by 50 s rest) for 2 days/week for 6 × weeks 
(Baar & Esser, 1999). Interestingly, increased p70S6K phosphorylation (a key downstream 
target of mTOR) was highly positively correlated (r > 0.99) with the ~14% increase in muscle 
mass post exercise (Baar & Esser, 1999). Soon after, the same group demonstrated that acute 
mechanical loading (6 cycles of 12% within 20 s, repeated 10 times with a 50 s rest between 
cycles) of C2C12 myotubes also demonstrated significant increases in phosphorylation of the 
protein translation initiator, p70S6K just 3 hrs post-loading (Baar et al., 2000). To further test 
the assumption as to whether mTOR signaling was indeed key for SkM 
anabolism/hypertrophy, researchers administered rapamycin (a known inhibitor of mTOR, 
hence its chosen name ‘target of rapamycin’; Davies et al. 2000) prior to functional 
overload/synergistic ablation in rodents (Bodine et al., 2001b) and acute RE in humans 
(Drummond et al., 2009) which induced a blunted hypertrophic and protein synthetic response 
in both rodent and human SkM, respectively. To confirm the role of mTOR in load-induced 
SkM hypertrophy, Goodman and Hornberger’s group later showed that administration of 
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rapamycin in mTOR-null mice (i.e. rapamycin-insensitive mice) did not prevent muscle 
hypertrophy (~40% increase in muscle size in 14 days) following functional 
overload/synergistic ablation and that rapamycin only ablated the hypertrophic response in 
wild-type mice that were sensitive to rapamycin-induced inhibition of mTOR (Goodman et al., 
2011). Taken together, the aforementioned studies clearly demonstrate that mTOR is somewhat 
sensitive to mechanical loading/RE and is considered the key positive regulator of SkM 
anabolism and hypertrophy (Philp et al., 2011). Another controversial mechanism which may 
be critical for hypertrophy (together with repair and regeneration of SkM) is the regulation of 
the key muscle-specific satellite cells. However, this topic is discussed in more details in 
section 1.2 above.  
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Schematic representation of the regulatory mTORC1 signaling pathway, a well-characterised 
regulator of SkM mass. Taken from Wackerhage (2014). 
 
1.5.2! Negative Regulators of Skeletal Muscle Mass 
The key proposed mechanism which negatively regulates SkM mass is the myostatin/Smad 
signaling pathway (see Figure 1.7). Indeed, early work first demonstrated that cattle possessing 
a mutation of the myostatin (also referred to as growth differentiation factor-8, GDF-8) gene 
displayed a ‘doubling’ in SkM hypertrophy (McPherron & Lee, 1997) which was further 
exaggerated in myostatin mutant mice overexpressing the Follistatin related gene (FLRG – a 
known inhibitor of myostatin), resulting in a substantial ‘quadrupling’ increase in muscle size 
(Lee, 2007). Furthermore, others determined myostatin-specific downstream signaling in ski 
(a transcriptional repressor) transgenic mice, demonstrating that a reduction in Smad can also 
permit muscle growth by ~3-fold (Sutrave et al., 1990). Despite the supraphysiological 
increases in muscle size observed following knockdown of myostatin/Smad, additional 
research reported compromised muscle quality, evidenced by a reduction in specific force 
(muscle force relative to muscle size or force/cross sectional area of muscle), regardless of 
increases in absolute force (Mendias et al., 2006). In-vitro experiments also demonstrated that 
myostatin administration (which increased Smad 2/3 activity) reduced mTOR/p70S6K 
signaling (see section 1.5.1) and myotube size in human muscle derived cells (Trendelenburg 
et al., 2009). Moreover, myostatin has been shown to be associated with FOXO signaling as 
suppression of the muscle-specific E3 ligase, MAFbx also resulted in reduced myostatin 
expression which ultimately enhanced cell differentiation and MyoD expression (Cong et al., 
2011). Interestingly, MAFbx (muscle atrophy F-box; FBXO32), together with MuRF-1 
(muscle RING finger 1; Trim63) are well-characterised muscle-specific E3 ubiquitin ligases 
Figure 1.6. mTORC1 signaling pathway 
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that are critical for the degradation of SkM proteins (Bodine et al., 2001a; Bodine & Baehr, 
2014). Therefore, their mechanistic roles and target proteins for degradation are discussed 
throughout subsequent chapters of this thesis (see Chapter 3, 5 and 6). Taken together, 
myostatin/Smad signaling and the activity of the muscle-specific ‘atro-genes’, MuRF1 and 
MAFbx are considered key regulators of SkM atrophy.  
 
Schematic representation of the regulatory myostatin/Smad signaling pathway which is 
proposed as a negative regulator of SkM mass. Taken from Wackerhage (2014). 
 
1.6! Epigenetics in Skeletal Muscle 
1.6.1! Chromatin, Histones and DNA  
The term ‘epigenetics’ (the Greek prefix ‘epi’ represents ‘above’ or ‘after’, gene/genetics) was 
first coined in 1942 by the embryologist, Conrad Waddington whom defined this area of 
Figure 1.7. Myostatin/Smad signaling pathway 
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research as the ‘whole complex of developmental processes’ which bridges the gap between 
the ‘genotype and phenotype’ (Waddington, 1942; Deichmann, 2016). Since the 1940’s 
however,  the drastic increase in epigenetics research (specifically from the year 2000) has 
evolved our current understanding of this topic which has led to its’ redefinition of heritable 
changes in gene activity that are not a consequence of changes in the DNA sequence (Haig, 
2012; Deichmann, 2016). Epigenetics involves the chemical regulation of histone, chromatin 
and DNA macromolecules which are located within the nucleus of eukaryotic cells. For this 
reason, a brief introduction into their structure is first described before focusing on the key 
epigenetic modifications that modulate these macromolecules. 
 
The nucleus within eukaryotic cells comprises the 23 pairs of chromosomes of which contain 
all of the genetic hereditary material (or the molecular blueprint) of each living cell. Each 
chromosome is made up of chromatin fibres which contain nucleosomes. The nucleosomes are 
small structures (~ 1 nm in diameter) which are commonly referred to as ‘beads on a string’ 
given their appearance (see Figure 1.8) as the DNA is wrapped around the core histone proteins 
which essentially act as scaffolds to enable condense packaging of the DNA molecules (see 
Figure 1.8). Within the nucleosomes, histone tails containing amino acid sequences extend 
from the central histone proteins which are prone to a number of post-translational 
modifications such as methylation (also referred to as ‘hyper’-methylation), demethylation 
(also referred to as ‘hypo’-methylation), acetylation (addition of a acetyl group), deacetylation 
(removal of an acetyl group) and phosphorylation (Ramakrishnan, 1997; Widmann et al., 
2019). Importantly however, histone modifications are determined via the chromatin state 
whereby condensed/closed (also termed heterochromatin) or decondensed/open chromatin 
(also termed euchromatin) prevents or enables such modifications and gene transcription to 
occur (Bannister & Kouzarides, 2011; Allis & Jenuwein, 2016). 
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Schematic representation of chromatin and nucleosomes extending from the chromosome. 
Taken from González-Pardo and Marino (2013). 
 
1.6.2! DNA Methylation  
As described in section 1.6.1, histone proteins within the nucleosomes may be subject to 
various modifications that are dependent on whether the chromatin structures are loosely (i.e. 
euchromatin state enabling gene transcription) or tightly (i.e. heterochromatin state suppressing 
gene transcription) condensed. At the DNA level however, epigenetic modifications are 
predominantly induced by the biochemical process, DNA methylation. DNA methylation (also 
known as hypermethylation) occurs when a covalent methyl chemical group attaches to the 5th 
Figure 1.8. Chomatin, histones and DNA structure 
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position of a cytosine nucleotide located within cytosine-phosphate-guanidine (CpG) base 
pairing sites which forms 5-mythlcytosine (5-mC; see Figure 1.9). CpG sites are abundant 
within most regulatory gene promoters, referred to as CpG islands (Sharples and Seaborne, 
2019; see Figure 1.9). DNA methylation within the promoter or enhancer regions of genes is 
capable of changing mRNA expression via two key distinct mechanisms. One mechanism 
involves the recruitment of CpG methyl binding proteins (MBD) when cytosine is methylated 
(hypermethylation) which inhibits binding of RNA polymerase, preventing gene transcription 
from occurring (Bogdanović & Veenstra, 2009). Additionally, recruitment of chromatin 
remodelling proteins, MecP-1/2, exhibits tightening of chromatin/hereochromatin which also 
prevents gene transcription (Jones et al., 1998). Taken together, increased CpG DNA 
methylation, particularly wihin the promoter region of a gene is associated with a reduction in 
mRNA expression whereas demethylation (or hypomethylation) may permit gene 
transcriptional activity, therefore increasing gene expression. It is important to highlight the 
mechnisms by which DNA methylation is controlled which is nicely presented in recent work 
by our group (Sharples and Seaborne, 2019; see Figure 1.9). Increased/hypermethylation is 
accomplished via the enzymatic activity of the DNA methyltransferases (DNMT), DNMT-1, -
3a and -3b. Specifically, DNMT1 is important for the maintenance of DNA methylation that 
may be retained during DNA replication whereas DNMT3a and 3b are responsible for de novo 
methylation, or the addition of ‘new’ methyl groups to cytosine residues which is achieved 
when a methyl group is cleaved from s-adenosyl methionine (SAM), producing 5mC and s-
adenosyl homocysteine (SAH; Trasler et al., 2003, Sharples and Seaborne, 2019; see Figure 
1.9). Alternatively, demethylation/hypomethylation is catalysed by the ten-eleven translocation 
(TET) enzymes via oxidation of 5mC to 5-hydroxy-methyl-cytoseine (5hmC; Delatte, Deplus 
and Fuks, 2014), or as a consequence of insufficient DNMT1 activity where methylation is 
passively lost during DNA replication (Sharples and Seaborne, 2019, Ito et al., 2010; see Figure 
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1.9). Collectively, the present section demonstrates that DNA methylation is tightly regulated 
via the activity of key enzymes, DNMTs and TETs, which determines whether methylation is 
increased (hypermethylation) or decreased (hypomethylation) ultimately affecting subsequent 
gene transcription. The following section will focus on the role of DNA methylation in SkM 
following exercise with a particular emphasis on the responses to mechanical loading/RE. 
 
 
Schematic representation of the enzymatic reactions assocated with increased 
(hypermethylation) or decreased (hypomethylation) DNA methyaltion. (CpG = cystosine-
phophate-guanine; TET = ten-eleven translocases; DNMT = DNA methyltransferases). Taken 
from Sharples and Seaborne (2019).
Figure 1.9. Mechanisms of DNA methylation 
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1.6.3! DNA Methylation and Exercise  
Despite decades of research demonstrating the transcriptional regulatory roles in SkM 
adaptation following mechanical loading/RE (as described in chapters 3, 4 and 5 of this thesis 
; Goldberg & Goodman, 1969; Goldberg et al., 1975; Egan & Zierath, 2012), the importance 
of epigenetics, specifically DNA methylation has only more recently begun to emerge. Indeed, 
it was not until 2014 that researchers first showed that RE could indeed modulate the human 
DNA methylome. In this study, Rowlands and colleagues subjected middle-aged (49 ± 5 yrs) 
type II diabetic male and female humans to chronic RE (6-8 reps × 2-3 sets × 8 full body 
exercise, 3 days/week for 16 weeks) and demonstrated differential DNA methylation across 
450K CpG sites at post- versus pre-exercise (Rowlands et al., 2014). Interestingly, the authors 
reported more genes being hypomethylated versus hypermethylated, and that these differences 
were in genes associated with ‘cellular assembly and organization, cellular development, tissue 
morphology, and cardiovascular system development and function’ following pathway 
enrichment analysis (Rowlands et al., 2014). It is also worth noting that the same study also 
demonstrated a global reduction in DNA methylation at post- versus pre-chronic endurance 
cycling exercise (40–60 min steady-state cycling exercise at 65%–85% of heart rate max, 3 
days/week for 16 weeks) with pathway enrichment analysis suggesting that genes were 
associated with ‘lipid/carbohydrate metabolism, metabolic disease, cell death and survival, 
cardiovascular system development/function, and haematological system 
development/function’ (Rowlands et al., 2014). This study therefore demonstrated for the first 
time that DNA methylation is regulated by mechanical loading/RE in-vivo which was 
influenced by the mode of exercise performed, evidenced by the different enriched pathways 
in RE vs. endurance exercise. Two years after, an Italian group of researchers reported a 
significant reduction in leukocyte-specific global DNA methylation following 12 weeks of 
chronic progressive RE (3 days/week, 10-12 reps × 3-4 sets at 70% 1RM which was assessed 
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via leg extension testing every 2 weeks) in male and female elderly humans (Dimauro et al., 
2016). Shortly after, DNA methylation in leukocytes was further investigated using genome-
wide array technology (450K CpG sites) to permit gene-specific methylation analysis 
following 8 weeks of chronic RE (3 days/week, 10-12 reps × 3-4 sets at 80% 1RM ensuring 3 
s contractions) in humans (Denham et al., 2016). In support of previous findings, RE also 
evoked hypomethylation of genes which were associated with ‘cancer, axon guidance, 
diabetes’. Interestingly, a number of anabolic signaling-related genes were also 
hypomethylated including insulin-like growth factor I receptor (IGF-IR), growth hormone-
releasing hormone (GHRH) and fibroblast growth factor 1 (FGF1), with the latter two genes 
also displaying corresponding increases in mRNA expression, further supporting the notion 
that epigenetic modifications are associated with changes in gene expression (Denham et al., 
2016). A year on, Robinson and colleagues analysed DNA methylation (450K array) profiles 
in young and old human SkM tissue following 12 weeks of either chronic RE, high-intensity 
interval training (HIIT) exercise or combined/concurrent exercise (Robinson et al., 2017). 
Interestingly, DNA methylation did not significantly change (<10%), regardless of exercise 
type or age group (Robinson et al., 2017). It is important to note however that only gene 
promoter DNA methylation was reported. Conversely, a study published within the same year 
demonstrated that RE was able to negate increased genome-wide hypermethylation induced by 
short term high fat feeding (consisting of >77% of total calorie intake) following bisulfite 
sequencing analysis (Laker et al., 2017). Using more recent genome-wide technology that 
permits greater CpG methylation coverage (850K CpG sites), work by our group also reported 
significant total and gene-specific DNA hypomethylation in response to acute and 7 weeks of 
chronic RE  (Seaborne et al., 2018a, 2018b). Interestingly, a large number of these 
hypomethylated genes also demonstrated corresponding changes in mRNA expression 
whereby hypomethylation determined by genome wide analysis, with follow up analysis of 
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candidate genes at the gene expression level following chronic exercise, were associated with 
increases in mRNA expression. For some genes, hypomethylation was retained during 7 weeks 
of detraining/unloading where muscle mass returned to baseline/pre-exercise levels of which 
further decreased following 7 week of retraining (where the greatest increase in muscle mass 
occurred) which also corresponded with the greatest increase in mRNA expression (Seaborne 
et al., 2018a). Suggestive of an ‘epigenetic memory’ (Sharples et al., 2016b) at the DNA level 
since earlier exercise encounters resulted in an retained response during future RE. Another 
subset of genes in this study also demonstrated an inverse relationship between mRNA 
expression and DNA methylation whereby expression and methylation increased and 
decreased, respectively after chronic RE. Following detraining however, both gene expression 
and DNA methylation returned back to baseline levels after which the increased mRNA and 
decreased methylation was enhanced after reloading, further supporting the notion that DNA 
methylation may indeed regulate gene expression in response to exercise. Specific details of 
these regulated gene such as names and their gene expression profiles are reported within 
chapter 5 of this thesis where the transcriptional and epigenetic regulation of these genes are 
also assessed following acute and chronic loading/RE in in bioengineered/rodent SkM. 
Although Seaborne et al., (2018) also assessed the genome-wide epigenetic responses to acute 
RE, there is still limited research that have studied the effects on DNA methylation after acute 
exercise/loading. Indeed, Zierath’s group demonstrated that acute endurance exercise (cycling 
exercise at 40 or 80% VO2peak until 1,674 KJ) in humans induced promoter associated 
hypomethylation of key metabolic genes, PPAR-δ, PGC1-α and PDK4, all of which also 
displayed increased mRNA expression (Barrès et al., 2012). It is also important to note 
however that altered DNA methylation of these genes only occurred after performing high 
intensity exercise (80% VO2peak) and that exercise-induced alterations in DNA methylation 
may therefore be load/intensity dependent. 
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1.7! Introduction to Monolayer Cell Culture Models 
In-vitro SkM monolayer culture experiments has provided considerable insights into the 
cellular and molecular mechanisms underpinning many important biological processes in SkM. 
These experiments entail extraction of SkM cells from muscle biopsies using a number of 
techniques such as explant culture (Martin et al., 2013), enzymatic digestion (Danoviz & 
Yablonka-Reuveni, 2012) or a combination of both methods (Owens et al., 2015; Turner et al., 
2019a). Alternatively, cells can be isolated from entire rodent muscle tissue which provides 
high cell yield or immortalised cells derived from humans (Mamchaoui et al., 2011) and 
rodents (Yaffe & Saxel, 1977; Blau et al., 1985) are considered useful for in-vitro experiments 
given their ability to infinitely grow without the risk of senescence as with primary cells. 
Furthermore, immortalized cells such as the commonly used C2C12 cell line have superior 
differentiation capacity and are 100% myogenic, suggestive that results derived from 
experiments using these cells are not influenced by changes in other cell sources present in 
muscle tissue (i.e. fibroblasts and small proportion of mesenchymal stem cells; Machida, 
Spangenburg and Booth, 2004). Once cells are readily available, they are grown in high serum 
growth media to ensure they are maintained within the cell cycle until they reach a desired 
confluent state (typically ~60-80%) upon which they are switched to low serum medium to 
enable cells to exit the cell cycle and differentiate into mature multinucleated myotubes (see 
Figure 1.10). These stages of culture essentially resemble the processes of SkM embryonic 
development (see section 1.1) and postnatal growth/regeneration in-vivo (see section 1.2). 
Traditionally however, SkM cells are cultured on rigid polystyrene plastic surfaces (~106 kPa) 
which does not recapitulate the stiffness or elasticity of native SkM (~12 kPa), ultimately 
affecting myotube maturation as cells being to detach after contraction (Engler et al., 2004; 
Gilbert et al., 2010; Chiron et al., 2012). There is also a lack of tension applied to the cells 
culture in monolayer which leads to the random, dysmorphic formation of myotubes that are 
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not aligned in parallel as is observed in-vivo (Eastwood et al., 1998; Smith et al., 2012; see 
Figure 1.10). To overcome these issues, a number of research groups have developed  
engineered SkM which entails culturing muscle cells within a surrounding representative 
extracellular matrix that is under tension (ECM, described in section 1.8).  
 
(A) Light and (B) fluorescent microscopic images (10×, actin-green) of C2C12 SkM cells 
cultured in monolayer and the resulting swirling myotube formations that occur when no 
tension is applied to cells (scale bar 100 µm;  unpublished images taken from our lab). (C) 
Macroscopic and (D) microscopic images of self-assembled fibrin bioengineered SkM (C2C12) 
displaying aligned myotube formation due to applied tension of the pinned silk sutures (scale 
bar 50 µm). Fluorescent staining for actin (green) and nuclei (blue). Figures taken from 
(Seaborne et al., 2019; Turner et al., 2019a). (E) Microscopic and (F) macroscopic 
representation of type I collagen C2C12 bioengineered SkM (scale bar 10 µm) taken from Player 
et al., (2014), displaying myotube formation (red desmin, blue nuclei) due to unilateral tension 
applied by the A-frames (scale bar 20 µm). (G) Fluorescently stained muscle fibres from in-
C 
D 
C 
D 
Figure 1.10. Myotube morphology in monolayer versus bioengineered SkM models 
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vivo tissue (Figure originally from Smith et al., 2012) suggesting that bioengineered muscle 
morphologically mimics native SkM tissue (scale bar 20 µm) versus monolayer. Figure adapted 
from (Kasper et al., 2018).  
 
1.8! Introduction to Skeletal Muscle Bioengineering 
Since initial pioneering work in the 1980’s (Vandenburgh et al., 1988; Vandenburgh & 
Karlisch, 1989) there has been incremental improvements in the development of bioengineered 
SkM for drug screening (Vandenburgh et al., 2008) or studying muscle physiology in response 
to exercise (Khodabukus et al., 2007, 2018b). However, there are a number of factors which 
influence the structure and function of these engineered muscles, including cell source (i.e. cell 
line, primary human/animal cells), media components (i.e. serum, protein crosslinkers, 
proteolytic inhibitors, antibiotics, nutrients), model (scaffold versus scaffold-free), ECM 
(synthetic versus biological) and the type of external stimulation applied to the resultant 
engineered muscle (i.e. electrical stimulation or mechanical loading). All of which are 
reviewed in Khodabukus and Baar, (2016). The following section however will briefly outline 
the most common biological ECM proteins used for the fabrication of bioengineered SkM 
whereas the influence of mechanical loading on these engineered tissues will be reviewed in 
chapter 3 of this thesis, as it is directly relevant to the experimental work conducted in this 
chapter.   
1.8.1! Collagen 
Collagen, is most abundant ECM protein in SkM, contributing to approximately 1-10% of dry 
muscle mass (Gillies & Lieber, 2011). Collagen type 1 makes up the majority of this and is 
therefore extensively used in tissue engineering research. The first studies to engineer animal 
(Vandenburgh et al., 1988) and human (Powell et al., 2002) SkM tissue embedded cells within 
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a type 1 collagen matrix which enabled long term culture (~2-3 weeks), resulting in mature 
myotubes that were highly aligned in parallel between the points of tension. Producing 
engineered collagen engineered muscle typically involves mixing large quantities of cells in 
type 1 collagen derived from the rat tail to polymerise whereby cells are then differentiated 
into aligned mature myotubes over a given period (typically ~2 weeks) as seen in figure 1.10 
(Cheema et al., 2005; Mudera et al., 2010; Player et al., 2014). The large number of cells 
required to produce mature collagen constructs imposes several issues including throughput, 
particularly if using human cells (~20-40 million cells per construct; Mudera et al., 2010) 
which are usually limited. However, recent work by the same group has further optimised this 
system to enable the production of collagen bioengineered muscle using much lower seeding 
densities using rat (~5 × 106; Torii et al. 2018) cells or C2C12 and HMDCs which ranged from 
104 – 2 × 106 cells/construct (Aguilar-Agon et al., 2019; Capel et al., 2019). It is important to 
note however that maturation and the quantity of material (i.e. protein) is compromised in the 
lower density constructs, evidenced by reduced myotube length, width and number and the 
need to use larger gel volumes for immunoblotting analysis, suggestive that collagen muscle 
may still therefore require the need for large quantities of cells. Despite this, there has been 
considerable progress continuously improving this model and is therefore still one of the most 
employed models in SkM bioengineering research. 
1.8.2! Laminin 
Laminin is the major non-collagenous protein within the basement membrane/basal lamina and 
is a critical cell adhesion molecule which connects the cytoskeleton to the ECM via the 
dystrophin-dystroglycan complex (Lewis et al., 2001). Use of laminin is therefore deemed 
appropriate for use in monolayer culture and bioengineered SkM experiments. Indeed culturing 
rat SkM cells on laminin coated plates demonstrated superior cell attachment, proliferation and 
myotube maturation compared to cells cultured on collagen-coated plates (Foster et al., 1987). 
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In laminin bioengineered muscle, primary rodent SkM cells were subjected to electrical 
stimulation which resulted in specific forces of ~4.2 kN/mm2 (Dennis et al., 2001) compared 
to ∼200 kN/m2 in adult rodent SkM in-vivo (Close, 1972), suggestive that the lack of force 
production does not particularly render laminin muscle a functional engineered SkM model. 
Interestingly however, others have shown that culturing HMDCs in laminin hydrogels enabled 
the production of engineered muscle with similar stiffness to native muscle (~12 kPa) that 
could be transplanted into hindlimb of mice which improved muscle regeneration in-vivo 
(Gilbert et al., 2010). Although force was not measured in this study, the low force production 
in earlier work by Dennis et al., (2001) may be a consequence of the model employed (self-
assembled laminin muscle). 
1.8.3! Fibrin 
In conjunction with collagen and laminin, the naturally occurring polymer fibrin is also 
extensively within the literature of SkM tissue engineering research. Fibrin is a developmental 
matrix, important for the blood clotting after following wound injury and has proven a useful 
material for studying muscular development, diseases and the physiological response to 
exercise in-vitro (Yen-Chih Huang, Robert G. Dennis, Lisa Larkin, 2005; Huang et al., 2006; 
Khodabukus et al., 2007, 2015, 2018b, 2018a; Khodabukus & Baar, 2012; Heher et al., 2015). 
Indeed, previous research has shown that fibrin engineered SkM displays similar 
stiffness/elasticity to native muscle (Chiron et al., 2012) and that when subjected to electrical 
stimulation, displays much greater increases in maximal absolute (~800 µN) and specific (~30 
kN/m2) forces (Huang et al., 2005; Huang et al., 2006) versus collagen and laminin engineered 
muscles, which increases myotube hypertrophy (Khodabukus et al., 2018a). Furthermore, 
fibrin is able to secrete its own ECM, and bind a number of key growth factors which promote 
differentiation, including vascular endothelial growth factor (VEGF), basic fibroblast growth 
factor-2 (bFGF-2), alongside indirect binding of insulin-like growth factor-1 (IGF-I) ultimately 
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improving maturation (Campbell et al., 1999; Sahni et al., 2003). Furthermore, cells are able 
to proliferate and migrate freely when cultured on fibrin. For this reason, much lower seeding 
densities are needed for producing mature engineered muscle versus collagen muscle whereby 
~10-18 × 104  C2C12 cell line or ~ 2-4 × 105 human cells are required to produce a single self-
assembling fibrin muscle construct (Khodabukus & Baar, 2009; Turner et al., 2019a). 
Furthermore, use of PDMS moulds now permit even lower seeding densities when culturing 
fibrin muscle, however, at the expense of reduced construct size (Heher et al., 2015; 
Khodabukus et al., 2018a). Recent work by Bursac’s group has more recently attempted to 
rectify this issue of using large primary SkM cell densities via using Pax7 overexpressed human 
pluripotent stem cells (hPSCs) which are much more readily available given their unlimited 
proliferative potential versus human SkM cells that are at risk of senescence following multiple 
passages (Rao et al., 2018). This will also open up exciting avenues for studying muscular 
diseases in representative in-vitro systems. It is also important to highlight a number of factors 
when using fibrin as the matrix in bioengineering. Indeed, studies have demonstrated batch 
variation in key fibrin constituents, fibrinogen and the protease thrombin and media 
components (i.e. streptomycin/glucose concentration and origin of serum),  all of which 
ultimately effect muscle functionality and fibrinolysis rates (i.e. the breakdown of the fibrin 
via the fibrinolytic enzyme plasminogen; Khodabukus and Baar, 2009, 2015). However, 
fibrinolysis can be controlled via the administration of plasminogen inhibitors such 
as aprotinin, aminocaproic acid/amino-hexanoic acid, or using cross-linkers such as genipin, 
although genipin autofluoresces, imposing difficulties for immunohistochemical analysis 
(Khodabukus and Baar, 2009). Therefore, these factors should be carefully considered 
according to the experimental aims of interest.  
 
 32 
Whilst the present section demonstrates the advances made in bioengineered SkM systems over 
many years it is worth acknowledging a number of common issues faced in bioengineering 
research. Firstly, bioengineering can be costly and requires a greater level of time and expertise 
given the stringent techniques involved and the much greater culture time periods versus 
traditional monolater culture systems. Furthermore, there is little research that has used gene-
specific knockdown or overexpression techniques to determine the mechanistic role a 
particular gene of interest. Indeed, the only study to the authors knowledge that has genetically 
manipulated gene expression in engineered muscle is that of Shahini et al., (2018) whom 
overexpressed NANOG in replicatively aged (multiple population doubled, MPD) C2C12 cells 
(Sharples et al., 2012, 2016a; Shahini et al., 2018) cultured in a type 1 collagen matrix and 
demonstrated restoration of differentiation that was impaired in non-treated control cells. 
Despite this recent work, to the authors knowledge, there are no other studies to date, 
particularly in fibrin muscle that have manipulated gene expression in bioengineered SkM. 
Therefore, monolayer culture models may prove beneficial in various scenarios given their cost 
effectiveness and simplicity relative to bioengineered culture methods, allowing experiments 
to be more easily repeated. Furthermore, required seeding densities are reduced in monolayer 
(Owens et al., 2015) versus bioengineered SkM models (Bradey et al., 2008; Mudera et al., 
2010; Martin et al., 2013), enabling higher experimental throughput from the originating 
sample. Moreover, due to the absence of a surrounding matrix, cells cultured in monolayer may 
be more easily transfected to induce gene-specific silencing/overexpression to investigate their 
mechanistic role in-vitro. Therefore, use of either or both monolayer and bioengineering in-
vitro systems in some circumstances would be beneficial, dependent upon the experimental 
aims of interest.  
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1.9! Thesis Aims and Objectives 
The overarching aim of the present thesis was to investigate whether acute mechanical loading 
of murine bioengineered fibrin SkM could recapitulate the transcriptional and epigenetic 
responses that occur following loading/RE in-vivo. Therefore, a series of experiments were 
conducted to achieve a number of aims: 
 
1.! Firstly, in chapter 3, this thesis aimed to mechanically load C2C12 fibrin bioengineered 
SkM using distinct loading regimes and determine the mechano-responses using a 
novel bioreactor system, not previously used for loading SkM. This was accomplished 
via assessing mRNA expression of known mechano-sensitive genes that have also been 
shown to be regulated after mechanical loading in other bioreactors previously 
published.  
 
2.! Secondly, in chapter 4, using large scale genome-wide bioinformatics analysis of 
publicly available data sets, we aimed to identify which genes were frequently regulated 
across both the human transcriptome and methylome after RE in human SkM. This 
would provide an appropriate subset of genes to investigate at the mRNA and DNA 
methylation level, to confirm if mechanical loading in fibrin bioengineered muscle 
mimicked the in-vivo loading response in the subsequent chapter (chapter 5 below). 
 
3.! In chapter 5, after identifying which genes were regulated across the transcriptome and 
methylome after RE in human SkM in chapter 4, the following aim was to assess the 
transcriptional and epigenetic response of these genes following mechanical loading in 
bioengineered SkM to establish whether loading fibrin engineered SkM in-vitro was a 
representative model that mimicked loading in humans and rodent muscle in-vivo. 
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4.! Finally,  in chapter 6 of this thesis, we aimed to induce gene-specific knockdown of the 
most upregulated gene (UBR5) identified after acute loading in bioengineered SkM 
alone and across all additional models and species of RE/loading (in chapter 5), in order 
to determine its mechanistic role following mechanical loading in human myotubes.  
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CHAPTER 2  
Materials and Methods 
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2.1!Cell Culture  
All cell culture procedures were undertaken in a Class II Microbiological Safety Cabinet (BSC; 
Kojair Biowizard Silverline, Finland) under aseptic conditions. All cells were sub-cultured and 
incubated in a HERAcell 150i CO2 humidified incubator (Thermo Fisher Scientific, Denmark) 
at 37 °C and 5% CO2 and were routinely monitored using an inverted light microscope 
(Olympus, CKX31, Japan). 
2.2!Conventional Monolayer Cell Culture   
2.2.1! The C2C12 Cell Line 
All murine C2C12 mouse skeletal muscle (SkM) myoblasts were sourced from the American 
Tissue Culture Collection (ATCC; Rockville, USA) and were passaged (~P12) to increase cell 
yield and were stored in liquid nitrogen (LN2) until required for experimentation. C2C12 cells 
are the C12 sub-clone and daughter of the C2 parental cell line, originally derived from the crush 
injured leg of the C3H mouse (Yaffe & Saxel, 1977; Blau et al., 1985). The C12 sub-clone was 
selected for their differentiation capability, hence the extensive use of this cell line for in-vitro 
SkM research. For bioengineered SkM experiments, C2C12 cells were first differentiated in 
monolayer culture over 7 days to determine their differentiation capacity (see Figure 2.1). 
Indeed, differential cloning of C2C12 cells has been shown to display high variation in myotube 
formation when cultured in fibrin bioengineered SkM (Khodabukus & Baar, 2009). Therefore, 
determining the differentiation potential in monolayer prior to using cells for tissue engineering 
purposes improved SkM construct maturation during bioengineered SkM experiments.
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Murine C2C12 myoblasts cultured in differentiation medium (DM) at (A) 0 hrs, (B) 72 hrs and (C) 7 days (10! magnification, Olympus, CKX31).
A B C 
Figure 2.1. C2C12 myoblasts differentiation in monolayer 
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2.2.2! Human Skeletal Muscle Derived Cells (HMDCs) 
SkM tissue (~200 mg) was obtained from the vastus lateralis quadricep muscle via a 
conchotome biopsy of consenting participants self-recruited from the university campus via 
email or verbal communication (see Table 2.1). All participants were considered healthy as 
determined by blood pressure, resting heart rate, and height and weight (for BMI) 
measurements, together with completion of a pre-biopsy medical history questionnaire. Muscle 
biopsies were undertaken in a designated biopsy suite in the Tom Reilly Building (TRB), 
Liverpool John Moores University, UK following participant recruitment and informed 
consent procedures. Ethical approval was granted for the collection of muscle tissue under the 
REC reference code [15/SPS/052]. 
 
Following sample collection, muscle tissue was immediately dissected in a sterile irradiated 
petri dish (100 mm, VWR, UK) using 2 ! disposable sterile scalpels (No. 11, Swann-Morton, 
UK) and placed in sterile microfuge tubes (Ambion®, Thermo Fisher Scientific Denmark) 
containing 1.5 ml of cool (4˚C) transfer media (TM) composed of Ham’s F-10 medium 
including 1 mM L-glutamine (LG; Thermo Fisher Scientific, Denmark), 0.1% heat inactivated 
fetal bovine serum (hiFBS; Gibco™, South America Origin, Fisher Scientific, UK), 0.1% heat 
inactivated new born calf serum (hiNBCS; Gibco™, New Zealand Origin, Fisher Scientific, 
UK), 100 U/ml penicillin (Lonza, UK), 100 µg/ml streptomycin (Lonza, UK), 2.5 µg/ml 
amphotericin B (Sigma-Aldrich, UK). Tubes containing the dissected tissue were then placed 
on ice and transported to the cell culture laboratory (Life Science Building, Liverpool John 
Moores University, UK) within 10 mins post-harvesting for subsequent cell isolation 
procedures.  
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Using a modified version of methods previously established (Crown et al., 2000) the contents 
of the cryovial containing transfer media was emptied into an irradiated 100 mm × 15 mm 
sterile petri dish (Sigma-Aldrich, UK) within a tissue culture hood. The excess transfer media 
was then removed followed by 3 × in phosphate buffered saline (1× PBS, Sigma-Aldrich, UK) 
washes and any visible connective and adipose tissue was removed using 2 × sterile scalpels. 
Five millilitres of 0.05% trypsin/0.02% ethylenediaminetetraacetic acid (trypsin/EDTA; 
Lonza, UK) was then added to the tissue where it was minced using sterile scalpels for 1-2 
mins. The trypsin solution was pipetted into a sterile 100 ml polypropylene specimen pot 
(Fisher Scientific, UK) containing a 6 mm × 35 mm magnetic stir bar (VWR, UK) and placed 
on a heated (37˚C) magnetic stirring platform at for 10 mins. This process was repeated before 
placing the homogenised tissue into a 15 ml sterile tube (Falcon®, Fisher Scientific, UK) 
containing 2 ml heat inactivated horse serum (hiHS; Gibco™, New Zealand Origin, Fisher 
Scientific, UK) to neutralise the trypsin. The tube was then centrifuged at 340 × g for 5 min at 
24˚C. Following centrifugation, the top 2.5 ml was discarded whilst the next 5 ml was seeded 
onto a pregelatinised (0.2% in dH2O; Type A, Sigma-Aldrich, UK) T25 flask (Nunc™, Thermo 
Fisher Scientific, Denmark) with 7.5 ml of human growth medium (HGM) composed of Ham’s 
F-10 medium that includes 1 mM LG, 10% hiFBS, 10% hiNBCS, 4 mM LG, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 2.5 µg/ml amphotericin B. Finally, the remaining 
contents were resuspended in 7.5 ml of fresh HGM and seeded on a separate pre-gelatinised (2 
ml of 0.2% gelatin in dH2O per T25 flask, incubated at RT for 15 mins). Both T25 flasks were 
then incubated for 5 days to allow cells to migrate out of the tissue explant and adhere to the 
culture flask surface. HGM was changed every 48 hrs until cells reached ~80% confluency (see 
Figure 2.2). 
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Table 2.1. SkM biopsy characteristics indicating participant number, age (in years), height (cm) and weight (kg) for BMI, biopsy 
procedure and muscle obtained, cell myogenicity (%) and final passage number used for mechanical loading  
 
 
 
 
 
 
 
 
  
Participant 
Number 
Age of Donor  
(yrs) 
Biopsy 
Procedure 
Biopsy Location 
Myoblast  
Proportion (%) 
001 25 Conchotome Vastus Lateralis 70.47 
002 19 Conchotome Vastus Lateralis 70.77 
003 24 Conchotome Vastus Lateralis 74.70 
 
Final Cell  
Passage Number (P) 
Body Mass  
(kg) 
Height  
(cm) 
Body Mass Index  
(BMI) 
 P8 79.25 179 24.87 
 P9 71.8 180 22.06 
 P7 75.1 183 22.40 
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Human skeletal muscle derived cells (HMDCs) at (A) 0 hrs, (B) 72 hrs, (C) 7 days and (D) 10 
days in HDM (10! magnification, Olympus, CKX31). 
 
 
 
 
A B 
C D 
Figure 2.2. Differentiation of HMDCs in monolayer  
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2.2.3! Passaging Cells 
C2C12 cells were sub-cultured in T75 flasks (Nunc™, Thermo Fisher Scientific, Denmark) 
containing growth medium (GM) composed of high glucose Dulbecco’s modified Eagle’s 
medium (DMEM, Lonza, UK), 10% hiFBS, 10% hiNBCS, 2 mM LG, 100 U/ml penicillin and 
100 µg/ml streptomycin until 80% confluency was attained (see Figure 1). Once primary 
HMDCs cultured in T25 flasks had reached 80% confluency (see Figure 2), cells were 
trypsinised and reseeded into T75 flasks to increase cell yield. Here, existing HGM/GM was 
removed, and cells underwent 2 × PBS washes. Either 500 µl (for T25 flasks) or 1 ml (for T75 
flasks) of trypsin was then added to the culture flask(s) and incubated for 5 minutes (37˚C, 5% 
CO2) in order to dissociate cells from the culture flask surface. Following detachment of cells, 
2.5 ml (for T25 flasks) or 4 ml (for T75 flasks) of HGM/GM was added to neutralise trypsin 
activity. The cell suspension was transferred to a 15 ml flacon tube and centrifuged at 340 × g 
for 5 min at 24˚C to obtain a cell pellet. The supernatant was discarded and the cell pellet was 
resuspended in either 1 ml (T25 flasks) or 3 ml (T75 flasks) ready for counting (see section 
2.2.4).  
 
2.2.4! Cell Counting 
After trypsinising cells (see section 2.2.3), the suspension was homogenised 5 × using a 19G 
hypodermic needle (Becton Dickinson, USA). Cells were then manually counted on a 
Neubauer haemocytometer (BLAUBRAND® Neubauer, Sigma-Aldrich, UK) using the trypan 
blue exclusion method whereby 10 µl of cell suspension was diluted with 10 µl 0.4% trypan 
blue stain (Sigma-Aldrich, UK) at a 1:1 ratio. The mixture was then pipetted onto either end of 
the haemocytometer, flooding both chambers via capillary action. Cells present within each 
quadrant were counted. Small, round and clearly visible cells were considered viable whereas 
larger, darker/blue stained cells were considered non-viable cells or debris and were therefore 
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excluded from cell counts (see Figure 2.3) for the purposes of calculating seeding density of 
future experiments. To determine the concentration of cells (cells/ml) present within the cell 
suspension, the mean number of cells in 8 × grids was calculated (average cell numbers per 0.1 
mm3 grid) which was multiplied by 2 (to account for the trypan blue dilution factor) and 104 
(to convert the number of cells in 0.1 mm3 to 1 cm3). The total number of cells present within 
the cell suspension was calculated via simply multiplying the cells/ml by the cell suspension 
volume in ml (see Equation 2.1). 
 
 
 
 
 
 
 
 
 
 
 
 
An example of cells within a quadrant on a Haemocytometer. Each quadrant contains 16 ! 
grids and a total of 8 ! quadrants were counted. Only viable cells (GREEN arrows) were 
included for all cell counts and nonviable cells/debris (RED arrows) were excluded (10! 
magnification, Olympus, CKX31). 
 
 
<
< < <
<
Figure 2.3. Cell counting using a Haemocytometer 
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Cell Counting Equation 
Cells/ml  = Average of 8 grids × dilution factor (2) × 104 cells/ml 
Total number of cells  = Cells/ml × cell suspension volume (ml) 
 
Cell Seeding Density Equation 
Cell suspension required (ml)  = Desired cell concentration (cells/ml) / current cell 
concentration (cells/ml) × required cell suspension volume (ml) 
Equation 2.1. An example of equations used to calculate cell concentrations (cells/ml), the 
total number of cells and the desired cell concentration for seeding cells. 
 
2.2.5! Cell Cryopreservation and Resuscitation  
Once counted (see section 2.2.4), GM/HGM was added to existing cell suspension to ensure a 
concentration of 1 × 106 cells/ml (for C2C12 cells) or 5 × 105 cells/ml (for HMDCs).  Dimethyl 
sulfoxide (DMSO; Sigma-Aldrich, UK), a cryoprotectant that prevents ice crystal formation, 
was added at 10% of the total cell suspension volume (Lovelock & Bishop, 1959) before  
distributing the cell suspension into labelled (name, cell type, passage number, concentration 
and date) 2 ml cryovials (Simport™, Fisher Scientific, UK). The cryovials were transferred to 
a cryopreservation container (‘Mr Frosty’, Thermo Fisher Scientific, Denmark) containing 200 
ml of isopropanol (Sigma-Aldrich, UK) and was placed in a -80°C freezer for 24 hrs to ensure 
a gradual freezing rate (-1˚C/min) before storing in liquid nitrogen (LN2). When resuscitating 
cells, a cryovial was removed from LN2, mist sprayed with 70% industrial methylated spirits 
(IMS) and placed in a BSC to thaw at RT. Cell suspension was then pipetted onto a pre-
gelatinised T75 flask(s) (5 ml of gelatin per T75, incubated at RT for 15 mins) containing 20 
ml of preheated (37˚C) HGM/GM and incubated at 37˚C, 5% CO2 to allow cell attachment and 
proliferation over the ensuing days. The time to reach ~80% confluency varied for HMDCs 
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given inter-individual differences in cell growth. However, 1 × 106 of C2C12 cells typically 
reached ~80% confluency at approximately 72 hrs.  
 
2.2.6! Differentiation of C2C12 Cells in Monolayer Culture 
As described in section 2.2.1, C2C12 cells were differentiated in monolayer culture over 7 days 
to first assess their differentiation capacity before using for SkM tissue engineering purposes 
(see Figure 2.1). This was to determine which stocks of C2C12 cells demonstrated the greatest 
increase in myotube formation and would therefore be sub-cultured within a fibrin muscle 
during bioengineered SkM experiments. During the initial monolayer experiments, various 
stocks of C2C12 ells were first sub-cultured to ~80% confluency in T75 flasks. Once ~80% 
confluency was attained, cells were trypsinised and seeded on pre-gelatinised 6-well plates (1 
ml of gelatin per well, incubated at RT for 15 mins) at a density of 8 × 104/ml in 2 ml of GM 
(see Equation 2.1). Well plates were incubated for 24 hrs to reach ~80% confluency before 
switching to differentiation medium (DM) composed of high glucose DMEM, 2% hiHS, 2 mM 
LG, 100 U/ml penicillin and 100 µg/ml streptomycin and was topped up with 1 ml of GM at 
72 hrs. The differentiation experiment was terminated at 7 days. 
 
2.2.7! Differentiation of Human Skeletal Muscle Derived Cells  
HMDCs were seeded onto fibronectin (F1141, Sigma-Aldrich, UK) at a concentration of 10 
µg/ml in PBS (1!) to promote cell attachment 6-well plates at a concentration of 9 × 104 
cells/ml in 2 ml of HGM (see Equation 2.1). Once cells had reached ~80% confluency 
(typically 2-3 days), HGM was switched to 2 ml human differentiation media (HDM) 
composed of Ham’s F-10 medium that includes 1 mM LG, 2% hiFBS, 4 mM LG, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 2.5 µg/ml amphotericin B. Each well received an 
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additional 1 ml of HDM at 72 hours and 7 days. The differentiation time course was terminated 
at day 10 (see Figure 2.2). 
 
2.3!Dosing of UBR5 siRNA in Human Myotubes 
2.3.1! Principle 
RNA interference (RNAi) is a natural mechanism that has become a popular tool for 
manipulating the activity of a target gene in order to characterise its mechanistic role both in-
vitro and in-vivo. This mechanism can be induced experimentally via transfecting cells or tissue 
with small (typically 21 nucleotides long) synthetic double stranded (ds) RNA molecules 
known as short interfering RNA’s (siRNA; Tuzmen et al., 2007). Delivery of siRNA into cells 
can be achieved using cationic lipids (e.g. lipofectamine) or using physical methods (e.g. 
electroporation; Oliveira, Storm and Schiffelers, 2006). Once inside the cell, siRNA’s bind to 
the protein argonaute to form the RNA-induced silencing complex (RISC). The siRNA ‘guide’ 
strand directs RISC to target mRNA transcripts with complimentary sequences to the bound 
siRNA molecule. mRNA is then cleaved and degraded, resulting in transcriptional silencing of 
the target gene (see Figure 2.4; Tuzmen et al., 2007). 
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Synthetic double stranded (ds) RNA molecules known as short interfering RNA’s (siRNA) are 
delivered into the cell using lipid (e.g. lipofectamine) or physical methods (e.g. 
electroporation). (B) Once inside the cell, siRNA’s bind to the argonaute protein to form the 
RNA-induced silencing complex (RISC). (C) The ‘guide’ strand is then cleaved from the ds 
siRNA molecule which (D) directs RISC to target mRNA transcripts with complimentary 
sequences to the bound siRNA molecule. (E) mRNA is then cleaved and degraded, resulting 
in transcriptional silencing of the target gene. Schematic representation was adapted from the 
Qiagen ‘Flexible RNAi Technologies’ handbook.  
 
A 
C 
D 
E 
5
’ 
3’ 
RISC 
siRNA 
mRNA recognition & degradation 
Cytoplasm 
Nucleus 
Argonaute 
B 
Figure 2.4. Mechanisms of siRNA silencing 
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2.3.2! Procedure 
Throughout this thesis, 4 × synthetic siRNAs (Flexitube GeneSolutions™, Qiagen, UK) were 
transfected into human myotubes (see section 2.2.7) to target various regions of the 10900 bp 
UBR5/EDD1 human gene in order to maximise post-transcriptional gene silencing potential 
(see Table 2.2). Each of the 4 × siRNA lyophilised pellets (1 nmol) were diluted in 100 µl of 
RNase-free H2O to ensure a 10 µM stock solution. For siRNA validation experiments, cells 
were also transfected with a negative control siRNA (AllStars Negative Control siRNA™, 
Qiagen, UK) to confirm whether changes in gene expression were specific to the gene of 
interest. The AllStars Negative Control siRNA™ pellet (5 nmol) was reconstituted in 1 ml of 
RNase-free H2O to ensure a 5 µM stock solution. HiPerFectTransfection™ (Qiagen, UK) 
reagent containing a blend of cationic and neutral lipids was used to facilitate uptake of siUBR5 
and negative control siRNA into differentiated cells. For siUBR5 validation experiments, 
human myotubes (see Section 2.2.7) from 3 participants (see Table 2.1) were washed 2 × in 
PBS and subjected to 1 of 4 conditions; Flexitube GeneSolutions™ (siUBR5) alone, AllStars 
Negative Control siRNA™ (negative siRNA) alone, HiPerFectTransfection™ (transfection 
reagent) alone and HDM alone. For the siUBR5 condition, 1 µl of each target siRNA was 
diluted in 1 ml of HDM containing 12 µl transfection reagent to ensure a 10 nmol working 
solution. Negative control cells received 2 µl of negative siRNA in 1 ml of HDM containing 
12 µl transfection reagent to ensure a 10 nmol working solution. The transfection reagent alone 
condition consisted of 12 µl of transfection reagent in 1 ml of HDM and the final condition 
received 1 ml of HDM only. After dosing, cells were incubated for 3 hrs before lysing with 
TRIzol for subsequent RNA isolation (see section 2.8.1). UBR5 expression was analysed via 
quantitative real-time polymerise chain reaction (qRT-PCR; see section 2.9.4) where the mean 
cycle threshold (CT) value of duplicates for each sample of each condition was analysed to 
confirm knockdown efficiency. Given the gene knockdown efficiency was low following 
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validation experiments (-25.72 ± 4.72%) using a concentration of 10 nmol, siRNA 
concentrations were increased to 20 nmol (1.5 µl of each target siRNA diluted in 750 µl of 
HDM containing 9 µl transfection reagent) during subsequent experiments and were able to 
confirm efficient knockdown of UBR5 (-77.39 ± 0.74%) as demonstrated in experimental 
chapter 6. 
 
Table 2.2. UBR5/EDD1 (NM_015902, 10900 bp length) siRNA target sequences 
Product Name  Target Sequence 
Hs_EDD1_3 CTGGTATTTCTTCAATGCCGA 
Hs_EDD1_2 CCAAATCTAGAGTGTATCCAA 
Hs_EDD1_1 TTCAACTTAGATCTCCTGAAA 
Hs_EDD_2 CAGGTATGCTTGAGAAATAAT 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B
C 
D 
Figure 2.5. UBR5 siRNA target sequence locations 
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Graphical representation of the 4 × siUBR5 sequence locations, targeting various regions of 
the 10900 bp UBR5 human gene. (A) Hs_EDD1_3. (B) Hs_EDD1_2.03 (C) Hs_EDD1_1. (D) 
Hs_EDD_2. 
 
2.4!Bioengineered Fibrin Skeletal Muscle Constructs 
The materials and methods used for tissue engineering purposes throughout this thesis have 
been described extensively elsewhere (Seaborne et al., 2019; Turner et al., 2019a) and the 
following sections have therefore been adapted from this published work throughout. Given 
batch variations in fibrin constituents (Khodabukus & Baar, 2009, 2016), batch catalogue 
numbers for each reagent are included throughout.  
2.4.1! Preparation of Reagents 
All reagents stored at -20˚C were thawed at RT prior to use. Reagents were never freeze-thawed 
and were therefore only used once. Fibrinogen from Bovine Plasma (F8630, Sigma-Aldrich, 
UK) was dissolved at 20 mg/ml in pre-heated (37˚C) Ham’s F12-K media (Sigma-Aldrich, 
UK) in a 100 mm specimen pot(s) containing a magnetic stir bar and was incubated at 37˚C on 
a magnetic stirrer for 2 hours.  Fibrinogen solution was then sterile vacuum filtered (0.22 µm, 
Merck™ Stericup™, Fisher Scientific, UK), aliquoted into 2 ml Eppendorf’s (Eppendorf, 
Germany) and stored at -20˚C. Thrombin from Bovine Plasma (T4648, Sigma-Aldrich, UK) 
was dissolved at 200 U/ml in high glucose DMEM. Thrombin solution was then sterile filtered 
(0.22 µm, Fisher Scientific, UK), aliquoted into 0.5 ml microfuge tubes (250 µl) and stored at 
-20˚C. Aprotinin from Bovine Lung (A3428, Sigma-Aldrich, UK) was dissolved at 10 mg/ml 
in distilled water (dH2O), sterile filtered (0.22 µm), aliquoted into 0.5 ml microfuge tubes (250 
µl) and stored at -20˚C. Six (6)-Aminocaproic Acid (6AA; A7824, Sigma-Aldrich, UK) was 
dissolved at 50 mg/ml in dH2O, sterile filtered (0.22 µm), aliquoted into 2 ml Eppendorf’s and 
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stored at -20˚C. L-Ascorbic Acid (LAA; A4403, Sigma-Aldrich, UK) was dissolved in high 
glucose DMEM at a concentration of 50 mM, sterile filtered (0.22 µm), aliquoted into 0.5 ml 
microfuge tubes (500 µl) and stored at 4˚C. L-Proline (LP; P8865, Sigma-Aldrich, UK) was 
dissolved in sterile PBS (1×) at a concentration of 50 mM, sterile filtered (0.22 µm), aliquoted 
into 0.5 ml microfuge tubes (500 µl) and stored at 4˚C. 
2.4.2! Preparation of Culture Dishes 
Easy-Grip 35 mm culture dishes (BD Falcon®, VWR, UK) were coated with approximately 1.5 
ml of sylgard (Sylgard™ 184 Elastomer Kit, Dow Corning, USA) using a 20 ml syringe without 
needle. Sylgard coated dishes were then left to cure for 2-3 days with the lids removed and 
stored for a further two weeks before use. Silk suture thread (Ethicon Mersilk, 2.0, Portugal) 
was then trimmed to 6 mm lengths and was pinned 12 mm apart using 0.15 mm minutien pins 
(Entomoravia, Czech Republic; see Figure 2.6). Culture dishes, including lids, were then filled 
with 70% IMS and left to sterilise and air-dry overnight under UV light (programmed to 1 hr) 
within a culture hood.  
 
 
 
 
 
 
 
 
 52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depicts (A) marked sylgard coated culture dish with (B) silk sutures pinned in place. (C) 
Depicts thrombin solution placement to ensure sutures are saturated and (D) indicates pipetting 
fibrinogen dropwise prior to gentle agitation to ensure even distribution across the cell culture 
dish surface. Taken from Turner et al., (2019). 
 
2.2.1!  Preparation and Maintenance of Fibrin Skeletal Muscle Constructs 
Once the culture dishes were thoroughly sterilised, 500 µl of thrombin solution consisting of 50 
µl/ml thrombin, 8 µl/ml aprotinin in GM containing 0.5 mg/ml 6AA was added to each dish, 
covering the sutures (outside to inside) first and then across the centre to join both sutures. 
Each plate was then agitated to ensure even distribution across the culture dish surface (see 
Figure 2.6). Two-hundred microliters of stock fibrinogen was then added dropwise to each 
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Figure 2.6. Fabrication of fibrin bioengineered SkM 
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plate (see Figure 2.6) and left to incubate for at RT for 10 mins before transferring to an 
incubator (37˚C, 5% CO2) for one hour to polymerise. Following polymerisation, C2C12 cells 
were seeded onto the fibrin gel at 5-9 × 104 cells/ml in 2 ml GM containing 0.5 mg/ml 6AA 
and 50 µM of both LAA and LP. GM was changed every 48 hrs until cells were ~90% 
confluent, at which point the media was switched to DM containing 1 mg/ml 6AA, 50 µM of 
both LAA and LP Following 48 hrs in DM, fibrin gels were washed 2 × with PBS and media 
was changed to maintenance medium (MM) composed of high glucose (4.5 g/l) DMEM that 
includes 4 mM LG, 3.5% hiFB, 3.5% hiNBCS, 2 mM LP, 100 U/ml penicillin, 100 µg/ml 
streptomycin, 1 mg/ml 6AA, 50 µM LAA and 50 µM LP. MM was changed every 48 hrs and 
0.5 ml was added on days where media was not changed until muscle constructs had matured 
into cylindrical-like ‘mini-muscles’ containing aligned myotubes at day 14 days (see Figure 
2.7).  
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Macroscopic image of polymerised gel at at (A) 0 days. Macro- and microscopic images of C2C12 fibrin constructs (B) 3-4 days, (C) 5-6 days and 
(D) 14 days in culture (10! magnification, Olympus, CKX31).
Figure 2.7. Differentiation of C2C12’s in fibrin bioengineered SkM 
   
Day 3-4 Day 5-6 Day 14 Day 0 
A B C D 
Grown to ~90% Confluency in 
20% hiFBS/hiNBCS 
Differentiated in  
2% hiHS  
Differentiated in 7% 
hiFBS/hiNBCS   
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2.5!Mechanical Loading of Fibrin Skeletal Muscle Constructs  
2.5.1! The TC-3 Bioreactor System 
Throughout this thesis, the TC-3 tension bioreactor (EBERS Medical Technology, Spain) was 
used to mechanically load fibrin SkM constructs. The TC-3 bioreactor is a commercially 
available system that is able to apply both mechanical and/or electrical stimuli to loaded tissues 
in vitro (see Figure 2.8). Tissues may be mechanically loaded via applying tension, 
compression or hydrostatic pressure in order to simulate forces applied to tissue in vivo. 
Although electrical stimulation was not employed throughout this thesis, the system now also 
has the capacity to induce coordinated mechanical and electrical inputs due to customised 
software modifications made by our lab. 
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An example of the TC-3 bioreactor system (EBERS Medical Technology, Spain) allowing 
mechanical loading, electrical stimulation, and perfused cell culture media into a cell culture 
chamber that can all be housed into an humidified CO2 incubator. (A) Electrical stimulation 
module, (B) electrical stimulation output box, (C) control module, (D) electrode anode/cathode 
splitter, (E) bioreactor mechanical stimulation box, (F) bioreactor culture chambers, (G) 
peristaltic pump/perfusion box, (H) laptop and controlling software. (2) Black—mains power; 
orange—laptop (G) to control module (C); yellow—control module (C) to bioreactor 
mechanical stimulation box (E); brown—anode (+ve) from electrical stimulation module (A) 
to electrical stimulation output box (B); green—neutral from electrical stimulation module (A) 
to electrical stimulation output box (B); blue—cathode (-ve) from electrical stimulation 
Figure 2.8. Example of the TC-3 bioreactor 
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module to electrical stimulation output box (B); purple—control module (C) to electrical 
stimulation module (B); red—electrical stimulation output box (B) to electrode anode/cathode 
splitter (D); peach/gold—anode (+ve) from electrode anode/cathode splitter (D) to bioreactor 
culture chambers (F); light blue—cathode (-ve) from electrode anode/cathode splitter (D) to 
bioreactor cell culture chambers (F); pink—perfusion box (G) to bioreactor cell culture 
chambers (F). Taken from (Kasper et al., 2018; Turner et al., 2019a). 
 
2.5.2! Procedure 
Once fibrin SkM constructs were considered mature at day 14, pins were removed using 2 ! 
sets of angled surgical tweezers (Sigma-Aldrich, UK) and the gels (including sutures) were 
transferred to the bioreactor chamber(s), ensuring a 12 mm (resting length) gap between the 
medial edge of either clamp. Muscle constructs were then submerged in 20 ml of MM. 
Typically, 3-5 muscle constructs were clamped within each chamber (see Figure 2.9). 
Assembled chambers containing the bioengineered muscles were them attached to the 
bioreactor system, housed in a humidified incubator (37˚C, 5% CO2) to undergo mechanical 
stimulation (see Figure 2.9). Using the TC-3 control software (EBERS Medical Technology, 
Spain), the resting length (12 mm) was programmed before adjusting the ‘velocity’ and 
‘frequency’ mode settings for the desired stretch regime (see Figure 2.10). The specific velocity 
and frequency mode settings will be specified within the methods section of each experimental 
chapter.  
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(A) 4 ! C2C12 fibrin constructs clamped within a bioreactor chamber (B) to undergo mechanical 
loading (B; white dashed lines outline the SkM constructs) whilst (C) incubating at 37˚C/5%.  
 
 
 
 
 
A 
B C 
Figure 2.9. Mechanical loading of fibrin bioengineered SkM 
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EBERS TC-3 Software. Mechanical stretch navigation menu for adjusting (A) velocity and (B) 
frequency mode settings. Taken from (Turner et al., 2019a). 
A 
B 
Figure 2.10. Velocity and frequency mode settings 
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2.6!Mechanical Loading of Human Myotubes 
2.6.1! The Flexcell® FX-5000™ Tension System 
In chapter 6, the Flexcell® FX-5000™ Tension system (Dunn Labortecknik,  Germany) was 
used to apply mechanical loading to human myotubes in-vitro. The Flexcell® FX-5000™ 
Tension system enables the application of defined equibiaxial, uniaxial and gradient 
mechanical strain (cyclic or static) to cells flexible-bottomed culture plates (BioFlex®, Dunn 
Labortecknik, Germany). This is achieved via regulated vacuum pressure which deforms the 
flexible silicon membrane on which cells are cultured on (see Figure 2.11). 
Schematic of cultured cells undergoing equibiaxial strain on BioFlex® well plates. Taken from 
the Flexcell International Corporation website (https://www.flexcellint.com/category/tension). 
 
 
 
Figure 2.11. Equibiaxial loading of cells in monolayer 
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2.6.2! Differentiation of Human Myotubes on BioFlex® Culture Plates 
BioFlex® culture plates (25 mm; Dunn Labortecknik, Germany) were first coated with 1 ml of 
fibronectin (F1141, Sigma-Aldrich, UK) at a concentration of 10 µg/ml in PBS (1!) to promote 
cell attachment. Fibronectin coated well plates were then incubated at 37˚C for 1 hr. Following 
incubation, excess fibronectin was aspirated and each well was rinsed 2 ! with PBS. HMDCs 
were then seeded at a density of 9 ! 104 cells/ml in 2 ml of HGM. Once cells reached ~80% 
confluency, HGM was switched to HDM to enable differentiation into multinucleated 
myotubes over the ensuing 10 days (see section 2.2.7). Each well was topped up with 1 ml of 
HDM at 72 hrs and 7 days. Once mature, cells were treated prior to mechanical loading (see 
section 2.3).  
2.6.3! Mechanical Loading of Human Myotubes Using the Flexcell® FX-5000™ 
Tension System 
Loading posts were first lubricated (Loctite, Germany) before placing the Flexcell® FX-5000™ 
Tension base plate in a humidified incubator (37˚C, 5% CO2). BioFlex® culture plates were 
assembled to the base plate ready for mechanical loading (see Figure 2.12). Myotubes were 
subject to a low frequency (0.15 Hz with sine wave) intermittent stretch regime which consisted 
of 4 ! 10 reps with 90 s rest between sets, representing 1 ! exercise (see Figure 2.12). There 
was a total of 5 exercises, each interspersed with a 3.5 min rest interval, totalling a regime of 
60 mins. Non-loaded myotubes acted as controls and were also assembled to the Flexcell® base 
plate, however, the vacuum entry was sealed with tape to avoid any unwanted stretch. All cells 
were lysed for RNA (see section 2.8.1) and protein (see section 2.11) immediately post (~30 
mins) and 3 hrs post stretch. Puromycin was first incorporated into myotubes before lysing for 
protein for a measure of global protein synthesis (see section 2.11).
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(A) Human myotubes mechanically loaded on BioFlex® well plates within a humidified 
incubator (37˚C/5%). (B) Example of the sine wave profile during the mechanical loading 
regime. 
A 
B 
Figure 2.12. Mechanical loading of human myotubes  
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2.7!Immunochemistry and Microscopy 
2.7.1! Principle  
Immunochemistry is a method typically employed to detect a particular protein of interest in 
cells (immunocytochemistry, ICC) and tissue (immunohistochemistry, IHC) via the use of 
fluorescent-labelled antibodies which bind to their target antigens. This technique enables 
researchers to visualise the localisation and morphology (i.e. the size and shape of the cell) of 
individual cell components which are maintained during immunochemistry procedures (Coons 
et al., 1942). 
Samples are first ‘fixed’ using crosslinking reagents (e.g. formaldehyde/formalin) which form 
bridges or organic solvents (e.g. methanol and acetone) to dehydrate cells and remove lipids in 
order to retain cytoskeletal morphology. Specific reagents such as Triton X-100 are then used 
for permeabilising the cell membrane, enabling antibodies to penetrate into the sample and 
bind to the antigen of interest. Serum, specifically that derived from the same species in which 
the secondary antibody was raised is used for ‘blocking’, preventing any unwanted binding of 
the primary antibody to non-specific sites within the sample which may lead to background 
staining. Permeabilising and blocking are usually undertaken together for time efficiency. 
There are two major classes of antibodies used within immunochemistry, namely polyclonal 
and monoclonal antibodies. Polyclonal antibodies are raised in-vivo, whereby animals are 
injected with the antigen of interest which allows B lymphocytes to produce quantities of the 
antibody which are later purified from the serum. Similarly, monoclonal antibodies are 
generated via immunising the host with the antigen. However, hybridomas derived from the 
fusion of lymphocytes of the animal spleen and myeloma cells are expanded in culture, forming 
a single clone (Köhler & Milstein, 1976). Monoclonal antibodies have high specificity as they 
are epitope specific and may therefore be considered preferable for therapeutic drug 
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development. However, polyclonal antibodies have a higher antibody affinity as they recognise 
multiple epitopes on a given antigen, suggesting a greater robust protein detection. The use of 
either antibody may therefore be determined based on the application of interest. 
Once the samples are permeabilised and ‘blocked’, a primary antibody is added which binds 
to the protein/antigen of interest. Following primary incubation, the antibody is removed, and 
the sample is washed several times. A secondary antibody conjugated to a fluorophore 
(fluorescent dye), which is raised against the host species in which the primary antibody was 
raised, is then added to the sample to enable detection of the antigen using fluorescence 
microscopy by absorbing and emitting light at specific wavelengths.  
2.7.2! Immunostaining Human Skeletal Muscle Derived Cells  
Cells within 6-well plates were washed 3 × TBS (1×; Sigma-Aldrich, UK) and fixed and 
dehydrated in ice-cold methanol:acetone:TBS (25:25:50) for 15 mins then a further 15 mins in 
methanol:acetone (50:50) only. Following 3 × further washes, 6-well plates were wrapped in 
parafilm and stored at 4˚C until required for immunostaining.  
Following fixation, cells were permeabilised in 0.2% Triton X-100 (Sigma-Aldrich, UK) and 
blocked in 5% goat serum (Sigma-Aldrich, UK) in TBS for 90 mins. Cells were then washed 
3 × in TBS and incubated overnight (4˚C) in 300 µl of anti-desmin (ab15200, Abcam, UK) 
primary antibody made up in TBS, 2% goat serum and 0.2% Triton X-100 at concentrations of 
1:50. After overnight incubation, the primary antibody was removed and cells were washed 3 
× in TBS. Cells were then incubated at RT for 3 hrs in 300 µl secondary antibody solution 
containing anti-rabbit TRITC (T6778, Sigma-Aldrich, UK) at a concentration of 1:75 in 1× 
TBS, 2% goat serum and 0.2% Triton X-100 to counterstain myoblasts. After a further 3 × TBS 
washes, 300 µl of DAPI (D1306, Thermo Fisher Scientific, Denmark) was added to the cells 
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at a concentration of 300 nM for 30 mins to counterstain myonuclei. Once stained, 2 ml of TBS 
was added to each well and culture plates were sealed with parafilm and covered with foil and 
were stored at 4˚C until required for fluorescence imaging. 
2.7.3! Immunostaining Bioengineered Skeletal Muscle  
Bioengineered SkM constructs were fixed using methanol and acetone as described in section 
2.7.2. The fixation method used will be described within the methods section of each 
experimental chapter throughout this thesis. Following fixation, pins were removed, and 
constructs were transferred to 2 ml Eppendorf tubes using 2 × sets of angled tweezers (see 
Figure 2.13). Gels were then permeabilised (0.2% Triton X-100) and blocked (5% goat serum) 
in TBS (1×) for 90 min and incubated overnight (4˚C) in 250 µl of Phalloidin-FITC antibody 
(P5282, Sigma-Aldrich, UK) at a concentration of 50 µg/ml. After overnight incubation, the 
antibody was aspirated and gels were washed 3 × in TBS before adding 250 µl of DAPI (300 
nM) for 90 mins to counterstain myonuclei. When immunostaining for desmin, antibody 
concentrations and incubation durations were the same as that described in section 2.7.2 for 
HMDCs cultured in 6-well plates. Once stained, muscle constructs were transferred to non-
sylgard coated culture dishes containing 2 ml of TBS and were wrapped in parafilm and foil 
and stored at 4˚C until required for fluorescence imaging.  
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Fixed SkM constructs (n = 4) were transferred to 2 ml Eppendorf’s held in place using blue 
tac. Windows were carved longitudinally to enable easy access of gels. Green circles highlight 
muscle constructs. 
 
2.7.4! Microscopy and Image Analysis 
Immunostained cells and SkM constructs were visualised using either an inverted fluorescence 
(Nikon, Eclipse Ti-S, Japan) or confocal (Olympus IX83, Japan) microscope and were imaged 
using corresponding software (Nikon, NIS Elements and FV10-ASW 4.2 for fluorescence and 
confocal microscopy, respectively). Microscopy equipment/procedures is detailed within the 
methods section of each experimental chapter. Myoblasts and myotubes were visualised using 
Figure 2.13. Immunostaining fibrin bioengineered SkM 
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FITC (Phalloidin-FITC, Excitation: 495 nm, Emission: 513 nm) and TRITC (Desmin, 
Excitation: 557 nm, Emission: 576 nm) filters and myonuclei was visualised using a DAPI 
filter cube (Excitation: 358 nm, Emission: 461 nm). All immunostained samples were imported 
to Fiji/ImageJ (version 2.0.0) software for subsequent analysis. Primary heterogenous cell 
populations were characterised via counting the total number of myoblasts (red) overlapping 
nuclei (blue) and dividing this by the total number of nuclei (see Figure 2.14). 
Example of immuno-stained (A-C) and bright-field (D) microscopic images of HMDCs 
(Nikon, Eclipse Ti-S, 10× magnification scale bar = 100 µm) stained with (A) primary antibody 
only (anti-desmin), (B) secondary antibody (anti-rabbit TRITC) or (C) desmin (red) and 
Figure 2.14. Immunostaining of HMDCs for determining myogenic population 
A B 
C D 
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myonuclei (blue). Myogenicity (%) was calculated via dividing the sum of all desmin positive 
cells by the total number of blue/nuclei cells present. 
 
2.8!Lysing and Homogenising Bioengineered Skeletal Muscle Tissue for RNA and 
DNA 
Following cessation of mechanical loading, SkM constructs were removed from the bioreactor 
chambers and transferred to MagNa Lyser green bead tubes (Roche, MagNA Lyser, USA) 
containing 600 µl of Buffer RLT and 6 µl β-Mercaptoethanol (β-ME) lysis buffer if samples 
were co-purified for RNA and DNA using the AllPrep RNA/DNA Mini Kit (Qiagen, UK). 
Alternatively, samples were dissected in two halves using sterile scalpels and each part was 
either submerged in 1 ml TRIzol (Invitrogen™, Thermo Fisher Scientific, Denmark) or 180 µl 
buffer ATL with 20 µl proteinase K (DNeasy Blood and Tissue Kit, Qiagen, UK) if solely 
purifying RNA or DNA, respectively. DNA samples were incubated at 56˚C in the lysis buffer 
(180 µl buffer ATL with 20 µl proteinase K) for 3 hrs. Both RNA and DNA lysates were then 
placed into a MagNAa Lyser instrument (Roche, MagNA lyser, USA) and were vigorously 
disrupted (6 m/s for 40 seconds, repeated 3 × with samples placed on ice for 5 mins after each 
disruption) to ensure sufficient homogenistion, tissue/cell lysis and the release of nucleic acids. 
The tissue lysates were then pipetted into nuclease-free tubes and stored in -20˚C until required 
for RNA extraction (see sections 2.9.1 and 2.9.2). 
2.8.1! Lysing Human Myotubes for RNA 
Cultured myotubes were thoroughly washed 2 × in PBS and 300 µl TRIzol was added to each 
well. Myotubes were left to incubate in lysis buffer for 5 mins before mechanically dissociating 
cells from the well surface using an autoclaved polypropylene cell scraper. Lysed myotubes 
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were then pipetted into nuclease-free tubes and stored at -20˚C until required for RNA 
extraction. 
 
2.9!RNA Extraction and Quantitative Real-Time Polymerase Chain Reaction (qRT-
PCR) 
2.9.1! RNA Extraction Using the AllPrep RNA/DNA Mini Kit 
RNA extraction using the commercially available AllPrep RNA/DNA Mini Kit (Qiagen, UK) 
was conducted according to the manufacturers’ instructions. All procedures, including 
centrifugation, were performed at RT. Homogenised tissue and cell lysates were thawed at RT 
and centrifuged for 3 mins at maximum speed (20,000 × g). The supernatant was transferred 
to AllPrep DNA spin columns placed in a 2 ml collection tube. The supernatant was then 
centrifuged for 30 s at 8,000 × g. The DNA spin column was placed into a fresh 2 ml collection 
tube and stored at 4˚C for later DNA extraction (see section 2.10.1). One volume (600 µl) of 
70% molecular grade ethanol (Sigma-Aldrich, UK) diluted in dH2O was added to the flow-
through. The mixture was then transferred to a RNeasy spin column placed in a 2 ml collection 
tube and centrifuged for 15 s at 8,000 × g. The column membrane was washed several times 
with Buffer RW1 (1 ×) and Buffer RPE (2 ×), centrifuging samples in between each wash for 
15 s at 8,000 × g with a longer duration of 2 mins following the final wash. Finally, the RNeasy 
spin column was placed in a 1.5 ml nuclease-free collection tube and 31 µl of nuclease-free 
H2O was added before centrifuging the samples for 1 min at 8,000 × g to elute the RNA. The 
final elution step was repeated using a separate collection tube to increase RNA yield without 
compromising final RNA concentrations. Samples were vortexed and stored at -20˚C until 
required for qRT-PCR (see section 2.9.4). 
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2.9.2! RNA Extraction Using TRIzol  
All procedures, including centrifugation were performed at 4˚C when purifying RNA using 
TRIzol. TRIzol is a monophasic reagent containing phenol and guanidine isothiocyanate, 
which maintains RNA integrity via inhibiting RNase activity whilst simultaneously disrupting 
and dissolving cellular components during cell/tissue lysis and homogenisation (see sections 
2.8 and 2.8.1). Once lysed, 200 µl of chloroform (Sigma-Aldrich, UK) was added to each 
sample which was shaken vigorously by hand to separate the sample into a lower red organic 
layer (containing phenol and chloroform), a cloudy interphase layer (containing little RNA 
with the majority DNA) and a clear upper aqueous layer (containing RNA). The samples were 
then centrifuged (12,000 × g for 15 minutes at 4˚C) and the upper aqueous layer containing 
RNA was carefully extracted (avoiding direct contact with the interphase) and pipetted into a 
new RNase-free tube. RNA was then supplemented with 1 volume of isopropanol which was 
briefly vortexed and incubated at RT for 10 min. The samples were then centrifuged at 12,000 
× g for 10 mins at 4˚C, forming a cell pellet containing RNA. Excess isopropanol was carefully 
removed, and the pellet washed with 75% molecular grade ethanol. The sample was then 
centrifuged for a final time at a lower speed (7,500 × g) and duration (8 mins). Finally, the 
excess ethanol was removed, and the pellet resuspended in 21 µl storage solution (Ambion® 
RNA Storage Solution, Invitrogen™, Thermo Fisher Scientific, Denmark). Samples were 
vortexed and stored at -20˚C until required for RNA extraction. 
2.9.3! Assessment of RNA Concentration and Purity 
RNA concentration and purity were assessed using a spectrophotometer (NanoDrop™ 2000, 
Thermo Fisher Scientific, Denmark). One microliter of extracted RNA was pipetted onto the 
NanoDrop probe and the amount of ultraviolet (UV) light absorbed at 260 nm, the wavelength 
at which nucleic acids best absorb light, was measured by a photo-detector to determine the 
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concentration inferred using the Beer-Lambert law (see Equation 2.2). Following assessment 
of RNA concentration, the purity or RNA ‘quality’ was determined from the ratio of 
absorbance at 260 nm to 280 nm, the wavelengths at which RNA/DNA and protein best absorbs 
UV light, respectively. Highly purified RNA is indicated by a A260/A280 ratio of 2. Other 
potential contaminants include ethanol, phenol or guanidine, which are measured at 230 nm. 
Therefore, the A260/A230  ratio is also measured where a reading >1.5 of is preferred. RNA 
concentrations and purities are reported within the methods section of each experimental 
chapter throughout this thesis.  
A= ЄlC 
Where: 
A = absorption at 260 nm 
Є = the molar extinction coefficient (40 µg/ml for RNA and 50 µg/ml for dsDNA) 
l = the path length of the spectrophotometer  
 C = concentration of RNA/DNA 
Equation 2.2 Quantifying RNA and DNA concentrations using spectrophotometry 
 
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
2.9.4! Principle 
In order to produce functional proteins and therefore alter the muscle phenotype, a gene must 
first be transcribed in the nucleus to produce a messenger ribonucleic acid (mRNA) which is 
later translated into protein within the ribosome. The amount of a gene expressed typically (yet 
not exclusively) translates to the amount of protein produced which may influence the overall 
structure and function of SkM tissue. Assessment of mRNA regulation in response to a given 
stimulus has therefore become of particular interest in cellular and molecular 
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physiology/biology. Since DNA is a very large molecule with such limited copies, assessment 
of mRNA expression proved difficult until the 1980’s where polymerase chain reaction (PCR), 
a technique widely used to amplify specific fragments of the DNA, was introduced by Kary 
Mullis who later won the Nobel prize in chemistry in 1993 (Mullis & Faloona, 1987). 
Following isolation of mRNA from tissue or cells (see sections 2.9.1 and 2.9.2), the single 
stranded RNA (ssRNA) must be reverse transcribed to form a complimentary DNA (cDNA) 
before the target sequence is amplified. In order for reverse transcription (RT) to occur, 
oligonucleotides (dNTPs) are added to the ssRNA using the enzyme reverse transcriptase and  
cDNA is synthesised from the 3’ to 5’ end of the mRNA molecule. Once synthesised, the DNA 
is amplified via three distinct steps, all of which represent 1 cycle of a PCR reaction that is 
repeated numerous times (30-40 cycles) to produce ~ 1 bn copies of the target sequence. These 
steps include: 1) Denaturation whereby the double stranded DNA (dsDNA) is subjected to 
high temperatures (95˚C) in order to separate the DNA into two strands exposing the 3’ end of 
the DNA. 2) Annealing of primers then occurs whereby the temperature is lowered (optimal 
temperature is primer specific, with all the primers used herein designed to anneal at 
approximately 60˚C) to enable binding of short sequence (approximately 18-30 bp) primers to 
the DNA strands. 3) Extension then takes place. Here, Taq polymerase, an enzyme derived 
from the bacterium species, Thermus Aquaticus that is able to withstand such high 
temperatures, binds to the primers and synthesises the complimentary strand using free dNTPs.  
During each PCR cycle, a fluorescent dye or probe, binds to each dsDNA molecule after 
primers anneal to the 3’ end. The amount of light excited and emitted from the fluorescent 
molecule is able to provide a ‘real-time’ measurement of DNA amplification as the amount of 
light measured by a fluorometer within the PCR thermocycler instrument is directly 
proportional to the amount of targeted DNA produced. This can easily be quantified following 
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each PCR run, according to the amount of cycles required to exceed the fluorescence cycle 
threshold (CT) self-reported. Thus, generally, the lower the CT value, the higher the expression 
levels as the fluorescence being detected earlier above background fluorescence reflects the 
larger amount of starting nucleic acid material. Conversely, the higher the cycle number, the 
later detection of fluorescence above background levels reflecting a lower starting abundance 
of the nucleic acid material. The resultant CT values of the target gene in each sample are then 
compared to the CT values of a housekeeper/reference gene (one of which should remain 
consistent, regardless of any given stimulus) to determine either absolute or relative quantities 
(Schmittgen & Livak, 2008).  
2.9.5! Procedure 
Throughout this thesis, a one-step PCR kit (QuantiFast SYBR® Green RT-PCR Kit, Qiagen, 
UK) was used to analyse mRNA expression whereby the cDNA synthesis and PCR steps were 
performed in the same reaction tube for time efficiency and reduced risk of cross 
contamination. Reaction tubes were either prepared manually by hand or automatically using 
the QIAgility robot instrument (Qiagen, Crawley, UK). Each reaction included 50% SYBR® 
Green master mix (containing HotStarTaq DNA polymerase, RT-PCR buffer, SYBR green 
fluorescent dye and ROX passive reference dye) 1% reverse transcriptase (RT) mix and 0.75% 
of forward and 0.75% reverse primer, with the remaining 47.5% as diluted RNA sample (7.37 
ng/µl in nuclease-free H2O). The preparation method (i.e. manual or automatic using the 
QIAgility robot), alongside the specific volumes (µl) of PCR reagents and RNA sample used 
per reaction will be specified within the methods section of each experimental chapter.  
Prepared reaction tubes were then transferred to a PCR thermal cycler (Rotor-Gene 3000Q, 
Qiagen, UK) to undergo reverse transcription/cDNA synthesis (hold 50˚C for 10 min), 
transcriptase inactivation and initial denaturation (95˚C for 5 min) followed by 40 × 
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amplification cycles consisting of; 95˚C for 10 s (denaturation), 60˚C for 30 s (annealing and 
extension).  
2.9.6! Quantification of Relative Gene Expression 
Following the completion of 40 × PCR cycles, melt curve analysis was first performed to 
ensure only the gene(s) of interest was amplified (see section 2.9.4.4). Sample efficiencies were 
also analysed and will be reported within the methods section of each experimental chapter. 
An efficiency value of 2 represents a 2-fold increase (100% which is derived from dividing the 
efficiency value by 2 and multiplying by 100) of amplicon with each PCR cycle. To obtain the 
raw CT values for each sample, a threshold line was self-adjusted on the amplification curve 
according to where an exponential rise is fluorescence occurred (see Figure 2.15). The CT 
values were used to quantify relative gene expression using the comparative Delta Delta CT 
(ΔΔCT) equation (Schmittgen & Livak, 2008) against a reference gene and a control group (see 
Equation 2.3 and Table 2.3). 
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Figure 2.15. Analysis of raw CT values for gene expression 
 
  
 
 
 
 
 
 
 
 
Figure 2.16. Melt curve analysis to determine specific target amplification 
 
 
A 
B 
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An example of melt curves analysed to determine primer specificity. (A) displaying a single 
peak which suggest no unspecific amplification whereas (B) a double peak suggests 
amplification of unintended targets and/or primer dimer issues. 
Delta Delta CT (ΔΔCT) Equation: 
1.! ΔCT = CT (Target Gene) - CT (Target Gene) 
2.! ΔΔCT = ΔCT (Target Sample) - ΔCT (Control Sample)   
3.! 2-ΔΔCT (normalised expression ratio) 
Equation 2.3. An example of the Delta Delta CT (ΔΔCT) equation used to calculate relative 
gene expression against a reference gene and control group.  
Table 2.3. Quantifying mRNA expression using the ΔΔCT method  
Calculation for quantifying the normalised gene expression ratio using the Delta Delta CT 
(ΔΔCT) equation (Schmittgen & Livak, 2008).  
 
2.9.7!  Primer Design 
All primers were self-custom designed according to a number of specific guidelines  
(Dieffenbach, Lowe and Dveksler, 1993; see Table 2.4) and were manufactured and ordered 
via Sigma-Aldrich (UK). All stock (desalted) primers were suspended in TE buffer (pH 8.0, 
Ambion®, Invitrogen, California, USA) to ensure a concentration of 100 µM. For genes with 
multiple transcript variants, primers were designed to target all mRNA sequences of the main 
transcript and its variants to enable a global measure of gene expression. This was performed 
Sample Mean CT  (Target Gene) 
Mean CT  
(Reference Gene) 
ΔCT ΔΔCT (2ΔΔCT) 
Sample 1 (Control) 21.34 18.22 3.12 0.00 1.00 
Sample (Test) 19.18 18.00 1.18 -1.94 3.83 
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using the Clustal Omega Multiple Sequence Alignment program 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) to identify gene regions which shared the same 
sequence across all transcript variants. After primer design, specificity was confirmed via 
performing a Basic Local Alignment Search Tool (BLAST) online 
(http://blast.ncbi.nlm.nih.gov/) search and following melt curve analysis. Melt curve analysis 
determines the melting temperature (Tm) and confirms that only the gene of interest was 
amplified (indicated by a single peak) without amplification of unintended targets (indicated 
by a double melt curve peak; see Figure 2.15). Primers sequences for the gene(s) of interest are 
described in the methods section of each experimental chapter.
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Table 2.4. Primer design guidelines  
Considerations Guidelines 
Primer Length 18-24 bp 
Temperature Melt (Tm) Between 56-62˚C to ensure optimal annealing temperatures  
GC Content (%) ~50% GC content 
3 or more GC bases were avoided in the last 5 bases at the 3‟ end of the primer were avoided 
Amplicon Length Less than 200 bp  
General Considerations Primers should span an exon-intron boundary 
Mismatches at the 3' end should be voided 
There should be no complimentary nucleotides at the 3' end for prime pairs 
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Figure 2.17. Mechanisms of pyrosequencing for DNA methylation 
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Example of the cascade of events during a pyrosequencing reaction. (A) Incorporation of a dATP into the DNA template. PPi is released and is 
converted to ATP which provides the necessary energy to oxidise luciferin, producing a light signal. (B) Represents the addition of 2 × 
complimentary dGTPs resulting in a double peak. (C) Depicts no incorporation of the dCTP due to non-complimentary base pairs. The nucleotide 
is therefore degraded by the enzyme apyrase, resulting in no peak. Schematic adapted from Tost and Gut (2007)
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2.10! DNA Extraction and DNA Methylation Analysis 
DNA was extracted using the AllPrep RNA/DNA Mini Kit (Qiagen, UK) if copurifying 
RNA and DNA. Alternatively, the DNeasy Blood and Tissue Mini Kit (Qiagen, UK) was 
used for exclusively extracting DNA. 
2.10.1! DNA Extraction Using the AllPrep RNA/DNA Kit 
Stored AllPrep DNA spin columns following the initial centrifugation step in section 2.9.1 
were first washed  with Buffer AW1 and centrifuged for 15 s at 8,000 × g. Samples were further 
washed with Buffer AW2 and centrifuged for a longer duration of 2 mins at maximum speed 
(20,000 × g). The DNA spin column was placed in a 1.5 ml collection tube and 31 µl of Buffer 
EB was added. Samples were left to incubate at RT for 1 min before centrifuging for 1 min at 
8,000 × g to elute the DNA. The elution step was repeated using a separate collection tube in 
attempt to increase DNA yield without compromising final DNA concentrations. 
2.10.2! DNA Extraction Using the DNeasy Blood and Tissue Kit 
DNA extraction using the commercially available DNeasy Blood and Tissue Kit (Qiagen, UK) 
was conducted according to the manufacturers’ instructions. All procedures, including 
centrifugation were performed at RT. Homogenised bioengineered muscle tissue and cell 
lysates were first thawed at RT. For cells, 200 µl buffer AL (without ethanol) was added to 
each sample and incubated at 56˚C for 10 mins. Following incubation, 200 µl ethanol (96%) 
was added and the new mixture was transferred to a DNeasy Mini spin column placed in a 2 
ml collection tube and centrifuged at 6,000 × g for 1 min. For bioengineered muscle, 200 µl 
buffer AL (with ethanol) and 200 µl ethanol was added in the same step. The spin column was 
then placed into a new 2 ml collection tube and the sample washed with 500 µl of Buffer AW1 
(followed by 1 min centrifugation at 6,000 × g) and 500 µl Buffer AW2 (followed by 3 min 
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centrifugation at 20,000 × g) to dry the DNeasy membrane. Finally, the spin column was placed 
in a 1.5 ml DNase-free collection tube and 21 µl of Buffer AE was added and centrifuged (6000 
× g for 1 min) to elute the sample. The final elution step was repeated in attempt to increase 
DNA yield without compromising purity. 
2.10.3! Assessment of DNA Concentration and Purity 
As with RNA, DNA concentration and purity were assessed using a spectrophotometer 
(NanoDrop™ 2000, Thermo Fisher Scientific, Denmark) with the exception that the extinction 
coefficient for DNA is 50 ng/µl as opposed to 40 ng/µl for RNA (see Equation 2.1). Briefly, 1 
µl of sample stock DNA was pipetted onto the NanoDrop probe and the light absorbed at 260 
nm was quantified to give the total yield (see Equation 2.2). DNA purity was determined from 
the A260/A280 and A260/A230 ratios, with 2 representing the highest quality DNA. DNA 
concentrations and purities are reported within the methods section of each experimental 
chapter throughout this thesis.  
2.10.4! DNA Bisulfite Conversion 
For assessment of DNA methylation, samples are first bisulfite converted (Frommer et al., 
1992). This method entails bisulfite treating purified DNA which converts unmethylated 
cytosine (C) nucleotides to uracil (U) while 5-methylcytosine remains unchanged (Tost & Gut, 
2007). During PCR amplification, U is then converted to thymine (T), allowing methylated and 
non-methylated loci to be distinguished following downstream sequencing analysis. Bisulfite 
conversion procedures throughout this thesis were undertaken using an EZ-96 DNA 
methylation kit (D5002, Zymo Research, USA). Firstly, 5 µl of M-Dilution Buffer was added 
to 500 ng of DNA sample. The total volume was adjusted to 50 µl using nuclease-free H2O 
and samples were incubated at 37˚C for 15 minutes. Following incubation, 100 µl of pre-
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prepared CT-Conversion Reagent was added and samples were transferred to a heating block 
(50˚C) to incubate overnight in the dark. After overnight incubation, samples were placed on 
ice for 10 mins. Once cooled, the sample was added to a Zymo-Spin™ IC Column containing 
400 µl of M-Binding Buffer and was inverted several times to mix the solution. The sample 
and additional M-Binding Buffer mixture was then centrifuged at full speed for 30 s. Each spin 
column was washed with 100 µl M-Wash Buffer before adding 200 µl of M-Desulphonation 
Buffer to each column which were left to incubate at RT for 20 mins. Samples were then 
centrifuged for 30 s at full speed before undergoing 2 × final washes (200 µl of M-Wash Buffer 
washes, interspersed with 30 s centrifugation at full speed). Finally, each spin column was 
transferred to a 1.5 ml nuclease-free tube and 10 µl of M-Elution Buffer was added directly to 
the column membrane. The tubes were centrifuged for 30 s at full speed to elute the bisulfite 
converted DNA, ready for downstream sequencing analysis. 
 
2.11! Loci-Specific Pyrosequencing 
2.11.1! Principle 
Pyrosequencing technology quantitatively determines the methylation status of DNA in real-
time via a series of biochemical reactions catalysed by four key enzymes. This is achieved 
through the release of pyrophosphate (PPi) when a complementary free nucleotide (dNTP) is 
incorporated into the DNA template via DNA polymerase (see Figure 2.17). PPi is then 
converted to ATP via ATP sulfurylase, providing the necessary energy for oxidising luciferin 
via the enzyme luciferase. These reactions result in a light signal which is displayed as a pyro 
gram peak. The enzyme apyrase degrades any unincorporated dNTP’s during each reaction. 
The pyro gram peak intensity is directly proportional to the number of complementary dNTP’s 
added to the DNA template (Tost & Gut, 2007). For example, the incorporation of 2 × dNTPs 
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results in a double peak whereas no incorporation results in no peak displayed (see Figure 
2.17). 
 
2.11.2!  Procedure 
Pyrosequencing assays were purchased from EpigenDX (Hopkinton, USA) and were designed 
to assess the methylation status of 6 × CpG sites in the Intron 1 region of the mouse UBR5 
gene. PCR bias testing was first performed via mixing unmethylated DNA control and 
methylated DNA at various ratios (0, 5, 10, 25, 50, 75 and 100%). Percentage of methylation 
following bias testing was highly correlated with the expected methylation (R2 = 0.9161). Five-
hundred nanograms of DNA was bisulfite converted (see section 2.10.4) and amplified via 
PCR as per the manufacturer’s instructions (HotStar Taq Polymerase, Qiagen). Briefly, each 
30 µl reaction consisting of: 3 µl (1×) of 10× PCR buffer (containing 15 mM MgCl2), 1.8 µl (3 
mM) of 25 mM MgCl2, 0.6 µl (200 µM) of 10 mM dNTPs, 0.6 µl (6 pmol) or forward and 
reverse primers (10 µM), 0.15 µl (0.75 U) HotStar Taq Polymerase (5 U/µl) and 1 µl of bisulfite 
treated DNA was amplified as follows: 95˚C for 15 mins (initial denaturation) followed by 45 
× cycles of 95˚C for 30 s (denaturation); 55˚C for 30 s (annealing); 68˚C for 30 s (extension) 
followed by a final 5 minutes at 68˚C. After amplification, 6-15 µl of PCR sample was mixed 
with a binding solution composed of 2-3 µl streptavidin sepharose beads HP (GE Healthcare 
Life Sciences), 40 µl 2× binding buffer (Qiagen, UK) and 15 µl dH2O. PCR products were then 
purified, washed, denatured with a 0.2 µM NaOH solution and rewashed using the 
Pyrosequencing Vacuum Prep Tool (Pyrosequencing, Qiagen, UK) as per the manufacturer’s 
instructions. Sepharose beads were released into annealing buffer (Qiagen, UK) containing 0.5 
µM of sequencing primer. Once annealed, PCR products were sequenced using the PSQ 96HS 
System (Qiagen, UK) following the manufacturer’s instructions and analysed using QCpG 92 
software (Qiagen, UK).  
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2.12! Targeted Next Generation Bisulfite Sequencing  
2.12.1!   Principle 
As with pyrosequencing, targeted next generation bisulfite sequencing (tNGBS) is a 
‘sequencing by synthesis’ method which uses Ion Torrent™ technology to quantitatively assess 
the methylation status of a number of targets genes at any given time. However, ion torrent 
sequencing relies of the release of hydrogen ions (H+) when complimentary free nucleotides 
(dNTPs) are incorporated into the DNA template by DNA polymerase (Rothberg et al., 2011). 
Firstly, a semiconductor chip is flooded with free dNTPs which fills each microwell containing 
a bead with DNA fragments (see Figure 2.18). If the dNTP is complementary to the DNA 
template, H+ is released which increases the pH. The pH is sensed by an ion sensor and 
converted into a voltage signal which is proportional to the number of nucleotides added to the 
DNA template (see Figure 2.18). For example, the incorporation of 2 × dNTPs releases 2 × H+ 
and a double bp is recorded whereas entry of non-complementary dNTPs results in no voltage 
recorded.  
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A simplified schematic of a bead containing fragments of the DNA template within each 
microwell and the underlying on sensor and electronics. When dNTPs complimentary to the 
DNA template are flood the microwell, H+ are released leading to a change in pH (∆pH) which 
induces a change in surface potential of the sensing layer and a change in potential (∆V). 
Schematic taken from (Rothberg et al., 2011). 
2.12.2!   Procedure 
Targeted Next Generation Bisulfite Sequencing (tNGBS) assays were purchased from 
EpigenDX (Hopkinton, USA) and the same assay design algorithm was used as that for 
pyrosequencing. Assays were designed to target various regulatory regions of mouse genes; 
MSN, TIMP3, WNT9a, CTTN, GSK3ß, PAX3, AGTR1a, BICC1, GRIK2, TRAF1, STAG1, 
ODF2 and UBR5. Two-hundred and fifty nanograms of DNA was first bisulfite converted (see 
section 2.10.4) and amplified via multiplex PCR. Each 20 µl PCR reaction was composed of 5 
U HotStar Taq Polymerase (Qiagen, UK), 0.2 µM of forward and reverse primers for the gene 
of interest and 2 µl of bisulfite treated DNA. All PCR products were verified and quantified 
using the QIAxcel Advanced System (Qiagen, UK). Prior to library preparation, PCR products 
from the same sample were pooled and purified using QIAquick PCR Purification Kit columns 
(Qiagen, UK). Libraries were then prepared using a custom method (EpigenDx, Hopkinton, 
USA). Library molecules were purified using Agencourt AMPure XP beads (Beckman Coulter, 
USA) and quantified using the Qiagen QIAxcel Advanced System. Template preparation and 
enrichment were performed using the Ion Chef system (Thermo Fisher Scientific, Denmark) 
using Ion 520™ and Ion 530™.ExT Chef reagents (Thermo Fisher Scientific, Denmark). 
Enriched template-positive library molecules were then sequenced on the Ion S5™ sequencer 
using an Ion 530™ sequencing chip (Thermo Fisher Scientific, Denmark). FASTQ files from 
Figure 2.18. Mechanisms of tNGBS for DNA methylation 
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the Ion Torrent S5 server were aligned to the local reference database using open-source 
Bismark Bisulfite Read Mapper with the Bowtie2 alignment algorithm. Methylation levels 
were calculated in Bismark by dividing the number of methylated reads by the total number of 
reads. If a data set displayed less than 30 reads, the results were considered unreliable and were 
therefore excluded from further analysis. 
 
2.13! Lysing for Protein and Puromycin Incorporation for Global Protein Synthesis  
2.13.1!   Principle 
Traditionally, muscle protein synthesis (MPS) rates are measured after administering an amino 
acid tracer labelled with either a stable or radioactive isotope. This is achieved via constant 
infusion or administering as a ‘flooding dose’. The rate at which the labelled amino acid is 
synthesised within the muscle is then assessed (Fiorotto et al., 2012). More recently however, 
a nonradioactive technique known as the surface sensing of translation (SUnSET) technique 
was developed to enable the investigation of global and single cell protein synthesis rates both 
in cultured cells (Schmidt et al., 2009) and tissue (Goodman & Hornberger, 2013). This method 
involves the incorporation of the antibiotic puromycin that is a structural analogue of tyrosyl-
tRNA and can therefore be incorporated into translating polypeptide chains at low 
concentrations. As the incorporation of puromycin into nascent peptide chains results in the 
termination of peptide elongation, the rate at which puromycin-labelled polypeptides (detected 
using anti-puromycin antibodies) are formed acts as an effective measure of MPS. 
2.13.2!   Procedure 
Puromycin was incorporated into loaded and non-loaded human myotubes to serve as a marker 
for measurement of global MPS. Following mechanical loading, existing media was aspirated 
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and 2 ml of fresh preheated HDM containing 10 µg/ml of puromycin (P7255, Sigma-Aldrich, 
UK) was added to each well and incubated at 37˚C, 5% CO2 for 15-30 mins. After incubation, 
media containing puromycin was aspirated and each well was thoroughly washed 3 × PBS. 
One-hundred microliters of ice-cold RIPA buffer (10× stock, diluted 1:10 with dH2O, Sigma-
Aldrich, UK) containing protease and phosphatase inhibitors (Pierce™, Thermo Fisher, 
Denmark) was then added to 2 × wells per condition and placed on ice for 10 mins. Lysed cells 
were then scraped and transferred to a 2 ml Eppendorf and centrifugation at 16,000 × g for 10 
mins (4˚C). The supernatant was then transferred to a new Eppendorf tube to undergo 
sonication for 1 min before proceeding with protein quantification (see section 2.12). 
 
2.14! Quantification of Protein Concentration Using the Bicinchoninic Acid (BCA) 
Protein Assay 
2.14.1!   Principle 
Cell lysates were quantified for protein using the bicinchoninic acid (BCA) protein assay. This 
method relies on the reduction of the cuprous ion, Cu+2 to Cu+1 using protein in an alkaline 
solution (Smith et al., 1985). Here, 2 × BCA molecules join with one Cu+1 ion resulting a purple 
coloured solution which is influenced by four key amino acids; cysteine, cystine, tryptophan 
and tyrosine. The colour density is determined by the amount of protein present in the samples 
whereby a dark purple solution suggests a higher protein concentration and vice versa. Protein 
present in each sample can be then be quantified via absorbance at 540-590 nm using a plate 
reader. 
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2.14.2!   Procedure 
The BCA assay was performed using a commercially available kit (23225, Pierce™, Thermo 
Fisher, Denmark) according to the manufacturer’s instructions. Standards were first made up 
using a 1 ml ampule of 2 mg/ml bovine serum albumin (BSA) to ensure known protein 
concentrations of 2000, 1500, 1000, 750, 500, 250, 125 and 25 µg/ml in dH2O. This enabled 
the determination of protein concentrations based on a standard curve generated using a plate 
reader (CLARIOstar® Plus, BMG LABTECH, Germany). The BCA working reagent was 
prepared by mixing reagent A (sodium carbonate, sodium bicarbonate, bicinchoninic acid and 
sodium tartrate in 0.1 M of sodium hydroxide) with reagent B (4% cupric sulphate) at a ratio 
of 1:50. Ten microliters of standard and a blank (dH2O) was pipetted into a 96-well plate in 
triplicates and 10 µl of raw sample was added in duplicates. Using a multichannel pipette, 190 
µl of working reagent was added to each well to ensure a total volume of 200 µl. The well plate 
was then sealed with parafilm and incubated at 37˚C for 30 mins to initiate the biuret reaction. 
Following incubation, the samples were cooled to RT for 5 mins before quantifying protein 
using a CLARIOstar® Plus plate reader at a wavelength of 562 nm.  
2.15! Acetone Protein Precipitation  
After protein quantification using the BCA assay, protein concentrations were considerably 
low for all samples (0.54 ± 0.11 µg/µl in 100 µl). Therefore, acetone protein precipitation 
procedures were carried out in attempt to increase the concentration:volume ratio and enable 
the required amount of protein (~20 µg) to be loaded during SDS-PAGE and western blot 
procedures (see section 2.14). This method entailed adding 5 volumes (~ 500 µl) of acetone to 
each sample and incubating at -20˚C for 1 hr. After incubation, samples were centrifuged  at 
5,000 × g for 5 mins. The supernatant was then removed and samples were left to air-dry in a 
fume hood for 5 mins. Finally, samples were resuspended in 50 µl of ice-cold 1× RIPA buffer 
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(10× stock, diluted 1:10 with dH2O, Sigma-Aldrich, UK) containing protease and phosphatase 
inhibitors (Pierce™, Thermo Fisher, Denmark).  
 
2.16! SDS-PAGE and Western Blot  
2.16.1! Sample Preparation 
Despite attempting to increase protein concentration:volume ratio as described in section 2.13, 
protein concentrations post-precipitation were still considerably low with significant variability 
(0.38 ± 0.37 µg/µl). Therefore, 4 × laemmli buffer (Bio-Rad Laboratories, USA) composed of 
62.5 mM Tris-HCl (pH 6.8), 10% glycerol, 1% SDS, 0.005% Bromophenol Blue was added 
directly to protein lysates. SDS is added for protein denaturation and to negatively charge 
proteins to enable separation according to size. Glycerol increases the density of the sample 
and ensures the sample remains in the well when loaded. ß-ME reduces both inter and intra-
molecular disulphide bonds when heated. Bromophenol blue is added for ease of sample 
detection when loading and running the sample during gel electrophoresis. Tris-HCI ensures 
the buffer is at the required pH, in this case pH 6.8. After dilution, samples were placed on a 
heat block for 10 mins at 95˚C and then placed on ice for a further 10 mins. All samples were 
then vortexed, ready for separation (see section 2.13.2).  
2.16.2! Procedure 
Precast gels (4-15%, Mini-PROTEAN® TGX Stain-Free™, Bio-Rad Laboratories, USA) were 
first assembled to an electrophoresis chamber (Bio-Rad Laboratories, USA) filled with 1× 
running buffer (10× 0.25 M Tris, 1.92 M Glycine, 1% SDS diluted in dH2O, National 
Diagnostics, USA). Ten microliters of molecular weight marker (peqGOLD, Protein Marker 
II, VWR, UK) was loaded into the first well followed by the addition of 25 µl of each sample 
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in subsequent wells ready to undergo separation via gel electrophoresis (15 minutes at 100 V, 
followed by 60 minutes at 150 V). Electrophoresis was terminated once all samples had 
transferred through the entire gel. Gels were then removed from the chambers and imaged 
using a ChemiDoc system (Bio-Rad Laboratories, USA). After imaging, the gels were 
sandwiched between transfer paper and nitrocellulose membrane using a Trans-Blot® Turbo™ 
RTA Mini Nitrocellulose Transfer Kit (Bio-Rad Laboratories, USA) and placed in a trans-blot 
turbo transfer system (Bio-Rad Laboratories, USA) for 7 mins. After transfer, nitrocellulose 
membranes were imaged using the ChemiDoc system to determine total protein. Membranes 
were washed 3 × 5 mins in Tris-buffered saline (0.19 M Tris pH 7.6, 1.3 M NaCl) containing 
0.1% Tween® 20 (TBST, Sigma-Aldrich, UK). Membranes were then blocked  for 1 hr at room 
temperature (RT) in 5% non-fat dry milk (Sigma-Aldrich) made up in TBST. After blocking, 
5 ml of anti-puromycin antibody (MABE343, Merck Millipore, USA) made up at 1:10000 in 
blocking buffer (5% non-fat dry milk in TBST) was added to the membranes and incubated 
overnight on a rocker (4˚C). After overnight incubation, membranes were washed 3 × 5 mins 
in TBST and a secondary antibody (rabbit anti-mouse IgG, ab6728, Abcam, UK) made up at 
1:1000 in blocking buffer, was added and incubated at RT for 2 hrs. Membranes underwent a 
final 3 × TBST washes before adding 1 ml of chemiluminescence signal solution (SuperSignal® 
West Pico Enhancer/Peroxide Solution, Thermo Scientific, UK) to visualise proteins using the 
ChemiDoc system.  
 
2.17! Statistical Analysis 
All statistical analysis throughout this thesis was conducted using either a statistical package 
for the social sciences software (SPSS, version 25.0, SPSS Inc, USA), MiniTab Statistical 
Software (Minitab, Version 18, USA) or GraphPad Software (Prism, Version 7.0a, San Diego, 
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CA). The software used, alongside the specific statistical tests conducted is specified within 
the methods section of each experimental chapter.  
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CHAPTER 3 
Characterisation of a Novel Bioreactor System for 
Mechanically Loading Fibrin Bioengineered Skeletal 
Muscle 
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3.1!Introduction 
Skeletal muscle (SkM) is an extremely mechano-sensitive tissue, responsive to both loading 
and unloading activity. Indeed, mechanical loading/resistance exercise (RE) is considered one 
of the most potent stimuli to influence SkM growth (Goldberg, 1967), remodelling (Benjamin 
& Hillen, 2003; Franchi et al., 2017) and strength (Sale, 1988). Conversely, muscle mass and 
function are somewhat diminished with inadequate loading, for example, during spaceflight, 
aging (sarcopenia) (Hughes et al., 2001; Morse et al., 2005) and periods of immobilization/bed 
rest (Dirks et al., 2016). Since SkM is crucial for locomotion and whole body metabolism, a 
reduction in tissue size and function may be detrimental, leading to earlier onset of disability 
(Laukkanen et al., 1995), morbidity (Kalyani et al., 2014) and all-cause mortality (Ruiz et al., 
2008), thus highlighting the clinical importance of SkM tissue. Understanding the cellular and 
molecular mechanisms that regulate muscle mass and function are therefore of paramount 
importance for characterising optimised loading (i.e. RE) regimes which evoke the greatest 
anabolic response and for the potential development of pharmacological interventions which 
target genes involved in the regulation of SkM mass. 
 
3.1.1! Models for Investigating the Mechanisms of Mechanical Loading In-Vivo 
Throughout the literature, a number of in-vivo and in-vitro models have been employed for 
investigating the physiological responses to mechanical loading. Seminal in-vivo work by 
Goldberg first demonstrated that overloading the plantaris and soleus muscles via removal of 
the gastrocnemius tendon (termed compensatory hypertrophy/synergistic ablation) in 
hypophysectomised rats increased muscle mass by 20 and 40%, respectively within just 5 days 
post tenotomy (Goldberg, 1967). This rapid growth response was directly proportional to the 
amount of labelled amino acids incorporated in the growing muscles (Goldberg, 1968), and an 
increase in total protein synthesis (Goldspink, 1977). Since this early work, several others have 
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employed this model for studying satellite cell activation and proliferation (Schiaffino et al., 
1972; Rosenblatt & Parry, 1992), growth and maturation (Esser & White, 1995), as well as the 
molecules which govern this extreme increase in muscle mass (Goodman et al., 2011; You et 
al., 2019). Despite the extensive use of this model within the literature, the substantial gains 
observed are somewhat supraphysiological since RE results in an increase in muscle size of 
approximately 1–2% per week (Baar & Esser, 1999; Seaborne et al., 2018a). Furthermore, a 
high level of expertise is required to conduct the surgeries and numerous animals are required 
to undertake each experiment which may be costly and not in line with the UK governments 
‘National Centre for the Replacement Refinement & Reduction of Animals in Research 
(NC3Rs)’ aims of reducing the number of animals in scientific research (Prescott & Lidster, 
2017).  
 
In humans, the cellular and molecular responses to mechanical loading in SkM are assessed 
via obtaining muscle biopsies for downstream analysis (Phillips et al., 1997) whereas scanning 
technology (i.e. dual-energy X-ray absorptiometry [DXA], computer tomography [CT] and 
magnetic resonance imaging [MRI]) are used to detect changes at the whole SkM tissue level 
(Franchi et al., 2018). A combination of both methods are typically employed within 
translational research (Seaborne et al., 2018a). After a SkM biopsy, the amount of tissue 
obtained is typically limited given a needle biopsy yields a total ~20–30 mg’s, whereas a 
conchotome biopsy can yield ~100–250 mg of tissue (Turner et al., 2019a). The need for 
repeated biopsies may therefore be necessary, especially if one wishes to explore multiple time 
points. Despite advances in bioptic techniques, the procedure itself can potentially mask any 
intervention-induced changes in mRNA (Friedmann-bette et al., 2012) and protein (Caron et 
al., 2011) expression, particularly if several biopsies are taken over a short time frame. 
Therefore, in-vtro techniques may prove benefical if a number of acute time points are to be 
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explored without the risk of inducing changes in the variables of interest due to the methods 
employed. 
 
3.1.2! Monolayer Culture Models for Investigating the Mechanisms of Mechanical 
Loading In-Vitro 
Methods for studying the mechanical load-induced responses in SkM in-vitro involves the use 
of bioreactors to stretch immortalised (Baar et al., 2000; Hornberger et al., 2005) and/or 
primary (Vandenburgh & Kaufman, 1979; Powell et al., 2002) muscle cells which can be 
routinely isolated via explant culture (Martin et al., 2013), enzymatic digestion (Danoviz & 
Yablonka-Reuveni, 2012) or a combination of both methods (Owens et al., 2015; Turner et al., 
2019a).  
 
Vandenburgh and Kaufman (1979) first applied an external mechanical loading stimulus to 
cultured cells in monolayer, whereby differentiated 12-day old embryonic chick myotubes 
cultured on an elastic silicone membrane underwent 18 hrs of multiaxial/stretch (10%), 
resulting in an increase in amino acid uptake, total/myofibrillar protein synthesis and myotube 
size (Vandenburgh and Kaufman, 1979; Vandenburgh and Kaufman, 1980). The same group 
(Vandenburgh, 1988; Vandenburgh et al., 1989) and others (Eastwood et al., 1996, 1998b; 
Mudera et al., 2000) later developed this model using a computerised step motor to enable the 
application of various stimulatory patterns which mimic the mechanical tension experienced 
in-situ (i.e. stretch-relaxation also termed cyclic stretch or continuous passive stretch which 
mimics bone elongation). Since, others have employed similar models to determine some 
important mechanisms involved in mechanical load-induced muscle development, anabolism 
and hypertrophy. Indeed, using a system based on the design of the horizontal computerised 
cell stimulator, Baar and colleagues demonstrated that acute uniaxial cyclic stretch (12%) of 
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C2C12 cells in monolayer significantly increased the phosphorylation of the well-
characterised protein translation initiator, p70S6K (Baar et al., 2000), a ribosomal kinase which 
was earlier shown to be highly correlated (r = 0.998) with increased muscle hypertrophy 
following chronic RE in rat muscle (Baar & Esser, 1999). It is important to highlight several 
limitations of culturing/loading cells in traditional monolayer culture models. Firstly, cells are 
grown on stiff substrates which can detach from the plastic culture surface after short term 
differentiation, affecting subsequent myotube maturation (Engler et al., 2004; Gilbert et al., 
2010). Given the lack of tension applied to cells in monolayer culture, myotubes form random 
and swirling formation which do not recapitulate the morphology of myofibres in-situ which 
are uniaxially aligned in the direction of tension (see Figure 1.10). As a consequence, 
contraction of cells causes non-uniaxial force production, making it difficult to measure SkM 
function (Brevet et al., 1976; Wehrle et al., 1994). Since force production is the primary 
function of SkM (Baar, 2005), the inability to assess such measures, together with the 
aforementioned environmental and morphological issues with traditional monolayer culture 
systems has led to the development of bioengineered SkM. Despite these limitations, it is also 
important to acknowledge the benefits surrounding monolayer culture models. Specifically, 
monolayer culture is cost effective and requires less technical or complicated culture systems 
compared to bioengineered 3D culture methods, allowing consistent experiments to be more 
routinely performed. Furthermore, required seeding densities are lower in monolayer (Owens 
et al., 2015) versus bioengineered SkM models (Bradey et al., 2008; Mudera et al., 2010; 
Martin et al., 2013) which is an important consideration when initial cell stocks are limited, 
particularly of precious primary cells that senesce if continually passaged. Moreover, cells 
cultured in monolayer may easily be transfected to induce gene-specific 
silencing/overexpression to investigate their mechanistic role(s), and while such methods in 
bioengineered SkM have been performed, they are not yet as well-characterised (Shahini et al., 
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2018). Therefore, careful consideration between the use of monolayer versus bioengineered 
culture systems are important based on the individual studies aims and the appropriate research 
design to address those aims.  
 
3.1.3! Mechanical Loading of Bioengineered SkM In-Vitro 
Pioneering work conducted by Vandenburgh’s group first demonstrated that suspending 
embryonic avian SkM cells onto a collagen gel prolonged cell survival (2-3 weeks) compared 
to traditional monolayer culture, leading to the formation of mature myotubes/fibres evidenced 
by the presence of a representative basal lamina, well-organised contractile machinery and 
myonuclei located on the periphery of the myofibres (Vandenburgh et al., 1988). The first 
studies to engineer human bioengineered muscle also presented similar morphological 
characteristics to in-vivo muscle tissue, given the improved maturation and presence of 
myotubes along the direction of the longitudinal axis (Powell et al., 2002; Mudera et al., 2010; 
Chiron et al., 2012; Martin et al., 2013). Although myotube maturation and morphology are 
somewhat improved when cultured in a representative extracellular matrix (ECM) under 
tension, there is a necessity for an external mechanical and/or electrical input to further improve 
muscle maturation in bioengineered SkM which is achieved via the use of bioreactor devices 
(see Figure 3.1). Indeed, both cyclic and passive stretch of embryonic avian pectoralis muscle 
cultured on collagen-coated elastic substratum’s has been shown to result in greater cell 
proliferation and myotube size (Vandenburgh & Karlisch, 1989; Vandenburgh et al., 1989). 
Furthermore, the same group demonstrated that a combination of both mechanical stimulatory 
patterns applied to human engineered myotubes suspended in a collagen/matrigel matrix led to 
an increase in myotube diameter (~12%) and area (~40%; Powell et al., 2002). Several others 
later mechanically loaded bioengineered SkM to determine the mechanisms underpinning 
load-induced anabolism (Cheema et al., 2005), matrix remodelling (Auluck et al., 2005) and 
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maturation (Heher et al., 2015). However, very few have compared the responses to various 
loading regimes to determine the optimal regime which elicits the greatest anabolic response. 
To bridge this gap, Player and colleagues cultured C2C12 myoblasts in 3D collagen constructs 
over 14 days, resulting in highly aligned myotubes in parallel prior to loading (Player et al., 
2014; see Figure 1.10). Collagen constructs were then subjected to either static (10% stretch 
held for 1 hr to mimic synergistic ablation/compensatory hypertrophy, see Section 3.1.1) or 
ramp (10% stretch attained over a 1 hr period) load using a modified version of the well-
characterised t-CFM bioreactor system (Mudera et al., 2000; Auluck et al., 2005; Cheema et 
al., 2005; Player et al., 2014). Interestingly, static loading increased IGF-I and MMP-9 
expression and decreased IGFBP-5 expression, with no significant change in catabolic genes, 
MuRF-1, MAFbx and myostatin. Taken together, this was suggestive of a positive anabolic 
response and perhaps a potential increase in myotube hypertrophy if this expression profile 
was maintained over a longer period. Indeed, combining both ramp and static load (15% stretch 
attained over a 1 hr period and held for a further 2 hrs) in the same model significantly increased 
myotube size and force production which was concomitant with upregulation of IGF-I and 
MMP-2 mRNA and increased phosphorylation of Akt, p70S6K, 4EBP-1 protein synthetic 
signaling (Aguilar-Agon et al., 2019).  
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A number of bioreactors used to apply mechanical loading to cultured cells. (A) Cells cultured 
on elastic membrane are stretched multiaxially via expansion of the surrounding frames (left 
image - unstretched, right image - stretched by 10%) (taken from Vandenburgh and Kaufman 
1979). (B) A more recent bioreactor used to apply uniaxial stretch to engineered muscle using 
a computerised step motor (taken from Player et al. 2014). (C) An example of the original 
tensioning culture force monitor (t-CFM; taken from Eastwood et al. 1998). (D) A system 
which enables uniaxial stretch of engineered tissues cultured in 6-well plates with higher 
throughput (taken from Powell et al. 2002). (E) The commercially available Flexcell® FX-
5000™ Tension system (Dunn Labortecknik, Germany) used to apply both uniaxial and 
multiaxial load to cells cultured on flexible-bottomed 6-well plates. 
 
Although mechanical loading of bioengineered SkM has served a useful tool for investigating 
the mechano-responses to external load, a regime which more closely mimics RE in-vivo is yet 
to be determined. Furthermore, the mechano-responses to loading have predominantly been 
investigated in collagen engineered muscle (Lewis et al., 2001; Powell et al., 2002; Auluck et 
al., 2005; Cheema et al., 2005; Mudera et al., 2000; Player et al., 2014; Capel et al., 2019) with 
little use of fibrin as the matrix (Heher et al., 2015; Kim et al., 2019). Indeed, the only studies 
to the authors knowledge either loaded C2C12 fibrin bioengineered muscle during 
differentiation (Heher et al., 2015) or to assess contractile force and ECM remodelling with or 
without simultaneous electrical stimulation (Kim et al., 2019). Others have also demonstrated 
that fibrin engineered muscle structure (i.e. stiffness and myotube alignment) is similar to 
native SkM in the absence of loading (Chiron et al., 2012; Martin et al., 2013). Depsite collagen 
(specifically isoform type 1) being the most prevalent matrix protein within native SkM, fibrin 
may prove advantagous for tissue engineering, owing to the lower required seeding densities, 
Figure 3.1. Bioreactor used for loading cells and bioengineered tissues 
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culture time (Yen-Chih Huang, Robert G. Dennis, Lisa Larkin, 2005; Huang et al., 2006; 
Khodabukus & Baar, 2009) and gel stiffness (~12 kPa) which is similar to that of intact muscle 
(Chiron et al., 2012). Moreover, fibrin directly binds vascular endothelial growth factor 
(VEGF) and basic fibroblast growth factor-2 (bFGF-2), alongside indirect binding of insulin-
like growth factor-1 (IGF-I), all of which improve maturation  (Campbell et al., 1999; Sahni & 
Francis, 2000; Sahni et al., 2003). 
 
3.1.4! Aims and Objectives 
As mentioned in section 3.1.3, static (Player et al., 2014; Aguilar-Agon et al., 2019) and 
cyclical/intermittent (Cheema et al., 2005) loading of bioengineered SkM has demonstrated 
changes in mechano-sensitive/anabolic gene expression, albeit in collagen muscle.  Therefore, 
the aim of the present chapter was to characterise the response of these known mechano-
responsive genes to distinct mechanical loading regimes (i.e. static loading versus intermittent 
loading which more closely mimics RE in-vivo) in fibrin muscle using a bioreactor that has not 
been previously used for loading engineered SkM (TC-3 Tension Bioreactor, EBERS Medical 
Technology, Spain; see section 2.5.1). The objective was to confirm that loading of C2C12 fibrin 
engineered SkM was responsive to mechanical loading using the previously uncharacterised 
TC-3 bioreactor system. This would assist in the initial validation of whether this bioreactor is 
a relevant and comparable system for loading fibrin engineered SkM, and for its subsequent 
use in future chapters.   
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3.2!  Methods 
3.2.1! Cell Culture 
C2C12 cells were sub-cultured in gelatin coated T75 flasks containing 20 ml of GM until ~80% 
confluency was attained (see sections 2.2.1 and 2.2.3). Cells were then trypsinised (see section 
2.2.3), counted (see section 2.2.4) and reseeded into new flasks until the required number of 
cells were obtained for fabrication of SkM constructs (see section 3.2.2). All cells throughout 
this chapter were used at passage 10 (P10).  
 
3.2.2! Fabrication of Fibrin Skeletal Muscle Constructs 
Fibrin SkM constructs were prepared as previously described in section 2.4 (Seaborne et al., 
2019; Turner et al., 2019a). Following polymerisation, C2C12 cells were seeded onto the fibrin 
matrix at a density of 5 ! 104 cells/ml in 2 ml GM (see section 2.2.4). GM was changed every 
48 hrs until the cells had reached ~90% confluency, whereby GM was switched to DM for 48 
hrs to initiate differentiation. After 48 hrs in DM, media was replaced with MM for the 
remainder of the experiment at which point, gels were fixed (see section 2.7.3) or removed 
from the sylgard culture dishes to undergo mechanical loading (see section 3.2.3).  
 
3.2.3! Mechanical Stimulation of Fibrin Skeletal Muscle Constructs 
After 14 days in culture, fibrin gels were removed from the culture dishes and transferred to 
the TC-3 bioreactor chambers (see section 2.5). The chambers containing the engineered 
muscle constructs were assembled to the bioreactor system, placed in a humidified incubator 
at 37 ˚C, 5% CO2, ready to undergo mechanical loading (see Figure 2.7). Constructs acting as 
controls (CON, n = 3 replicate cultures) were kept at resting length (12 mm) for 1 hr whereas 
loaded constructs were subject to 10% (1.2 mm) strain, a percentage tension which has been 
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shown to increase myotube hypertrophy (Powell et al., 2002), differentiation (Heher et al., 
2015) and an increased anabolic response at the transcription level (Player et al., 2014) in 
bioengineered muscle. The intermittent loading regime (INT, n = 3 replicate cultures) consisted 
of 4 sets × 10 repetitions (frequency of 0.3 Hz, 0.4 mm/s), each set interspersed with 90 s rest, 
representing 1 of 5 ‘exercises’. Each exercise was separated by 3.5 mins rest whereby 
constructs were kept at resting length. Constructs subjected to static loading (STAT, n = 4 
replicate cultures) were held at 10% of resting length for 1 hr to mimic mechanical overload 
(Player et al., 2014), similar to that observed in in-vivo synergistic ablation/compensatory 
hypertrophy (Goldberg, 1967).  
 
3.2.4! Immunohistochemistry (IHC)  
SkM constructs were fixed in methanol:acetone as described in section 2.7.2. Following 
fixation, fibrin gels were removed from the culture dishes and transferred to 2 ml Eppendorf 
tubes ready for immunostaining (see section 2.7.3). SkM constructs were stained for the 
cytoskeletal intermediate filament protein, desmin (red) and myonuclei (blue) was determined 
using DAPI (see section 2.7.2). Stained gels were then visualised using an inverted 
fluorescence microscope (Nikon, Eclipse Ti-S, Japan) to confirm the formation of highly 
aligned multinucleated myotubes (see Figure 3.2).  
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Immuno-stained microscopic (Nikon, Eclipse Ti-S) images of C2C12 bioengineered fibrin 
muscle constructs at (A) 10× (scale bar = 50 µm) (B) 20× (scale bar = 20 µm) and (C) 40× 
(scale bar = 20 µm) magnification. (D) Z-stack confocal (Olympus, IX83) microscopic image 
(40× magnification). Constructs were stained for desmin (red) and myonuclei (blue) (taken 
from Turner et al. 2019a).  
 
3.2.5! RNA Extraction and Quantitative Real-Time Polymerase Chain Reaction 
(qRT-PCR) 
Three hours post mechanical loading, gels were removed from the bioreactor chambers and 
lysed in 1 ml TRIzol (see section 2.8) for subsequent RNA extraction (see section 2.9.2). RNA 
concentration (387.23 ± 20.30 ng/µl) and purity (2 ± 0.01A260/A280) was assessed using a 
Figure 3.2. Immunostained fibrin bioengineered SkM  
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NanoDrop (see section 2.9.3). Samples were then diluted in nuclease-free H2O to ensure a 
concentration of 70 ng in 9.5 µl (7.37 ng/µl) which was added to 10.5 µl of master mix 
composed of 10 µl SYBR green, 0.2 µl of reverse transcriptase (RT) mix and 0.15 µl of both 
forward and reverse primers in PCR reaction tubes (0.1 ml strips and caps, Qiagen, UK). All 
samples/genes were ran in duplicate. Primer sequences and locations for the genes analysed 
throughout this chapter are described in Table 3.1. After preparation, reaction tubes were 
transferred to a PCR thermal cycler for amplification (see section 2.9.4.2). Once amplified, 
gene expression was quantified using the DDCT (ΔΔCT) equation (Schmittgen & Livak, 2008) 
against the mean CT values of the reference gene, RP-IIß (16.73 ± 0.39, with low variation of 
2.37%) and a non-loaded control (CON) group (see section 2.9.4.3). PCR efficiencies for the 
reference gene (91.95 ± 3.4%, with low variation of 3.71%) and genes of interest (93.44 ± 
8.6%, with a variation of 9.2%) were similar. 
 
Table 3.1 Mouse primers for assessing mechano-responsive genes after loading in 
bioengineered SkM 
Target Gene Primer Sequence (5'-3' end) 
Product 
Length 
Reference 
Sequence Number 
MHC-1 F: CGGTCGAAGTTGCATCCCTA 149 NM_030679.1 
 R:TTCTGAGCCTCGATTCGCTC   
MHC-2 F: GCGAAGAGTAAGGCTGTCCC 76 NM_001039545.2 
 R: GGCGCATGACCAAAGGTTTC   
MHC-4 F: AGGAGGCTGAGGAACAATCC 192 NM_010855.3 
 R: TTCTCCTGTCACCTCTCAACA   
MHC-7 F: TGTGCTACCCAGCTCCAAG 77 NM_080728.2 
 R: CTGCTTCCACCTAAAGGGCTG   
IGF-1 F: CACACCTCTTCTACCTGGCG 189 NM_001314010.1 
 107 
 R: CCACAATGCCTGTCTGAGGT 
  
IGF-1Ea F: GCTTGCTCACCTTTACCAGC 300 NM_010512  
 R: AATGTACTTCCTTCTGGGTCT   
MGF F: GCTTGCTCACCTTTACCAGC 353 NM_010512.5 
 R: AAATGTACTTCCTTTCCTTCTC   
IGFBP-2 F: GATCTCCACCATGCGCCTTC 77 NM_001310659.1 
 R: TGTCACAGTTGGGGATGTGC   
IGFBP-5 F: GAAGAGGTGGTGACAGAG 104 NM_010518.2  
 R: TGACAACAAGATCGGGAA   
MMP-2 F: GACAAGTTCTGGAGATAC 155 NM_008610.2  
 R: TAATAAGCACCCTTGAAG   
MMP-9 F: CTGGCAGAGGCATACTTG 76 NM_013599.2  
 R: GCCGTAGAGACTGCTTCT   
MyoD F: CATTCCAACCCACAGAAC 125 NM_010866.2  
 R: GGCGATAGAAGCTCCAA   
Myogenin F: CCAACTGAGATTGTCTGTC 173 NM_031189.2 
 R: GGTGTTAGCCTTATGTGAAT   
MuRF-1 F: GAGGGCCATTGACTTTGGGA 97 NM_001039048.2 
 R: TTTACCCTCTGTGGTCACGC    
MAFbx F: TCGACTGCCATCCTGGATTC 104 NM_133521.1  
 R: TTCTTTTGGGCGATGCCACT   
RP-IIß F: GGTCAGAAGGGAACTTGTGGTAT 197 NM_153798.2  
  R: GCATCATTAAATGGAGTAGCGTC     
    
3.2.6!  Statistical Analysis 
All statistical analysis was conducted using SPSS software (version 25, SPSS Inc, USA). A 
one-way between subjects’ ANOVA was used to detect statistical differences in gene 
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expression between conditions. A pair-wise comparison post-hoc test was performed using 
Tukey HSD where main effects for condition occurred. The alpha value of significance was 
set at P < 0.05. All data is represented as the mean ± standard error of mean (SEM). 
 
3.3! Results 
3.3.1! Myosin Heavy Chain (MHC) mRNA Expression After Mechanical 
Loading 
The mRNA expression of myosin heavy chain (MHC) genes, MHC-1, MHC-2, MHC-4 and 
MHC-7, encoding for contractile proteins, MHC-IIx, MHC-IIa, MHC-IIb and MHC-1, 
respectively, were first determined in loaded (INT and STAT) and non-loaded (CON) 
constructs.  
MHC-1 Expression 
There was no significant main effect for condition on MHC-1 mRNA expression (F2,9 = 2.30, 
P = 0.17), despite a greater increase following STAT (1.34 ± 0.18) versus INT (0.87 ± 0.19, 
95% CI = -1.15 to 0.21, P = 0.17) and CON (1.01 ± 0.09, 95% CI = -0.34 to 1.02, P = 0.37; 
see Figure 3.3). There was also no statistical difference between INT and CON conditions 
(95% CI = -0.86 to 0.59, P = 0.85). 
MHC-2 Expression 
As with MHC-1, there was no significant main effect for condition on MHC-2 mRNA 
expression (F2,8 = 2.36, P = 0.18), despite an increase following STAT (1.5 ± 0.18) versus INT 
(1.11 ± 0.18, 95% CI = -1.12 to 0.33, P = 0.29) and CON (1.02 ± 0.14, 95% CI = -1.21 to 0.24, 
P = 0.18; see Figure 3.3). Furthermore, there was no statistical difference between INT and 
CON conditions (95% CI = -0.64 to 0.81, P = 0.93). 
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MHC-4 Expression 
There was no significant main effect for condition on MHC-4 mRNA expression (F2,9 = 0.38, 
P = 0.7), with no significant difference between CON (1.02 ± 0.15) versus INT (1.29 ± 0.41, 
95% CI = -1.38 to 0.83, P = 0.76) and STAT (1.3 ± 0.17, 95% CI = -1.31 to 0.75, P = 0.72; see 
Figure 3.3). There was also no statistical difference between INT and STAT conditions (95% 
CI = -1.04 to 1.03, P = 1). 
MHC-7 Expression 
There was no significant main effect for condition on MHC-7 expression (F2,9 = 0.82, P = 0.48), 
wuth no statistical difference between CON (1.07 ± 0.3) versus INT (0.94 ± 0.22, 95% CI = -
1.5 to 1.76, P = 0.97) and STAT (1.56 ± 0.45, 95% CI = -2.01 to 1.04, P = 0.64; see Figure 
3.3). Furthermore, there was no significant difference between INT and STAT conditions (95% 
CI = -2.14 to 0.91, P = 0.49).  
Overall, the present section suggests that neither acute STAT or INT loading was able to induce 
a significant change in myosin heavy chain mRNA expression, despite a non-significant 
increase after STAT for all isoforms analysed herein. This could be due to the acute loading 
stimulus applied and that chronic loading may induce significant changes in MHC mRNA 
expression in bioengineered SkM. However, MHC gene expression following chronic loading 
in fibrin engineered SkM warrants future investigation. 
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Myosin heavy chain mRNA expression in loaded (INT, n = 3 and STAT, n = 4) and non-loaded 
(CON, n = 3) bioengineered SkM constructs. There was no significant main effect for loading 
on myosin heavy chain-1, 2, 4 or 7 mRNA expression (P > 0.05). Data is presented as mean ± 
standard error of mean (SEM). 
 
3.3.2! IGF-1, IGF-IEa and MGF mRNA Expression After Mechanical Loading 
To investigate the response of known transcripts associated with the anabolic response to 
loading in bioengineered SkM (Cheema et al., 2005; Player et al., 2014), mRNA expression of 
total mature IGF-I and isoforms, IGF-IEa and MGF were quantified following the contrasting 
INT/STAT regimes. 
IGF-I Expression 
There was no significant main effect for condition on IGF-I mRNA expression (F2,9 = 1.36, P 
= 0.32), despite a greater increase following INT (1.58 ± 0.40) versus STAT (1.02 ± 0.25, 95% 
CI = -0.56 to 1.66, P = 0.36) and CON (1 ± 0.04, 95% CI = -0.61 to 1.76, P = 0.38; see Figure 
Figure 3.3. MHC mRNA expression after mechanical loading 
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3.4). There was also no statistical difference between STAT and CON (95% CI = -1.09 to 1.13, 
P = 1). 
IGF-IEa 
There was a significant main effect for condition on IGF-IEa mRNA expression (F2,9 = 13.71, 
P < 0.01) which was greatest following INT (2.97 ± 0.37) versus STAT (1.31 ± 0.28, 95% CI 
= 0.53 to 2.79, P = 0.01) and CON (1 ± 0.07, 95% CI = 0.76 to 3.18, P = 0.01; see Figure 3.4). 
However, there was no statistical difference between STAT and CON (95% CI = -0.82 to 1.44, 
P = 0.72). 
MGF  
As with IGF-IEa, there was a significant main effect for condition on MGF mRNA expression 
(F2,9 = 17.67, P < 0.01) which significantly increased following INT (2.18 ± 0.1) versus STAT 
(1.17 ± 0.19, 95% CI = 0.42 to 1.77, P = 0.01) and CON (1.01 ± 0.08, 95% CI = 0.63 to 2.07, 
P < 0.01; see Figure 3.4). However, there was no statistical difference between STAT and CON 
( 95% CI = -0.41 to 0.93, P = 0.53). 
Despite the non-significant increase in IGF-1 mRNA expression following INT loading, the 
present section suggests that INT loading elicited the greatest anabolic response given 
isoforms, IGF-IEa and MGF demonstrated a significant increase in mRNA expression after 
INT versus STAT and CON.  
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IGF-I , IGF-IEa and MGF mRNA expression in loaded (INT, n = 3 and STAT, n = 4) and non-
loaded (CON, n = 3) bioengineered SkM. There was no significant main effect for loading on 
IGF-1 mRNA expression (P > 0.05), however, IGF-IEa and MGF mRNA was significantly 
upregulated after INT versus CON (*) and STAT (#) loading (P < 0.05). Data is presented as 
mean ± standard error of mean (SEM). 
 
3.3.3! IGFBP-2 and IGFBP-5 mRNA Expression After Mechanical Loading 
Following determination of the transcriptional IGF-I responses after loading, mRNA 
expression of IGF binding protein genes, IGFBP-2 and IGFBP-5 were also quantified due to 
previous studies demonstrating an altered response to loading in bioengineered muscle (Player 
et al., 2014). 
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Figure 3.4. IGF-I, IGF-IEa and MGF mRNA expression after mechanical loading 
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IGFBP-2 
There was no significant main effect for condition on IGFBP-2 mRNA expression (F2,9 = 0.97, 
P = 0.43), despite a non-significant reduction following INT (0.73 ± 0.25) versus STAT (1.25 
± 0.27, 95% CI = -1.61 to 0.58, P = 0.40) and CON (1.06 ± 0.26, 95% CI = -1.49 to 0.84, P = 
0.7; see Figure 3.5). There was also no statistical difference between STAT and CON (95% CI 
= -0.9 to 1.28, P = 0.87). 
IGFBP-5 
As with IGFBP2, there was no significant main effect for condition on IGFBP-5 mRNA 
expression (F2,8 = 1.23, P = 0.36), despite a reduction following INT (0.8 ± 0.09) versus STAT 
(1.31 ± 0.38, 95% CI = -1.5 to 0.49, P = 0.33,) and CON (1 ± 0.04, 95% CI = -1.2 to 0.8, P = 
0.82; see Figure 3.5). There was also no statistical difference between STAT and CON (95% 
CI = -0.69 to 1.3, P = 0.64). 
Collectively, the present section demonstrates that neither loading regime elicited a significant 
response in IGFBP-2 and -5 mRNA expression. Interestingly however, the non-signficant 
reduction in mRNA following INT coincides with the non-significant increase in IGF-1 and 
upregulation of IGF-IEa and MGF after INT (see section 3.3.2). 
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IGFBP-2 and -5 mRNA expression in loaded (INT, n = 3 and STAT, n = 4) and non-loaded 
(CON, n = 3) bioengineered SkM. There was no significant main effect for loading on IGFBP-
2 and -5 mRNA expression (P > 0.05). Data is presented as mean ± standard error of mean 
(SEM). 
 
3.3.4! MMP-2 and MMP-9 mRNA Expression After Mechanical Loading 
The mRNA expression of matrix remodelling genes, MMP-2 and MMP-9 were investigated to 
determine whether such loading regimes in fibrin muscle had the potential to initiate ECM 
turnover as shown previously after loading in engineered collagen muscle (Mudera et al., 2000; 
Auluck et al., 2005; Player et al., 2014). 
MMP-2 
There was no significant main effect for condition on MMP-2 mRNA expression (F2,9 = 0.25, 
P = 0.79) with no statistical differences between CON (1 ± 0.05) versus INT (1.15 ± 0.02, 95% 
Figure 3.5. IGFB-2 and IGFBP-5 mRNA expression after mechanical loading 
 
 
C
O
N
IN
T
ST
AT
C
O
N
IN
T
ST
AT
0.0
0.5
1.0
1.5
2.0
ΔΔ
C
T 
Ex
pr
es
sio
n 
Va
lu
e
IGFBP-2 IGFBP-5
 115 
CI = -0.8 to 0.51, P = 0.8) and STAT (1.03 ± 0.2, 95% CI = -0.64 to 0.58, P = 0.99; see Figure 
3.6) together with no significant difference between INT and STAT (95% CI = -0.49 to 0.73, 
P = 0.84). 
MMP-9 
Interestingly, there was a significant main effect for loading on MMP-9 mRNA expression 
(F2,9 = 9.69, P = 0.01) with the greatest increase observed after INT (1.89 ± 0.32) versus STAT 
(0.89 ± 0.03, 95% CI = 0.29 to 1.7, P = 0.01) and CON (1.01 ± 0.09, 95% CI = 0.13 to 1.63, P 
= 0.03; see Figure 3.6). However, there was no statistical difference between STAT and CON 
(95% CI = -0.82 to 0.59, P = 0.88). 
Taken together, the present data suggests that INT loading evoked the greatest ECM turnover 
response in following mechanical loading in fibrin bioengineered SkM. This was evidenced by 
the significant increase in MMP-9 mRNA expression observed following INT versus STAT 
and CON. 
 
  
 
 
 
 
 
MMP-2 and MMP-9 mRNA expression in loaded (INT, n = 3 and STAT, n = 4) and non-
loaded (CON, n = 3) bioengineered SkM. There was no significant main effect for loading on 
Figure 3.6. MMP-2 and MMP-9 mRNA expression after mechanical loading 
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MMP-2 mRNA expression (P > 0.05), however, MMP-9 mRNA was significantly upregulated 
after INT versus CON (*) and STAT (#) loading (P < 0.05). Data is presented as mean ± 
standard error of mean (SEM). 
 
3.3.5! MyoD and Myogenin mRNA Expression After Mechanical Loading 
Given the importance of the well-characterised myogenic regulatory factors, myoD and 
myogenic during development and regeneration following damaging stimuli, their mRNA 
expression was analysed in response to distinct loading regimes. 
MyoD 
There was no significant main effect for condition on myoD mRNA expression (F2,8 = 1, P = 
0.42), despite an elevation following INT (1.38 ± 0.23) versus CON (1.01 ± 0.11, 95% CI = -
1.2 to 0.45, P = 0.41) and STAT (1.14 ± 0.21, 95% CI = -0.58 to 1.1, P = 0.64; see Figure 3.7). 
There was also no statistical differences between CON and STAT (95% CI = -0.95 to 0.7, P = 
0.89). 
Myogenin 
There was no significant main effect for condition on myogenin mRNA expression (F2,8 = 1.23, 
P = 0.36), despite a lower expression in CON (1.03 ± 0.18) versus INT (2.02 ± 0.62, 95% CI 
= -2.94 to 0.97, P = 0.33) and STAT (1.65 ± 0.44, 95% CI = -2.57 to 1.34, P = 0.62; see Figure 
3.7). There was also no statistical differences between INT and STAT (95% CI = -1.59 to 2.32, 
P = 0.84). 
The present data demonstrates that mechanical loading of fibrin bioengineered SkM did not 
evoke a significant change in myoD or myogenin, despite a slight increase following INT 
versus STAT and CON.  
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MyoD and myogenin mRNA expression in loaded (INT, n = 3 and STAT, n = 3) and non-
loaded (CON, n = 3) bioengineered SkM. There was no significant main effect for loading on 
myoD and myogenin mRNA expression (P > 0.05). Data is presented as mean ± standard error 
of mean (SEM). 
 
3.3.6! MuRF-1 and MAFbx mRNA Expression After Mechanical Loading 
After analysing the acute anabolic response to the loading regimes employed herein, the 
expression of the well-characterised E3 ubiquitin ligases MuRF-1 and MAFbx involved in 
muscle atrophy were examined. 
MuRF-1 
There was no significant main effect for loading regime on MuRF-1 mRNA expression (F2,8 = 
4.48, P = 0.06), despite lower mRNA expression in CON (1.01 ± 0.11) versus INT (2.72 ± 
0.31, 95% CI = -3.66 to 0.25, P = 0.08) and STAT (2.61 ± 0.71, 95% CI = -3.55 to 0.36, P = 
Figure 3.7. MyoD and myogenin mRNA expression after mechanical loading 
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0.1; see Figure 3.8). There was also no statistical differences between INT and STAT (95% CI 
= -1.85 to 2.06, P = 0.98). 
MAFbx 
As with MuRF-1, there was no significant main effect for condition on MAFbx mRNA  
expression (F2,8 = 2.11, P = 2.02), despite in an non-signficant increase following STAT (1.8 
± 0.41) versus INT (1.21 ± 0.24, 95% CI = -1.81 to 0.63, P = 0.36) and CON (1.02 ± 0.13, 95% 
CI = -2 to 0.43, P = 0.1; see Figure 3.8). There was also no statistical significance between INT 
and CON (95% CI = -1.41 to 1.02, P = 0.88). 
Data reported herein clearly demonstrates an increase in MuRF-1 and MAFbx mRNA 
expression following mechanical loading. Interestingly however, such changes failed to reach 
statistical significance, potentially due to the large variation observed within loading conditions 
(i.e. INT and STAT). Future studies should therefore consider increasing sample size to 
determine whether mechanical loading of fibrin muscle is indeed able to induce a significant 
change in gene expression that could be representative of the acute upregulatory response 
observed following mechanical overload in-vivo (Baehr et al., 2014). 
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MuRF-1 and MAFbx mRNA expression in loaded (INT, n = 3 and STAT, n = 3) and non-
loaded (CON, n = 3) bioengineered SkM. There was no significant main effect for condition 
on MuRF-1 and MAFbx mRNA expression (P > 0.05). Data is presented as mean ± standard 
error of mean (SEM). 
3.4! Discussion 
The aim of the present chapter was to characterise the use of a novel bioreactor system for 
loading bioengineered SkM in-vitro. Therefore, targeted gene expression of known mechano-
responsive genes in-vivo that have also been shown to be regulated after loading collagen 
muscle using previously published bioreactor systems (Mudera et al., 2000; Cheema et al., 
2005; Player et al., 2014; Aguilar-Agon et al., 2019) were assessed after loading in fibrin 
engineered SkM. Specifically, genes involved in SkM maturation/phenotype, 
anabolism/hypertrophy, atrophy and SkM/ECM remodelling were compared after static 
(STAT) and intermittent (INT) loading in murine fibrin bioengineered SkM using the TC-3 
bioreactor. The comparison of STAT and INT loading which mimic synergistic 
ablation/compensatory hypertrophy and acute eccentric lengthening exercise in-vivo, 
respectively also enabled the characterisation of which regime elicits the greatest anabolic 
response to loading in mature fibrin bioengineered SkM.  
 
3.4.1! Myosin Heavy Chain (MHC)-1, 2, 4 and 7 mRNA Expression After 
Loading 
Mechanical load-induced mRNA changes of myosin heavy chains (MHC)-1, 2, 4 and 7 which 
encode for contractile proteins, MHC-IIx, IIa, IIb and I, respectively were first assessed. MHCs 
Figure 3.8. MuRF-1 and MAFbx mRNA expression after mechanical loading 
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are cytoskeleton proteins which determine the stage of maturation during embryogenesis and 
the muscle phenotype in adult tissue. During the developmental stages, embryonic (MHC-3) 
and slow (MHC-7) isoforms are firstly expressed, followed by MHC-8 (perinatal) during the 
foetal and neonatal stages where fast (MHC-1, 2 and 4) isoform expression becomes prominent 
during late foetal myogenesis (Schiaffino & Reggiani, 2011; Chal & Pourquié, 2017). 
Mechanical loading has been shown to alter MHC phenotypic expression whereby a single 
bout of RE was sufficient in upregulating expression of MHC-1, 2 and 7 in human SkM with, 
MHC1 (IIx) considered the most responsive (~75% increase versus ~40% and 45% increase in 
MHC-7 and MHC-2, respectively; Willoughby & Nelson, 2002). Mechanical loading fibrin 
muscle within the present chapter failed to recapitulate such findings since neither regime 
elicited a significant alteration in MHC expression (see Figure 3.3). It is worth noting however 
that changes in MHC expression was only prevalent 6 hrs post exercise (versus pre and 30 mins 
post), suggestive that the discrepancies in results may not necessarily be a consequence of the 
model and/or regimes employed herein, but possibly the timepoint at which MHC mRNA was 
analysed in loaded engineered muscle (3 hrs post). Furthermore, Sugiura et al., (1993) observed 
alterations in MHC isoforms following synergistic ablation in 6 week old Wistar rats whereby 
tenotomy of the gastrocnemius muscle resulted in a decrease in MHC-IIb with a concomitant 
increase in MHC-IIx and MHC-I in the plantaris muscle (Sugiura et al., 1993). However, 
overload of the soleus muscle increased MHC-I only, highlighting the influence of the 
originating muscle phenotype. Such findings therefore make direct comparisons to MHC 
expression within the present chapter difficult since C2C12 cells used herein are derived from 
the thigh muscle of C3H mice which is composed of mixed muscle fibres.  
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3.4.2! IGF-IEa and MGF mRNA Expression Significantly Increased After 
Loading 
To determine which loading regime elicits the greatest anabolic response in fibrin 
bioengineered muscle, mRNA expression of known anabolic genes, insulin-like growth factor 
I (IGF-I) together with isoforms, IGF-IEa and mechano-growth factor (MGF; IGF-IEb in 
rodents and IGF-IEc in humans) were investigated. IGF-I is a growth factor with a pivotal role 
in inducing SkM hypertrophy, alongside stimulating cell proliferation and differentiation 
(Florini et al., 1996). Despite IGF-I being primarily produced in the liver as an endocrine 
hormone, Matheny and colleagues highlighted the importance of local production of IGF-I 
from the muscle, reporting similar strength gains following 16 weeks of RE in severely liver 
IGF-I deficient (~80%) mice compared to wild-type mice (Matheny et al., 2009). Furthermore, 
local infusion of IGF-I in rat tibialis anterior (TA) muscle resulted in a ~9% increase in lean 
mass compared to the contralateral control TA muscles (Adams & McCue, 1998). An 
associated increase in IGF-I mRNA expression following mechanical loading of bioengineered 
muscle has also been observed, whereby stretching mature (14 days in culture) C2C12 type 1 
collagen constructs significantly increased IGF-I mRNA expression, specifically in response 
to static load (10% stretch for 1 hr) versus continuous (increased stretch over 1 hr until 10% 
load was attained) and non-loading constructs (Player et al., 2014). Such findings would 
oppose those presented herein considering IGF-I mRNA expression was not significantly 
regulated in response to STAT versus CON and INT (see Figure 3.4). Furthermore, IGF-1 was 
not significantly altered following INT, despite a modest increase versus CON and STAT (see 
Figure 3.4). 
 
IGF-IEa and mechano-growth factor (MGF) are splice variants of the IGF-I gene and have 
different modes of action in SkM (Yang et al., 1996; Goldspink, 1999; Yang & Goldspink, 
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2002). The mechano-sensitive isoform, MGF enhances C2C12 cell proliferation (independent 
of IGF-I receptor) but inhibits terminal differentiation, whilst IGF-IEa promotes cell 
differentiation (Yang & Goldspink, 2002; Matheny & Nindl, 2011). Furthermore, single legged 
knee extension RE (10 × 6 reps, 80% 1RM) significantly increased MGF, but not IGF-IEa 
expression in young human muscle, supporting the notion that the MGF isoform is markedly 
upregulated in response to mechanical loading (Hameed et al., 2003). Cheema and colleagues 
(2005) assessed MGF and IGF-IEa expression in response to 12 hrs of 10% cyclic (1, 5 and 10 
cycles/hr) and ramp (10% stretch for 10 min [held for remaining 11 hr 50 mins], 1 hr [held for 
remaining 11 hr] and 12 hr) stretch in C2C12 type 1 collagen 3D matrices (maintained in DM 
over 6 days; Cheema et al., 2005). Both IGF-IEa and MGF expression were greatest when 
constructs were subject to 10% ramp stretch over 1 hr (and held at 10% for the remaining 11 
hr). During cyclic stretch, IGF-IEa expression decreased in a dose dependant manner whereas 
MGF expression significantly increased at a rate of 10%/hr (1 cycle/hr) relative to unloaded 
static controls. Therefore, this study was suggestive of a suitable anabolic response following 
ramp stretch whereas MGF and IGF-IEa expression within the present chapter was greatest 
following INT loading in fibrin muscle (see Figure 3.4). Such opposing findings may be a 
consequence of the level of maturation given a low percentage (5%) of myotubes were 
identified within Cheema et al. (2005), suggestive that constructs were not fully mature and 
perhaps represented a model of muscle development during bone growth (e.g. ramp stretch) 
and the results cannot therefore be necessarily extrapolated to the effect of mechanical loading 
on mature myotubes.  
 
3.4.3! IGFBP-2 and IGFBP-5 mRNA Expression After Loading 
After examining IGF-I, IGF-IEa and MGF gene expression, mRNA of IGF binding proteins, 2 
(IGFBP-2) and 5 (IGFBP-5), were assessed given their importance in modulating IGF-I action, 
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having stimulatory and inhibitory effects both in-vivo (Rehfeldt et al., 2010) and in-vitro 
(Sharples & Stewart, 2011; Sharples et al., 2013). Indeed, IGFBP-2 binds extracellularly to 
IGF-I with high affinity which subsequently reduces IGF-I binding to its receptor (IGF-IR) and 
downstream signaling of the MAPK and Akt pathway, responsible for cell proliferation and 
differentiation, respectively (Florini et al., 1996; Coolican et al., 1997; Li et al., 2000) and are 
involved in protein synthesis/hypertrophy in response to mechanical overload in-vivo 
(Miyazaki et al., 2011). Work from our laboratory also demonstrated impaired Akt signaling 
and C2C12 cell differentiation when neutralising IGFBP-2, which was subsequently restored 
following knockdown of the downstream target, phosphatase tensin homologue (PTEN), 
evidenced by the increase in myotube hypertrophy (Sharples et al., 2013). In-vivo, mice 
overexpressing IGFBP-2 also displayed higher fat mass and lower lean mass and myofibre size 
as a result of reduced satellite cell proliferation (identified via a reduction in marker Ki67; 
Rehfeldt et al., 2010). Furthermore, IGF-I and IGFBP-5 expression significantly increased and 
decreased, respectively following mechanical overload of the mouse soleus muscle (Awede et 
al., 1999). In humans, isometric leg strength is also compromised in older men possessing 
higher serum IGFBP-2 concentrations (van den Beld et al., 2003), demonstrating the 
relationship between increased IGFBP-2 and impaired muscle function. Such findings 
corroborate with the increase in IGF-I and decrease in IGFBP-5 expression following static 
load (1 hour of 10% stretch) in bioengineered collagen muscle constructs (Player et al., 2014). 
However, the imposed anabolic response may be compromised given IGFBP-2 was also 
elevated, reducing the affinity of IGF-1 to its receptor and downstream signaling of 
MAPK/ERK and Akt pathway. The modest increase in IGF-I and isoforms, MGF and IGF-IEa 
(see Figure 3.5) following INT within the present chapter coincided with the lowest, albeit non-
significant reduction in IGFBP-2 and IGFBP-5 mRNA expression (see Figure 3.5), indicating 
that INT loading of fibrin muscle results in a the greatest anabolic response. In contrast, IGF-I 
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and IGFBP’s demonstrated a non-significant increase and decrease in mRNA expression, 
respectively in response to STAT showing a consistent correlation between gene regulatory 
networks of both IGF-I and its binding proteins following mechanical loading. The present 
chapter therefore suggests that MAPK and Akt signaling may be enhanced following INT 
stretch which may result in protein synthesis and subsequent muscle hypertrophy if such 
expression was maintained overtime. However, MAPK and Akt signaling in fibrin muscle, 
alongside interactions between IGF-I and IGFBP’s that have been explored within monolayer 
culture (Sharples et al., 2013) warrant future investigation in bioengineered SkM.  
 
3.4.4! mRNA Expression of the Matrix Remodelling Gene, MMP-9 Significantly 
Increased After Loading 
Given the importance of matrix remodelling for cell migration and fusion during muscle 
development and regeneration (Lewis et al., 2000), expression of the matrix metalloproteinases 
(MMPs), MMP-2 (gelatinase A) and MMP-9 (gelatinase B) were assessed.  MMP-2 and MMP-
9 are highly expressed in single muscle derived cells (Lewis et al. 2000) and are key for 
degradation of basement membrane proteins during matrix remodelling (Lewis et al., 2001). 
Under resting condition, MMP-2 is constitutively expressed in SkM, which is further 
upregulated following mechanical stretch (Mudera et al., 2000; Auluck et al., 2005). Indeed, 
ramp (15% for 6 hours) but not cyclic (1.5 min stretch, 1.5 min hold followed by 1.5 min 
release of stretch for 6 hrs) stretch induced a significant increase in MMP-2 expression in 
human masseter muscle suspended onto 3D collagen sponges (Auluck et al., 2005). 
Furthermore, 4 hrs of ramp and static load combined (15% stretch attained over 1 hr and held 
for an additional 3 hrs) significantly increased MMP-2 expression 21 hrs post stretch in C2C12 
collagen engineered muscle which coincided with increased myotube width and fusion index 
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(Aguilar-Agon et al., 2019). In the present chapter however, no significant difference in MMP-
2 expression was observed, regardless of the stretch regime employed (see Figure 3.6).  
MMP-9 expression is upregulated following muscle damaging stimuli (Carmeli et al., 2004). 
Under nondamaging conditions (i.e. muscle development) however, the absence of MMP-9 in 
female null mice significantly altered muscle fibre CSA and fibre type distribution compared 
to wild-type mice with no change in type IV collagen or hindlimb twitch force, suggestive that 
decreased MMP-9 may attenuate perinatal and postnatal growth (Mehan et al., 2011). Others 
have also observed an altered muscle fibre CSA in MMP-9 overexpressed mice, resulting in 
larger TA and soleus muscle CSA, alongside increased fibre diameter and isometric muscle 
strength (Dahiya et al., 2011). Taken together, these studies highlight the associated 
upregulation in MMP-9 and muscle hypertrophy, strength and matrix remodelling, although 
the exact mechanisms underpinning these responses are yet to be determined. In-vitro, Player 
and colleagues observed a significantly higher MMP-9 expression following static versus ramp 
load (Player et al., 2014). Interestingly however, combined ramp and static loading (15% 
stretch attained over 1 hr and held for an additional 3 hrs) using the same model (C2C12 collagen 
engineered muscle) failed to replicate such findings given no change in MMP-9 mRNA was 
observed (Aguilar-Agon et al., 2019). In fibrin engineered muscle, MMP-9 expression was 
greatest following INT versus STAT, suggestive of an elevated signal for matrix remodelling 
that would potentiate muscle hypertrophy if the upregulated expression was chronically 
maintained (see Figure 3.6). Despite the discrepancies in MMP-9 expression in response to 
mechanical load, both studies demonstrated that MMP-9 is mechano-sensitive in bioengineered 
muscle, regardless of the matrix in which cells are cultured in. 
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3.4.5! mRNA Expression of the Myogenic Regulatory Factors, MyoD and 
Myogenin After Loading 
Seminal work in the 1980’s first described the importance of the myogenic regulatory factors 
(MRFs), myoD and myogenin for myogenic determination and differentiation, respectively 
(Davis et al., 1987; Wright et al., 1989). Since, these basic helix-loop-helix (bHLH) 
transcription factors have received considerable attention to further determine their roles during 
developmental myogenesis and satellite cell function and regeneration in adult/mature muscle 
(reviewed extensively in Zammit, 2017). Several groups have also investigated the mechano-
responses following passive stretch in rodents (Gomes et al., 2006; Peviani et al., 2007) and 
RE in humans (Willoughby & Nelson, 2002; McKay et al., 2008). Indeed, passive stretching 
of the rat soleus muscle via manually holding the ankle in full dorsiflexion for 10 × 1 mins 
(each stretch interspersed with 30 s rest) induced a ~1.7-fold increase whereas continuous 
stretch for 30 mins induced a ~3.5-fold increase in MyoD gene expression at 24 hrs post but 
not immediately, 8, 48, 72 or 168 hrs (Gomes et al., 2006; Peviani et al., 2007). In humans, 
performing 300 × maximal knee extensions (30 × 10 reps, each set interspersed with 1 min 
rest) induced a 2-fold increase in myoD just 4 hrs post exercise which dropped by 24 hrs and 
remained stable from thereon (~120 hrs post; McKay et al., 2008). Interestingly however, 
myogenin significantly increased at 4 hrs (~2.2-fold) but peaked at 72 hrs (~2.8-fold) and 
remained elevated at 120 hrs post (~2.5-fold). Such findings suggests myoD may be acutely 
regulated following damaging stimuli to enable satellite cell activation and therefore initiate 
regeneration, whereas myogenin is more present during the latter stages where myoblasts 
terminally differentiate to repair the damage portion of the muscle fibre (Zammit, 2017). In-
vitro, mechanically stretching (15% for 1 s followed by 1 s rest for ~48 hrs) C2C12 cells 
differentiated on collagen-coated flexible-bottomed 6-well plates significantly increased 
expression of both myoD and myogenin after 24 hrs of stretch (Abe et al., 2009). Despite an 
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elevation in myoD and myogenin following INT loading in the present chapter, this increase 
did not reach statistical significance and therefore did not support the aforementioned previous 
findings (see Figure 3.8). It is important to note however that expression of myoD (Seward et 
al., 2001) and myogenin (Loughna & Brownson, 1996) is muscle and fibre type specific and 
may partially explain discrepancies observed when compared to in-vivo rodent studies (Gomes 
et al., 2006; Peviani et al., 2007). Indeed, passive stretch was conducted in the rat soleus 
muscles that have different fibre type compositions to the C3H mice thigh muscles of which 
C2C12 cells are derived. Furthermore, the direction of stretch (i.e. multiaxial versus uniaxial) 
has also been shown to induce differential mechano-responses even when using the same C2C12 
cell line cells (Hornberger et al., 2005), making direct comparisons between stretch in these 
disparate in-vitro model difficult. Additionally, the loading duration and/or timepoint at which 
mRNA expression was assessed throughout this chapter may not have been long enough to 
detect any significant changes. Finally, myoD and myogenin are more highly expressed in 
single satellite cells than mature myofibres as they commit to differentiate (myoD) and during 
differentiation (myogenin). Therefore, any changes in myoD and/or myogenin observed after 
exercise may be a consequence of changes in satellite cells rather than mature myofibres.  
 
3.4.6! Expression of E3 Ubiquitin Ligases, MuRF-1 and MAFbx After Loading 
MuRF-1 (muscle RING finger 1; Trim63) and MAFbx (muscle atrophy F-box; FBXO32) are  
two muscle-specific E3 ubiquitin ligases which have been extensively characterised in SkM, 
and shown to target muscle specific proteins for degradation, specifically during various 
atrophic conditions (Bodine et al., 2001a; Bodine & Baehr, 2014). Indeed, MuRF-1 and 
MAFbx mRNA expression significantly increased following denervation, immobilisation and 
hindlimb unloading-induced atrophy of the rat gastrocnemius muscle within 14 days of post 
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treatment (Bodine et al., 2001a). Furthermore, administering rat medial gastrocnemius muscle 
tissue with interleukin-1 (IL-1) and dexamethasone and treating differentiated C2C12 cells with 
a MAFbx adenovirus upregulated mRNA expression and reduced myotube size (Bodine et al., 
2001a). Finally, denervation of the TA and gastrocnemius muscles (via cutting the sciatic 
nerve) resulted in a 36% and 56% muscle sparing in MuRF-1 and MAFbx KO versus wild-
type mice, respectively which coincided with increased fibre size (in MAFbx null mice only) 
at 14 days post-surgery. Such findings using various models of atrophy therefore highlights the 
importance of these ‘atrogenes’ during episodes of severe muscle loss (Bodine & Baehr, 2014). 
Interestingly, work from the same group suggests a potential role for these genes during 
remodelling post mechanical loading given expression of both MuRF-1 and MAFbx are 
increased in mice plantaris muscles after 1 day of overload (tenotomy of the soleus and 
gastrocnemius muscles) which is reduced thereon ~14 days, with MAFbx dropping below basal 
levels at 7 and 10 day post tenotomy (Baehr et al., 2014; Bodine & Baehr, 2014). To test this 
assumption in-vitro, MuRF-1 and MAFbx was assessed following STAT and INT loading in 
fibrin engineered SkM. Despite an elevation in MAFbx following STAT and MuRF-1 in 
response to both loading regimes, neither loading protocol induced statistically significant 
changes (see Figure 3.9). Others have also reported no increase in MuRF-1/MAFbx mRNA 
following ramp or static loading (Player et al., 2014) or when both regimes were performed 
simultaneously (Aguilar-Agon et al., 2019) in collagen C2C12 engineered muscle. 
 
3.5! Conclusion 
The present chapter clearly demonstrates that INT loading (which more closely resembles acute 
RE in-vivo) of fibrin bioengineered SkM using a novel bioreactor was able to induce 
comparable transcriptional responses to those observed following loading in collagen muscle 
using the t-CFM bioreactor system (Mudera et al., 2000; Cheema et al., 2005; Player et al., 
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2014; Aguilar-Agon et al., 2019). Moreover, the mechano-transcriptional responses in loaded 
fibrin muscle were also similar to reported changes in targeted gene expression after 
RE/loading in-vivo. Indeed, IGF1-IEa and MGF significantly increased following INT versus 
CON and STAT with a modest, albeit non-significant increase and reduction in mature IGF-1 
and binding proteins, IGFBP-2 and 5. Furthermore, an increase in the matrix remodelling gene, 
MMP-9 alongside a non-statistical increase in RING E3 ligases MuRF-1 and MAFbx suggests 
that these genes may help initiate the remodelling process following mechanical loading in 
engineered fibrin muscle. Since the present chapter has characterised the cell culture methods, 
loading regime and transcriptional response of known ‘mechano-sensitive’ candidate genes 
using the TC-3 bioreactor, the next experimental chapter (chapter 4) will conduct extensive in-
silico and bioinformatic genome-wide analysis to determine the associated transcriptomic and 
epigenetic response to acute loading/RE in human SkM. The most significantly regulated 
transcripts at the mRNA and DNA methylation level identified in chapter 4 will then be 
assessed in response to mechanical loading in fibrin bioengineered SkM using the bioreactor 
and loading regime employed herein. This approach will enable a direct comparison of the 
mechano-response to loading in murine fibrin bioengineered muscle versus loading/RE in 
human SkM and therefore determine whether loading bioengineered SkM is able to mimic the 
transcriptional and DNA epigenetic response to loading/RE in human SkM in-vivo.  
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CHAPTER 4 
Transcriptomic and Epigenomic Analysis of Acute 
Resistance Exercise in Human Skeletal Muscle 
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4.1!Introduction 
Skeletal muscle (SkM) displays a high level of plasticity, undergoing considerable hypertrophy 
following repetitive bouts of resistance exercise (RE)/mechanical loading (Goldberg, 1967; 
Phillips et al., 1997; Seaborne et al., 2018a) or atrophy during periods of disuse as a result of 
injury or ageing (reviewed in Sharples et al., 2015; Sharples, Stewart and Seaborne, 2016). 
Several transcriptome-wide studies have provided significant insights into the gene regulatory 
networks that regulate SkM anabolism and hypertrophy following acute (MacNeil et al., 2010; 
Raue et al., 2012; Murton et al., 2014; Vissing & Schjerling, 2014; Lundberg et al., 2016) and 
chronic (Liu et al., 2010a; MacNeil et al., 2010; Raue et al., 2012; Phillips et al., 2013; 
Thalacker-Mercer et al., 2013; Murton et al., 2014; Vissing & Schjerling, 2014) RE, 
respectively. However, little is known whether such alterations across the transcriptome 
correspond to epigenetic changes at the DNA level.  
 
As discussed in section 1.6, epigenetics represents changes in gene function that are not due to 
alterations in the DNA sequence itself but involves the addition or removal of specific 
molecules on the DNA or the surrounding histone proteins that may ultimately determine the 
level of gene expression. Epigenetics is influenced by several environmental factors including 
diet and exercise, specifically in SkM as evidenced in previous work by our group (Seaborne 
et al., 2018a) and others (Barrès et al., 2012). A major key epigenetic modification, known as 
DNA methylation involves the attachment (also known as ‘hyper’-methylation) or detachment 
(also referred to as ‘hypo’-methylation) of a covalent methyl chemical tag on the 5’ position of 
a cytosine residue within cytosine-guanidine dinucleotide base pairing sites (CpG site). As 
described in section 1.6, increased CpG methylation (hypermethylation), particularly within 
the promoter regions of a gene is able to inhibit binding of RNA polymerase or tightening of 
the chromatin (termed heterochromatin), ultimately preventing gene transcription from 
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occurring (Bogdanović & Veenstra, 2009). Conversely, reduced DNA methylation 
(hypomethylation) is able to expose regulatory regions of a gene to permit gene transcription, 
subsequently increasing mRNA expression (Sharples & Seaborne, 2019). 
 
Previous work by our group analysed the DNA methylome (850K CpG sites) following acute 
(4 sets × 10 reps of 5 exercises) and chronic (3 days/per week for 7 weeks) RE/loading followed 
by 7 weeks of unloading (cessation of RE) and a further 7 weeks reloading (3 days/per week 
for 7 weeks) in untrained humans (Seaborne et al., 2018a, 2018b). Within this study, clusters 
of genes previously uncharacterised in SkM were epigenetically altered after chronic training 
(evoking a ~6.5% increase in lower limb lean mass) and further retraining (evoking a ~12.5% 
versus baseline; Seaborne et al., 2018a, 2018b). Indeed, one gene cluster (including 
genes; RPL35a, BICC1, ZFP2, UBR5, HEG1, PLA2G16, SETD3 and ODF2 which are 
described in chapter 5) demonstrated increased gene expression and reduced DNA methylation 
after training, with a larger increase in mRNA expression and greater reduction in methylation 
after further retraining. Interestingly, another group of genes (including genes; AXIN1, TRAF1 
and GRIK2 which are also described in chapter 5) demonstrated increased and decreased 
mRNA expression and DNA methylation, respectively after chronic RE which was retained 
during detraining (where muscle mass reduced back to baseline levels) and further regulated 
after retraining. Finally, a number of genes were epigenetically modified after just one single 
bout of RE with reduced methylation being retained after 7 weeks of chronic training and 
retraining, suggesting a potential important role for these genes in ‘muscle memory’ (Seaborne 
et al., 2018a, 2018b). 
 
The gene expression responses to mechanical loading in bioengineered SkM are typically 
determined via assessing the mRNA expression of well-characterised mechano-sensitive 
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genes. Considering the role of epigenetics in SkM has only more recently begun to emerge, 
there has previously been no attempt to establish the epigenetic responses to mechanical 
loading in bioengineered SkM. Therefore, identifying the most frequently regulated genes 
across transcriptome-wide human RE studies which are also epigenetically regulated across 
the methylome would provide a more comprehensive list of relevant genes to assess at the 
transcript and epigenetic level following mechanical loading in engineered SkM. This would 
firstly validate the use of loading C2C12 fibrin bioengineered muscle in-vitro as a representative 
model of loading/RE in-vivo. Moreover, if loading bioengineered SkM recapitulates the 
epigenomic and transcriptomic responses to loading/RE in-vivo, this would potentially 
demonstrate a plausible in-vitro model for studying the mechanistic regulation of load-induced 
anabolism/muscle growth via gene-specific overexpression, knockdown and hormonal or 
pharmacological manipulation.  
 
4.1.1! Aims and Hypothesis 
The aims of the present chapter were to therefore identify genes which were significantly 
expressed across the human transcriptome after acute RE in all published human transcriptome 
data sets to date (April 2018), and further determine whether such alterations in gene 
expression corresponded to changes at the DNA level of the same genes across the methylome 
from Seaborne et al., (2018). To achieve this, publicly available transcriptome-wide data files 
that compared pre- versus post-acute RE in humans were pooled to enable the detection of 
mechano-sensitive genes. The significantly expressed genes across all studies were then 
mapped against the DNA methylome data derived from previously published work by our 
group (Seaborne et al., 2018a, 2018b). Gene expression and DNA methylation patterns 
identified herein would therefore enable identification of which genes to examine after 
mechanical loading in bioengineered SkM throughout subsequent chapters of this thesis. It was 
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hypothesised that a number of genes, previously known and unknown to be epigenetically 
regulated in response to acute RE in-vivo would be identified. 
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4.2! Methods 
4.2.1! Identification of Transcriptomic Studies  
The pooled transcriptome-wide studies analysed after acute RE in humans are summarised in 
Table 4.1. All transcriptomic data files included throughout the present chapter were derived 
from a publicly available database (Gene Expression Omnibus, [GEO]) which were deposited 
before April 2018 (time of the first analysis). Studies were selected according to a number of 
inclusion and exclusion criteria to enable a suitable comparison across all acute RE 
transcriptomic studies. Indeed, only healthy adult male humans were included to ensure a 
similar population when mapping the transcriptomic data with the previously published 
methylome array data from our group (Seaborne et al., 2018a). Furthermore, RE only array 
data files and not aerobic or concurrent exercise data were included, due to RE being associated 
with muscle growth versus these other modes of exercise. For sampling timepoints, biopsies 
obtained within 24 hrs post-acute exercise were included and samples collected after 24 hrs 
were therefore excluded. Given the variation in post-exercise timepoints at which samples were 
collected between and within studies (with only 2 studies sampling at the same post-exercise 
timepoint; see Table 4.1), all samples obtained within the first 24 hrs post-exercise were pooled 
and contributed to the same ‘post-exercise’ condition. Any study with less than 10,000 gene 
probe-sets annotated by ‘gene symbol’ were also excluded since these studies used earlier gene 
array platforms with a low number of gene transcripts analysed versus more recent data sets 
which enabled an analysis of approximately 15,000 gene transcripts, detailed later. 
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Table 4.1. Transcriptome-wide acute RE studies pooled for comparative analysis 
Details of all transcriptomic studies analysed throughout the present chapter including each studies pubmed ID (PMID) and gene expression 
omnibus (GEO) accession numbers, the array platform and exercise intervention employed, timepoint(s) at which muscle biopsies were collected 
(all obtained from the vastus lateralis quadricep muscle) and general notes highlighting the samples that were removed from each study according 
to the inclusion and exclusion criteria outlined in section 4.2.1. Note that only two studies (MacNeil et al., 2010; Lundberg et al., 2016) sampled 
at the same post-exercise timepoint (i.e. 3 hrs). All biopsies which were collected ~24 hrs post acute RE were therefore pooled to ensure an 
adequate sample number for the post-exercise condition. 
Acute RE Studies PMID GEO  Array 
Platform 
Exercise Protocol Timepoint(s) Notes 
 
(MacNeil et al., 
2010) 
20502695 GSE19062 GPL6255 
Illumina 
humanRef-8 
v2.0 
Eccentric quadricep 
exercise. 
15 sets × 10 reps, maximal 
resistance of knee flexion 
at 120˚/s. 
1 min rest between sets. 
Pre, 
3 hrs Post 
The E2 supplement group was removed. 
Only the placebo/no supplement group 
was analysed. 
(Raue et al., 2012) 22302958 GSE28422 GPL570 [HG 
U133_Plus_2] 
Bilateral quadricep knee 
extension. 
3 sets × 10 reps at 70-75% 
of 1RM. 
Pre,  
4 hrs Post 
Elderly male/female and young female 
adult acute/chronic RE groups were 
removed. Only the young male adult 
group analysed. 
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(Vissing & 
Schjerling, 2014) 
25984345 GSE59088 GPL6244 
[HuGene-1_0-
st] 
3 individual quadricep 
exercises. 
 4 × sets at 12 RM. 
1.5 mins rest between 
exercises. 
Pre,  
2.5 & 5 hrs 
Post 
The endurance exercise group was 
removed.  
Only pre and post-acute RE were 
analysed.  
(Murton et al., 
2014) 
24265280 GSE45426 GPL570 [HG 
U133_Plus_2] 
Quadricep knee 
extensions. 
5 sets × 30 maximal 
isokinetic contractions at 
180°/s. 
 1 min rest between sets. 
Pre,  
24 hrs Post 
Non-exercise group was removed. 
Pre/post-acute RE group used for the 
analysis. 
Lundberg et al. 
(2016) 
27101291 GSE74194 GPL17692 
[HuGene-2_1-
st] 
Quadricep knee extensions. 
4 sets × 7 reps (70% 1RM). 
2 mins rest between sets. 
3 hrs Post 
Only 
No relevant ‘pre’, as the comparison 
was ‘post’-acute RE from one limb (that 
performed RE) versus the contralateral 
limb that underwent both RE plus 
endurance exercise. Post RE limb 
samples used for the analysis only. 
RE+endurance limb samples were 
therefore removed. 
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4.2.2! Bioinformatic Pooled Transcriptome Analysis 
All transcriptomic data files were downloaded from the National Institutes of Health (NIH) 
GEO data base and imported into Partek Genomics Suite software (version 7.18.0518, Partek 
Inc. Missouri, USA) as .CEL or .TXT files. The relevant gene array platform annotation file 
was then assigned to the appropriate data set. All intensity values were Log transformed (if not 
done so already upon downloading) prior to continuing. The highest-scoring probe set was 
selected whenever more than one probe set was detected for a given gene. This was to enable 
a comparison of the unambiguous expression estimate of an individual gene, and to compare 
across different studies and array platforms. Such methods have previously been considered 
appropriate when accounting for altered hybridisation efficiency across multiple probe sets for 
the same gene and across array platforms (Li et al., 2011; Gravendeel et al., 2012). To enable 
direct comparisons of gene expression between studies, the common gene symbol annotations 
across all studies were identified. This enabled filtering of each individual data set by gene 
symbols that were uniformly shared across the different array platforms, allowing a comparison 
of identical genes across all studies. Samples were then defined as ‘pre’ or ‘post’ acute RE, 
also in line with the inclusion/exclusion criteria stated in section 4.2.1. Quality assurance (QA) 
and control (QC) analyses were undertaken on all data sets using principal component analysis 
(PCA), box/whisker charts and sample frequency/density plots by lines to identify sample 
outliers and to analyse the normal distribution of intensity values (see Figure 4.1). Samples 
were considered outliers if they fell outside 2 standard deviations (SD) from the centroid using 
ellipsoids as well as showing different distribution patterns to the samples of the same condition 
(pre/post) or within each study. All outliers were subsequently removed from further analysis. 
Batch correction was performed using Partek Genomics Suite ‘Remove Batch Effects’ tool 
(uses ANOVA approach) to account for any differences in sample processing or array platform 
methods between studies. This method has previously been identified as an appropriate batch 
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correction tool when dealing with data of non-trivial size (i.e. large number of samples per 
condition; Nygaard, Rødland and Hovig, 2016). A detailed description of the QA/QC and batch 
removal can be seen in the appropriate figure legend (see Figure 4.1). Detection of 
differentially expressed genes was then performed on Partek Genomics Suite software (version 
7.18.0518, Partek Inc. Missouri, USA) using an ANOVA and a gene list of all the significantly 
(P ≤ 0.01) up/downregulated genes was created. 
 
4.2.3! Overlapping the Pooled Transcriptome with the DNA Methylome  
Using Venn diagram analysis, the significant differentially regulated gene lists generated from 
the pooled transcriptomic gene expression analysis described in section 4.2.2 were overlapped 
with the significantly differentially modified CpG sites lists from the methylome array data file 
(Seaborne et al., 2018a). Genome-wide DNA methylation data was processed as previously 
described (Seaborne et al., 2018a, 2018b). Briefly, raw .IDAT files were processed on Partek 
Genomic Suite software (version 6.6, Partek Inc. Missouri, USA) and background 
normalisation was performed via the Subset-Quantile Within Array Normalisation (SWAN) 
method (Maksimovic et al., 2012) and imported using the MethylationEPIC_v-1-0_B2.bpm 
manifest file. This analysis enabled the comparison of genes that were both up/downregulated 
at the mRNA expression level and hypo/hypermethylated at the DNA level after acute RE. 
Also, to determine the association of genes that were up/down regulated in the comparative 
transcriptome analysis after acute RE that were hypo/hypermethylated at the DNA level. 
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4.2.4! Pathway Analysis 
Using statistically generated gene expression and CpG data (see section 4.2.3), KEGG 
signaling pathway analysis (Kanehisa, 1997; Kanehisa et al., 2016, 2017; see results/figures in 
section 4.3 for significance level of enrichment P values) was performed in Partek Genomic 
Suite software and Partek Pathway (version 7.18.0518, Partek Inc. Missouri, USA). Once 
significant enrichment was determined via Venn diagram analysis, regulated pathways 
identified both in the transcriptome and methylome analysis were overlapped. 
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(A) Venn diagram analysis identified 14,992 shared annotated genes by ‘gene symbol’ across 
all pooled transcriptomic studies after acute RE. The number of genes identified in Murton et 
al., (2014) and Raue et al., (2012) are depicted as different despite both studies using the same 
array platform. This is due to the highest probe set analysis (see section 4.2.2) altering the 
number of genes that could be compared in the present chapter. (B) Box/whisker charts and 
(C) frequency/density plots by lines prior to batch correction enabled detection signal/value 
variation as a result of batch effects across studies. (D) Box/whisker chart and (E) frequency 
normalisation plots by lines post batch correction. (F) PCA by sampling timepoint (pre/post) 
and (G) PCA by study post batch correction. Samples located outside 2 SD of the centroid 
value using ellipsoids were identified as outliers and were removed (depicted by line 
strikethrough) prior to analysis. (H) Depicts sample box/whisker chart and (I) frequency plot 
by lines after batch correction and with outlier samples (highlighted in F/E) removed.  
 
4.3!Results 
4.3.1! Pooled Transcriptome Analysis Overlapped with the Methylome in Human 
Skeletal Muscle After Acute Resistance Exercise 
In total, 110 gene arrays were included for the pooled transcriptome analysis in the present 
chapter, all of which were derived from all pre- and post-exercise SkM biopsies across the 5 
studies analysed (see Table 4.1). This included 41 baseline (pre) samples and 69 post-acute RE 
samples (37 pre/57 post after outlier removal). All 5 studies analysed herein identified 14,992 
of the same annotated genes by ‘gene symbol’ (see Figure 4.1A). Relevant QA/QC and outlier 
removal is depicted in figure 4.1 and described in the corresponding figure legend. 
Downstream gene expression analysis of the transcriptome data across all 5 studies 
Figure 4.1. QC/QA, Venn diagram and PCA analysis 
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demonstrated that 1,802 genes were significantly differentially modified (P ≤ 0.01) after acute 
RE (full gene list described in Supplementary File 4.1A). Out of these genes, 866 were 
upregulated and 936 genes were downregulated. Out of the 866 upregulated genes, 270 of these 
genes were also hypomethylated (see Figure. 4.2A; full gene list described in Supplementary 
File 4.1B) which equated to 355 different CpG sites on these 270 genes as some individual 
genes had more than one CpG site that was hypomethylated per gene (full gene list described 
in Supplementary File 4.1C). Furthermore, 216 out of the 866 upregulated genes were 
hypermethylated. Out of the 936 downregulated genes, 216 were also hypermethylated (see 
Figure 4.2B; full gene list described in Supplementary File 4.1D) which equated to 268 
different CpG sites on these 216 genes given some genes had more than one hypomethylated 
CpG site per gene (full gene list described in Supplementary File 4.1E). Furthermore, 298 out 
of the 936 downregulated genes were hypomethylated. 
 
 
(866) Significantly  
UP-regulated genes in 
pooled transcriptome 
analysis post-acute RE.  
 
(5752) Significantly 
HYPO-methylated 
genes post-acute RE 
 (Seaborne et al., 2018). 
 
(936) Significantly 
DOWN-regulated genes 
in pooled transcriptome 
analysis post-acute RE. 
 
(4604) Significantly 
HYPER-methylated 
genes post-acute RE  
(Seaborne et al., 2018). 
 
A 
 
B 
 
Figure 4.2. Analysis of upregulated/hypomethylated and downregulated/hypermethylated 
genes after acute RE in human SkM 
 
 144 
Venn diagram analysis identified (A) out of the 866 upregulated genes, 270 of these genes were 
also hypomethylated across the methylome (Seaborne et al., 2018a, 2018b) and (B) out of the 
936 genes that were downregulated across the pooled transcriptome, 216 of these genes were 
also hypermethylated in the methylome data following acute RE in humans (Seaborne et al., 
2018a, 2018b). Venn diagrams were created using Partek Genomics Suite software (version 
7.18.0518, Partek Inc. Missouri, USA). 
 
4.3.2! Genes Associated with Cancer Pathways are Enriched in Both the 
Transcriptome and Methylome Data Sets in Human Skeletal Muscle After 
Acute Resistance Exercise  
KEGG Pathway analysis of the top 20 pathways included 483 genes that were differentially 
expressed with statistical significance at post versus pre-exercise (P ≤ 0.01) and significantly 
enriched (Enrichment P value ≤ 0.003). Out of these 483 genes, 35% (168 genes) were genes 
associated with 5 different enriched ‘cancer’ pathways including ‘Proteoglycans in cancer’, 
‘Transcriptional misregulation in cancer’, ‘Colorectal cancer’, ‘Small cell lung cancer’ and 
‘Pathways in cancer’ (full list of all enriched pathways across the transcriptome are described 
in Supplementary File 4.2A). While the ‘cancer’ term is not relevant to analysis of healthy 
SkM tissue, these cancer pathways e.g. KEGG term ‘pathways in cancer’  incorporates well 
described molecular pathways in the regulation of SkM mass such as; focal adhesion, MAPK 
signaling, PI3K-Akt-mTOR signaling, p53 signaling, Jak-STAT signaling, TGF-ß and Notch 
signaling. Indeed, in a closer analysis of the specific genes (detailed below), they were 
specifically related to pathways associated with matrix/actin structure and remodelling, 
mechano-transduction, TGF-ß/calcium/IL-6/retinoic acid signaling and protein synthesis as 
described below. As some of the same genes were also present in more than one of these KEGG 
cancer pathways, 106 out of the total 168 genes were unique and were either up- (69 cancer 
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genes) or down-regulated (37 cancer genes) after acute RE across all 5 ‘cancer pathways’. 
Pathway analysis on the methylome-wide data also identified ‘Proteoglycans in cancer’ and 
‘Pathways in cancer’ as significantly enriched (P ≤ 0.001), appearing within the top 20 KEGG 
pathways list after acute RE (full list of all enriched pathways across the methylome are 
described in Supplementary File 4.2B; schematic representation of 
upregulated/hypomethylated and downregulated/hypermethylated cancer genes are displayed 
in Figure 4.3). Comparison of the pathway diagrams demonstrated that there was a larger 
proportion of upregulated versus downregulated genes included in ‘Pathways in Cancer’ and 
‘Proteoglycans in cancer’ for the pooled transcriptome analysis (see Supplementary File 4.2C 
and D, respectively). A larger number of hypomethylated versus hypermethylated CpGs within 
‘Pathways in Cancer’ and ‘Proteoglycans in cancer’ were also observed (see Supplementary 
File 4.2E and F, respectively). Other than ‘pathways in cancer’ and ‘proteoglycans in cancer’, 
no other top 20 KEGG pathway was enriched in both the pooled transcriptome and methylome 
analysis (full list of all enriched pathways across the transcriptome and methylome are 
described in Supplementary File 4.2A and B, respectively). Out of the genes up (69) and 
downregulated (37) across these ‘cancer’ pathways (full gene list described in Supplementary 
File 4.2G and H, respectively), these genes were overlapped with those which were hypo- and 
hypermethylated, respectively across the methylome after acute RE (Seaborne et al., 2018a) 
(see Figure 4.3A and B). This analysis identified 23 transcripts that were upregulated in the 
pooled transcriptome analysis that also demonstrated significant hypomethylation of the same 
gene following acute RE (see Figure 4.4A; full gene list described in Supplementary 4.2I/J). 
This related to 29 CpG sites mapping to the 23 transcripts (as some genes had more than 1 CpG 
site modification per gene) (full gene list with CpG sites described in Supplementary File 4.2J). 
The genes identified included: MSN, FOS, THBS1, ITPR3, TIMP3, RARA, FLNB, LAMA5, 
RASSF5, CRK, SMAD3, STAT3, COL4A1, ITGA2, WNT9A, ITGB3, KDR, ADCY3, 
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CTTN, CD63, DOT1L, F2RL3 and GSK3ß (see Figure 4.4A; full gene list described in 
Supplementary File 4.2I/J). The largest proportion (57%) of the CpG’s were located in a 
promotor region for the same gene (for at least one of their gene transcripts; full gene list with 
CpG sites described in Supplementary File 4.2J). In SkM, 13 out of 23 genes are associated 
with matrix/actin structure or remodelling and mechano-transduction (MSN, THBS1, TIMP3, 
FLNB, LAMA5, CRK, COL4A1, ITGA2, ITGB3, CD63, CTTN, RASSF5, F2RL3), 3 genes 
associated with TGF-ß signaling (SMAD3, FOS, WNT9A), 2 genes with calcium signaling 
(ITPR3, ADCY3), and 1 gene with IL-6 signaling (STAT3), protein synthesis (GSK3ß) and 
retinoic acid signaling (RARA). Finally, 12 genes that were downregulated in the comparative 
transcriptomic analysis were also hypermethylated in  (see Figure 4.4B; full gene list described 
in Supplementary File 4.2K/L). Here, 14 CpG sites were identified in the methylome analysis 
as some genes had more than 1 CpG site modification (full gene list with CpG sites described 
in Supplementary File 4.2L). This included genes: RUNX1T1, GAB1, ESR1, LAMA3, 
NANOG, SMO, ANK3, GADD45G, DROSHA, ATM, APAF1 and AGTR1 (see Figure 4.4B; 
full gene list described in Supplementary File 4.2K), with varied functions in SkM (see section 
4.4). Again, the largest proportion (64%) of the CpG’s were also located in a promotor region 
for the same gene (for at least one of their gene transcripts; full gene list with CpG sites 
described in Supplementary File 4.2L).  
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KEGG pathway analysis of the top 20 enriched pathways identified (A) ‘pathways in cancer’ 
and (B) ‘proteoglycans in cancer’ as significantly enriched across both the pooled 
transcriptome and the methylome (Seaborne et al., 2018a). For mRNA expression, genes 
highlighted in ‘GREEN’ represent ‘upregulated’ genes whereas genes highlighted in ‘RED’ 
represent ‘downregulated’ genes. For DNA methylation, genes highlighted in ‘BLUE’ 
represent ‘hypomethylated’ genes, genes highlighted in ‘YELLOW’ represent 
‘hypermethylated’ genes. Figures were created using Partek Genomics Suite software (version 
7.18.0518, Partek Inc. Missouri, USA). 
Figure 4.3. ‘Pathways- and proteoglycans in cancer’ were significantly  enriched pathways 
across the human transcriptome and methylome after acute RE 
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 (A) Depicts ‘cancer’ pathway genes upregulated (GREEN bars) in pooled transcriptomic studies (P ≤ 0.01) and hypomethylated (BLUE bars) (P ≤ 0.05) after 
acute RE. (B) Depicts ‘cancer’ genes that were downregulated (RED bars) and hypermethylated (YELLOW bars) across the pooled transcriptome and 
methylome (Seaborne et al., 2018a), respectively after acute RE in humans. Figures were created in Partek Genomics Suite software (version 7.18.0518, Partek 
Inc. Missouri, USA). 
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Figure 4.4. Upregulated/hypomethylated and downregulated/hypermethylated enriched in cancer genes after acute RE in humans 
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4.4!Discussion  
In the present chapter, extensive bioinformatic analysis was undertaken in order to identify 
genes that were differentially expressed with statistical significance across publicly available 
transcriptome studies after acute RE in human SkM. Pooled data sets were then overlapped 
with the DNA methylome data derived from previously published work by our group 
(Seaborne et al., 2018a) in attempt to identify novel genes/gene pathways that were also 
epigenetically modified at the DNA methylation level after acute RE in-vivo. Transcriptionally 
and epigenetically modified genes identified herein would therefore enable the detection of 
suitable genes to analyse after acute mechanical loading in bioengineered SkM throughout 
subsequent chapters of this thesis. This would further enable the validation of whether acute 
mechanical loading of bioengineered SkM in-vitro induces similar responses to RE in-vivo. 
 
Following acute RE, 866 up- and 936 down-regulated genes were identified. Out of the 866 
upregulated genes, 270 were also hypomethylated and out of the 936 downregulated genes, 
216 were also hypermethylated. After KEGG pathway analysis, genes associated with 
‘pathways in cancer’ and ‘proteoglycans in cancer’ were significantly enriched in both the 
pooled transcriptome analysis and methylome data after acute RE. This resulted in 23 
upregulated and 12 downregulated ‘cancer’ genes that were also hypo- and hypermethylated, 
respectively. The largest proportion of CpG sites on both the upregulated/hypomethylated 
(57%) and downregulated/hypermethylated (64%) ‘cancer’ genes were promoter associated. 
DNA methylation, specifically within the promotor region of coding genes, is known to be an 
important regulator of downstream transcript expression, due to manipulation of RNA 
polymerase to bind to gene regulatory regions for gene transcription to occur (Bogdanović & 
Veenstra, 2009). The present chapter therefore identifies an important role for promoter-
associated DNA methylation within human SkM after just an acute bout of exercise, supporting 
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previous findings following both acute resistance (Seaborne et al., 2018a) and aerobic (Barrès 
et al., 2012) exercise in humans. 
 
4.4.1! Enriched Upregulated and Hypomethylated Cancer Genes Involved in 
ECM/Actin Structure/Remodelling and Mechano-Transduction in Human 
Skeletal Muscle After Acute Resistance Exercise  
Of the 23 upregulated/hypomethylated genes identified across the transcriptome after acute 
RE, a large proportion (13 out of 23) were associated with ECM/actin structure and 
remodelling as well as mechano-transduction in SkM.  
 
Actin Structure and Remodelling Genes 
Genes that were upregulated/hypomethylated after acute RE that are involved in actin structure 
and remodelling include; MSN, FLNB and CTTN. MSN (also known as moesin) is part of the 
ezrin-radixin-moesin (ERM) protein family involved in crosslinking actin filaments with the 
plasma membrane and has been linked with dystrophy-associated fibrosis in mice and young 
human muscle via SMAD3/TGF-ß signaling (Pines et al., 2017). Furthermore, a recent study 
reported hypomethylation of moesin in lifelong active aged individuals versus aged sedentary 
individuals (Sailani et al., 2019), however, no studies have yet investigated mRNA expression 
or DNA methylation directly in response to exercise. Another actin-plasma membrane 
crosslinker identified as upregulated and hypomethylated in the present chapter is FLNB 
(Filamin B). Whilst mutations in Filamin isoforms, A (FLNA) and C (FLNC) are associated 
with variety of hereditary diseases (i.e. circulatory, CNS and skeletal systems), FLNB 
mutations are solely associated with skeletal system deformities, suggesting an importance for 
FLNB in skeletal development (Xu et al., 2017). In SkM, deletion of the FLNB hinge-1 region 
improved myotube formation in C2C12 cells, indicative that FLNB is important for myoblast 
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differentiation, although the exact mechanisms remain unknown (Van Der Flier et al., 2002). 
In addition to FLNB, CTTN (Src substrate cortactin) was also upregulated across the human 
transcriptome after both acute and chronic RE in recently published work by our group (Turner 
et al., 2019b). CTTN contributes to the formation of the actin cytoskeleton whereby siRNA 
knockdown completely abolishes actin formation and glucose uptake in L6 myotubes (Nazari 
et al., 2011). Despite upregulation and hypomethylation of both FLNB and CTTN after acute 
RE in the present chapter, no other studies have directly investigated the roles of these genes 
in response to exercise or loading in bioengineered muscle.  
 
ECM Structure and Remodelling Genes 
Of the upregulated/hypomethylated genes involved in structure/remodelling of the ECM, these 
include THBS1, TIMP3, ITGA2, ITGB3, LAMA5 and COL4A1. THBS1 (Thrombospondin-
1) is a large adhesive glycoprotein that binds to fibrinogen and ECM proteins, fibronectin, 
laminin, collagen and integrins. In SkM, THBS1 is considered anti-angiogenic whereby 
chronic (12 days) administration of a THBS1 mimetic (which targets the CD36 THBS1 
receptor) in mice resulted in a 20, 11 and 35% decrease in capillarity of the gastrocnemius, 
plantaris and soleus muscles, respectively (Audet et al., 2013). VEGF protein expression also 
decreased (140% and 62% in gastrocnemius and soleus, respectively with no change in the 
plantaris) whereas serum VEGF and endogenous THBS1 remained unchanged, suggestive that 
alterations were mediated via the CD36 receptor (Audet et al., 2013). Others have reported that 
THBS1 null mice are protected from high fat diet-induced weight gain (fat and total mass) and 
insulin resistance (Inoue et al., 2013). In relation to exercise, THBS1 mRNA increased after 
both acute aerobic exercise (45 mins at 70% VO2max) and chronic concurrent exercise (4 
days/week for 12 weeks; 2 × HIIT [1 × 7 min cycling intervals at 85% HRmax, 1 × 2 mins 
intervals at >90% HRmax], 2 × RE [3 sets × 8 upper/lower body exercises] sessions) in humans 
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(Hjorth et al., 2015). However, this may be a consequence of the HIIT exercise and not RE 
given no change in gene expression was observed after acute RE (3 × 12 reps at 70% 1-RM on 
leg press and extension exercises) alone in young and old human muscle (Wessner et al., 2019). 
The same acute RE study also reported no significant change in TIMP3 or ITGA2 mRNA 
expression, albeit ITGB3 expression increased in young but not aged human muscle (Wessner 
et al., 2019). TIMP3 (tissue inhibitor of metalloproteinase 3) is a member of the TIMP protein 
family (TIMP1-4) which regulate MMP activity and matrix homeostasis. TIMP3 mRNA and 
protein expression has been shown to decrease during C2C12 myoblast differentiation whereas 
overexpression inhibits myotube formation via reduced TNFα release, P38 MAPK activity and 
myogenin mRNA expression (Liu et al., 2010b). Furthermore, TIMP3 expression is reduced 
in regenerating CTX-injured and overloaded soleus mouse muscle (Liu et al., 2010b) which is 
interesting given TIMP3 was upregulated across the human transcriptome in the present 
chapter. ITGA2 (Integrin alpha-2/beta-1) is a major integrin collagen binding transmembrane 
receptor which mediates cell-ECM adhesion and signaling. ITGA2 has a similar structure to 
ITGA1, however has opposing actions via activating distinct signaling pathways (Kang et al., 
2011). In SkM, high fat feeding-induced insulin resistance was prevented in ITGA2 but not 
ITGA1 null mice, potentially due to reduced accumulation of collagen and increased 
vascularisation in KO vs. wild-type rodents (Kang et al., 2011). Furthermore overexpression 
of ITGA2 in human osteosarcoma cells (Ivaska et al., 1999) and primary human fibroblasts 
(Langholz et al., 1995) also increased collagen expression when cultured on 3D collagen 
matrices, highlighting the associated integrin-collagen interaction in various cell types. 
Similarly, ITGB3 (Integrin subunit beta-3) is a binding receptor for ECM proteins fibronectin 
and vitronectin and is highly expressed in craniofacial muscle cells, particularly during cell 
migration but not differentiation (Sinanan et al., 2008). Despite the reported roles of these 
integrin genes in response to exercise, nutrition and during cell culture, the present chapter 
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demonstrates that ITGA2 and ITGB3 are also regulated at both the mRNA and DNA 
methylation level after acute RE in humans. LAMA5 (laminin subunit alpha-5) and COL4A1 
(Collagen type IV alpha-1 chain) which are isoforms of the laminin and collagen ECM 
proteins, respectively are a further two ECM structure/remodelling genes identified as 
upregulated and hypomethylated after RE in the present chapter. The greater abundance of 
LAMA5 in dystrophic muscle has been demonstrated (Patton et al., 1999), albeit, this may be 
a consequence of muscle regeneration given its high expression in various types of muscle 
dystrophies (DMD, LGMD, CMD and EMD) and in regenerating mouse muscle after crush 
(Patton et al., 1999) and CTX (Rayagiri et al., 2018) injury. Moreover, LAMA5 was expressed 
7 days post-CTX administration in injured but not undamaged muscle and in single EDL mouse 
myofibres after 72 hrs in culture with little expression at 0 hrs, further suggesting an important 
role in muscle regeneration (Rayagiri et al., 2018). COL4A1 is a major component of the 
basement membrane and is increased after acute resistance (10 sets × 10 reps of quadriceps 
eccentric-lengthening) and chronic aerobic (6-7 × 20 s cycling sprints at 170% VO2max, 4 
days/week for 6 weeks) exercise (Hyldahl et al., 2015). Furthermore, COL4A1 mRNA was 
reduced after 14 days of hindlimb unloading in the soleus muscles of young (3 months) Wistar 
rats which increased after 7 days reloading (Kanazawa et al., 2017). Interestingly however, this 
trend was not observed in old (20 months) rats suggestive that COL4A1 is important for matrix 
remodelling after exercise and injury in SkM, albeit aging attenuates the synthesis of collagen 
during recovery from atrophy (Kanazawa et al., 2017). Despite evidence suggesting a role for 
these genes in matrix structure and remodelling after exercise and injury, the present chapter is 
the first to report changes in LAMA5 and COL4A1 DNA methylation patterns after RE which 
are inverse to expression patterns identified at the mRNA level. 
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Mechano-Transduction genes 
Genes that were upregulated and hypomethylated after acute RE across the human 
transcriptome are also involved in mechano-transduction. These include genes CRK (also 
known as proto-oncogene) and CD63 (also known as CD63 antigen). CRK is an adapter protein 
involved in ERK, JNK and p38 MAPK signaling and has been shown to regulate cell adhesion 
via activation of FAK in C2C12 cells (Goel & Dey, 2002). CD63 functions as a cell surface 
glycoprotein receptor for TIMP1 and is involved in integrin/FAK/Akt signaling. Indeed, 
knockdown of CD63 (via shRNA) in epithelial MCF10A cells cultured on 3D matrigel 
matrices reduced cell surface binding of TIMP1 (Jung et al., 2006). Furthermore, researchers 
have demonstrated increases in CD63 protein expression following acute high-intensity 
aerobic exercise in rats (Oliveira et al., 2018), although to the authors knowledge, no one has 
yet confirmed the effects of CD63 following RE at the transcript and/or epigenetic level. 
Despite findings demonstrating the importance of these actin/ECM structure/remodelling 
genes in satellite cell regulation and after aerobic and/or RE at the mRNA and protein level, 
there is a paucity of data suggesting that such genes are epigenetically modified. The present 
chapter therefore provides novel mechanistic findings that frequently regulated genes/gene 
pathways identified across the human transcriptome after acute RE in humans are also 
differentially methylated and that this occurs via hypomethylation and upregulation of genes 
associated with structure and remodelling of the matrix and cytoskeleton as well as mechano-
transduction in SkM.   
 
Genes, RASSF5 (Ras association domain-containing protein 5 also referred to as RAPL) and 
F2LR3 (also referred to as Proteinase-activated receptor 4, PAR-4) were 2 out of 23 genes that 
were upregulated and hypomethylated in the present chapter. RASSF5 is a tumor suppressor 
gene and despite no known role in SkM, is associated with extension of microtubules in 
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HUVEC cells (Fujita et al., 2005). F2LR3 is part of the G receptor protein family which binds 
thrombin and trypsin and has been shown to have limited effects on fusion in primary rodent 
muscle cells (Chinni et al., 1999). However, together with RASSF5, no previous studies have 
examined the mechano-responses to acute RE at either the transcript or methylation level. 
DOT1L (disruptor of telomeric silencing-like, also known as Kmt4) was also upregulated and 
hypomethylated in the present chapter. DOT1L is a methyltransferase which mediates histone 
3 lysine-79 (H3K79) methylation and is crucial for embryonic development and muscle 
function via regulation of dystrophin in mouse cardiomyocytes and C2C12 muscle cells (Nguyen 
et al., 2011). In SkM tissue, proteomic analysis revealed that DOT1L was reduced in muscle 
wasting COPD patients whereas muscle-specific knockdown in human SkM satellite cells 
increased p21WAF1/Cip1 involved in cellular senescence (Lakhdar et al., 2017). The present 
chapter, together with previous work therefore suggests that DOT1L is important for muscle 
growth and maintenance and that a reduction may potentially be a contributor to sarcopenia via 
decreased and increased dystrophin and p21 expression, respectively. However, its role in 
ageing SkM warrants future investigation. Such experiments may be achieved via genetic 
manipulation of DOT1L in-vivo to determine whether successful muscle-specific knockdown 
or overexpression has significant effects on muscle weight and/or fibre size (i.e. CSA) in aged 
rodent SkM. 
 
4.4.2! Enriched Upregulated and Hypomethylated Cancer Genes Involved in Protein 
Synthesis and TGF-ß, Calcium, Retinoic and IL-6 Signaling in Human Skeletal 
Muscle After Acute Resistance Exercise  
In the present chapter, a further 8 ‘cancer’ genes were significantly upregulated and 
hypomethylated across the human transcriptome and methylome after acute RE. This included 
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genes associated with protein synthesis (GSK3ß), TGF-ß (FOS, SMAD3, WNT9A), calcium 
(ITPR, ADCY3), IL-6 (STAT3) and retinoic acid (RARA) signaling. 
 
Protein Synthesis 
GSK3ß (Glycogen synthase kinase-3 beta) is a downstream target of Akt and once 
phosphorylated, becomes inactivated and regulates protein synthesis via controlling the activity 
of eukaryotic initiation factor 2B (eIF2B) (Glass, 2003; Léger et al., 2006). Inhibition of 
GSK3ß regulates myogenesis during C2C12 differentiation (Litwiniuk et al., 2016) and 
recovery from atrophy in mice (Pansters et al., 2015). In humans, GSK3ß protein 
phosphorylation is significantly increased (~40%) in response to chronic (2 days/week for 4 
weeks, 3 days/week for 4 weeks) RE-induced hypertrophy (~10% increase in quadricep CSA) 
with phosphorylation decreasing by ~30% after 8 weeks detraining-induced atrophy (~5% 
reduction in CSA) (Léger et al., 2006). Moreover, recent studies have highlighted that basal 
GSK3ß protein content is greater in lifelong aged physically active versus physically inactive 
humans, although no difference was observed in promoter-related DNA methylation (Sailani 
et al., 2019). Furthermore, no studies have yet determined whether GSK3ß is epigenetically 
modified directly after exercise in SkM. The present chapter therefore demonstrates for the 
first time that GSK3ß is regulated at the mRNA and DNA level after acute RE in human SkM. 
 
TGF-ß Signaling  
TGF-ß (transforming growth factor beta) signaling is fundamental for a number of biological 
processes such as cell growth, differentiation and development and is important in SkM mass 
regulation and exercise adaptation. To the authors knowledge however, the present chapter is 
the first to report simultaneous genetic (upregulation) and epigenetic (hypomethylation) 
regulation of a number of genes involved in TGF-ß signaling after acute RE in human SkM. 
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One of the genes is FOS (c-FOS) which has been demonstrated to increase at the mRNA and 
protein level immediately after 30 mins of running in humans (Puntschart et al., 1999) and after 
acute RE in rats (Chen et al., 2002) and humans (Trenerry et al., 2007). Despite evidence 
reporting epigenetic alterations of c-Fos in response to electroconvulsive stimulation in the 
brain (Dyrvig et al., 2012), there is limited evidence investigating epigenetic changes of FOS 
in SkM after exercise. Recent evidence suggests the JNK/SMAD (intracellular signal 
transducer and transcriptional modulator) axis is critical for exercise adaptation. Indeed, 
increased and suppressed JNK/SMAD activity was associated with increased muscle size after 
RE and enhanced oxidative/endurance capacity after aerobic exercise, respectively, therefore 
acting as a molecular switch in response to different modes of exercise (Lessard et al., 2018). 
Such findings are contradictory to previous research highlighting that SMAD3 (Smad family 
member 3), is increased after denervation in mice whereas muscle-specific knock-down 
prevents muscle atrophy (Tando et al., 2016). It is worth noting however that knock-down 
induced changes were only observed at the protein and not mRNA level. The present chapter 
therefore demonstrates novel findings that SMAD3 is transcriptionally and epigenetically 
regulated after acute RE in humans. Finally, WNT9a (Wingless-Type MMTV Integration Site 
Family, Member 9A) which functions via the canonical Wnt/beta-catenin signaling pathway 
was also upregulated and hypomethylated in the present chapter. WNT9a is also considered 
important in differentiation of SkM satellite cells whereby RNA sequencing and subsequent 
targeted mRNA expression analysis revealed that WNT9a, together with TGF-ß2 and FGFR4, 
was key for development of SkM (Zhang et al., 2018). Interestingly, work from the same lab 
later mapped the transcriptome data derived from their previous work (Zhang et al., 2018) 
across the methylome of the same mouse samples and demonstrated promoter-associated 
hypomethylation of WNT9a with corresponding transcriptional upregulation at earlier stages 
of development (6 weeks), however WNT9a was downregulated and hypermethylated during 
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the later stages (Zhang et al., 2019a). Taken together, previous and current findings highlight 
the importance of WNT9a during SkM development and RE in humans, further supporting the 
notion that TGF-ß/wnt signaling is involved in critical muscle-specific biological events.  
 
Calcium, IL-6 and Retinoic Signaling 
In the present chapter, calcium signaling-related genes were also upregulated and 
hypomethylated after acute RE in humans. This included ITPR3 (also known as IP3R - Inositol 
1,4,5-trisphosphate receptor type/isoform 3) and ADCY3 (also referred to as adenylate cyclase 
3). ITPR3, present in satellite cells, has been associated with Ca2+ release which contributes to 
increased muscle fibre growth and NMJ stabilisation (Powell et al., 2003). Transcriptomic and 
proteomic analysis also revealed that ITPR3 was upregulated after acute high intensity exercise 
in horses (Bryan et al., 2017) and in differentiated muscle but not adipose precursor cells 
derived from the latissimus dorsi of pigs (Zhang et al., 2019b). The present chapter however is 
the first demonstrate changes in ITPR3 after exercise in human muscle at both the mRNA and 
DNA level. Despite the lack of research demonstrating a distinct role for ADCY3 in SkM, 
adenylate cyclases catalyse the production of the signaling molecule cAMP via G-protein 
signaling which regulate Ca2+-dependent insulin secretion in HEK cells (Ding et al., 2004). 
Furthermore, DNA methylation is altered in adipose tissue following chronic high fat feeding 
in mice (Li et al., 2018). However, there is currently a paucity of data surrounding the role of 
ADCY3 in SkM. STAT3 (also known as signal transducer and activator of transcription factor 
3) is downstream of both IL-6 and TGF-ß and has been examined in response to load-induced 
hypertrophy and muscle dystrophies (recently reviewed in Guadagnin et al., 2018). Indeed, 
research has shown increased STAT3 phosphorylation after an acute bout of RE in Wistar rats 
(Begue et al., 2013), albeit, recent evidence has shown that STAT3 phosphorylation is not 
altered after acute RE in humans and is not required for overload-mediated hypertrophy in 
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rodent SkM (Pérez-schindler et al., 2017). IL-6 has been shown to promote DNA methylation 
of STAT3 in human colon cancer cells (Yang et al., 2010). However, to the authors knowledge, 
the present chapter is the first to report epigenetic changes in the IL-6/STAT3 signaling 
pathway in SkM. Finally, the nuclear receptor RARA (Retinoic acid receptor alpha) has been 
shown to modulate human myoblast differentiation (El Haddad et al., 2017). Indeed, RARA 
treated cells displayed reduced myogenic regulatory factor expression and myotube formation 
whereas enhanced differentiation was observed after knock-down (El Haddad et al., 2017). To 
the authors knowledge, there is no previous evidence to suggest that any of these calcium/IL-
6/retinoic acid signaling genes are differentially methylated in SkM following acute RE and 
the present chapter therefore suggests a potential role for DNA methylation in modulating the 
acute transcriptional response after RE in humans.   
 
4.4.3! Enriched Downregulated and Hypermethylated Cancer Genes Identified in 
Human Skeletal Muscle After Acute Resistance Exercise  
Of the 35 regulated ‘cancer’ across the human transcriptome, the present chapter demonstrates 
that 12 of these genes were downregulated and hypermethylated. These included genes,  
GADD45G, ATM, APAF1, RUNX1T1, GAB1, LAMA3, NANOG, SMO, ANK3, DROSHA, 
AGTR1 and ESR1 which have several opposing functions within SkM, although with the 
exception of those relating to apoptosis (GADD45G, ATM, APAF1), are not inter-linked. 
RUNX1T1 (Partner Transcriptional Co-Repressor 1) encodes corepressor proteins which 
suppress gene transcription in myeloid cells, although its role in SkM remains elusive. GAB1 
(GRB2 Associated Binding Protein 1) is part of the IRS-1 protein family and is involved in cell 
growth and muscle development. Indeed, c-Met dependant GAB1 signaling is crucial for 
muscle development whereby forelimb and diaphragm muscle formation is completely ablated 
in GAB1 deficient mice (Sachs et al., 2000). As with LAMA5 (described in section 4.4.1), 
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LAMA3 (laminin subunit alpha-3) is a major structural basement membrane protein. However, 
in SkM, researchers reported no change in LAMA3 mRNA during satellite cell regeneration in 
rodents after CTX injury (Rayagiri et al., 2018) or acute RE in young and aged humans 
(Wessner et al., 2019). Such findings are confounding given LAMA3 was significantly 
downregulated and hypermethylated after acute RE in the present chapter. NANOG (Nanog 
Homeobox is important in cell proliferation and self-renewal and maintains pluripotency of 
embryonic stem cells. Interestingly, recent evidence demonstrates the importance of NANOG 
in muscle/satellite cell differentiation whereby overexpression in collagen 1 bioengineered 
SkM improved myogenic potential in highly passaged (>40 passages) C2C12 cells which 
displayed reduced myotube formation and suppressed MRF (myoD, myog, MRF4, myf5, 
mef2a/c) mRNA expression in untreated cells (Shahini et al., 2018). Despite research reporting 
methylation changes in testicular tumor cell line (Nettersheim et al., 2011) and primary 
epithelial (Zhou et al., 2017) cells, the present chapter is the first to demonstrate epigenetic 
regulation of NANOG in SkM which coincided with alterations at the mRNA level after acute 
RE. SMO (Smoothened, Frizzled Class Receptor) is G-protein receptor involved in signal 
transduction. SMO, downstream of the sonic hedgehog protein complex, is expressed in chick 
pectoralis muscle during maturation and during proliferation and differentiation in C2 cell line 
cells suggesting a role in muscle development and myotube formation (Elia et al., 2007). 
Others have also shown that downregulation of SMO in colon cancer cell lines is associated 
with increased promoter methylation (Zhu et al., 2004), however, no studies have reported such 
findings in SkM. ANK3 (Akyrin 3) is a membrane-actin cytoskeleton crosslinker protein and 
is expressed in SkM (Peters et al., 1995), associated with muscle development and myopathies 
(reviewed in Tee and Peppelenbosch, 2010). To the authors knowledge however, the present 
chapter presents, for the first time, simultaneous mRNA and DNA methylation changes in 
human muscle after exercise. DROSHA (also known as Drosha Ribonuclease III) catalyses the 
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initial stages of miRNA biogenesis (Lee et al., 2003) and has been shown to increase (35%) at 
the mRNA level 3 hrs post-acute aerobic exercise (60 mins cycling at ∼70% VO2peak) in young 
males (Russell et al., 2013). Interestingly however, DROSHA was downregulated and 
hypermethylated after RE in the present chapter, suggestive that regulation of this gene may 
be dependent on the mode of exercise performed. Furthermore, there is currently no evidence 
to suggest that changes at the mRNA level may be somewhat attributable to changes at the 
DNA level. AGTR1 (angiotensin II receptor type I) is part of the G protein receptor family and 
has been shown to be mechano-responsive in different cells. Indeed, mechanical loading 
increased AGTR1 in HEK cells (Yasuda et al., 2008) and cardiomyocytes, alongside cardiac 
tissue (Zou et al., 2004). Interestingly however, AGTR1 mRNA expression was reduced in the 
present chapter after acute RE in human SkM. Furthermore, muscle specific knock-down in 
rodent SkM prolonged life span and improved repair and regeneration of the TA muscles after 
cryoinjury (Yabumoto et al., 2015), suggestive that AGTR1 may have pleiotropic effects which 
are tissue-specific. In regards to DNA methylation, researchers have reported increased 
promoter-associated DNA methylation in lung tumor vs. non-tumor tissue (Chen et al., 2017), 
however the present chapter is the first to report AGTR1 hypermethylation patterns in human 
SkM, specifically after RE. PAX3 (paired box 3), together with PAX7 is highly expressed in 
quiescent and activated SkM progenitor cells which drives them to the myogenic lineage 
(Relaix et al., 2005). PAX3 is therefore crucial for myogenesis whereby expression activates 
the key MRF, myoD (Relaix et al., 2006). Studies have also demonstrated DNA 
hypermethylation in human rhabdomyosarcoma muscle tissue (Kurmasheva et al., 2005) and 
myoblasts (Tsumagari et al., 2013). To the authors knowledge however, the present chapter is 
the first to report hypermethylation of PAX3 in SkM, specifically after RE. Finally, ESR1 
(estrogen receptor 1) was downregulated and hypermethylated in the present analysis, where 
others have demonstrated muscle weakness in ESR1 mutant female mice (Collins et al., 2018), 
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yet, overexpression has been shown induce a sihft in muscle fibre type to a slow muscle fibre 
phenotype (Chen et al., 2016). Therefore, a reduction observed in adult male humans in the 
present chapter may therefore be associated with reduced slow fibre formation and 
subsequently may be conducive to faster fibre formation, previously identified to occur after 
RE. The associated hypermethylation and downregulation of ESR1 and its role in fibre type 
transition however warrants further investigation. Such experiments may be achieved via 
subjecting ESR1 mutant and overexpressed rodents to resistance (i.e. chronic high-frequency 
[100 Hz] electrical stimulation or mechanical overload/synergistic ablation to induce a fast 
muscle fibre type transition) and/or endurance (i.e. chronic low-frequency electrical 
stimulation [10 Hz] or wheel running to induce a slow muscle fibre type transition) exercise 
followed by the assessment of muscle function/force ex-vivo, fibre type (using histological 
techniques) and ESR1 DNA methylation (via tNGBS or pyrosequencing). This would enable 
the characterisation of ESR1 mRNA expression and DNA methylation on muscle fibre type 
transition in response to different modes of exercise. 
 
4.5!Limitations  
It is worth noting a key limitation of the acute RE analysis performed in the present chapter. 
Specifically, the post-acute RE samples pooled for transcriptomic analysis included samples 
taken immediately post and ~24 hrs post whereas the samples derived from the methylome data 
were collected just 30 minutes post RE (Seaborne et al., 2018a, 2018b). This was due to very 
few transcriptomic studies sampling at the same timepoint and therefore pooling all post-RE 
datasets across studies up to 24 hrs post enabled an adequate sample number. Furthermore, 
recent work by our group demonstrated that DNA methylation changes observed just 30 mins 
post-acute RE in humans correlate with changes in mRNA expression after acute RE and even 
after chronic training and retraining (Seaborne et al., 2018a, 2018b). However, a time-course 
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that includes multiple timepoints at both the transcriptomic and methylome level is required to 
directly investigate the temporal relationship between DNA methylation and gene expression 
after acute RE.  
 
4.6!Conclusion  
The present chapter provides novel mechanistic findings that differentially expressed genes 
identified across the human transcriptome are also epigenetically altered at the DNA 
methylation level after acute RE in human SkM. Specifically, mRNA expression and DNA 
methylation of genes enriched in ‘cancer’ pathways were significantly modified across the 
human transcriptome and DNA methylome after acute RE in humans. These genes are known 
to have specific roles in SkM including ECM/actin structure and remodelling, TGF-
ß/calcium/IL-6/retinoic acid signaling as well as mechano-transduction. As described in 
section 4.5, future studies should assess transcriptome-wide gene expression and DNA 
methylation across multiple timepoints to directly investigate their temporal relationship in 
response to acute RE in human SkM. Furthermore, the present analysis was performed in young 
male humans only and future experiments should aim to investigate the differential 
transcriptional and epigenetic responses to exercise in young female and aged female/male 
humans to expand our current knowledge of the molecular mechanisms of exercise-induced 
SkM adaptation across wider populations. Finally, performing integrative 
transcriptomic/methylomic and proteomic analysis in SkM following RE would also enable 
the detection of whether such acute changes at the transcript and DNA methylation level 
correspond to functional changes at the protein and whole tissue (i.e. muscle/fibre size) level. 
Despite such possible questions arising from the present chapter, the data reported herein 
provides a detailed account of which genes to assess in regards to mRNA expression and DNA 
methylation after mechanical loading in fibrin bioengineered SkM (chapter 5) using the TC-3 
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bioreactor which was characterised in chapter 3. Analysis of mRNA expression and DNA 
methylation in fibrin muscle will enable the validation of whether loading bioengineered SkM 
in-vitro mimics the transcriptional and epigenetic response to RE/loading in human SkM in-
vivo.  
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CHAPTER 5  
The Transcriptional and Epigenetic Regulation of 
Murine Fibrin Bioengineered Skeletal Muscle in 
Response to Mechanical Loading 
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5.1!Introduction 
Skeletal muscle (SkM) is a highly abundant (constituting approximately ~40% of overall body 
mass; Janssen et al., 2000) and malleable tissue, displaying functional and morphological 
changes in the presence or absence of mechanical loading. Indeed, muscle size and strength are 
enhanced in response to resistance exercise (RE)/mechanical loading (Goldberg, 1967; Baar & 
Esser, 1999; Seaborne et al., 2018a) whereas SkM mass and function are somewhat 
compromised during periods of unloading, such as that during aging (Hughes et al., 2001; 
Morse et al., 2005), spaceflight (Edgerton et al., 1995) and bed rest (Dirks et al., 2016). 
 
Despite the well-established role of transcriptional activity during load-induced SkM 
hypertrophy (Goldberg & Goodman, 1969), the importance of epigenetics, specifically DNA 
methylation, has only more recently begun to emerge (Sharples & Seaborne, 2019). As 
described in section 4.1, DNA methylation is a key epigenetic modification and is characterised 
by the addition (hypermethylation) or removal (hypomethylation) of covalent methyl groups 
located within cytosine nucleotide bases of cytosine-guanidine base pairing (CpG) sites. The 
presence or absence of these methyl tags, specifically within the promotor or enhancer regions 
of coding genes, is able to permit (via hypomethylation) or prevent (via hypermethylation) 
gene transcription, ultimately controlling the level of gene expression (described in Sharples, 
Stewart and Seaborne, 2016; Sharples and Seaborne, 2019).  
 
Recently published work by our group investigated differential genome-wide (850K CpG sites) 
DNA methylation responses after acute and chronic RE in untrained humans, followed by 
several weeks of unloading and reloading (Seaborne et al., 2018a). Interestingly, a number of 
genes were epigenetically altered after just one single bout of RE, displaying significant 
hypomethylation which preceded increases in gene expression after chronic loading and 
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reloading (Seaborne et al., 2018a). As described in chapter 4 of this thesis, the methylome 
array data (Seaborne et al., 2018a) was then mapped against publicly available transcriptomic 
data files derived from the acute human RE studies to date (April 2018), in order to determine 
whether frequently regulated genes across the human transcriptome after acute RE were also 
epigenetically modified at the DNA level. Interestingly, a number of genes enriched in cancer 
pathways (i.e. ‘pathways in cancer’ and ‘proteoglycans in cancer’) were either 
upregulated/hypomethylated (23 genes) or downregulated/hypermethylated (12 genes), 
supporting the notion that a single bout of exercise alone is able to induce inversely associated 
transcriptional and epigenetic changes in SkM. 
 
As discussed in section 3.1.1, rodent models such as functional overload/synergistic ablation 
have been extensively used for studying the molecular mechanisms underpinning the 
anabolic/hypertrophic response to mechanical loading in-vivo (Goldberg, 1967; Bodine et al., 
2001a; Goodman et al., 2011). However, a recent model developed by our group using 
electrical peroneal and tibial nerve stimulation to enable co-contraction of the plantar- and 
dorsi-flexor hindlimb muscles, respectively has been shown to induce significant increases in 
rodent SkM mass. Indeed, high frequency (100 Hz) intermittent stimulation of the plantar-
flexors which places considerable load on the dorsi-flexor muscles evoked a 14% and 19% 
increase in TA SkM mass and fibre CSA, respectively after 4 weeks of stimulation (Schmoll 
et al., 2018; Seaborne et al., 2019). This method (termed ‘SpillOver’ stimulation) therefore 
provides a useful novel in-vivo rodent model for studying the molecular responses to RE. 
 
The molecular responses following mechanical loading in bioengineered SkM are typically 
determined via assessing the mRNA (Player et al., 2014) and more recently, protein 
phosphorylation (Aguilar-Agon et al., 2019) of well-characterised mechano-sensitive 
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genes/proteins. However, there is limited data that has used such isolated in-vitro models to 
assist in characterising the activity of potential novel mechano-responsive genes. Indeed, recent 
work by our group mechanically loaded murine fibrin bioengineered SkM (the same model 
used throughout this thesis) to investigate the response of the E3 ubiquitin ligase, UBR5, 
following acute anabolic stimuli (Seaborne et al., 2019). Interestingly, UBR5 mRNA 
expression increased to a similar extent following acute RE/loading in human (~1.7-fold) and 
bioengineered (~1.6-fold) SkM, with no change in DNA methylation observed in either model 
of loading/RE (Seaborne et al., 2018a, 2019). With the exception of this previous work, there 
has previously been no attempt to study the epigenetic responses to loading in bioengineered 
SkM. Indeed, if loading of fibrin C2C12 bioengineered SkM resembles the transcriptional and 
epigenetic responses to loading of SkM in-vivo, this system would provide a representative in-
vitro model for studying the underlying mechanisms underpinning load-induced anabolism and 
hypertrophy. 
 
5.1.1! Aims and Objectives 
The aims of the present chapter were therefore: To determine whether transcriptional and 
epigenetic responses in loaded C2C12 bioengineered muscle in-vitro (using the INT loading 
regime and the TC-3 bioreactor characterised in chapter 3) mimics those identified in chapter 
4, as well as changes observed previously after RE in humans (Seaborne et al., 2018a, 2018b), 
and after chronic stimulation/RE in rodents in-vivo (Schmoll et al., 2018; Seaborne et al., 
2019). This will help validate or invalidate whether mechanical loading of C2C12 bioengineered 
muscle is a representative in-vitro model of loading/RE in-vivo.  
 
Given that mRNA and DNA methylation is altered after just a single bout of resistance  
(described in chapter 4 of this thesis and Seaborne et al., 2018a) and endurance (Barrès et al., 
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2012) exercise in-vivo, it was hypothesised that acute mechanical loading of fibrin 
bioengineered SkM may also evoke transcriptional and epigenetic changes at the mRNA and 
DNA level, respectively of regulated genes across the human transcriptome and methylome 
and that these would mimic the responses identified after loading/RE in human and rodent SkM 
in-vivo.  
 
5.2!Methods  
5.2.1! Cell Culture 
C2C12 cells were expanded in T75 culture flasks as described in sections 2.2.1 and 2.2.3. Once 
80% confluency was attained, cells were trypsinised (see section 2.2.3) and counted (see 
section 2.2.4) for subsequent fabrication of SkM constructs (see section 5.2.2). All cells 
throughout this chapter were used at passage 10 (P10).  
 
5.2.2! Fabrication of Fibrin Skeletal Muscle Constructs 
Preparation of fibrin SkM constructs is described in section 2.4 and in previously published 
work by our group (Seaborne et al., 2019; Turner et al., 2019a). C2C12 cells were then seeded 
onto the pre-polymerised fibrin matrix at a density of 9 ! 104 cells/ml in 2 ml GM (see section 
2.2.4). GM was changed every 48 hrs until the ~90% confluency was attained after which fibrin 
gels were washed 2 × in PBS before switching to DM for 48 hrs to initiate differentiation. DM 
was then replaced with MM for a further 10 days (see Figure 2.5) at which point, gels were 
fixed (see section 2.7.3) or removed from the sylgard culture dishes to undergo mechanical 
loading (see section 5.2.3).  
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5.2.3! Mechanical Loading of Fibrin Skeletal Muscle Constructs  
After a total of 14 days in culture, fibrin gels were transferred from the culture dishes to the 
TC-3 bioreactor chambers (see section 2.5) and were clamped into position (12 mm resting 
length) before filling each chamber with 20 ml of MM (see Figure 5.1A). The chambers 
containing the engineered muscle were then assembled to the mechanical stimulation unit, 
placed in a humidified incubator at 37˚C, 5% CO2, ready to undergo mechanical loading (see 
Figure 5.1B). Constructs acting as controls (CON) were kept at resting length for 1 hr whereas 
loaded constructs were subject to intermittent loading (INT) as described in section 3.2.3. 
Briefly, the INT regime consisted of 4 sets × 10 repetitions (frequency of 0.3 Hz, 0.4 mm/s) at 
10% stretch, representing 1 of 5 ‘exercises’. Each set of 10 repetitions was interspersed with a 
1.5 min rest and each exercise was separated with 3.5 mins rest whereby constructs were kept 
at resting length.  
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(A) C2C12 fibrin constructs (n = 5 replicate cultures per time point) were clamped within the 
bioreactor chambers to (B) undergo mechanical loading whilst incubating at 37˚C/5% (yellow 
and blue circled chambers represent those within INT and CON conditions, respectively). (C) 
C2C12 bioengineered fibrin muscle constructs were immuno-stained for f-actin (phalloidin-
FITC, green) and myonuclei (DAPI, blue) and imaged using confocal microscopy (Olympus 
IX83, Japan; 20×, scale bar = 50 µm; taken from Seaborne et al., 2019).  
 
A 
 
C 
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Figure 5.1. Mechanical loading and immunostaining of fibrin bioengineered SkM 
 
Figure 5.2. Heat map representation of temporal mRNA expression after loading 
bioengineered SkMFigure 5.1. Mechanical loading and actin immunostaining fibrin 
bioengineered SkM 
 
Figure 5.2. Heat ap representation of temporal mRNA expression after loading 
bioengineered SkM 
 
Figure 5.3. Temporal mRNA expression of actin/ECM structure and remodelling related 
genes after loading in bioengineered SkMFigure 5.2. Heat map representation of temporal 
mRNA expression after loading bioengineered SkMFigure 5.1. Mechanical loading and actin 
immunostaining fibrin bioengineered SkM 
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5.2.4! Chronic High-Frequency Electrical Stimulation in Rats 
In order to compare the loading response in fibrin engineered muscle with the responses to RE 
in rodent SkM, adult (6 months) male Wistar rats were subject to high frequency (100 Hz) 
electrical stimulation as previously described in published work by our group (Schmoll et al., 
2018; Seaborne et al., 2019). Briefly, rodents were equipped with an implantable stimulator 
connected to electrodes placed near the common peroneal and tibial nerves. Dorsiflexor 
muscles were then loaded via resisting against the plantarflexors during the electrical 
stimulation protocol. Doris-flexor and plantar-flexor muscles were intermittently stimulated 
once a day for 4 weeks (5 sets ! 10 reps, each rep lasted 2 s with a 2 s rest between reps and 
2.5 mins rest between sets), evoking a 14% and 19% increase in TA SkM weight and fibre 
CSA, respectively (Schmoll et al., 2018). Following cessation of electrical stimulation, RNA 
was isolated from the TA muscle of the stimulated and contralateral unstimulated (control) 
limbs (n = 5) using the TRIzol method as described in section 2.8. Experimental procedures 
were conducted according to permissions within a project license granted under the British 
Home Office Animals (Scientific Procedures) Act 1986. 
 
5.2.5! Acute and Chronic Resistance Exercise in Humans 
In order to compare the genetic and epigenetic responses to loading in bioengineered SkM with 
those following RE in humans, 8 healthy young (27.6 ± 2.4 yrs) males were subjected to both 
acute and chronic RE as described in previously published work by our group (Seaborne et al., 
2018a, 2018b). Briefly, following a week of familiarisation, untrained male participants 
performed an acute bout of RE consisting of several lower body exercises (4 sets ! 10 reps, 
~90–120 s rest between sets and ~3 mins rest between exercises). This was repeated 3 times 
per week for a total of 7 weeks (chronic RE), evoking a 6.5% (± 1%) increase in lower limb 
lean mass as determined via dual-energy x-ray absorptiometry (DEXA) scanning technology. 
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RNA was isolated using the TRIzol method as described in section 2.8 and in the original 
published work (Seaborne et al., 2018a, 2018b). Ethical approval was granted by the NHS 
West Midlands Black Country, UK, Research Ethics Committee (NREC approval no. 
16/WM/0103). 
 
5.2.6! Immunohistochemisty (IHC) 
SkM constructs were fixed in methanol:acetone as described in section 2.7.2. Following 
fixation, fibrin gels were removed from the culture dishes and transferred to 2 ml Eppendorf 
tubes ready for immunostaining (see section 2.7.3) for f-actin (phalloidin-FITC, green) and 
myonuclei (DAPI, blue) as described in section 2.7.3. Immunostained gels were then visualised 
using a confocal fluorescence microscope (Olympus IX83, Japan) and imaged using supporting 
software (FV10-ASW 4.2, Olympus, Japan) as described in section 2.7.4 to illustrate the 
alignment of mature myotubes in the direction of uniaxial tension (see Figure 5.1C). 
 
5.2.7! RNA Extraction and Quantitative Real-Time Polymerase Chain Reaction 
(qRT-PCR) 
Following cessation of mechanical loading, engineered muscles (n = 5 replicate cultures per 
time point) were removed from the bioreactor chambers at 30 mins, 3 hrs and 24 hrs post-
loading. SkM constructs used for assessing mRNA expression of genes identified in chapter 4 
were lysed in 600 µl of Buffer RLT containing 6 µl β-Mercaptoethanol (β-ME) as described in 
section 2.8 ready for RNA isolation using the AllPrep RNA/DNA Mini Kit (see section 2.9.1). 
Bioengineered  muscles analysed for transcript expression of genes identified after 30 mins 
post-acute RE in previously published work by our group (Seaborne et al., 2018a) were 
dissected down the middle to ensure two separate parts. One part was then placed in 1 ml 
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TRIzol (see section 2.8) for subsequent RNA extraction (see section 2.9.2). RNA 
concentrations and purities were assessed using a NanoDrop (see section 2.9.3) which were 
greater following isolations using the AllPrep Mini Kit (4.1 ± 2.42 µg conc.; 2.05 ± 
0.03A260/A280) versus the traditional TRIzol method (1.92 ± 0.65 µg concentration; 1.88 ± 
0.12A260/A280). Once isolated, samples were diluted in Nuclease-free H2O to ensure a 
concentration of 35 ng in 4.75 µl (7.37 ng/ul) which was added to 5.25 µl of master mix 
composed of 5 µl SYBR green, 0.1 ml of reverse transcriptase (RT) mix and 0.075 µl of both 
forward and reverse primers in PCR reaction tubes (0.1 ml strips and caps, Qiagen, UK). All 
primer sequences and locations for the genes analysed in bioengineered, rat and human SkM 
are described in Tables 5.1-5.5 in the thesis appendices. After preparation, reaction tubes were 
transferred to a PCR thermal cycler to undergo amplification (see section 2.9.4.2). All gene 
expression was relativized using the DDCT (ΔΔCT) method as described in section 2.9.4.3 
(Schmittgen & Livak, 2008). For bioengineered SkM, the pooled CT values from the non-
loaded controls (CON) at each individual time point (30 mins, 3 hrs and 24 hrs) were used as 
the calibrator condition and were relativised to the mean CT value of the reference gene, RP-
IIß (18.64 ± 0.74, with a low 3.97% variation). For rat SkM, the contralateral non-stimulated 
limb for each animal and the mean reference gene (Pol2ra) CT value across all rodents (24.12 
± 0.67 with low 2.78% variation) was used for the ΔΔCT equation. For human SkM, gene 
expression was also quantified using the ΔΔCT equation which included each individuals 
baseline (pre RE) CT value and mean CT value for reference gene, RPL13a across all 
participants (20.48 ± 0.64, with low variation 3.17%). PCR efficiencies across all species were 
similar for reference genes (bioengineered = 92.24 ± 5.43%, with 5.88% variation; rodent = 
94.5 ± 4.27% with 4.52% variation) and genes of interest (bioengineered = 93.64 ± 5.91% with 
low variation 6.31%; rodent = 93 ± 4.92%, with 5.29% variation).  
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5.2.8! DNA Isolation, Bisulfite Conversion and Targeted DNA Methylation  
Samples were lysed in 600 µl of Buffer RLT containing 6 µl β-ME if DNA was extracted using 
the AllPrep RNA/DNA Mini Kit (see section 2.10.1), specifically when analysing the DNA 
methylation of genes identified in chapter 4. Remaining dissected tissue was lysed (see section 
2.8) and purified (see section 2.10.2) using a DNeasy spin column kit for samples used to assess 
the DNA methylation status of genes previously described in published work by our group 
(Seaborne et al., 2018a). As with RNA, DNA concentrations and purities were assessed using 
a NanoDrop (see section 2.9.3). However, concentrations and A260/A280 ratios were similar 
between AllPrep Mini (2.68 ± 1.95 µg conc.; 1.89 ± 0.06A260/A280) and DNeasy (2.46 ± 0.8 µg 
conc.; 1.78 ± 0.1A260/A280) spin column kits. Stock DNA was diluted in Nuclease-free dH2O to 
ensure 500 ng at a concentration of 20 ng/µl ready for bisulfite conversion using the EZ-96 
DNA Methylation Kit (Zymo Research Corp., USA) as described in section 2.10.4. Bisulfite 
converted DNA was then analysed for DNA methylation using targeted next generation 
bisulfite sequencing (tNGBS, as described in section 2.10.6) or loci-specific pyrosequencing 
(as described in section 2.10.5). Specifically, tNGBS assays were designed to target numerous 
regulatory regions of mouse genes; MSN, TIMP3, WNT9a, CTTN, GSK3ß, PAX3, AGTR1a 
and UBR5 3 hrs post-loading and genes; BICC1, GRIK2, TRAF1, STAG1, ODF2 and UBR5 
30 mins post-loading (see section 2.10.6). Furthermore, additional pyrosequencing was 
undertaken to assess the methylation status of 6 × CpG sites in the intron 1 region of the mouse 
UBR5 gene (see section 2.10.5). 
 
5.2.9! Statistical Analysis 
A multivariate analysis of variance (MANOVA) was conducted using a statistical package for 
the social sciences software (SPSS®, version 24.0, Chicago) to determine main effects for 
groups of genes between conditions (CON vs. INT), across time (30 mins, 3 and 24 hrs). A 
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two-way mixed ANOVA (2 × 3) was performed using Minitab® software (Version 18, USA) 
to detect statistical significant interactions for condition and time. Post-hoc analysis (Fisher 
LSD) was carried out to confirm statistical significance between condition (CON vs. INT) and 
within time (30 mins vs. 3 hrs vs. 24 hrs), respectively whenever significant interactions were 
observed. A one-way ANOVA was conducted to detect differences in mRNA expression 
between models of loading/RE (RE/loading in bioengineered and human SkM, and chronic 
RE/electrical stimulation in humans/rats). When comparing expression of genes previously 
identified in  across models of loading, follow up post-hoc analyses (with Tukey HSD 
correction) enabled detection of where main effects occurred. However, unpaired t-tests were 
conducted to determine where main effects for occurred for regulated genes identified in 
chapter 4. This was because the mean expression value across all transcriptomic studies 
analysed in chapter 4 was obtained and not mean expression values for each individual study 
employed. Therefore a post-hoc analysis could not be performed to compare individual models 
of loading. Finally, unpaired t-tests were carried out to determine mRNA expression between 
conditions (CON vs. INT) at 30 mins post-loading in fibrin bioengineered SkM alone for 
previously identified genes (Seaborne et al., 2018a) and also for CpG DNA methylation at 30 
mins (UBR5, ODF2, BICC1, GRIK2, STAG1, TRAF1) and 3 hrs (UBR5, MSN, WNT9a, 
GSK3ß, CTTN, TIMP3) post-loading in bioengineered SkM. The alpha value of significance 
was set at P < 0.05. All data is presented as the mean ± standard error of mean (SEM). 
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5.3!Results 
5.3.1! mRNA Expression of Genes that are Upregulated/Hypomethylated After 
Resistance Exercise in Human Skeletal Muscle were Assessed After 
Loading in Bioengineered Muscle 
In the present chapter, mRNA expression of genes which were upregulated and 
hypomethylated across the human transcriptome and methylome in chapter 4 were investigated 
at 30 mins, 3 and 24 hrs post-acute mechanical loading in bioengineered SkM. Specifically, 
genes involved in ECM/actin structure and remodelling (MSN, CTTN, FLNB, TIMP3, ITGB3, 
LAMA5, COL4A1, THBS1), mechano-transduction (CRK, CD63), protein synthesis (GSK3ß) 
and TGF-ß (FOS, SMAD3, WNT9A), calcium (ITPR, ADCY3), IL-6 (STAT3) and retinoic 
acid (RARA) signaling were analysed. Collective mRNA expression of all 
upregulated/hypomethylated genes assessed after loading in bioengineered SkM is presented 
in Figure 5.2.  
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mRNA expression of upregulated/hypomethylated (green dotted line indicated on the left y-
axis) and downregulated/hypermethylated (red dotted line indicated on the left y-axis) genes 
identified in chapter 4, however, following mechanical loading in bioengineered SkM (n = 5 
replicate cultures/muscles per condition [CON and INT) and time point [30 mins, 3 and 24 
hrs]). Transcript expression was assessed at 30 mins, 3 hrs and 24 hrs post-loading (as indicated 
on the x-axis) and fold-change was determined via relativising mRNA expression in loaded 
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Figure 5.2. Heat map representation of temporal change in mRNA expression after 
mechanical loading in bioengineered SkM 
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(INT) versus non-loaded (CON) fibrin muscle for each separate timepoint (30 mins, 3 hrs or 
24 hrs). The colour density represents the level of fold-change in mRNA expression (as 
indicated on the right y-axis). Upregulated/hypomethylated genes identified in chapter 4 were 
graphed in order of the greatest (i.e. UBR5) to lowest (i.e. ADCY3) increase in mRNA 
expression at 3 hrs post-loading.  Conversley, downregulated/hypermethylated genes identified 
in chapter 4 were graphed in order of the greatest (i.e. PAX3) to lowest (i.e. LAMA3) reduction 
in mRNA expression at 3 hrs post-loading in bioengineered SkM.  
 
Actin Structure and Remodelling Genes 
There was a significant main effect for loading (F1,23 = 6.62, P = 0.02) and time (F2,23 = 15.83, 
P < 0.001) on MSN transcript expression with a significant interaction (F2,23 = 12.82, P < 
0.001). Expression was significantly increased at 3 hrs (1.43 ± 0.15) relative to 30 mins (0.99 
± 0.04, t = -4.62, 95% CI -0.64 to -0.24, P < 0.001) and 24 hrs (0.96 ± 0.04, t = -5.05, 95% CI 
-0.66 to -0.28, P < 0.001) with no difference between 30 mins and 24 hrs (t = 0.28, 95% CI -
0.17 to 0.22, P = 0.79). Transcript expression was significantly greater after INT vs. CON at 3 
hrs post (1.06 ± 0.17 CON vs. 1.8 ± 0.08 INT, t = 5.67, 95% CI 0.47 to 1.01, P < 0.001) with no 
difference between conditions at 30 mins (1.01 ± 0.07 CON vs. 0.97 ± 0.05 INT, t = -0.3, 95% CI 
-0.33 to 0.25, P = 0.77) and 24 hrs post-loading (1.01 ± 0.08 CON vs 0.9 ± 0.04 INT, t = -0.81, 
95% CI -0.38 to 0.17, P = 0.43; see Figure 5.3).  
 
There was no significant main effect for loading (F1,22 = 0.35, P = 0.56) on CTTN transcript 
expression but there was for time (F2,22 = 15.46, P < 0.001) with no significant interaction (F2,22 
= 2.89, P = 0.08). Mean expression at 3 hrs (1.26 ± 0.04) was significantly greater than that at 
30 mins (0.93 ± 0.05; t = -5.29, 95% CI -0.46 to -0.2, P < 0.001) and 24 hrs (1 ± 0.05, t = -
4.18, 95% CI -0.38 to -0.13,  P < 0.001) with no significant difference between 30 mins and 
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24 hrs (t = -1.27, 95% CI -0.20 to 0.05, P = 0.22). There was no significant difference in mRNA 
expression post-loading at 30 mins (1.01 ± 0.05 CON vs. 0.83 ± 0.07 INT, t = -1.97, 95% CI -0.36 
to 0.01, P = 0.06), 3 hrs (1.19 ± 0.06 CON vs. 1.31 ± 0.04 INT, t = 1.42, 95% CI -0.06 to 0.31, P 
= 0.17) and 24 hrs (1.01 ± 0.09 CON vs. 0.98 ± 0.04 INT, t = -0.48, 95% CI -0.21 to 0.13, P = 
0.64; see Figure 5.3). 
 
For FLNB transcript expression, there was no significant main effect for condition (F1,23 = 
0.37, P = 0.55) nor time (F2,23 = 2.7, P = 0.09), with no significant interaction (F2,23 = 3.05, P 
= 0.07). Mean expression at 30 mins (1.01 ± 0.05) was not significantly different versus 3 hrs 
(1.06 ± 0.04; t = -0.63, 95% CI -0.19 to 0.1, P = 0.53) and 24 hrs (0.90 ± 0.06, t = 1.55, 95% 
CI -0.04 to 0.26,  P = 0.13), however, mRNA expression was significantly lower at 24 hrs 
versus 3 hrs (t = -2.26, 95% CI -0.3 to -0.01, P = 0.03). There was no significant difference in 
mRNA expression post-loading at 30 mins (1.01 ± 0.06 CON vs. 1.02 ± 0.11 INT, t = 0.09, 95% 
CI -0.21 to 0.23, P = 0.93) and 3 hrs (1 ± 0.03 CON vs. 1.11 ± 0.07 INT, t = 1.12, 95% CI -0.09 
to 0.31, P = 0.28), however, mRNA was significantly lower in INT vs. CON at 24 hrs (1.01 ± 
0.08 CON vs. 0.79 ± 0.08 INT, t = -2.29, 95% CI -0.43 to -0.02, P = 0.03; see Figure 5.3). 
 
ECM Structure and Remodelling Genes 
There was a significant main effect for loading (F1,23 = 4.25, P = 0.05) and time (F2,23 = 4.39, 
P = 0.02) on TIMP3 expression with a significant interaction (F2,23 = 5.09, P = 0.02). Mean 
mRNA expression at 30 mins (0.94 ± 0.08) was significantly lower than 3 hrs (1.19 ± 0.08, t = 
-2.6, 95% CI -0.52 to -0.00, P = 0.05) and 24 hrs (1.19 ± 0.09, t = -2.6, 95% CI -0.52 to -0.00, 
P = 0.05) post-loading with no significant difference between 3 hrs and 24 hrs (t = -0.02, 95% 
CI -0.25 to 0.25, P = 1). There was no statistical significance between CON vs. INT at 30 mins 
(1.03 ± 0.12 CON vs. 0.83 ± 0.08 INT, t = -1.41, 95% CI -0.51 to 0.1, P = 0.17), although 
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expression was greater following INT at 3 hrs (1.01 ± 0.08 CON vs. 1.36 ± 0.07 INT, t = 2.55, 
95% CI 0.07 to 0.63, P = 0.02) and 24 hrs post-loading (1.01 ± 0.07 CON vs. 1.36 ± 0.14 INT, t = 
2.59, 95% CI 0.07 to 0.64, P = 0.02; see Figure 5.3). 
 
There was no significant main effect for condition (F1,23 = 0.10, P = 0.75) on ITGB3 transcript 
expression, albeit, there was a significant main effect for time (F2,23 = 5.47, P = 0.01) with a 
significant interaction (F2,23 = 5.44, P = 0.01). Mean expression 3 hrs (1.21 ± 0.09) was 
significantly greater than that at 30 mins (0.96 ± 0.08, t = -2.83, 95% CI -0.46 to -0.07, P = 
0.001) and 24 hrs (0.95 ± 0.05, t = -2.83, 95% CI -0.46 to -0.07, P = 0.01) with no difference 
between 30 mins and 24 hrs (t = -0.06, 95% CI -0.19 to 0.19, P = 0.96). Transcript expression 
was significantly greater following INT at 3 hrs (1.03 ± 0.11 CON vs. 1.4 ± 0.06 INT, t = 2.91, P 
= 0.01, 95% CI 0.03 to 0.7) with no difference between CON vs. INT at 30 mins (1.04 ± 0.13 
CON vs. 0.86 ± 0.09 INT, t = -1.29, 95% CI -0.46 to 0.11, P = 0.21) and 24 hrs post-loading (1.02 
± 0.08 CON vs. 0.9 ± 0.03 INT, t = -0.96, 95% CI -0.39 to 0.14, P = 0.35; see Figure 5.3). 
 
There was no significant main effect for loading (F1,23 = 0, P = 0.99) nor time (F2,23 = 1.68, P 
= 0.21) on LAMA5 transcript expression with no significant interaction (F2,23 = 1.43, P = 0.26). 
Mean expression at 30 mins (0.98 ± 0.04) was not significantly different versus 3 (1.09 ± 0.06; 
t = -1.49, 95% CI -0.27 to 0.04, P = 0.15) and 24 hrs (0.96 ± 0.05, t = 0.11, 95% CI -0.15 to 
0.17, P = 0.91). Furthermore, there was no statistical significance between 3 and 24 hrs (t = -
1.66, 95% CI -0.27 to 0.03, P = 0.11). There was no significant difference in mRNA expression 
post-loading at 30 mins (1 ± 0.05 CON vs. 0.94 ± 0.08 INT, t = -0.57, 95% CI -0.29 to 0.17, P = 
0.58), 3 (1.02 ± 0.09 CON vs. 1.16 ± 0.09 INT, t = 1.38, 95% CI -0.07 to 0.36, P = 0.18) or 24 hrs 
(1.01 ± 0.06 CON vs. 0.92 ± 0.07 INT, t = -0.8, 95% CI -0.3 to 0.13, P = 0.44; see Figure 5.3). 
 
 184 
There was a significant main effect for condition (F1,19 = 7.89, P = 0.01) on COL4A1 transcript 
expression, albeit, there was no significant main effect for time (F2,19 = 0.56, P = 0.58) with no 
significant interaction (F2,19 = 2.17, P = 0.14). Mean expression at 30 mins (1.01 ± 0.08) was 
not significantly different versus 3 (1.01 ± 0.07; t = 0.05, 95% CI -0.2 to 0.21, P = 0.96) and 
24 hrs (1.1 ± 0.09, t = -0.88, 95% CI -0.29 to 0.12, P = 0.39). Furthermore, there was no 
statistical significance between 3 and 24 hrs (t = 0.96, 95% CI -0.11 to 0.29, P = 0.35). There 
was no significant difference in mRNA expression between CON vs. INT at 30 mins (1.12 ± 
0.1 CON vs. 0.9 ± 0.12 INT, t = -1.60, 95% CI -0.52 to 0.07, P = 0.13) and 3 hrs (1.02 ± 0.1 CON 
vs. 1 ± 0.11 INT, t = -0.17, 95% CI -0.3 to 0.26, P = 0.87). However, COL4A1 expression was 
significantly lower at 24 hrs post-loading (1.31 ± 0.07 CON vs. 0.89 ± 0.06 INT, t = -3.03, 95% 
CI -0.72 to 0.13, P = 0.01; see Figure 5.3). 
 
There was a significant main effect for loading (F1,19 = 11.3, P = 0.003) and time (F2,19 = 5.33, 
P = 0.02) on THBS1 expression with a significant interaction (F2,19 = 3.59, P = 0.05). Mean 
mRNA expression at 30 mins (1 ± 0.07) was significantly greater than that at 24 hrs (0.77 ± 
0.03, t = 3.26, 95% CI 0.08 to 0.39, P = 0.004) post-loading with no significant difference 
between 3 hrs (0.88 ± 0.07) and 30 mins (t = 1.87, 95% CI -0.02 to 0.27, P = 0.08) and 24 hrs 
(t = -1.49, 95% CI -0.25 to 0.04, P = 0.15). Mean mRNA expression was significantly lower 
at 30 mins (1.15 ± 0.06 CON vs. 0.84 ± 0.07 INT, t = -3.13, 95% CI -0.52 to -0.1, P = 0.01) and 3 
hrs (1.02 ± 0.08 CON vs. 0.72 ± 0.07 INT, t = -3.11, 95% CI -0.5 to -0.1, P = 0.01) post INT 
loading with no difference between CON vs. INT at 24 hrs post-loading (0.75 ± 0.07 CON vs. 
0.78 ± 0.04 INT, t = 0.28, 95% CI -0.19 to 0.25, P = 0.78; see Figure 5.3). 
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Gene expression of actin (i.e. MSN, CTTN, FLNB) / ECM (i.e. TIMP3, ITGB3, LAMA5, 
COL4A1, THBS1) structure and remodelling related genes was assessed at 30 mins, 3 hrs and 
24 hrs post-loading in loaded (INT) and non-loaded (CON) bioengineered SkM (n = 5 replicate 
cultures/muscles per condition [CON and INT] and time point [30 mins, 3 and 24 hrs]). (*) 
depicts significant mRNA expression fold-change after INT relative to CON at the same 
relative timepoint (P < 0.05). Data is presented as mean ± standard error of mean (SEM). 
 
Mechano-Transduction Genes 
There was no significant main effect for condition (F1,18 = 1.87, P = 0.19) on CRK transcript 
expression, albeit, there was a significant main effect for time (F2,18 = 4.16, P = 0.03) with a 
significant interaction (F2,18 = 6.04, P = 0.01). Mean expression 30 mins (0.77 ± 0.07) was 
significantly lower than that at 3 hrs (1.09 ± 0.13, t = -2.88, 95% CI -0.58 to -0.09, P = 0.01), 
however there was no significant difference at 30 mins vs. 24 hrs (0.91 ± 0.08, t = -1.57, 95% 
CI -0.42 to 0.06, P = 0.13), nor 3 vs. 24 hrs (t = -1.44, 95% CI -0.38 to 0.07, P = 0.17). 
Furthermore, there was no statistical difference in transcript expression between CON vs. INT  
at 30 mins (0.89 ± 0.07 CON vs. 0.62 ± 0.09 INT, t = -1.02, 95% CI -0.38 to 0.13, P = 0.32) and 
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Figure 5.3. mRNA expression of actin/ECM structure and remodelling related genes after 
loading in bioengineered SkM 
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3 hrs (0.93 ± 0.12 CON vs. 1.24 ± 0.21 INT, t = 1.1, 95% CI -0.12 to 0.39, P = 0.29), however 
mRNA significantly reduced after 24 hrs post-loading (1.14 ± 0.09 CON vs. 0.72 ± 0.02 INT, t = 
-2.42, 95% CI -0.51 to -0.04, P = 0.02; see Figure 5.4). 
 
There was no significant main effect for condition (F1,23 = 3.41, P = 0.08) on CD63 transcript 
expression, albeit, there was a significant main effect for time (F2,23 = 5.22, P = 0.01) with a 
significant interaction (F2,23 = 4.67, P = 0.02). Mean expression 30 mins (0.86 ± 0.07) was 
significantly lower than that at 3 (1.05 ± 0.06, t = -3.19, 95% CI -0.35 to -0.07, P = 0.004) and 
24 hrs (0.98 ± 0.04, t = -2.14, 95% CI -0.28 to -0.004, P = 0.13) with no difference 3 and 24 
hrs (t = -1.08, 95% CI -0.2 to 0.06, P = 0.29). Furthermore, mRNA expression significantly 
reduced after loading at 30 mins (1 ± 0.05 CON vs. 0.68 ± 0.05 INT, t = -3.38, 95% CI -0.53 to -
0.13, P = 0.003), however there was no difference in CON vs. INT at 3 (1.02 ± 0.09 CON vs. 
1.09 ± 0.07 INT, t = 0.74, 95% CI -0.12 to 0.26, P = 0.47) and 24 hrs post-loading (1 ± 0.03 CON 
vs. 0.96 ± 0.07 INT, t = -0.42, 95% CI -0.23 to 0.15, P = 0.68; see Figure 5.4). 
 
Protein Synthesis 
There was no significant main effect for loading (F1,23 = 0.06, P = 0.8) on GSK3ß mRNA 
expression, albeit there was for time (F2,23 = 6.97, P = 0.004) with a significant interaction 
(F2,23 = 6.8, P = 0.01). GSK3ß mean expression was significantly greater at 3 hrs (1.13 ± 0.06) 
versus 30 mins (0.92 ± 0.06, t = -3.57, 95% CI -0.35 to -0.09, P = 0.002) and 24 hrs (0.97 ± 
0.03, t = -2.69, 95% CI -0.29 to -0.04, P = 0.01) with no difference between 30 mins and 24 
hrs (t = -0.96, 95% CI -0.19 to 0.07, P = 0.35). Transcript expression was significantly lower 
in INT vs. CON at 30 mins (1.01 ± 0.07 CON vs. 0.8 ± 0.04 INT , t = -2.26, P = 0.03, 95% CI -
0.4 to -0.02). However, expression was greater after INT loading at 3 hrs (1.01 ± 0.08 CON vs. 
1.25 ± 0.07 INT, t = 2.79, 95% CI 0.06 to 0.42, P = 0.01) with no difference between conditions 
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at 24 hrs post-loading (1 ± 0.04 CON vs. 0.93 ± 0.04 INT, t = -0.85, 95% CI -0.25 to 0.11, P = 
0.41; see Figure 5.4). 
 
TGF-ß Signaling  
There was a significant main effect for condition (F1,17 = 18.21, P = 0.001) and time (F2,17 = 
12.49, P < 0.001) on FOS mRNA expression with a significant interaction (F2,17 = 3.89, P = 
0.04). Mean expression at 30 mins (1.66 ± 0.2) was statistically greater than that at 3 (1.04 ± 
0.15, t = 3.87, 95% CI 0.26 to 0.88, P = 0.001) and 24 hrs (1 ± 0.06, t = 4.82, 95% CI 0.37 to 
0.95, P < 0.001) with no difference between 3 and 24 hrs (t = -0.66, 95% CI -0.36 to 0.19, P = 
0.52). Interestingly, transcript expression significantly reduced after INT loading at 30 mins 
(2.02 ± 0.08 CON vs. 1.3 ± 0.25 INT, t = -3.34, 95% CI -1.18 to -0.27, P = 0.004) and 3 (1.42 ± 
0.16 CON vs. 0.76 ± 0.06 INT, t = -3.27, 95% CI -1.09 to -0.23, P = 0.01) with no difference 
between conditions at 24 hrs post-loading (1.04 ± 0.14 CON vs. 0.97 ± 0.1 INT, t = -0.41, 95% CI 
-0.42 to 0.29, P = 0.69; see Figure 5.4). 
 
There was no significant main effect for condition (F1,23 = 0.13, P = 0.72), nor time (F2,23 = 
1.63, P = 0.22) on SMAD3 mRNA expression with no significant interaction (F2,23 = 1.7, P = 
0.2). Mean expression at 30 mins (0.93 ± 0.05) was not statistically different than that at 3 (1.06 
± 0.04, t = -1.76, 95% CI -0.3 to 0.02, P = 0.09) and 24 hrs (1.02 ± 0.07, t = -1.27, 95% CI -
0.26 to 0.06, P = 0.22) with no difference between 3 and 24 hrs (t = -0.51, 95% CI -0.2 to 0.12, 
P = 0.62). Furthermore, transcript expression was not statistically different between CON and 
INT at 30 mins (1.01 ± 0.07 CON vs. 0.84 ± 0.05 INT, t = -1.50, 95% CI -0.41 to 0.07, P = 0.15) 
and 3 (1 ± 0.04 CON vs. 1.12 ± 0.06 INT, t = 1.1, 95% CI -0.12 to 0.34, P = 0.28) and 24 hrs post-
loading (1.03 ± 0.13 CON vs. 1.02 ± 0.07 INT, t = -0.15, 95% CI -0.24 to 0.21, P = 0.88; see 
Figure 5.4). 
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There was no significant main effect for condition (F1,23 = 0.03, P = 0.865) on WNT9a mRNA 
expression, albeit, there was for time (F2,23 = 11.97, P < 0.001) with a significant interaction 
(F2,23 = 12.63, P < 0.001). Mean WNT9a expression at 3 hrs (1.28 ± 0.13) was greater than that 
at 30 mins (0.81 ± 0.1, t = -4.79, 95% CI -0.71 to -0.28, P < 0.001) and 24 hrs (0.96 ± 0.05, t 
= -3.21, 95% CI -0.53 to -0.12, P = 0.004) with no difference between 30 mins and 24 hrs (t = 
-1.67, 95% CI -0.39 to 0.04, P = 0.11). Furthermore, transcript expression was significantly 
lower in INT vs. CON at 30 mins (1.03 ± 0.11 CON vs. 0.55 ± 0.04 INT, t = -3.18, 95% CI -0.79 
to -0.17, P = 0.004) but was greater at 3 hrs post (1.01 ± 0.08 CON vs. 1.56 ± 0.17 INT, t = 3.82, 
95% CI 0.25 to 0.84, P = 0.001) with no difference between conditions 24 hrs (1.01 ± 0.08 CON 
vs. 0.9 ± 0.07 INT, t = -0.75, 95% CI -0.4 to 0.18, P = 0.46; see Figure 5.4). 
 
Calcium Signaling 
There was a significant main effect for condition (F1,22 = 9.87, P = 0.01) on ITPR3 transcript 
expression, albeit, there was no significant main effect for time (F2,22 = 3.28, P = 0.06) with no 
significant interaction (F2,22 = 2.72 P = 0.09). Mean expression at 24 hrs (0.82 ± 0.06) was 
significantly lower than that at 3 hrs (0.99 ± 0.05; t = -2.41, 95% CI -0.32 to -0.02, P = 0.03) 
post-loading with no significant difference between 30 mins (0.96 ± 0.07) and 3 hrs (t = -0.49, 
95% CI -0.19 to 0.12,  P = 0.63) nor 30 mins vs. 24 hrs (t = 1.91, 95% CI -0.01 to 0.28,  P = 
0.07). There was no significant difference in mRNA expression post-loading at 30 mins (1.02 
± 0.11 CON vs. 0.89 ± 0.07 INT, t = -1.26, 95% CI -0.34 to 0.08, P = 0.22) and 3 hrs (1.02 ± 0.09 
CON vs. 0.96 ± 0.02 INT, t = -0.52, 95% CI -0.27 to 0.16, P = 0.61). However, gene expression 
was significantly lower at 24 hrs post-loading (1 ± 0.04 CON vs. 0.64 ± 0.02 INT, t = -3.78, 95% 
CI -0.57 to -0.17, P = 0.001; see Figure 5.4). 
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There was a significant main effect for condition (F1,23 = 16.94, P < 0.001) on ADCY3 
transcript expression, albeit, there was no significant main effect for time (F2,23 = 0.94, P = 0.4) 
with no significant interaction (F2,23 = 0.79 P = 0.46). There was no significant difference in 
mean mRNA expression at 30 mins (0.85 ± 0.09) vs. 3 hrs (0.86 ± 0.07, t = -0.29, 95% CI -
0.21 to 0.15, P = 0.77) and 24 hrs (0.94 ± 0.07, t = -1.29, 95% CI -0.29 to 0.07,  P = 0.21) nor 
between 3 and 24 hrs (t = 1.03, 95% CI -0.09 to 0.26,  P = 0.31). Gene expression significantly 
reduced after loading at 30 mins (1.02 ± 0.11 CON vs. 0.64 ± 0.05 INT, t = -3.03, 95% CI -0.65 
to -0.12, P = 0.01) and 3 hrs (1.02 ± 0.09 CON vs. 0.7 ± 0.04 INT, t = -2.64, 95% CI -0.56 to -
0.07, P = 0.02) with no difference between CON vs. INT at 24 hrs (1.03 ± 0.13 CON vs. 0.86 ± 
0.04 INT, t = -1.43, 95% CI -0.42 to 0.08, P = 0.17; see Figure 5.4). 
 
 IL-6 Signaling 
There was no significant main effect for loading (F1,21 = 0.02, P = 0.89) on STAT3 mRNA 
expression, albeit, there was a significant main effect for time (F1,21 = 11.95, P < 0.001) with 
no significant interaction (F2,21 = 2.24, P = 0.13). Mean expression at 3 hrs (1.34 ± 0.07) was 
significantly greater than that at 30 mins (0.91 ± 0.06, t = -4.85, 95% CI -0.64 to -0.51, P < 
0.001) and 24 hrs (1.06 ± 0.06, t = -3.16, 95% CI -0.47 to -0.1, P = 0.01) with no difference 
between 30 mins and 24 hrs (t = -1.88, 95% CI -0.34 to 0.02, P = 0.08). Transcript expression 
was not significantly different between CON and INT at 30 mins (1.01 ± 0.07 CON vs. 0.78 ± 
0.07 INT, t = -1.8, 95% CI -0.49 to 0.04, P = 0.09), 3 hrs (1.29 ± 0.13 CON vs 1.39 ± 0.06 INT, t = 
0.73, 95% CI -0.18 to 0.38, P = 0.48) or 24 hrs post-loading (1.01 ± 0.06 CON vs. 1.11 ± 0.11 
INT, t = 0.84, 95% CI -0.15 to 0.35, P = 0.41; see Figure 5.4). 
 
 Retinoic Signaling 
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There was no significant main effect for condition (F1,23 = 1.69, P = 0.21), nor time (F2,23 = 
1.35, P = 0.28) on RARA mRNA expression with no significant interaction (F2,23 = 1.43, P = 
0.26). There was no statistical difference in mean expression at 30 mins (0.92 ± 0.08) vs. 3 
(1.05 ± 0.06, t = -1.61, 95% CI -0.32 to 0.04, P = 0.12) and 24 hrs (0.96 ± 0.04, t = -0.6, 95% 
CI -0.24 to 0.13, P = 0.55) with no further difference between 3 and 24 hrs (t = -1.04, 95% CI 
-0.27 to 0.09, P = 0.31). Furthermore, transcript expression was not statistically different 
between CON and INT at 30 mins (1.03 ± 0.12 CON vs. 0.79 ± 0.09 INT, t = -1.83, 95% CI -0.5 
to 0.03, P = 0.08), 3 (1.02 ± 0.1 CON vs. 1.08 ± 0.08 INT, t = 0.51, 95% CI -0.19 to 0.31, P = 
0.61) and 24 hrs post-loading (1.01 ± 0.08 CON vs. 0.91 ± 0.04 INT, t = -0.87, 95% CI -0.36 to 
0.15, P = 0.39; see Figure 5.4). 
 
Gene expression of genes associated with mechano-transduction (CRK, CD63), MPS (GSK3ß) 
and TGF-ß (FOS, SMAD3, WNT9a) / calcium (ITPR3, ADCY3) / IL-6 (STAT3) / retinoic 
acid (RARA) signalling was assessed at 30 mins, 3 hrs and 24 hrs post-loading in loaded (INT) 
and non-loaded (CON) bioengineered SkM (n = 5 replicate cultures/muscles per condition 
[CON and INT] and time point [30 mins, 3 and 24 hrs]). (*) depicts significant mRNA 
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Figure 5.4. mRNA expression of genes associated with mechano-transduction, MPS and 
TGF-ß/calcium/IL-6/retinoic acid signalling after loading in bioengineered SkM. 
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expression fold-change after INT relative to CON at the same relative timepoint (P < 0.05). 
Data is presented as mean ± standard error of mean (SEM). 
 
Other 
There was no significant main effect for loading (F1,22 = 1.6, P = 0.22) nor time (F2,22 = 0.54, 
P = 0.59) on RASSF5 transcript expression with no significant interaction (F2,22 = 0.62, P = 
0.55). Furthermore, there was no significant difference in mean expression at 30 mins (0.96 ± 
0.06) versus 3 (0.95 ± 0.08; t = 0.02, 95% CI -0.2 to 0.2, P = 0.98) and 24 hrs (1.03 ± 0.06, t = 
-0.88, 95% CI -0.28 to 0.11, P = 0.39) with no statistical difference between 3 and 24 hrs (t = 
0.9, 95% CI -0.11 to 0.28, P = 0.38). Additionally, there was no significant difference in mRNA 
expression post-loading at 30 mins (1.02 ± 0.1 CON vs. 0.88 ± 0.06 INT, t = -1.04, 95% CI -0.43 
to 0.14, P = 0.87), 3 hrs (1.03 ± 0.13 CON vs. 0.86 ± 0.09 INT, t = -1.26, 95% CI -0.46 to 0.11, P 
= 0.22) and 24 hrs (1.02 ± 0.1 CON vs. 1.04 ± 0.06 INT, t = 0.16, 95% CI -0.25 to 0.29, P = 0.88; 
see Figure 5.5). 
 
There was no significant main effect for condition (F1,22 = 1.69, P = 0.21), nor time (F2,22 = 
2.59, P = 1) on F2LR3 mRNA expression with no significant interaction (F2,22 = 3.1, P = 0.07). 
There was no statistical difference in mean expression at 30 mins (0.96 ± 0.07) vs. 3 hrs (1.06 
± 0.05, t = -1.34, 95% CI -0.29 to 0.06, P = 0.19) and 24 hrs (0.88 ± 0.07, t = 0.88, 95% CI -
0.1 to 0.25, P = 0.39). However mRNA was significantly lower at 24 vs. 3 hrs (t = -1.34, 95% 
CI -0.29 to 0.06, P = 0.19) post-loading. Furthermore, transcript expression was not statistically 
different between CON and INT at 30 mins (1.02 ± 0.09 CON vs. 0.89 ± 0.13 INT, t = -1.02, 95% 
CI -0.38 to 0.13, P = 0.32) and 3 hrs (1 ± 0.03 CON vs. 1.13 ± 0.1 INT, t = 1.1, 95% CI -0.12 to 
0.39, P = 0.29), albeit, expression significantly reduced at 24 hrs post-loading (1.02 ± 0.1 CON 
vs. 0.74 ± 0.04 INT, t = -2.42, 95% CI -0.51 to -0.04, P = 0.02; see Figure 5.5). 
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There was no significant main effect for condition (F1,22 = 1.05, P = 0.32), nor time (F2,22 = 
1.08, P = 0.36) on DOT1L mRNA expression with no significant interaction (F2,22 = 0.92, P = 
0.41). There was no statistical difference in mean expression at 30 mins (1.01 ± 0.06) vs. 3 hrs 
(1.12 ± 0.07, t = -1.26, 95% CI -0.28 to 0.07, P = 0.22) and 24 hrs (1.01 ± 0.04, t = -0, 95% CI 
-0.18 to 0.18, P = 1) with no difference between 3 and 24 hrs (t = -1.26, 95% CI -0.28 to 0.07, 
P = 0.22) post-loading. Furthermore, transcript expression was not statistically different 
between CON and INT at 30 mins (1.02 ± 0.09 CON vs. 0.89 ± 0.13 INT, t = -1.04, 95% CI -0.43 
to 0.14, P = 0.31), 3 (1 ± 0.03 CON vs. 1.13 ± 0.1 INT, t = -1.26, 95% CI -0.46 to 0.11, P = 0.22) 
and 24 hrs post-loading (1.02 ± 0.1 CON vs. 0.74 ± 0.04 INT, t = 0.16, 95% CI -0.25 to 0.29, P = 
0.88; see Figure 5.5). 
 
There was no significant main effect for condition (F1,15 = 0.5, P = 0.49) on KDR mRNA 
expression, however there was for time (F2,15 = 4.27, P = 0.03) with no significant interaction 
(F2,15 = 3.41, P = 0.06). Mean expression at 30 mins (0.94 ± 0.04) was significantly lower vs. 
3 hrs (1.19 ± 0.1, t = -2.82, 95% CI -0.43 to -0.06, P = 0.01) and 24 hrs (1.11 ± 0.04, t = -2.19, 
95% CI -0.34 to -0, P = 0.05) with no difference between 3 and 24 hrs post-loading (t = -0.89, 
95% CI -0.24 to 0.1, P = 0.39). Furthermore, transcript expression significantly increased in 
INT vs. CON at 3 hrs (1.04 ± 0.04 CON vs. 1.34 ± 0.16 INT, t = 2.45, 95% CI 0.04 to 0.56, P = 
0.03) with no difference between CON and INT at 30 mins (0.98 ± 0.04 CON vs. 0.9 ± 0.08 INT, 
t = -0.63, 95% CI -0.34 to 0.18, P = 0.54) and 24 hrs post-loading (1.16 ± 0.1 CON vs. 1.08 ± 
0.03 INT, t = -0.8, 95% CI -0.3 to 0.14, P = 0.44; see Figure 5.5). 
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Gene expression of genes associated with DNA methylation (DOT1L), angiogenesis (KDR) 
and tumor suppression (RASSF5) was assessed at 30 mins, 3 hrs and 24 hrs post-loading in 
loaded (INT) and non-loaded (CON) bioengineered SkM (n = 5 replicate cultures/muscles per 
condition [CON and INT] and time point [30 mins, 3 and 24 hrs]). (*) depicts significant 
mRNA expression fold-change after INT relative to CON at the same relative timepoint (P < 
0.05). Data is presented as mean ± standard error of mean (SEM). 
 
After analysing mRNA expression of upregulated/hypomethylated genes identified in chapter 
4) at 30 mins, 3 hrs and 24 hrs post mechanical loading in bioengineered SkM alone, gene 
expression at 3 hrs post-loading was compared to that following acute and chronic loading/RE 
in human and rat SkM, respectively (see Figure 5.6). Interestingly, there was a significant main 
effect for model on F2LR3 (F2,9 = 5.98, P = 0.03), THBS1 (F2,9 = 28.23, P < 0.01) and FOS 
(F2,10 = 60.12, P < 0.01). However, there no significant main effect for model/species of loading 
for genes; WNT9a (F2,10 = 1.16, P = 0.84), MSN (F2,10 = 0.29, P = 0.76), ITGB3 (F2,10 = 0.89, 
P = 0.45), STAT3 (F2,9 = 0.5, P = 0.63), TIMP3 (F2,10 = 0.26, P = 0.78), CTTN (F2,9 = 0.31, P 
= 0.72), DOT1L (F2,10 = 0.41, P = 0.68), GSK3ß (F2,10 = 0.06, P = 0.94), UBR5 (F2,9 = 0.43, 
P = 0.67), LAMA5 (F2,10 = 0.07, P = 0.93), SMAD3 (F2,10 = 0.21, P = 0.82), COL4A1 (F2,9 = 
1.53, P = 0.28), FLNB (F2,9 = 1.11, P = 0.89), CD63 (F2,10 = 1.91, P = 0.21), RARA (F2,10 = 
0.73, P = 0.51), CRK (F2,8 = 1.44, P = 0.31), RASSF5 (F2,9 = 1.13, P = 0.38), ITPR3 (F2,9 = 
Figure 5.5. mRNA expression of upregulated/hypomethylated genes associated with DNA 
methylation, angiogenesis and tumor suppression after loading in bioengineered SkM. 
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1.76, P = 0.24), ADCY3 (F2,10 = 1.67, P = 0.25) and KDR (F2,8 = 1.06, P = 0.4; see Figure 
5.6). After detecting main effects for condition, unpaired t-tests were then performed for genes 
which were differentially regulated between models/species (i.e. F2LR3, THBS1 and FOS) to 
identify where main effects occurred.  
 
F2LR3 
For F2LR3, there was a significant difference in mean expression for bioengineered (1.13 ± 
0.1) and rat (2.35 ± 0.72; t7 = -3.23, 95% CI -2.11 to -0.33, P = 0.01) SkM, however, there was 
no statistical difference between bioengineered and human SkM (1.08 ± 0; t3 = 0.24, 95% CI -
0.65 to 0.76, P = 0.82). Furthemore, there was no significant difference rat and human SkM (t4 
= 1.61, 95% CI -0.93 to 3.48, P = 0.18; see Figure 5.6) 
 
THBS1  
For THBS1, mean expression was significantly lower in bioengineered (0.72 ± 0.07) versus rat 
(1.54 ± 0.12; t7 = -5.53, 95% CI -1.17 to -0.47, P = 0.001) and human (2.36 ± 0; t3 = -10.19, 
95% CI -2.16 to -1.13, P = 0.002) SkM. There was also a significant difference in THBS1 
mRNA between rat and human SKM (t4 = -2.83, 95% CI -1.63 to -0.02, P = 0.05; see Figure 
5.6). 
 
FOS 
FOS mRNA expression did not significantly differ between bioengineered (0.76 ± 0.06) and 
rat (0.58 ± 0.11; t7 = 1.35, 95% CI -0.13 to -0.48, P = 0.22). However, transcript expression 
was significantly greater in human SkM (2.89 ± 0) versus bioengineered (t3 = -16.98, 95% CI 
-2.53 to -1.73, P < 0.001) and rat SkM (t3 = -8.85, 95% CI -3.03 to -1.58, P = 0.001; see Figure 
5.6). 
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The current section demonstrates that out of the 22 upregulated/hypomethylated genes 
identified in chapter 4 that were also assessed after loading in bioengineered SkM in the present 
chapter, no genes were upregulated at 30 mins post-loading, however, 22% (5; THBS1, CD63, 
GSK3ß, WNT9a, ADCY3) showed a reduction in mRNA expression. At 3 hrs, 33% (7; MSN, 
TIMP3, ITGB3, GSK3ß, WNT9a, DOT1L, KDR) showed an increase in mRNA expression 
whereas 14% (3; THBS1, FOS, ADCY3) decreased with the remaining genes demonstrating 
no statistical significant change. Finally, 1 gene (TIMP3) showed an increase at 24 hrs post-
loading whereas 19% (4; MSN, CRK, ITPR3 F2LR3) of genes showed a decrease in mRNA 
expression. Overall, the present section suggests that gene expression is reduced immediately 
post-loading whereas the most abundant increase is observed at 3 hrs with expression 
decreasing again by 24 hrs.  
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As described in section 5.3.1 above, mRNA expression of upregulated/hypomethylated genes identified in chapter 4 were compared across various 
models of loading/RE - bioengineered SkM (clear circles) versus acute RE in humans (bold triangles) and chronic electrical stimulation/RE in rats 
(clear triangles). Bold circles with errors represent mean ± SEM for all models of exercise pooled. (*) represents statistical significance (P < 0.05) 
between loaded bioengineered SkM versus exercised human SkM; (#) = bioengineered versus stimulated rat SkM; (&) = human versus rat SkM
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Figure 5.6. Comparison of upregulated/hypomethylated genes after mechanical loading/RE in bioengineered, rodent and human SkM. 
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5.3.2! Epigenetic Regulation of Upregulated/Hypomethylated Genes were 
Assessed After Loading in Bioengineered Skeletal Muscle 
After detection of the most significantly regulated genes at 3 hrs post mechanical loading in 
section 5.3.1 that were also upregulated/hypomethylated after acute RE in-vivo (identified in 
chapter 4), DNA methylation of a selection of these genes was also assessed to determine 
whether changes in mRNA corresponded to epigenetic modifications of the same gene. 
Specifically, the DNA methylation status of various regulatory regions of mouse genes; MSN, 
TIMP3, WNT9a, CTTN, GSK3ß, TIMP3 was assessed at 3 hrs post-loading via tNGBS (see 
sections 5.2.8 and 2.10.6). Transcripts analysed for DNA methylation were carefully 
considered based on changes in gene expression after 3D loading or their well-characterised 
regulatory role(s) in SkM after exercise in-vivo. For example, MSN and WNT9a displayed the 
greatest increase in mRNA at 3 hrs post-loading and are important genes involved in actin 
crosslinking and TGFß signaling, respectively. Furthermore, GSK3ß and TIMP3 (which were 
also significantly increased at 3 hrs post-loading). Despite a non-significant increase in CTTN 
observed in the present chapter (see Figure 5.3), this gene is important for actin cytoskeleton 
remodelling and together with FLNB, was 1 of 23 genes highlighted in chapter 4 that was 
significantly upregulated and hypomethylated after both acute and chronic RE in humans 
(Turner et al., 2019b). CTTN and not FLNB, was therefore selected for methylation analysis 
given CTTN demonstrated a non-significant increase whereas FLNB did not change after 
loading (see Figure 5.3). 
 
MSN 
There was no significant difference in MSN intron 2 (1 ± 0.02 CON vs. 1.04 ± 0.02 INT, t25 = 
1.76, 95% CI -0.09 to -0.01, P = 0.09) or 5-upstream (1 ± 0.03 CON vs. 1.1 ± 0.04 INT, t34 = 1.93, 
95% CI -0.2 to -0.01, P = 0.06) region-specific DNA methylation after INT loading. 
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Interestingly however, intron 1 (1 ± 0.02 CON vs. 1.04 ± 0.02 INT, t25 = 1.76, 95% CI -0.09 to -
0.01, P = 0.09) and pooled (intron 1/2 and 5-upstream combined) methylation (1 ± 0.01 CON 
vs. 1.1 ± 0.02 INT, t142 = 4.213, 95% CI -0.14 to -0.05, P < 0.001) significantly increased after 
INT loading (see Figure 5.7A). 
 
WNT9a 
There was no significant change in WNT9a intron 1 (1 ± 0.1 CON vs. 1.22 ± 0.14 INT, t160 = 1.26, 
95% CI -0.57 to 0.13, P = 0.21) nor 5-upstream (1 ± 0.07 CON vs. 1.13 ± 0.08 INT, t124 = 1.23, 
95% CI -0.34 to 0.08, P = 0.22) region-specific DNA methylation after loading. Furthermore, 
no changes were observed when both intron 1 and 5-upstream regions were pooled (1 ± 0.06 
CON vs. 1.18 ± 0.08 INT, t286 = 1.66, 95% CI -0.4 to 0.03, P = 0.1; see Figure 5.7B). 
 
GSK3ß 
Despite a reduction in GSK3ß intron 1 (1 ± 0.2 CON vs. 0.7 ± 0.18 INT, t52 = 1.11, 95% CI -0.24 
to 0.84, P = 0.27) methylation, changes failed to reach statistical significance. Furthermore, 
there was no significant changes in exon 1 (1 ± 0.06 CON vs. 1.13 ± 0.14 INT, t34 = 0.81, 95% CI 
-0.47 to 0.2, P = 0.42) and 5-upstream (1 ± 0.16 CON vs. 1.34 ± 0.26 INT, t88 = 1.05, 95% CI -1 
to 0.31, P = 0.42) region-specific DNA methylation, nor when pooling all regions (intron 1, 
exon 1 and 5-upstream) analysed (1 ± 0.1 CON vs. 1.11 ± 0.15 INT, t178 = 0.58, 95% CI -0.48 to 
0.26, P = 0.56; see Figure 5.7C). 
 
TIMP3 
There was no significant different in TIMP3 intron 1 (1 ± 0.18 CON vs. 1.22 ± 0.3 INT, t16 = 0.59, 
95% CI -0.22 to 0.37, P = 0.56), exon 1 (1 ± 0.11 CON vs. 1.05 ± 0.12 INT, t43 = 0.32, 95% CI -
0.37 to 0.27, P = 0.75) nor 5-upstream (1 ± 0.04 CON vs. 1.04 ± 0.05 INT, t97 = 0.6, 95% CI -0.17 
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to 0.09, P = 0.55) region-specific DNA methylation after loading. Furthermore, no changes 
were observed for DNA methylation when all regions assessed (intron 1, exon 1 and 5-
upstream) were pooled (1 ± 0.05 CON vs. 1.06 ± 0.05 INT, t160 = 0.87, 95% CI -0.2 to 0.08, P = 
0.38; see Figure 5.7D). 
 
CTTN  
Interestingly, CTTN intron 1 specific DNA methylation significantly increased after INT 
loading in engineered SkM (1 ± 0.05 CON vs. 1.32 ± 0.1 INT, t171 = 2.64, 95% CI -0.56 to -0.08, 
P = 0.01). However, there was no significant difference in intron 2 (1 ± 0.01 CON vs. 1.01 ± 
0.01 INT, t16 = 0.62, 95% CI -0.03 to 0.02, P = 0.54) nor 5-UTR (1 ± 0.14 CON vs. 0.79 ± 0.17 
INT, t159 = 0.95, 95% CI -0.23 to 0.66, P = 0.34), despite a reduction in 5-UTR methylation after 
loading. Furthermore, no changes were observed when all regions assessed (intron 1/2 and 5-
UTR) were pooled (1 ± 0.07 CON vs. 1.06 ± 0.1 INT, t332 = 0.49, 95% CI -0.31 to 0.19, P = 0.62; 
see Figure 5.7E). 
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mRNA expression and DNA methylation of upregulated/hypomethylated genes, (A) MSN, (B) 
WNT9a, (C) GSK3ß, (D) TIMP3 and (E) CTTN in loaded (INT) and non-loaded (CON) 
bioengineered SkM (n = 5 replicate cultures/muscles per condition [CON and INT]) at 3 hrs 
post-loading. (*) Depicts significant difference (P < 0.05) in mRNA expression and/or region 
specific DNA methylation after INT versus CON with specific changes described in each 
figure section (A-E). Data is presented as mean ± standard error of mean (SEM).  
(*) Depicts significant hypermethylation in intron 1 region after loading (INT) 
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Figure 5.7. mRNA expression and DNA methylation of upregulated/hypomethylated genes 
identified in chapter 4 following mechanical loading in bioengineered SkM. 
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5.3.3! mRNA Expression of Genes that are Downregulated/Hypermethylated fter 
Exercise in Human Skeletal Muscle were Assessed After Loading in 
Bioengineered Muscle 
After analysing the mechano-responses of upregulated/hypomethylated genes identified in 
chapter 4 following loading in bioengineered SkM (see section 5.3.1), mRNA expression of 
genes that were downregulated and hypermethylated in the previous chapter were also assessed 
at 30 mins, 3 hrs and 24 hrs post-acute loading (INT) in engineered SkM. This included genes; 
AGTR1, PAX3, NOS2, ESR1, NANOG, LAMA3, ATM, GADD45G, ANK3, DROSHA, 
SMO and APAF1 (see Figure 5.8). Collective mRNA expression of all 
downregulated/hypermethylated genes assessed all three time points after 3D loading is 
presented in Figure 5.2. 
 
AGTR1a 
There was a significant main effect for condition/loading (F1,20 = 12.75, P = 0.002) and time 
(F2,20 = 5.12, P = 0.02) on AGTR1a mRNA expression with no significant interaction (F2,20 = 
1.15, P = 0.34). Mean transcript expression  at 3 hrs (0.67 ± 0.12) post-loading significantly 
reduced compared to 30 mins (1.06 ± 0.07, t = 3.2, 95% CI 0.14 to 0.64, P = 0.01) with no 
difference between 3 and 24 hrs (0.87 ± 0.1, t = 1.7, 95% CI -0.05 to 0.44, P = 0.11) and 30 
mins vs. 24 hrs post-loading (t = 1.68, 95% CI -0.05 to 0.43, P = 0.11). There was no statistical 
difference in mRNA after loading at 30 mins (1.14 ± 0.09 CON vs. 0.98 ± 0.11 INT, t = -0.97, 
95% CI -0.52 to 0.19, P = 0.35), however expression significantly reduced after 3 hrs (0.94 ± 
0.14 CON vs. 0.46 ± 0.07 INT, t = -3.10, 95% CI -0.89 to -0.17, P = 0.01) and remained suppressed 
after 24 hrs post-loading (1.03 ± 0.14 CON vs. 0.7 ± 0.12 INT, t = -2.13, 95% CI -0.65 to -0.01, 
P = 0.05).   
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PAX3 
There was a significant main effect for condition/loading (F1,20 = 30.82, P < 0.001) and time 
(F2,20 = 17.66, P < 0.001) on PAX3 mRNA expression with a significant interaction (F2,20 = 
14.60, P < 0.001). Mean transcript expression at 3 hrs (0.54 ± 0.08) significantly lower after 
loading compared to 30 mins (1.03 ± 0.06, t = 5.9, 95% CI 0.29 to 0.61, P < 0.001) and 24 hrs 
(0.74 ± 0.14, t = 2.59, 95% CI 0.04 to 0.36, P = 0.02). Expression was also significantly lower 
at 24 hrs vs. 30 mins (t = 3.45, 95% CI 0.1 to 0.41, P = 0.003). There was no statistical 
difference in mRNA in CON vs. INT at 30 mins (1.01 ± 0.05 CON vs. 1.06 ± 0.12 INT, t = 0.55, 
95% CI -0.16 to 0.27, P = 0.59), however expression significantly reduced at 3 hrs (0.76 ± 0.14 
CON vs. 0.41 ± 0.03 INT, t = -3.08, 95% CI -0.59 to -0.11, P = 0.01) and remained suppressed at 
24 hrs post INT loading (1.15 ± 0.08 CON vs. 0.41 ± 0.04 INT, t = -7.1, 95% CI -0.96 to -0.52, P 
< 0.001; see Figure 5.8). 
 
NOS2 
There was a significant main effect for condition/loading (F1,18 = 12.60, P = 0.002) and time 
(F2,18 = 39.23, P < 0.001) on NOS2 mRNA expression with a significant interaction (F2,18 = 
34.72, P < 0.001). Mean transcript expression at 24 hrs (1.95 ± 0.43) post-loading was 
significantly greater than that at 30 mins (0.81 ± 0.07, t = -7.86, 95% CI -1.45 to -0.84, P < 
0.001) and 3 hrs (0.84 ± 0.1, t = 7.97, 95% CI 0.82 to 1.4, P < 0.001) with no significant 
difference between 30 mins and 3 hrs (t = -0.28, 95% CI -0.3 to 0.23, P = 0.78). Despite a 
reduction in transcript expression after loading at 30 mins, changes did not to reach statistical  
significance (0.92 ± 0.07 CON vs. 0.74 ± 0.1 INT, t = -1.23, 95% CI -0.63 to 0.17, P = 0.24). 
Interestingly however, mRNA was statistically lower in INT vs. CON at 3 hrs (1.02 ± 0.12 CON 
vs. 0.66 ± 0.1 INT, t = -2.18, 95% CI -0.73 to -0.01, P = 0.04), but increased after loading at 24 
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hrs post (1.05 ± 0.14 CON vs. 2.85 ± 0.30 INT, t = 8.19, 95% CI 1.34 to 2.26, P < 0.001; see 
Figure 5.8). 
 
ESR1  
There was no significant main effect for loading (F1,23 = 1.63, P = 0.21) nor time (F2,23 = 1.67, 
P = 0.21) on ESR1 mRNA expression with no significant interaction (F2,23 = 1.66, P = 0.21). 
There was no significant difference in mean mRNA expression at 30 mins (0.9 ± 0.08) vs. 3  
(1.01 ± 0.06, t = -1.44, 95% CI -0.31 to 0.06, P = 0.16) and 24 hrs (1.03 ± 0.06, t = -1.72, 95% 
CI 0.33 to 0.03, P = 0.1) with no difference between 3 and 24 hrs post-loading (t = 0.29, 95% 
CI -0.15 to 0.2, P = 0.77). Interestingly, gene expression reduced at 30 mins post-loading (1.02 
± 0.1 CON vs. 0.74 ± 0.05 INT, t = -2.15, 95% CI -0.54 to -0.01, P = 0.04) with no difference 
between CON vs. INT at 3 hrs (1.02 ± 0.09 CON vs. 1 ± 0.09 INT, t = -0.18, 95% CI -0.27 to 
0.23, P = 0.86) and 24 hrs post-loading (1.02 ± 0.11 CON vs. 1.05 ± 0.05 INT, t = 0.21, 95% CI -
0.23 to 0.28, P = 0.84; see Figure 5.8). 
 
NANOG  
There was no significant main effect for loading (F1,21 = 2.28, P = 0.15) nor time (F2,21 = 2.26, 
P = 0.13) on NANOG mRNA expression with no significant interaction (F2,21 = 1.08, P = 
0.36). There was no significant difference in mean mRNA expression at 30 mins (1.01 ± 0.06) 
vs. 3  (1.01 ± 0.05, t = 0.09, 95% CI -0.15 to 0.17, P = 0.93) and 24 hrs (0.87 ± 0.05, t = 1.83, 
95% CI -0.02 to 0.31, P = 0.08) with no difference between 3 and 24 hrs post-loading (t = -
1.85, 95% CI -0.29 to 0.02, P = 0.08). Despite a reduction in gene expression following INT 
vs. CON at 30 mins post-loading (1.13 ± 0.06 CON vs. 0.9 ± 0.08 INT), such changes failed to 
reach statistical significance (t = -1.99, 95% CI -0.47 to 0.01, P = 0.06). Furthermore, there 
was no difference between CON vs. INT at 3 hrs (1.02 ± 0.11 CON vs. 1 ± 0.03 INT, t = -0.23, 
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95% CI -0.24 to 0.19, P = 0.82) and 24 hrs post-loading (0.89 ± 0.06 CON vs. 0.86 ± 0.09 INT, t 
= -0.31, 95% CI -0.26 to 0.19, P = 0.76; see Figure 5.8). 
 
LAMA3 
There was no significant main effect for loading (F1,23 = 0.17, P = 0.68), however there was 
for time (F2,23 = 3.67, P = 0.04) on LAMA3 mRNA expression with a significant interaction 
(F2,23 = 3.27, P = 0.05). Mean mRNA expression at 30 mins (0.89 ± 0.06) was significantly 
lower than that at 3 hrs (1.17 ± 0.11, t = -2.56, 95% CI -0.53 to -0.6, P = 0.02) with no difference 
between 30 mins vs. 24 hrs (0.95 ± 0.07, t = -0.61, 95% CI -0.31 to 0.17, P = 0.55). Expression 
was also significantly lower at 3 hrs compared to 24 hrs (t = -2.01, 95% CI -0.46 to 0.01, P = 
0.05) post-loading. There was no significant difference between CON vs. INT at 30 mins (1 ± 
0.05 CON vs. 0.75 ± 0.07 INT, t = -1.53, 95% CI -0.6 to 0.09, P = 0.14) 3 hrs (1.03 ± 0.12 CON vs. 
1.32 ± 0.18 INT, t = 1.84, 95% CI -0.04 to 0.62, P = 0.08) and 24 hrs post-loading (1.02 ± 0.11 
CON vs. 0.87 ± 0.09 INT, t = -0.96, 95% CI -0.48 to 0.18, P = 0.35; see Figure 5.8). 
 
GADD45G 
There was no significant main effect for loading (F1,22 = 0.61, P = 0.44) nor time (F2,22 = 1.59, 
P = 0.23) on GADD45G mRNA expression with no significant interaction (F2,22 = 0.37, P = 
0.69). There was no significant difference in mean mRNA expression at 30 mins (1.17 ± 0.05) 
vs. 3 hrs (1.06 ± 0.04, t = 1.28, 95% CI -0.07 to 0.28, P = 0.22) and 24 hrs (1.02 ± 0.07, t = 
1.74, 95% CI -0.03 to 0.32, P = 0.1) with no difference between 3 and 24 hrs post-loading (t = 
-0.5, 95% CI -0.2 to 0.12, P = 0.63). Furthermore, expression did not statistically differ between 
CON vs. INT at 30 mins (1.14 ± 0.09 CON vs. 1.19 ± 0.06 INT, t = 0.44, 95% CI -0.2 to 0.31, P 
= 0.67), 3 hrs (1 ± 0.04 CON vs. 1.12 ± 0.06 INT, t = 1.07, 95% CI -0.11 to 0.35, P = 0.3) or 24 
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hrs post-loading (1.03 ± 0.13 CON vs. 1.02 ± 0.07 INT, t = -0.15, 95% CI -0.25 to 0.21, P = 0.88; 
see Figure 5.8). 
 
DROSHA 
There was a significant main effect for loading (F1,21 = 43.44, P < 0.001) on DROSHA mRNA 
expression, however, there was no significant main effect for time (F2,21 = 0.81, P = 0.46) with 
no significant interaction (F2,21 = 0.91, P = 0.42). There was no significant difference in mean 
mRNA expression at 30 mins (0.81 ± 0.1) vs. 3 hrs (0.83 ± 0.08, t = -1.19, 95% CI -0.25 to 
0.07, P = 0.25) and 24 hrs (0.74 ± 0.08, t = -0.3, 95% CI -0.19 to 0.14, P = 0.77) with no 
difference between 3 and 24 hrs post-loading (t = -0.9, 95% CI -0.22 to 0.08, P = 0.36). 
Interestingly, transcript expression significantly reduced after INT at 30 mins (1 ± 0.5 CON vs. 
0.47 ± 0.08 INT, t = -4.57, 95% CI -0.77 to -0.29, P < 0.001), 3 hrs (1.02 ± 0.1 CON vs. 0.64 ± 
0.04 INT, t = -3.77, 95% CI -0.59 to -0.17, P = 0.001) and 24 hrs post-loading (0.92 ± 0.11 CON 
vs. 0.6 ± 0.06 INT, t = -3.03, 95% CI -0.55 to -1, P = 0.01; see Figure 5.8). 
 
ANK3 
There was no significant main effect for loading (F1,23 = 0.32, P = 0.58) nor time (F2,23 = 0.31, 
P = 0.74) on ANK3 mRNA expression with no significant interaction (F2,23 = 0.13, P = 0.88). 
There was no significant difference in mean mRNA expression at 30 mins (1.07 ± 0.08) vs. 3 
hrs (1.11 ± 0.12, t = -0.24, 95% CI -0.32 to 0.25, P = 0.81) and 24 hrs (1 ± 0.07, t = 0.51, 95% 
CI -0.21 to 0.35, P = 0.62) with no difference between 3 and 24 hrs post-loading (t = -0.77, 
95% CI -0.38 to 0.17, P = 0.45). Furthermore, expression was not statistically different between 
CON vs. INT at 30 mins (1.02 ± 0.11 CON vs. 1.12 ± 0.14 INT, t = 0.52, 95% CI -0.31 to 0.52, P 
= 0.61), 3 hrs (1.05 ± 0.17 CON vs. 1.16 ± 0.17 INT, t = 0.54, 95% CI -0.29 to 0.49, P = 0.59) or 
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24 hrs post-loading (1.01 ± 0.09 CON vs. 1 ± 0.11 INT, t = -0.1, 95% CI -0.41 to 0.37, P = 0.92; 
see Figure 5.8). 
 
SMO 
There was a significant main effect for condition/loading (F1,16 = 8.6, P = 0.01) and time (F2,16 
= 10.59, P = 0.001) on SMO mRNA expression with a significant interaction (F2,16 = 4.56, P 
= 0.03). Mean transcript expression at 30 mins (0.81 ± 0.11) post-loading was significantly 
lower than that at 3 hrs (1.09 ± 0.07, t = -2.70, 95% CI -0.49 to -0.06, P = 0.02) and 24 hrs 
(1.24 ± 0.11, t = -4.55, 95% CI -0.67 to -0.25, P < 0.001) with no significant difference between 
3 hrs and 24 hrs (t = 1.78, 95% CI -0.04 to 0.41, P = 0.09). Interestingly, transcript expression 
was lower after 30 mins (1.01 ± 0.09 CON vs. 0.65 ± 0.16 INT, t = -2.96, 95% CI -0.7 to -0.12, P 
= 0.01) and 24 hrs (1.5 ± 0.08 CON vs. 1.05 ± 0.09 INT, t = -3, 95% CI -0.76 to -0.13, P = 0.01) 
post-loading with no difference at 3 hrs (1.03 ± 0.17 CON vs. 1.14 ± 0.03 INT, t = 0.78, 95% CI 
-0.2 to 0.43, P = 0.45; see Figure 5.8). 
 
APAF1 
There was no significant main effect for condition (F1,18 = 0.58, P = 0.46) nor time (F2,18 = 
0.58, P = 0.57) on SMO mRNA expression with no significant interaction (F2,18 = 0.47, P = 
0.63). There was no significant difference in mean mRNA at 30 mins (0.98 ± 0.08) vs. 3 hrs 
(1.04 ± 0.05, t = -0.7, 95% CI -0.27 to 0.13, P = 0.49) and 24 hrs (0.94 ± 0.05, t = 0.31, 95% 
CI -0.16 to 0.2, P = 0.76) with no further significant difference between 3 hrs and 24 hrs (t = -
1.07, 95% CI -0.28 to 0.09, P = 0.30). Furthermore, transcript expression did not significantly 
change after loading at 30 mins (1.02 ± 0.1 CON vs. 1.06 ± 0 INT, t = -0.65, 95% CI -0.37 to -
0.2, P = 0.52), 3 hrs (1.02 ± 0.14 CON vs. 1.06 ± 0.02 INT, t = 0.32, 95% CI -0.24 to 0.33, P = 
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0.75) and 24 hrs post-loading (1.01 ± 0.06 CON vs. 0.88 ± 0.08 INT, t = -1.1, 95% CI -0.36 to 
0.11, P = 0.28; see Figure 5.8). 
 
ATM 
There was no significant main effect for condition (F1,17 = 0.48, P = 0.5) nor time (F2,17 = 0.43, 
P = 0.66) on ATM mRNA expression with no significant interaction (F2,17 = 0.49, P = 0.62). 
There was no significant difference in mean mRNA at 30 mins (0.96 ± 0.04) vs. 3 hrs (1.03 ± 
0.04, t = -0.91, 95% CI -0.28 to 0.11, P = 0.38) and 24 hrs (0.97 ± 0.06, t = -0.31, 95% CI -0.2 
to 0.15, P = 0.76) with no further significant difference between 3 hrs and 24 hrs (t = -0.68, 
95% CI -0.24 to 0.12, P = 0.51). Furthermore, transcript expression did not significantly change 
after INT loading at 30 mins (1.01 ± 0.7 CON vs. 0.89 ± 0.01 INT, t = -0.94, 95% CI -0.38 to 
0.15, P = 0.36), 3 hrs (1 ± 0.06 CON vs. 1.06 ± 0.08 INT, t = 0.41, 95% CI -0.23 to 0.34, P = 0.69) 
and 24 hrs post-loading (1.01 ± 0.09 CON vs. 0.93 ± 0.1 INT, t = -0.79, 95% CI -0.3 to 0.14, P = 
0.44; see Figure 5.8). 
 
The current section demonstrates that out of the 12 downregulated/hypermethylated genes 
identified in chapter 4 that were also assessed after loading in bioengineered SkM, 25% (3; 
DROSHA, ESR1, SMO) of genes at 30 mins and 33% (4) of genes at 3 (PAX3, AGTR1, 
DROSHA, NOS2) and 24 hrs (PAX3, AGTR1, DROSHA, SMO) post-loading showed a 
reduction in mRNA expression, whereas only 1 gene (NOS2) increased at 24 hrs. As with the 
upregulated/hypomethylated genes assessed after loading in section 5.3.1, data reported herein 
suggests that gene expression demonstrates the greatest change at 3 hrs post loading with genes 
showing continuous downregulation at 24 hrs.
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As described in section 5.3.3 above, gene expression of downregulated/hypermethylated genes identified in chapter 4 were assessed at 30 mins, 3 
hrs and 24 hrs post mechanical loading in loaded (INT) and non-loaded (CON) bioengineered SkM (n = 5 replicate cultures/muscles per condition 
[CON and INT) and time point [30 mins, 3 and 24 hrs]). (*) depicts significant change in mRNA expression after INT versus CON at the same 
relative timepoint (P < 0.05). Data is presented as mean ± standard error of mean (SEM). 
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Figure 5.8. mRNA expression of downregulated/hypermethylated genes after loading in bioengineered SkM. 
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After analysing mRNA expression of downregulated/hypermethylated genes (identified in 
chapter 4) after mechanical loading in bioengineered SkM alone across all time points (30 
mins, 3 and 24 hrs), gene expression at 3 hrs post-loading only was compared to that following 
acute and chronic loading/RE in human (see section 4.3; Turner et al., 2019b) and rat (Schmoll 
et al., 2018; Seaborne et al., 2019) SkM, respectively (see Figure 5.9). Interestingly, the 
majority of downregulated/hypermethylated genes demonstrated significant main effects for 
the model/species of loading employed. These included; PAX3 (F2,10 = 4.85, P = 0.04), NOS2  
(F2,10 = 15, P = 0.002), ESR1 (F2,10 = 8.99, P = 0.01), LAMA3 (F2,10 = 22.12, P = 0.001), 
GADD45G (F2,10 = 6.32, P = 0.02), DROSHA (F2,10 = 7.65, P = 0.01), ANK3 (F2,10 = 7.04 , P 
= 0.02) and ATM (F2,9 = 14.12, P = 0.003). Therefore AGTR1 (F2,10 = 4.24, P = 0.06) and 
NANOG (F2,10 = 2.29, P = 0.16) were the only two downregulated/hypermethylated genes that 
did not display differential gene expression across models of loading (see Figure. 2.9). After 
main effects were detected, unpaired t-tests were performed to determine where main effects 
occurred for genes; PAX3, NOS2, LAMA3, GADD45G, DROSHA, ANK3 and ATM. 
 
PAX3 
There was a significant difference in PAX3 mean expression between bioengineered (0.41 ± 
0.03) versus rat (2.27 ± 0.76; t8 = -2.46, 95% CI -3.61 to -0.12, P = 0.04) and human SkM (-
1.06 ± 0; t4 = -18.24, 95% CI 1.24 to 1.69, P < 0.001). Interestingly however, there was no 
statistical difference between rat and human SkM (-1.06 ± 0; t4 = 1.8, 95% CI -1.81 to 8.47, P 
= 0.15; see Figure 5.9), 
 
NOS2 
For NOS2, there was a significant difference in mean gene expression between bioengineered 
(0.66 ± 0.1) versus rat (1.97 ± 0.34; t8 = -3.73, 95% CI -2.13 to -0.5, P = 0.04) and human SkM 
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(-1.03 ± 0; t4 = 6.98, 95% CI 1.02 to 2.36, P = 0.002). Furthermore, NOS2 expression was 
significantly lower in human versus rat SkM (t4 = 3.62, 95% CI 0.7 to 5.3, P = 0.02; see Figure 
5.9). 
 
ESR1 
There was no significant difference in ESR1 transcript expression between bioengineered (1 ± 
0.09) and rat SkM (1.57 ± 0.37; t8 = -1.53, 95% CI -2 to -0.5, P = 0.04). However, expression 
was significantly lower in human (-1.18 ± 0) versus bioengineered (t4 = 10.29, 95% CI 1.59 to 
2.77, P = 0.001) and rat SkM (t4 = 3.07, 95% CI 0.27 to 5.24, P = 0.04) following loading/RE 
(see Figure 5.9). 
 
LAMA3 
There was a significant difference in LAMA3 mRNA expression between bioengineered (1.32 
± 0.18) and rat SkM (0.78 ± 0.11; t8 = 2.51, 95% CI 0.04 to 1.03, P = 0.05). Transcript 
expression was also significantly lower in human (-1.13 ± 0) versus bioengineered (t4 = 5.47, 
95% CI 1.21 to 3.69, P = 0.01) and rat SkM (t4 = 7.08, 95% CI 1.16 to 2.66, P = 0.002; see 
Figure 5.9). 
 
GADD45G 
There was a significant difference in GADD45G transcript expression after loading in 
bioengineered (1.12 ± 0.06) versus rat (1.99 ± 0.56; t8 = -1.54, 95% CI -2.16 to 0.43, P = 0.01) 
and human SkM (-1.42 ± 0; t4 = 16.32, 95% CI 2.11 to 2.97, P < 0.001). However, there was 
no statistical significance in the loading response for rat versus human SkM (t4 = 2.5, 95% CI 
-0.38 to 7.19, P = 0.07; see Figure 5.9). 
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DROSHA 
There was a significant difference in DROSHA mRNA expression between bioengineered 
(0.64 ± 0.04) and rat (1.71 ± 0.44; t8 = -2.42, 95% CI -2.08 to -0.05, P < 0.001) and human 
SkM (-1.07 ± 0; t4 = 15.92, 95% CI 1.41 to 2.01, P < 0.001). Interestingly however, there no 
statistical difference between rat versus human SkM (t4 = 2.59, 95% CI -0.2 to 5.75, P = 0.06; 
see Figure 5.9). 
 
ANK3 
For the ANK3 gene, there was no significant difference in transcript expression between 
bioengineered (1.16 ± 0.17) and rat SkM (1.41 ± 0.36; t8 = -0.63, 95% CI -1.17 to 0.67, P = 
0.15). Interestingly however, transcript expression was significantly lower in human (-1.17 ± 
0) versus bioengineered (t4 = 5.49, 95% CI 1.15 to 3.5, P = 0.01) and rat SkM (t4 = 2.91, 95% 
CI 0.13 to 5, P = 0.04) following loading/RE (see Figure 5.9). 
 
ATM 
Finally, there was no significant difference in ATM mRNA expression between bioengineered 
(1.11 ± 0.04) and rat SkM (1.5 ± 0.26; t7 = -1.29, 95% CI -1.09 to 0.32, P = 0.15). However, 
transcript expression was significantly lower in human (-1.09 ± 0) versus bioengineered (t3 = 
23.16, 95% CI 1.9 to 2.5, P < 0.01) and rat SkM (t4 = 4.05, 95% CI 0.81 to 4.36, P = 0.02) 
following loading/RE (see Figure 5.9).
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As described in section 5.3.3 above, mRNA expression of downregulated/hypermethylated genes identified in chapter 4 were compared across 
various models of loading/RE - bioengineered SkM (clear circles) versus acute RE in humans (bold triangles) and chronic electrical stimulation/RE 
•
N
A
N
O
G
L
A
M
A
3
D
R
O
SH
A
E
SR
1
A
N
K
3
AT
M
N
O
S2
G
A
D
D
45
G
A
G
T
R
1a
PA
X
3-2
-1
0
1
2
3
4
5
ΔΔ
C
T 
Ex
pr
es
sio
n 
Va
lu
e
Rat Chronic (Schmoll et al., 2018)
Human Acute (Turner et al., 2019)
Bioengineered Acute
Mean Fold-Change
*
&
*#
&*&
*# *#*#
&* &*
#
Figure 5.9. Comparison of downregulated/hypermethylated genes identified in chapter 4 after loading/RE in bioengineered, rodent and 
human SkM. 
 
 
Figure 5.9. Comparison of downregulated/hypermethylated genes after loading/RE in bioengineered, rodent and human SkM 
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in rats (clear triangles). Bold circles with errors represent mean ± SEM for all models of exercise pooled. (*) represents statistical significance (P 
< 0.05) between loaded bioengineered SkM versus exercised human SkM; (#) = bioengineered versus stimulated rat SkM; (&) = human versus rat 
SkM.
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5.3.4! Epigenetic Regulation of Downregulated/Hypermethylated Genes After 
Loading in Bioengineered Skeletal Muscle  
After detection of which downregulated/hypomethylated genes (identified in chapter 4) were 
significantly downregulated at the mRNA level 3 hrs post-acute mechanical loading in 
bioengineered SkM (see section 5.3.3), the present chapter next wished to determine whether 
such genes were also epigenetically modified at the DNA methylation level. Transcripts which 
were most significantly downregulated at the mRNA level at 3 hrs post-loading (see section 
5.3.1) were analysed at the methylation level. Specifically, numerous regions of the mouse 
AGTR1a and PAX3 genes were assessed at 3 hrs post-loading. 
 
AGTR1a 
There was no significant alterations in AGTR1a intron 1 (1 ± 0.02 CON vs. 0.98 ± 0.02 INT, t219 
= 0.84, 95% CI -0.03 to 0.08, P = 0.39), intron 2 (1 ± 0.01 CON vs. 1 ± 0.01 INT, t76 = 0.31, 95% 
CI -0.03 to 0.04, P = 0.76) nor 5-upstream (1 ± 0.04 CON vs. 1.02 ± 0.03 INT, t34 = 0.35, 95% CI 
-0.11 to 0.08, P = 0.73) region-specific DNA methylation after loading. Furthermore, no 
changes were observed for DNA methylation when all regions assessed (intron 1, intron 2 and 
5-upstream) were pooled (1 ± 0.01 CON vs. 0.99 ± 0.01 INT, t333 = 0.78, 95% CI -0.02 to 0.05, P 
= 0.44; see Figure 5.10A). 
 
PAX3 
There was no significant change in PAX3 intron 1 (1 ± 0 CON vs. 1 ± 0.01 INT, t178 = 0.15, 95% 
CI -0.01 to 0.01, P = 0.88), exon 2 (1 ± 0 CON vs. 1 ± 0 INT, t52 = 0.3, 95% CI -0.01 to 0.01, P = 
0.77) nor 5-upstream (1 ± 0.01 CON vs. 1 ± 0.01 INT, t250 = 1.06, 95% CI -0.01 to 0.02, P = 0.29) 
region-specific DNA methylation after loading. Furthermore, no changes were observed for 
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DNA methylation when all regions assessed (intron 1, exon 2 and 5-upstream) were pooled (1 
± 0 CON vs. 1 ± 0 INT, t484 = 1.01, 95% CI -0 to 0.01, P = 0.31; see Figure 5.10B). 
 
mRNA expression and DNA methylation of the most significantly downregulated, (A) AGTR1 
and (B) PAX3 in loaded (INT) and non-loaded (CON) bioengineered SkM (n = 5 replicate 
cultures/muscles per condition [CON and INT]) at 3 hrs post-loading. (*) Depicts significant 
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Figure 5.10. mRNA expression and DNA methylation of the most significantly 
downregulated genes after loading in bioengineered SkM. 
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difference (P < 0.05) in mRNA expression and/or region specific DNA methylation after INT 
versus CON with specific changes described in each figure section (A-B). Data is presented as 
mean ± standard error of mean (SEM).  
 
5.3.5! mRNA Expression of Genes that are Significantly Altered After Acute and 
Chronic Resistance Exercise in Human Skeletal Muscle were Assessed 
After Mechanical Loading in Bioengineered Muscle  
Following mRNA and DNA methylation analysis of regulated genes identified in chapter 4, 
another subset of genes that were upregulated immediately after acute RE in humans in 
previous published work by our group (Seaborne et al., 2018a) were also analysed at 30 mins 
post-loading in engineered muscle. After MANOVA analysis, there was a significant main 
effect for loading on mRNA expression for all genes combined (P = 0.01). Unpaired t-tests 
were then conducted to determine which genes were significantly regulated after loading in 
engineered SkM. 
 
After just 30 mins post-loading, there was a significant increase in UBR5 (1 ± 0.02 CON vs. 1.77 
± 0.23 INT; t5 = -3.90, 95% CI -1.28 to -0.26, P = 0.01), ODF2 (1.01 ± 0.08 CON vs. 1.93 ± 0.10  
INT, t5 = -7.55, 95% CI -1.24 to -0.61, P = 0.001), RSU1 (0.88 ± 0.13 CON vs. 1.65 ± 0.09 INT, t4 
= -4.93, , 95% CI -1.2 to -0.34, P = 0.01), SETD3 (0.88 ± 0.14 CON vs. 1.48 ± 0.17 INT, t4 = -
2.76, 95% CI -1.2 to 0, P = 0.05), GRIK2 (0.91 ± 0.03 CON vs. 1.40 ± 0.1 INT, t4 = -3.56, 95% 
CI -0.87 to -0.11, P = 0.02), RPL35a (0.91 ± 0.05 CON vs. 1.38 ± 0.22 INT, t4 = -2.12, 95% CI -
1.1 to 0.15, P = 0.05) and AXIN1 (1 ± 0.05 CON vs. 1.41 ± 0.03 INT, t5 = -6.5, 95% CI -0.57 to -
0.24, P = 0.001) transcript expression at 30 mins post-loading (see Figure 5.11). Although non-
significant, there was also an increase in TRAF1 (1.38 ± 0.73 CON vs. 1.74 ± 1.07 INT, t5 = -0.29, 
95% CI -3.55 to 2.83, P = 0.78), and STAG1 (1.04 ± 0.16 CON vs. 1.24 ± 0.2 INT, t5 = -0.8, 95% 
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CI -0.85 to 0.45, P = 0.46) with a non-significant reduction in PLA2G16 (1 ± 0.05 CON vs. 0.89 
± 0.06 INT, t5 = 1.47, 95% CI -0.09 to 0.32, P = 0.2) and KLHDC1 (0.87 ± 0.1 CON vs. 0.62 ± 
0.07 INT, t4 = 2.03, 95% CI -0.09 to 0.59, P = 0.11) mRNA expression (see Figure 5.11). 
Furthermore, there was no statistical difference in HEG1 (1.22 ± 0.18 CON vs. 1.38 ± 0.08 INT, 
t4 = -0.78, 95% CI -0.7 to 0.39, P = 0.48), AFF3 (1.05 ± 0.21 CON vs. 1.19 ± 0.57 INT, t5 = -0.25, 
P = 0.81, 95% CI -1.52 to 1.25), ZFP2 (1.03 ± 0.13 CON vs. 1.13 ± 0.07 INT, t5 = -0.64, 95% CI 
-0.53 to 0.32, P = 0.55) and BICC1 (1.02 ± 0.13 CON vs. 1 ± 0.04 INT, t5 = 0.15, 95% CI -0.38 
to 0.42, P = 0.89) mRNA expression 30 mins post-loading (see Figure 5.11). 
 
After analysing gene expression in response to acute loading in bioengineered SkM alone, such 
changes were compared to mRNA expression following acute and chronic RE in humans 
(Seaborne et al., 2018a) and chronic high-frequency electrical stimulation in rats (Schmoll et 
al., 2018; Seaborne et al., 2019). Interestingly, there was no significant differences in mRNA 
across all models of exercise for UBR5 (F3,16 = 0.22, P = 0.88), ODF2 (F3,17 = 1.38, P = 0.28), 
AXIN1 (F3,18 = 0.5, P = 0.69), RSU1 (F3,14 = 0.46, P = 0.72), HEG1 (F3,12 = 1.24, P = 0.32), 
TRAF1 (F3,18 = 0.57, P = 0.64), RPL35a (F3,16 = 0.91, P = 0.46), SETD3 (F3,18 = 0.36, P = 
0.79), GRIK2 (F3,18 = 0.08, P = 0.97), STAG1 (F3,18 = 0.34, P = 0.8), PLA2G16 (F3,14 = 1.16, 
P = 0.36), KLHDC1 (F3,13 = 1.41, P = 0.29), AFF3 (F3,19 = 0.42, P = 0.74), BICC1 (F3,15 = 
0.04, P = 0.99) and ZFP2 (F3,19 = 0.77, P = 0.53; see Figure 5.11). 
 
The present section demonstrates that almost half (47%; UBR5, ODF2, RSU1, SETD3, 
GRIK2, RPL35a and AXIN1) of the genes analysed herein displayed a significant increase in 
mRNA expression at 30 mins post-loading. Interestingly, there was no significant difference 
in mRNA expression between models of loading/RE, suggestive that mechanical loading of 
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murine bioengineered SkM in-vitro demonstrates similar transcriptional responses to 
loading/RE in-vivo.
 220 
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As described in section 5.3.5 above, mRNA expression of regulated genes identified in Seaborne et al., (2018a) after acute and chronic RE in 
human SkM were compared across various models of loading/RE - bioengineered SkM (clear circles) versus acute (shaded squares) and chronic 
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Figure 5.11. Comparison of mRNA epression for genes identified in Seaborne et al., (2018a) after loading/RE in bioengineered, rodent and 
human SkM 
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(bold triangles) RE in humans (Seaborne et al., 2018a) and chronic electrical stimulation/RE in rats (clear triangles; Schmoll et al., 2018). Bold 
circles with errors represent mean ± SEM for all models of loading/exercise pooled. (*) Depicts significant increase (P < 0.05) in transcript 
expression at 30 mins post-loading in bioengineered SkM alone. There was no significant difference in mRNA expression across all models of 
loading/RE for any of the genes analysed.
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5.3.6! DNA Methylation of Upregulated/Hypomethylated Genes in 
Bioengineered and Human Skeletal Muscle were Assessed After Loading 
In-Vitro 
 
Given ODF2 (together with UBR5 as discussed in section 5.3.7) was one of the most 
significantly regulated genes across all models of mechanical loading assessed throughout the 
present chapter (acute loading/RE in engineered and human SkM, chronic RE in human and 
rat SkM, see Figure 5.11), the DNA methylation status of this gene was also assessed. Despite 
no significant change in mRNA expression observed for genes; BICC1, GRIK2, STAG1 and 
TRAF1 after loading in bioengineered muscle, the DNA methylation was also assessed given 
these genes were hypomethylated after just one single bout of RE in human SkM, which 
preceded significant upregulation of mRNA and subsequent muscle hypertrophy after chronic 
loading in human SkM (Seaborne et al., 2018a).   
 
ODF2 
There was no significant difference in ODF2 5-upstream (1 ± 0.01 CON vs. 0.95 ± 0.03 INT, t38 
= 1.58, 95% CI -0.01 to 0.11, P = 0.12), 5-UTR (1 ± 0.11 CON vs. 0.83 ± 0.16 INT, t22 = 0.85, 
95% CI -0.24 to 0.57, P = 0.41), intron 2 (1 ± 0.02 CON vs. 1 ± 0 INT, t54 = 0.75, 95% CI -0.07 
to 0.06, P = 0.94), intron 3 (1 ± 0.01 CON vs. 1 ± 0.01 INT, t30 = 0.81, 95% CI -0.05 to 0.02, P = 
0.43) and exon 5 (1 ± 0.01 CON vs. 1 ± 0.01 INT, t30 = 0.81, 95% CI -0.05 to 0.02, P = 0.43) 
region-specific DNA methylation after loading. Furthermore, there was no statistical difference 
in DNA methylation when all regions assessed (5-upstream, 5-UTR, intron 2, intron 3 and exon 
5) were pooled (1 ± 0.01 CON vs. 0.98 ± 0.02 INT, t222 = 0.94, 95% CI -0.02 to 0.07, P = 0.35; 
see Figure 5.12A). 
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BICC1 
There was no significant difference in BICC1 intron 1 (1 ± 0.01 CON vs. 0.97 ± 0.01 INT, t86 = 
1.74, 95% CI -0 to 0.06, P = 0.09) or 5-upstream (1 ± 0.01 CON vs. 0.98 ± 0.01 INT, t64 = 0.99, 
95% CI -0.02 to 0.06, P = 0.33) region-specific DNA methylation after loading. Interestingly 
however, BICC1 was hypomethylated when all regions assessed (intron 1 and 5-upstream) 
were pooled (1 ± 0.01 CON vs. 0.98 ± 0.01 INT, t152 = 1.96, 95% CI 0 to 0.05, P = 0.05; see Figure 
5.12B). 
 
GRIK2 
There was no significant difference in GRIK2 5-upstream (1 ± 0.09 CON vs. 1.35 ± 0.44 INT, t171 
= 0.77, 95% CI -1.26 to 0.55, P = 0.44) or 5-UTR (1 ± 0.19 CON vs. 1.94 ± 0.59 INT, t54 = 1.33, 
95% CI -2.35 to 0.48, P = 0.19) region-specific DNA methylation after loading. Interestingly 
however, GRIK2 intron 2 was hypomethylated after loading (1 ± 0.17 CON vs. 0.42 ± 0.09 INT, 
t29 = 2.93, 95% CI 0.17 to 0.98, P = 0.01). Finally, there was no statistical difference in DNA 
methylation when all regions assessed (5-upstream, 5-UTR and intron 2) were pooled (1 ± 0.07 
CON vs. 1.39 ± 0.32 INT, t258 = 1.13, 95% CI -1.06 to 0.29, P = 0.26; see Figure 5.12C). 
 
STAG1 
There was no significant difference in STAG1 5-upstream (1 ± 0.63 CON vs. 2.32 ± 1.52 INT, t11 
= 0.65, 95% CI -5.75 to 3.11, P = 0.53), 5-UTR (1 ± 0.26 CON vs. 1.05 ± 0.32 INT, t62 = 0.11, 
95% CI -0.87 to 0.77, P = 0.91), intron 1 (1 ± 0.2 CON vs. 1.39 ± 0.76 INT, t104 = 0.46, 95% CI 
–2.03 to 1.26, P = 0.64), region-specific DNA methylation after loading. Furthermore, there 
was no statistical difference in DNA methylation when all regions assessed (5-upstream, 5-
UTR and intron 1) were pooled (1 ± 0.2 CON vs. 1.35 ± 0.47 INT, t181 = 0.68, 95% CI -1.37 to 
0.67, P = 0.5; see Figure 5.12D). 
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TRAF1 
There was no significant difference in TRAF1 intron 2 (1 ± 0.24 CON vs. 0.83 ± 0.15 INT, t22 = 
0.58, 95% CI -0.43 to 0.76, P = 0.57) nor intron 3 (1 ± 0.03 CON vs. 0.96 ± 0.04 INT, t62 = 0.74, 
95% CI -0.06 to 0.14, P = 0.46) region-specific DNA methylation after loading. Interestingly 
however, TRAF1 5-upstream was hypermethylated after loading (1 ± 0.04 CON vs. 1.14 ± 0.04 
INT, t62 = 2.48, 95% CI -0.26 to -0.03, P = 0.02). Finally, there was no statistical difference in 
DNA methylation when all regions assessed (5-upstream, 5-UTR and intron 2) were pooled (1 
± 0.04 CON vs. 1.02 ± 0.04 INT, t150 = 0.33, 95% CI -0.13 to 0.09, P = 0.74; see Figure 5.12E). 
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mRNA expression and DNA methylation of genes identified in (Seaborne et al., 2018a) - (A) 
ODF2, (B) BICC1, (C) GRIK2, (D) STAG1 and (E) TRAF1 in loaded (INT) and non-loaded 
(CON) bioengineered SkM (n = 5 replicate cultures/muscles per condition [CON and INT]) at 
30 mins post-loading. (*) Depicts significant difference (P < 0.05) in mRNA expression and/or 
region specific DNA methylation after INT versus CON with specific changes described in 
each figure section (A-E). Data is presented as mean ± standard error of mean (SEM).  
  
5.3.7! mRNA Expression and DNA Methylation of the Most Significantly 
Upregulated Gene Across All Models of Loading  
As discussed in section 5.3.5, UBR5 was the most significantly upregulated transcript across 
all models of loading/exercise (see Figure 5.11). Specifically at 30 mins post-acute loading in 
human and bioengineered SkM and also following chronic RE/high-frequency electrical 
stimulation in human and rat SkM (Schmoll et al., 2018; Seaborne et al., 2018a, 2019). 
Therefore, UBR5 mRNA expression was further assessed at 3 and 24 hrs post-loading. 
 
UBR5 mRNA Expression  
There was a significant main effect for loading (F1,17 = 33.14, P < 0.001) and time (F2,17 = 
12.57, P < 0.001) on UBR5 expression with a significant interaction (F2,17 = 12.11, P = 0.001). 
Mean mRNA expression at 30 mins (1.33 ± 0.18) was significantly greater than that at 24 hrs 
(1 ± 0.05, t = 2.85, 95% CI 0.1 to 0.67, P = 0.01) post-loading with no significant difference 
between 30 mins vs. 3 hrs (1.69 ± 0.33; t = -2, 95% CI -0.63 to 0.02, P = 0.06). Furthermore, 
mean expression was significantly greater at 3 vs. 24 hrs (t = -4.91, 95% CI -0.99 to -0.39, P < 
Figure 5.12. mRNA expression and DNA methylation of regulated genes after RE in 
human SkM were assessed after loading in bioengineered SkM 
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0.001). Mechanical loading elicited a significant increase in UBR5 expression at 30 mins  (1 ± 
0.02 CON vs. 1.77 ± 0.23 INT, t = 3.70, 95% CI 0.33 to 1.21, P = 0.002) and 3 hrs (1.05 ± 0.22 
CON vs. 2.34 ± 0.26 INT, t = 5.81, 95% CI 0.82 to 1.76, P < 0.001) with no change at 24 hrs post-
loading (1.02 ± 0.1 CON vs. 0.98 ± 0.03 INT, t = -0.27, 95% CI -0.41 to 0.32, P = 0.79; see Figure 
5.13). 
 
UBR5 DNA Methylation 30 mins Post-loading 
Given UBR5 exponentially increased at the mRNA level at 30 mins and 3 hrs with no change 
at 24 hrs post-loading (see Figure 5.2 and data above in section 5.3.7), the DNA methylation 
status at 30 mins and 3 hrs post-loading was assessed. At 30 mins post-loading, there was no 
significant difference in UBR5 5-upstream (1 ± 0.19 CON vs. 1.18 ± 0.36 INT, t = 0.44, 95% CI 
-0.99 to 0.63, P = 0.66) or intron 1 (1 ± 0.01 CON vs. 1.01 ± 0.02 INT, t = 0.41, 95% CI -0.05 to 
0.03, P = 0.68) region-specific DNA methylation or when regions assessed (5-upstream and 
intron 1) were pooled (1 ± 0.04 CON vs. 1.05 ± 0.08 INT, t = 0.51, 95% CI -0.22 to 0.13, P = 
0.61; see Figure 5.13). 
 
UBR5 DNA Methylation 3 hrs Post-loading 
There was no significant difference in UBR5 5-upstream (1 ± 0.09 CON vs. 1.12 ± 0.13 INT, t = 
0.68, 95% CI -0.46 to 0.22, P = 0.50) or intron 1 (1 ± 0.03 CON vs. 1.04 ± 0.03 INT, t = 0.95, 
95% CI -0.12 to 0.04, P = 0.34) region-specific DNA methylation after loading with also no 
statistical difference in DNA methylation when regions 5-upstream and intron 1 were pooled 
(1 ± 0.03 CON vs. 1.05 ± 0.03 INT, t = 1.16, 95% CI -0.14 to 0.04, P = 0.25; see Figure 5.13).  
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UBR5 was the most significantly upregulated transcript after loading in bioengineered SkM 
alone (see Figure 5.2) and across all models of RE (see Figure 5.11). Therefore, region specific 
DNA methylation was assessed at 30 mins and 3 hrs post-loading in bioengineered SkM which 
was then mapped against changes in mRNA expression at 30 mins, 3 and 24 hrs post-loading 
(n = 5 replicate cultures/muscles per condition [CON and INT] and timepoint). (*) Depicts 
significant upregulation of UBR5 at 30 mins and 3 hrs post-loading (P < 0.05). Data is 
presented as mean ± standard error of mean (SEM). 
 
After analysing region-specific DNA methylation, 6 × CpG sites in the intron 1 region of the 
were also assessed in order to investigate CpG-specific DNA methylation. There was a non-
significant increase in CpG-7 (1 ± 0.08 CON vs. 2.42 ± 0.88 INT, t5 = 1.91, 95% CI -3.33 to 0.49, 
P = 0.12), -8 (1 ± 0.12 CON vs. 1.79 ± 0.55 INT, t5 = 1.63, 95% CI -2.04 to 0.46, P = 0.16), -9 (1 
± 0.34 CON vs. 2.67 ± 0.94 INT, t5 = 1.88, 95% CI -3.94 to 0.61, P = 0.12) and -11 (1 ± 0.04 CON 
vs. 1.82 ± 0.44 INT, t5 = 2.17, 95% CI -1.79  to 0.15, P = 0.08) intron 1 methylation (see Figure 
14). Despite a reduction in methylation at CpG-10, such changes did not reach statistical 
(*) Depicts significantly increased mRNA expression after loading (INT) 
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Figure 5.13. UBR5 mRNA expression and DNA methylation after mechanical loading in 
bioengineered SkM 
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significance (1 ± 0.14 CON vs. 0.61 ± 0.32 INT, t5 = 1.26, 95% CI -0.41 to 0.18, P = 0.27). 
Interestingly however, CpG-6 (1 ± 0.1 CON vs. 2.04 ± 0.33 INT, t5 = 3.48, 95% CI -1.8 to -0.27, 
P = 0.02) was significantly hypermethylated, alongside all CpG sites (6-11) combined  (1 ± 0.1 
CON vs. 1.89 ± 0.24 INT, t47 = 4.16, 95% CI -1.32 to -0.46, P < 0.001) at 30 mins post-loading 
(see Figure 5.14). 
 
 
 
 
 
 
 
 
 
CpG-specific DNA methylation (pyrosequencing) in the intron 1 region of UBR5 at 30 mins 
post mechanical loading in bioengineered SkM (n = 5 replicate culutres/muscle per condition 
[CON and INT]). (*) Depicts significant hypermethylation on CpG-6 and when all CpG’s 
assessed (6-11) were pooled (P < 0.05). Date published in Seaborne et al., (2019). 
 
5.4!Discussion 
In the present chapter, mRNA expression and DNA methylation of a number of frequently 
regulated genes across the human transcriptome and methylome after acute RE identified in 
chapter 4 and previous work by our group (Seaborne et al., 2018a) were analysed in response 
to acute mechanical loading in murine bioengineered fibrin SkM to determine whether 
Figure 5.14. CpG-specific DNA methylation of UBR5 after loading in bioengineered SkM 
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mechanical loading of bioengineered SkM somewhat mimics the molecular responses after 
loading/RE in-vivo. Similar observations would subsequently validate the use of the 
bioengineered SkM model described throughout this thesis when attempting to delineate novel 
transcript and epigenetic mechanisms involved in SkM adaptation after RE in future studies. 
 
5.4.1! mRNA Expression of Upregulated/Hypomethylated Genes After Acute 
Resistance Exercise in Humans were Assessed Following Mechanical 
Loading in Bioengineered Skeletal Muscle  
Transcript expression of a number of genes that were upregulated and hypomethylated across 
the pooled transcriptome after acute RE in humans (as described in chapter 4) were assessed 
in response to mechanical loading in bioengineered SkM. Specifically, expression of genes 
involved in ECM/actin structure/remodelling, mechano-transduction, protein synthesis, TGF-
ß/calcium/retinoic/IL-6 signaling, methylation and tumor suppression were examined.  
 
Out of the 22 genes that were upregulated and hypomethylated across the human transcriptome 
and methylome in chapter 4 and were analysed after mechanical loading in the present chapter, 
22% (5; THBS1, CD63, GSK3ß, WNT9a, ADCY3) of genes displayed a reduction in mRNA 
expression at 30 mins post-loading. At 3 hrs post-acute loading, 33% (7; MSN, TIMP3, ITGB3, 
GSK3ß, WNT9a, DOT1L, KDR) of genes increased whereas 14% (3; THBS1, FOS, ADCY3) 
decreased with the remaining genes showing no statistical change. Finally, 1 gene (TIMP3) 
increased at 24 hrs post-loading, however 19% (4; MSN, CRK, ITPR3 F2LR3) decreased with 
the remainder of genes showing no significant change in transcript expression. As described in 
section 4.4.1 of this thesis, ITGB3 (integrin subunit beta-3) is an ECM protein binding receptor 
and is involved in migration of craniofacial muscle cells (Sinanan et al., 2008) and is also 
increased after acute RE (3 × 12 reps at 70% 1-RM on leg press and extension exercises) in 
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young but not old human SkM (Wessner et al., 2019). KDR (also known as kinase insert 
domain receptor) is a major VEGF receptor (specifically VEGFR-2) involved in angiogenesis 
and has been shown to increase following submaximal aerobic exercise (45 min of cycling at 
50% VO2max) in both young and aged individuals (Ryan et al., 2006) and also in lengthening 
TA muscle post osteotomy in mice (Nishisho et al., 2012). MSN (or moesin) is a member of 
the ezrin-radixin-moesin (ERM) protein family and is an important actin-plasma membrane 
crosslinker, associated with dystrophy myopathies (Pines et al., 2017). Furthermore, the 
methylation status of moesin has also been reported in active and sedentary aged individuals 
whereby those whom participated in frequent exercise throughout their life span displayed 
hypomethylation relative to those who were less active (Sailani et al., 2019). As discussed in 
chapter 4 of this thesis, TIMP3 (tissue inhibitor of metalloproteinase 3) is part of the TIMP 
protein family which contributes to ECM turnover and is downregulated during C2C12 muscle 
differentiation and also in regenerating CTX-injured and overloaded soleus mouse muscle (Liu 
et al., 2010b). Such findings are interesting given TIMP3 was significantly upregulated and 
hypomethylated after acute RE in humans (see chapter 4 of this thesis) and also increased at 
the transcript level expression after acute mechanical loading in C2C12 engineered SkM in the 
present chapter. Discrepancies observed in TIMP3 expression between models of loading 
therefore suggests that following the initial increase immediately post-loading, TIMP3 is 
subsequently reduced to enable MMP activity to assist in initiating the ECM remodelling and 
hypertrophic response observed after functional overload (Zhang et al., 2014). GSK3ß 
(Glycogen synthase kinase-3 beta) is an important MPS regulator, downstream of Akt (Glass, 
2003) and is key for muscle (C2C12) differentiation (Litwiniuk et al., 2016). Furthermore, 
GSK3ß protein phosphorylation is increased and decreased during hypertrophy and atrophy, 
respectively in human SkM (Léger et al., 2006). Moreover, basal GSK3ß protein content is 
greater in lifelong aged physically active versus physically inactive aged human SkM, although 
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no difference was observed in promoter-related DNA methylation (Sailani et al., 2019). As 
described in section 4.4.2 of this thesis, WNT9a which functions via the canonical Wnt/beta-
catenin signaling pathway has been demonstrated to be key during SkM development both at 
the transcript (Zhang et al., 2018) and DNA methylation level (Zhang et al., 2019a).  
 
5.4.2! DNA Methylation of Upregulated/Hypomethylated Genes After Acute 
Resistance Exercise in Humans were Assessed Following Mechanical 
Loading in Bioengineered Skeletal Muscle  
The genes analysed for DNA methylation were carefully considered according the reported 
changes in gene expression after loading or due to their well-characterised regulatory role in 
SkM after RE in-vivo. Firstly, the methylation status of genes, MSN and WNT9a, at 3 hrs post-
loading were analysed given the mRNA expression of these genes displayed the greatest 
increase relative to all other upregulated/hypomethylated genes (identified in chapter 4) after 
loading (see section 5.3.1). Whilst DNA methylation of the actin crosslinker MSN is altered in 
SkM of lifelong active individuals and WNT9a changes during muscle development (see 
section 4.4.1 and 5.4.2), the present chapter is the first to report the epigenetic response of these 
genes after mechanical loading. Interestingly, no change was observed in methylation for 
WNT9a, however, MSN global (5-upstream and intron 1/2 combined) and intron 1 methylation 
increased 3 hrs post-loading (see Figure 5.7). DNA methylation of TIMP3 and GSK3ß was 
also analysed on the basis that these genes are important for SkM ECM remodelling and protein 
synthesis, respectively (see section 4.4.1 and 5.4.2). As with WNT9a, there was no significant 
changes in DNA methylation for TIMP3 and GSK3ß (see Figure 5.7). Despite the non-
significant increase in CTTN observed after loading in the present chapter, this gene is 
important for actin cytoskeleton remodelling and together with FLNB, was 1 of 23 genes 
highlighted in chapter 4 that was significantly upregulated and hypomethylated after both acute 
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and chronic RE (Turner et al., 2019b). Similarly, to MSN, the CTTN intron 1 region was 
significantly hypermethylated after loading with no change in 5-UTR or intron 2 region-
specific methylation nor when all regions assessed were pooled (see Figure 5.7).  
 
5.4.3! mRNA Expression of Downregulated/Hypermethylated Genes After Acute 
Resistance Exercise in Humans were Assessed Following Mechanical 
Loading in Bioengineered Skeletal Muscle  
Out of the 12 genes that were downregulated and hypermethylated across the human 
transcriptome and methylome in chapter 4, and were also assessed after mechanical loading in 
the present chapter, 25% (3; DROSHA, ESR1, SMO) significantly reduced at 30 mins whereas 
mRNA expression in 33% (4) of genes decreased at both 3 (PAX3, AGTR1, DROSHA, NOS2) 
and 24 hrs (PAX3, AGTR1, DROSHA, SMO) post-loading in bioengineered SkM. No genes 
significantly increased at 30 mins and 3 hrs post-loading. However, only 1 gene (NOS2) 
significantly increased at 24 hrs post-loading (see Figure 5.8). Genes which significantly 
reduced after loading included; AGTR1a, PAX3, NOS2, ESR1, DROSHA and SMO. Their 
roles (or lack of) in SkM are described in section 4.4.3 of this thesis. Briefly, AGTR1 is an 
angiotensin receptor (angiotensin II receptor type I) displaying mechano-sensitive properties 
in various cells types (Zou et al., 2004; Yasuda et al., 2008). In SkM, AGTR1 knock-down 
prolonged life-span and improved repair and regeneration after injury in rodents (Yabumoto et 
al., 2015). Therefore, reduced AGTR1 mRNA expression during regeneration and across the 
human transcriptome after acute RE in chapter 4 and after acute loading in bioengineered 
muscle in the present chapter suggests an important role for this gene in anabolism and 
regeneration in human and rodent SkM. PAX3 (paired box 3) is highly expressed in SkM 
satellite cells and determines myogenic stem cell fate via activation of the MRF, myoD (Relaix 
et al., 2005, 2006). NOS2 (nitric oxide synthase 2 or inducible nitric oxide) produces nitric 
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oxide and is expressed during SkM development and in adult SkM tissue subject to 
inflammation (Rigamonti et al., 2013). Indeed, it has been demonstrated that NOS2 is 
exclusively expressed in macrophages infiltrating regenerating SkM following CTX-induced 
muscle damage in mice (Rigamonti et al., 2013). Furthermore, basal NOS2 protein expression 
is significantly greater in old vs. young sedentary rat gastrocnemius muscle which also supports 
the notion that NOS2 is abundant in inflamed tissue (Song et al., 2009). Interestingly however, 
NOS2 expression was significantly reduced after chronic exercise (treadmill running at 75% 
VO2max, 1 hr/day, 5 days/week for 12 weeks) in aged, as well as young rats (Song et al., 2009), 
supporting findings observed in the present study that NOS2 is reduced after exercise. ERS1 
is an estrogen receptor 1 and is associated with muscle weakness in female mice with ESR1 
deletion  (Collins et al., 2018), yet, overexpression results in a slow muscle phenotype (Chen 
et al., 2016). Given RE typically increases size and abundance of type II fibres, it seems logical 
that a reduction was observed after RE in humans (see chapter 4) and loading in engineered 
SkM. SMO (Smoothened, Frizzled Class Receptor), a G-protein receptor involved in signal 
transduction is highly expressed in developing SkM tissue and myotubes (Elia et al., 2007). 
DROSHA (also known as Drosha Ribonuclease III) is important for formation of miRNA’s 
(Lee et al., 2003) and is increased at the mRNA level after acute aerobic exercise (Russell et 
al., 2013). Given DROSHA was increased after RE/loading in human and bioengineered SkM 
suggests that regulation of this gene may be dependent on the specific stimulus the muscle is 
subjected to (i.e. mode of exercise performed).   
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5.4.4! DNA Methylation of Downregulated/Hypermethylated Genes After Acute 
Resistance Exercise in Humans were Assessed Following Mechanical 
Loading in Bioengineered Skeletal Muscle  
After detection of which downregulated/hypomethylated genes (identified in chapter 4) were 
also downregulated at the mRNA level 3 hrs post-acute mechanical loading in bioengineered 
SkM (see section 5.4.3), the DNA methylation status of the most significantly downregulated 
genes at the mRNA level at 3 hrs post-loading were assessed. Specifically, PAX3 and AGTR1a 
were analysed at the DNA methylation level. Interestingly, previous studies demonstrated 
increased methylation of PAX3 in human rhabdomyosarcoma muscle tissue (Kurmasheva et 
al., 2005) and SkM myoblasts (Tsumagari et al., 2013). Additionally, promoter-associated 
DNA hypermethylation of AGTR1 has also been reported in lung tumor, but not healthy tissue 
(Chen et al., 2017). With the exception of the work conducted in chapter 4 of this thesis, nobody 
has yet reported the methylation patterns of both PAX3 and AGTR1 in response to 
RE/mechanical loading. The present chapter is therefore the first to determine DNA 
methylation after loading, specifically in engineered SkM. Despite PAX3 and AGTR1 
displaying the greatest differential transcript expression after loading in the present chapter and 
their known hypermethylated profiles in malignant tissue, no changes in region-specific (5-
upstream, intron 1/2) or global (all regions assessed pooled) DNA methylation was observed 
for both genes.  
 
5.4.5! mRNA Expression of Genes that are Significantly Altered After Acute and 
Chronic Resistance Exercise in Humans were Assessed After Mechanical 
Loading in Bioengineered Muscle  
After analysing genes that were both upregulated/hypomethylated and 
downregulated/hypermethylated across the human transcriptome and methylome after acute 
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RE (see chapter 4), genes that were significantly regulated in previous work by our group after 
RE (Seaborne et al., 2018a) were also analysed following mechanical loading in bioengineered 
SkM. Specifically, mRNA expression of genes including; UBR5, ODF2, AFF3, RSU1, HEG1, 
TRAF1, AXIN1, RPL35a, SETD3, GRIK2, PLA2G16, ZFP2, BICC1, KLHDC1 and STAG1 
were assessed at 30 mins post-loading in engineered SkM. This timepoint was selected due to 
muscle biopsies being taken immediately post (~30 mins) RE in human SkM (Seaborne et al., 
2018a). Interestingly, almost half (47%) of these genes were significantly upregulated at 30 
mins post-loading in bioengineered SkM with the remaining 53% showing no statistical change 
in transcript expression. Specifically, genes UBR5, ODF2, RSU1, SETD3, GRIK2, RPL35a 
and AXIN1 displayed differential mRNA expression 30 mins post-loading.  
 
ODF2 (also known as outer dense fibre of sperm tails 2) is a major component of the sperm 
tail cytoskeletal structure and is important for embryonic development (Salmon et al., 2006). 
Furthermore, ODF2 mRNA expression was highest in quiescent (G0 phase) mouse NIH3T3 
fibroblast cells with minimal expression during the G1/G2 phase of the cell cycle (Pletz et al., 
2013). However, to the authors knowledge, no previous research has reported ODF2 expression 
during myogenesis, nor in SkM tissue after RE (with the exception of previous work by our 
group which identified ODF2 as upregulated and hypomethylated after RE Seaborne et al., 
2018a). RSU1 (ras suppressor protein 1) is involved in ras-specific signal transduction and 
integrin adhesion complexes. In SkM, overexpression of ras has been shown to inhibit myotube 
formation and MHC protein expression in 10TI/2 cells whereas treatment with MyoD 
expression vector displayed distinct myotubes after 48 hrs of treatment (Mitin et al., 2001). 
Therefore, an increase in RSU1 observed after acute loading in bioengineered SkM and RE in 
humans (Seaborne et al., 2018a) may suggest that a reduction in Ras1 signaling may 
subsequently permit regeneration of myotubes/SkM tissue after loading. Interestingly, recent 
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work has demonstrated that RSU1 knockdown in the drosophilia/fruit fly results in a reduction 
and an increase myofibre diameter and sarcomere length, respectively and regulates PINCH 
activity which is important for integrin adhesion in the myotendinous junction of flight 
muscles. Furthermore, recent work has also shown that RSU1 is downregulated in 
atherosclerotic human VSMCs (Fasehee et al., 2019) and that RSU1 regulates AChR 
distribution in C. elegans muscle cells (Pierron et al., 2016). Previous work by our group 
demonstrated that SETD3 (SET Domain Containing 3) gene expression correlated with 
changes in SkM hypertrophy in human muscle after RE (Seaborne et al., 2018a). Indeed, 
mRNA increased after load-induced hypertrophy which reduced to basal levels after 7 weeks 
unloading (Seaborne et al., 2018a). Furthermore, mRNA increased to a greater extent after 
chronic reloading (where the greatest increase in hypertrophy was observed) which coincided 
with a reduction in DNA methylation. SETD3 is a H3K4/H3K36 methyltransferase and is 
expressed in high abundance in SkM (Eom et al., 2011). Overexpressing SETD3 has been 
shown to enhance C2C12 muscle differentiation via activation of muscle creatine kinase and the 
MRF, myogenin and Myf6 (or MRF4; Eom et al., 2011). Conversely, shRNA-induced 
inhibition of SETD3 negatively affected myoblast differentiation (Eom et al., 2011) which may 
be regulated by two specific miRNA’s, miR-15b and miR-322, shown to target the 3-UTR of 
SETD3 and subsequently repress its mRNA expression (Zhao et al., 2019). Collectively, these 
results suggest that SETD3 is important for SkM regeneration which may explain the increase 
in expression observed post mechanical loading in the present chapter. As with SETD3, 
RPL35a (ribosomal protein L35a) was also associated with SkM hypertrophy following RE 
exercise in humans whereby mRNA expression and DNA methylation somewhat increased and 
decreased, respectively to the greatest level after 7 weeks of retraining (Seaborne et al., 2018a). 
RPL35a is part of the ribosomal 60S large subunit, essential for the translation of proteins. 
Two-hybrid yeast screening revealed a protein-protein interaction  between RPL35a and 
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CMYA1 (aka Xin) in bovine SkM (Xin et al., 2017). XIN is an actin binding protein involved 
in SkM development. Under normal conditions, this gene is expressed in the myotendinous 
junction, albeit, was localised in SkM satellite cells of damaged single EDL myofibres with 
significant increase in mRNA expression ~2 days post CTX (Hawke et al., 2007). These 
findings therefore suggest the importance of XIN in muscle regeneration, which was later 
confirmed by the same group whereby shRNA-induced silencing in mouse TA muscle ablated 
muscle regeneration post CTX injury, evidenced by expression of the embryonic MYHC 
(MYHC-3) and reduced myofibre size (Nissar et al., 2012). In regards to exercise, work from 
the same lab also reported significantly increased XIN expression 24 hrs post eccentric exercise 
(300 × maximal eccentric quadricep lengthening contractions) in healthy human VL muscle 
(Nilsson et al., 2013). Taken together, the increase in RPL35a mRNA expression observed 
within the present chapter suggests a potential role in regeneration via interacting with 
CMYA1/XIN post-loading in bioengineered mouse SkM. However, future studies 
investigating the expression of CMYA1/XIN and other interacting proteins post-loading is 
warranted. GRIK2 (glutamate ionotropic receptor kainate type subunit 2) is a member of the 
glutamate receptor kainate family, composed of four subunits which function as ligand-
activated ion channels (Han et al., 2010). Previous work by our group demonstrated that 
GRIK2 was one of four genes which was hypomethylated after just one single bout of RE in 
humans and that changes in DNA methylation preceded upregulation of gene transcription after 
the first and second periods of chronic RE (Seaborne et al., 2018a). Suggestive that acutely 
regulated DNA methylation changes determined subsequent transcript expression after 
repeated RE. Finally, AXIN1 was also significantly upregulated after acute loading in the 
present chapter (see Figure 5.11) and was also upregulated and hypomethylated after training 
and later retraining in human SkM (Seaborne et al., 2018a). AXIN1 (together with AXIN2) is 
a major component of the ß-catenin destruction complex and inhibits WNT signaling (Figeac 
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& Zammit, 2015). Furthermore, AXIN1 is abundantly expressed in proliferating primary and 
C2C12 muscle cells compared to differentiated cells whereby siRNA AXIN1 knockdown 
significantly inhibited cell proliferation (Figeac & Zammit, 2015; Huraskin et al., 2016). 
Previous and current data within the present chapter therefore suggests that upregulation of 
AXIN1 may assist in initiating the SkM regeneration process after mechanical loading/RE.  
 
5.4.6! DNA methylation of Upregulated/Hypomethylated Genes in Bioengineered 
and Human Skeletal Muscle were Assessed After Loading In-Vitro 
After assessing the mRNA expression of significantly regulated genes after acute and chronic 
RE in humans as described in section 5.4.3, the DNA methylation status of the most 
significantly upregulated genes were assessed. Specifically, this included genes UBR5 and 
ODF2 which were not only the most significantly upregulated genes after loading in 
bioengineered SkM but also displayed the greatest mean increase in expression across all 
models of loading (i.e. acute/chronic RE in humans and rats). Interestingly however, no 
changes in DNA methylation was observed for both ODF2 (see Figure 5.12) or UBR5 (see 
section 4.5.7). It is important to note that UBR5 methylation was not significantly altered after 
acute RE in humans, albeit was significantly hypomethylated after chronic RE (Seaborne et 
al., 2018a, 2019), suggestive that repetitive loading stimuli may be required for inducing 
significant changes in UBR5 DNA methylation. However, further work is required to 
determine UBR5 DNA methylation after chronic loading in bioengineered SkM.  
 
Despite a non-significant change in mRNA expression of genes, STAG1, TRAF1 and BICC1  
in engineered SkM after acute loading in the present chapter (see section 5.4.5), previous work 
demonstrated similar non-significant changes in mRNA after acute RE in-vivo (Seaborne et 
al., 2018a). Interestingly however, these genes (together with GRIK2) were hypomethylated 
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after just one single bout of exercise which preceded increased transcript expression after 
chronic RE (Seaborne et al., 2018a). The DNA methylation status of TRAF1, STAG1, BICC1 
and GRIK2 after loading in bioengineered SkM was therefore determined. TRAF1 (TNF 
receptor associated factor 1) encodes a member of the inflammatory cytokine TNF-α receptor 
family which together with TRAF2, regulates MAPK, JNK and NF-κß activation (Pomerantz, 
1999). In-vivo, TNF-α significantly increased following exercise-induced muscle damage (2 × 
5 min bouts of downhill running at 10% decline, 85% VO2max) which correlated with increased 
Pax7+ cell number (Van De Vyver & Myburgh, 2012). Furthermore, the associated increase in 
satellite cell number after exercise was ablated in response to NSAID administration following 
a 36-km run in male endurance athletes (Mackey et al., 2007), suggestive that the acute TNF-
α inflammatory cytokine response after exercise is crucial for initiating the myogenic 
regeneration process. Indeed, administration of TNF-α in cultured primary and C2C12 SkM 
cells increases myoblast proliferation via ERK, JNK and P38 MAPK signaling (Foulstone et 
al., 2004; Li et al., 2005), however chronic exposure inhibits myoblast differentiation and 
promotes myotube atrophy in C2C12 myoblasts, due to a reduction in IGF1 and myogenin 
expression and increased Fox03 (Girven et al., 2016) and Atrogin 1/MAFbx (Li et al., 2005) 
mRNA expression. Furthermore, previous work by our group also demonstrated that early 
TNF-α administration in low passaged C2C12 cells exacerbated the reduction in myotube 
formation when cells having undergone 30 population doubling cells were retreated with TNF-
α, which coincided with increased and decreased MyoD DNA methylation and mRNA 
expression, respectively (Sharples et al., 2016a). Suggestive that gene expression and 
morphology may be determined by early changes observed in DNA methylation. Interestingly 
however, TRAF1, specifically the 5-upstream region was hypermethylated in the present 
chapter after acute loading in engineered muscle (see Figure 5.12). Suggestive that TRAF1 
may not change or even decrease at the mRNA level if engineered muscle was subject to 
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chronic loading given promoter-specific methylation is able to suppress corresponding mRNA 
expression of the same gene after exercise (Barrès et al., 2012; Seaborne et al., 2018a). STAG1 
(aka stromal antigen 1) DNA methylation was also assessed after mechanical loading in 
bioengineered SkM, and displayed no statistical significant change in region-specific (5-
upstream, 5-UTR and intron 1) or pooled methylation (see Figure 5.12). STAG1 is part of the 
cohesin complex, critical for the cohesion of sister chromatids and segregation of chromosomes 
during mitosis, and is responsive to DNA damage in HeLa cells (Kong et al., 2014). With the 
exception of previous work by our group following RE in humans (Seaborne et al., 2018a), 
there is limited research suggesting a role for STAG1 in SkM regulation at the cellular and 
tissue level. Finally, the DNA methylation status of BICC1 and GRIK2 was also reported in 
the present chapter. BICC1 (bicaudal C homolog 1) is an RNA-binding protein and is involved 
in embryonic development, specifically during the formation of the mesoderm of which SkM 
is derived (Zhang et al., 2005). Moreover, BICC1 transcript expression was reported in prenatal 
developing muscle in two different pig breads (Muráni et al., 2007). Interestingly, BICC1 
displayed hypomethylation after mechanical loading when 5-upstream and intron 1 regions 
were pooled (see Figure 5.12). Such findings observed in the present chapter, together with 
those following RE in-vivo (Seaborne et al., 2018a) suggests DNA methylation may precede 
changes in mRNA, and that upregulation in transcript expression may occur if engineered 
muscle was subjected to chronic intermittent loading, particularly if the gene remained 
hypomethylated. However, mRNA expression and DNA methylation patterns after repeated 
loading in bioengineered SkM requires further investigation. Finally, GRIK2, specifically the 
intron 2 region was hypomethylated after loading in bioengineered SkM which coincided with 
upregulation of transcript expression (see Figure 5.12). As discussed in section 5.4.5, GRIK2 
is a member of the glutamate receptor family with no defined role in SkM. However, 
upregulation and hypomethylation of GRIK2 after 3D loading in the present chapter and in 
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response to acute and chronic RE in humans (Seaborne et al., 2018a) suggests an important 
mechano-sensory role of this gene in murine engineered and human SkM in-situ.  
 
5.4.7! mRNA Expression and DNA Methylation of the Most Significantly 
Upregulated Gene Across All Models of Loading  
In the present chapter, UBR5 was the most significantly upregulated transcript across all 
models of RE (see Figure 5.10), displaying an exponential increase in mRNA at 30 mins and 
3 hrs post-loading (see Figure 5.13). Specifically, at 30 mins post-acute loading in human and 
bioengineered SkM and also following chronic RE/high-frequency electrical stimulation in 
human and rat SkM (Schmoll et al., 2018; Seaborne et al., 2018a). Together with ODF2, UBR5 
was the most significantly upregulated transcript at 30 mins post-loading and also demonstrated 
the greatest increase at 3 hrs post (see Figure 5.14). As with MuRF-1 and MAFbx, UBR5 is 
also an E3 ubiquitin ligase. However, MuRF-1 and MAFbx contain a RING domain while 
UBR5 contains a HECT domain, both of which differ in how they catalyse ubiquitin to their 
protein substrates. Indeed, E3 RING finger proteins act as a scaffold to bring E2 ubiquitin-
conjugating enzymes to the protein substrates together whereas E3 HECT domain ligases 
directly catalyses attachment of ubiquitin to the protein substrate (Bodine & Baehr, 2014). 
Unlike RING domain E3 proteins, the roles of HECT E3 ligases in SkM adaptation have only 
recently begun to emerge (Seaborne et al., 2018a, 2019). Indeed, previous work by our group 
demonstrated a significant increase in UBR5 mRNA expression after exercise-induced 
hypertrophy and anabolism in humans (Seaborne et al., 2018a) and rodents (Seaborne et al., 
2019). Furthermore, recent work by our group demonstrated a reduction and an increase in 
UBR5 expression during periods of muscle atrophy and recovery from atrophy, respectively 
(Seaborne et al., 2019), suggesting an opposing role to the atrophy associated E3 ligases, 
MuRF1 and MAfbx which increased with atrophy but did not change during recovery from 
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atrophy. The increase in mRNA expression observed in the present chapter after 3D loading 
further supports the notion that UBR5 may indeed be an important anabolic regulator of SkM 
after RE/loading. It is also worth noting that despite no change observed in DNA methylation 
(see Figures 5.13 and 5.14) after loading in the present chapter, methylation also did not 
significantly change after acute RE in human SkM (Seaborne et al., 2018a, 2019). Indeed, 
DNA methylation significantly increased after chronic RE only (Seaborne et al., 2018a), 
suggestive that continuous loading in engineered muscle may be required to potentially evoke 
changes in UBR5 methylation. However, DNA methylation after chronic mechanical loading 
chronic in bioengineered SkM warrants future investigation.  
 
5.5!Limitations 
It is worth acknowledging the limitations of the present chapter. Firstly, mRNA expression of 
regulated genes across the human transcriptome and methylome identified in chapter 4 were 
assessed at 30 mins, 3 hrs and 24 hrs post-loading in bioengineered muscle whereas pooled 
expression from the myriad of transcriptome studies was derived from biopsy samples taken 
immediately post in-vivo exercise to ~24 hrs post exercise making direct comparisons between 
loaded engineered muscle and RE in-vivo more complex. Furthermore, engineered SkM in the 
present chapter was subjected to mechanical loading alone and therefore represents a model of 
intermittent eccentric lengthening contraction only, with no concentric portion induced via 
electrical stimulation, therefore neglecting the importance of a replicative neural input which 
has been shown to elicit an anabolic and hypertrophic response in human fibrin bioengineered 
SkM (Khodabukus et al., 2018a). This may somewhat explain the limited alterations observed 
in DNA methylation. Future studies should therefore ascertain transcript expression and DNA 
methylation of genes described herein after electrical stimulation alone, alongside 
simultaneous mechanical loading to more closely mimic a muscle contraction in-vivo. 
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Moreover, future studies should wish to assess the transcriptional and epigenetic status of genes 
known to be regulated after chronic RE in humans (Seaborne et al., 2018a; Turner et al., 2019b) 
following chronic loading in engineered SkM. This would enable the identification of whether 
changes in DNA methylation precede alterations in mRNA in engineered SkM that ultimately 
leads to hypertrophy as seen following chronic RE in humans (Seaborne et al., 2018a). 
 
5.6!Conclusion 
Data obtained within the present chapter suggests that mechanical loading of bioengineered 
SkM alone is sufficient for inducing changes in mRNA expression of genes which were 
significantly regulated at the mRNA and/or DNA level after acute RE in human SkM (Seaborne 
et al., 2018a). However, acute loading alone displayed limited changes in DNA methylation, 
potentially suggesting a need for chronic repetitive loading and/or an electrical input as 
described in section 5.5. Interestingly, UBR5 presented the greatest increase in mRNA 
expression after mechanical loading alone and across all additional models of exercise 
employed, indicative that mechanical loading of bioengineered SkM alone may be a useful in-
vitro model for characterising potential novel anabolic mechano-responsive genes at the 
mRNA level.  
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CHAPTER 6 
The Mechanistic Role of UBR5 in Response to 
Mechanical Loading in Human Myotubes 
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6.1!Introduction 
In chapter 5, the ubiquitin protein ligase E3 component n-recognin 5 (UBR5 aka EDD1) gene 
displayed the greatest change in mRNA expression after mechanical loading in fibrin 
bioengineered SkM alone and also when all models of loading/resistance exercise (RE) across 
species were compared (i.e. acute and chronic loading/RE in humans and chronic high 
frequency electrical stimulation/RE in rats; Schmoll et al., 2018; Seaborne et al., 2018a, 2019). 
As discussed extensively in section 5.4.7 of this thesis, UBR5 is an E3 ubiquitin ligase 
containing a HECT domain which directly catalyses ubiquitin to the target protein substrate. 
UBR5 therefore functionally differs from RING-finger domain E3 ubiquitin ligases which act 
as a scaffold to bring E2-conjugating enzymes and the protein substrate together for recognition 
and subsequent degradation within the 26S proteasome system.  
 
In SkM, UBR5 mRNA expression increased after just one bout of acute RE, which 
exponentially increased to a greater extent following several weeks of training and retraining-
in human SkM (Seaborne et al., 2018a), suggestive that UBR5 may have opposing roles in 
SkM to the well-characterised RING finger E3-ubiquitin ligases, MuRF1 (Trim63) and 
MAFbx/Atrogin 1 (Fbxo32) which are associated with SkM atrophy (Bodine et al., 2001a; 
Bodine & Baehr, 2014). Furthermore, recent work by our group supported this hypothesis 
demonstrating that UBR5 significantly increased after acute loading in bioengineered SkM and 
in response to synergistic ablation or chronic electrical stimulation-induced hypertrophy in 
rodent muscle with no change in MuRF-1 and MAFbx expression (Seaborne et al., 2019). 
Moreover, UBR5 also increased during recovery from hindlimb unloading (HU) and 
tetrodotoxin (TTX)-induced atrophy, with no increase in MuRF1 and MAFbx during recovery 
from atrophy (Seaborne et al., 2019), further supporting the notion that UBR5 may contribute 
to the fundamental hypertrophic processes following anabolic stimuli and recovery following 
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catabolic stimuli. Despite previous work demonstrating significant upregulation of UBR5 in 
human, rodent and murine bioengineered SkM after mechanical loading/RE, the loading 
response in human myotubes has not been characterised. Furthermore, the manipulation of 
UBR5 using gene silencing technology in the presence and/or absence of mechanical loading 
is required to further investigate and confirm its mechanistic role both in-vivo and in-vitro. 
 
6.1.1! Aims and Objectives 
As UBR5 increased to the greatest extent at the transcriptional level across human, rodent 
tissue and in murine bioengineered SkM models of loading/RE in chapter 5, the present chapter 
first aimed to ascertain UBR5 gene expression after loading in human myotubes. The present 
chapter then aimed to induce gene-specific knockdown (via siRNA) of UBR5 during 
mechanical loading in attempt to further confirm its mechanistic role in response to acute 
loading in-vitro. In previous chapters, a murine self-assembling fibrin engineered SkM models 
was employed to investigate the transcriptional and epigenetic responses to loading in C2C12 
cells. In the present chapter however, myotubes were differentiated and loaded in monolayer 
to overcome many of the technical challenges (i.e. high seeding densities and inter-individual 
maturation capacity/rates) of producing human self-assembled fibrin bioengineered SkM and 
transfecting myotubes embedded within a surrounding fibrin matrix. Given UBR5 significantly 
increased in various models of loading/RE in chapter 5, it was hypothesised that mechanical 
loading of human myotubes would upregulate UBR5 gene expression, and that silencing of 
UBR5 would prevent the load-induced increase in mRNA, ultimately impairing the anabolic 
response to loading in human myotubes (assessed by global protein synthesis measures via 
puromycin incorporation). 
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6.2!Materials and Methods 
6.2.1! Cell Culture 
HMDCs were derived from SkM biopsies obtained from the vastus lateralis (VL) muscle of 
consenting young males as described in section 2.2.2. Donor information is also detailed in 
Table 2.1. After collection of SkM tissue, samples were transported to the cell culture 
laboratory for subsequent cell isolations (see section 2.2.2) and serial passaging (see section 
2.2.3) to increase cell yield. Once expanded, cells were trypsinised (see section 2.2.3), counted 
(see section 2.2.4) and reseeded onto fibronectin (10 µg/ml in 1! PBS) coated 6-well plastic 
(for the 0 hr time point) or flexible-bottomed BioFlex® (for the 3 hr +/- loading 
timepoint/condition) culture plates at a concentration of 9 × 104 cells/ml  in 2 ml of HGM as 
described in section 6.2.3. Once~80% confluency was attained (typically ~48 hrs), cells were 
rinsed 2 ! with PBS and switched to low serum HDM to promote differentiation of HMDCs 
into multinucleated myotubes over the ensuing 10 days (see section 2.2.7 and Figure 2.2). 
HDM was topped up with 1 ml at 72 hrs and 7 days. Once mature, myotubes were dosed with 
either siRNA or fresh HDM (see section 6.2.2). 
6.2.2! Dosing of Human Myotubes 
As described in section 2.3.2, myotubes were dosed with 4 × synthetic siRNAs (see Table 2) 
targeting various regions of the UBR5 human gene to maximise transcriptional gene silencing 
(see Figure 2.5). For the initial validation experiment, myotubes were subjected to 1 of 4 
conditions. Specifically, myotubes were dosed with 2 ml HDM containing either; 10 nmol 
Flexitube GeneSolutions™ (siUBR5) and 12 µl HiPerFectTransfection™ (transfection reagent), 
10 nmol AllStars Negative Control siRNA™ (siScram) and 12 µl transfection reagent, 
transfection reagent alone or HDM alone for the non-treated group (see Section 2.3.2 and 
Figure 6.1). Myotubes were then incubated for 3 hrs before lysing for subsequent RNA 
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isolation and qRT-PCR to quantify UBR5 gene expression (see section 6.2.4). Due to the low 
knockdown efficiency after dosing with 10 nmol within the validation experiments (-25.72 ± 
4.72%), siRNA concentrations were increased to 20 nmol during subsequent experiments 
which enabled a reduction in UBR5 gene expression by 77.39 ± 0.74% after 3 hrs incubation 
(see Figure 6.1).  
 
6.2.3! Mechanical Loading of Human Myotubes 
BioFlex® culture plates containing treated/non-treated myotubes were assembled to the 
Flexcell® FX-5000™ system housed in a humidified incubator at 37˚C, 5% CO2 for subsequent 
loading as described in section 2.6.3. Once assembled, myotubes were subjected to a low 
frequency (0.15 Hz with sine wave; see Figure 2.11) intermittent loading (10%) regime (INT) 
similar to that employed when loading bioengineered SkM in chapters 3 and 5. Specifically, 
the loading protocol consisted of 4 ! 10 reps which represented 1 of 5 ‘exercises’. Each set was 
interspersed with a 90 s rest whereas each exercise was separated with 3.5 mins rest where 
myotubes were kept at resting length. Non-loaded cells acting as controls (CON) were also 
assembled to the Flexcell® base plate, however, the vacuum entry was sealed with tape to avoid 
any unwanted loading. Cells cultured on BioFlex® culture plates were incubated for a further 3 
hrs post-loading. Cells grown on 6-well plastic culture plates were incubated during the stretch 
regime (37˚C, 5% CO2) and were lysed for RNA (see section 6.2.4) and protein (see section 
6.2.5) at 30 mins (0 hrs) post-loading. 
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The dotted timeline depicts initial siRNA validation experiment whereby dosing with 10 nmol siUBR5 resulted in -25.72 ± 4.72% KD at 3 hrs 
post-treatment (n = 3 per condition [CON/INT] and treatment [HDM/siUBR5] at each timepoint [0/3 hrs]). The solid line indicates repetition of 
experiments with higher 20 nmol siUBR5 dose +(INT) / -(CON) loading and RNA and protein was isolated at 0 and 3 hrs post resulting in a -
77.39 ± 0.74% reduction of UBR5 mRNA expression at 3 hrs.
Figure 6.1. Schematic representation of siUBR5 experimental procedures 
 
 
 
Figure 6.2. UBR5 mRNA expression following mechanical loading in non-treated human myotubesFigure 6.1. Schematic 
representation of siUBR5 experimental procedures 
 
 
 
Figure 6.2. UBR5 mRNA expression following mechanical loading in non-treated human myotubes 
 
 
 
Figure 6.3. UBR5 mRNA expression in human myotubes after loading and gene silencingFigure 6.2. UBR5 mRNA expression 
following mechanical loading in non-treated human myotubesFigure 6.1. Schematic representation of siUBR5 experimental 
procedures 
 
 
 
Figure 6.2. UBR5 mRNA expression following mechanical loading in non-treated human myotubesFigure 6.1. Schematic 
representation of siUBR5 experimental procedures 
 
 
Figure 6.2. UBR5 mRNA expression following mechanical loading in non-treated human myotubes 
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6.2.4! RNA Extraction and Quantitative Real-Time Polymerase Chain Reaction 
(qRT-PCR) 
Following the relevant incubation period post-loading (0/3 hrs), existing media was aspirated 
and myotubes were washed 2 × in PBS before lysing with 300 µl TRIzol (section 2.8.1) for 
subsequent RNA extraction (see section 3.2.5). RNA concentrations (76.64 ± 57.94 ng/ul) and 
purities (A260/A280 ratio, 1.91 ± 0.22) were then quantified using a spectrophotometer (see section 
2.9.3). After RNA quantification, samples were diluted in nuclease-free H2O to ensure a 
concentration of 35 ng in 10 µl reactions, made up of: 4.75 µl (7.37 ng/µl) RNA sample, 5.25 
µl of master mix (MM), composed of 5 µl SYBR green, 0.1 µl of reverse transcriptase (RT) 
mix and 0.075 µl of both forward and reverse primers. Alternatively, sample ‘003’ was diluted 
in nuclease-free H2O to ensure a total 35 ng RNA reaction, however due to a lower 
concentration:volume ratio for this sample, reactions were prepared in a total volume of 20 µl: 
9.5 µl (3.68 ng/µl) RNA, mixed with 10.5 µl of MM with components adjusted accordingly 
(10 µl SYBR green, 0.2 µl RT mix and 0.15 µl of both forward/reverse primers for 10.5 µl total 
MM). All primer sequences and location information for the genes analysed are described in 
Table 6.1. PCR reactions were then transferred to a thermal cycler for amplification (see section 
2.9.4.2) and subsequent quantification of gene expression using the DDCT (ΔΔCT) equation 
(Schmittgen & Livak, 2008) against the mean of 2 reference genes (B2M and RPL13a, 15.33 
± 0.7 with low variation of 4.56%) and the mean CT value derived from the HDM non-treated 
group for each time point (0/3 hrs) and condition (CON/INT; see section 2.9.4.3). 
Alternatively, all samples were relativised to the mean of the 2 reference genes and non-treated 
HDM cells at 0 hrs post-loading only. The PCR efficiencies were similar for reference genes, 
RPL13a (97.4 ± 7.75%, with 7.96% variation) and B2M (92.08 ± 3.18%, with 3.46% variation), 
and UBR5 (90.93 ± 4.94%, with 5.43% variation). 
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Table 6.1. Human primer sequences for genes analysed 
UBR5 mRNA expression was relativised to the mean CT value for reference genes, RPL13a 
and B2M 
Target 
Gene Primer Sequence (5'-3') 
Product 
Length (bp) 
Reference Seq. 
 Number  
UBR5 F: AGGCAACACCTTAGGAAGC 81 NM_015902.6  
 R: GCTCCAGCTGATGACCTAC 
 
XM_024447179.1  
  
 
XM_024447178.1 
  
 
XM_011517106.3 
  
 
XM_017013534.2  
  
 
XM_017013533.2 
  
 
XM_011517105.3 
  
 
XM_011517104.3  
  
 
NM_001282873.1  
RPL13a F: GGCTAAACAGGTACTGCTGGG 104 NM_012423.4  
 R:GGAAAGCCAGGTACTTCAACTT 
  
B2M F: CCGTGTGAACCATGTGACT 91 NM_004048.3 
 R: TGCGGCATCTTCAAACCT   
 
6.2.5! Puromycin Incorporation and SDS-PAGE  
After 0 and 3 hrs incubation post-loading, myotubes were thoroughly washed 3 × in PBS prior 
to incubating cells for 15-30 mins in 2 ml of fresh HDM containing 10 µg/ml of puromycin 
(see section 2.11), as a measure of global protein synthesis. After incubation, media containing 
puromycin was aspirated and 100 µl ice-cold RIPA buffer (1×) containing protease and 
phosphatase inhibitors was then added to myotubes and placed on ice for 10 mins. Lysed cells 
were then scraped and centrifuged (16,000 × g for 10 mins, 4˚C) in fresh 2 ml Eppendorf’s (see 
section 2.11). The supernatant was then transferred to a new Eppendorf tube which was 
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sonicated for 1 min prior to protein quantification using the BCA assay (see section 2.12) and 
precipitated using the acetone method (see section 2.13). 
Given that protein concentrations were considerably low and variable for each sample, even 
after acetone precipitation procedures (0.38 ± 0.37 µg/µl in 20 µl), 4 × laemmli buffer was 
added directly to the samples as described in sections 2.13 and 2.14. Samples were placed on 
a heat block for 10 mins at 95˚C and then on ice for a further 10 mins. All samples were then 
vortexed, ready for separation (see section 2.13.2). Once separated and imaged for total protein 
using stain-free technology (see sction 2.15.2), membranes were blocked (1 hr at RT in 5% 
non-fat dry milk in TBST) and incubated overnight on a rocker at 4˚C in anti-puromycin 
antibody (1:10000 in blocking buffer) as described in section 2.13.2. After overnight 
incubation, membranes underwent 3 × 5 min TBST washes prior to incubating in secondary 
antibody (rabbit anti-mouse IgG, 1:1000 in blocking buffer) at RT for 2 hrs (see section 2.15.2). 
  
6.2.6! Statistical Analysis 
A paired t-test was first conducted using GraphPad Software (Prism, Version 7.0a, San Diego, 
CA) to determine UBR5 mRNA fold-change in non-loaded (CON) vs. loaded (INT) myotubes 
dosed with HDM alone. Unpaired t-tests were then carried out to assess knockdown efficiency 
(%) in siUBR5 treated vs. HDM non-treated cells at 0 and 3 hrs in loaded and non-loaded cells. 
Finally, unpaired t-tests were performed when normalising all samples to HDM non-treated 
cells at 0 hrs only. Data is present as mean ± standard error of the mean (SEM).  P < 0.05 
represents statistical significance. 
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6.3!Results 
6.3.1! UBR5 mRNA Expression After Mechanical Loading in Non-Treated 
Myotubes 
In chapter 5, UBR5 significantly increased after loading in bioengineered SkM and after RE in 
humans and rats. Therefore, the aim of the present chapter was to first ascertain UBR5 mRNA 
expression in response to mechanical loading (INT) in non-treated myotubes. Despite an 
increased mean fold-change in UBR5 expression after INT (1.58 ± 0.65) vs. CON (1 ± 0), such 
changes failed to reach statistical significance (t2 = 0.89, 95% CI -3.36 to 2.21, P = 0.47; see 
Figure 6.2 and Table 6.2). 
 
 
 
 
 
 
 
 
UBR5 mRNA expression was assessed in loaded (INT, n = 3) and non-loaded (CON, n = 3) 
human myotubes that were doesed with HDM alone to determine gene expression fold-change 
due to loading alone. Data is present as mean ± standard error of mean (SEM). 
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Figure 6.2. UBR5 mRNA expression following mechanical loading in non-treated 
human myotubes 
 
 
 
Figure 6.3. UBR5 mRNA expression in human myotubes after loading and gene 
silencingFigure 6.2. UBR5 mRNA expression following mechanical loading in non-
treated human myotubes 
 
 
 
Figure 6.3. UBR5 mRNA expression in human myotubes after loading and gene 
silencing 
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Table 6.2. Raw CT values for each timepoint and condition  
Raw CT values obtained in treated (siUBR5) / non-treatment (HDM) and loaded (INT) / non-loaded (CON) myotubes at each timepoint (0 and 3 
hrs) after qRT-PCR analysis (n = 3). CT values are presented as mean ± standard error of mean (SEM). HDM = human differentiation medium 
only; siUBR5 =  siRNA targeting UBR5; CON = non-loaded ; INT = loaded. 
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3 hr HDM CON 
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3 hr siUBR5 CON 
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3 hr HDM INT 
CT Values 
3 hr siUBR5 INT 
CT Values 
RPL13a 15.84 ± 0.5 16.33 ± 0.66 15.66 ± 0.72 15.33 ± 0.36 15.46 ± 0.19 15.8 ± 0.63 
B2M 15.46 ± 0.07 15.62 ± 0.57 14.43 ± 0.24 15.21 ± 0.75 14.56 ± 0.06 14.57 ± 0.25 
UBR5 26.56 ± 3.25 26.72 ± 3.39 25.08 ± 3.38 27.22 ± 3.29 24.76± 4.3 25.1 ± 4.13 
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 (A) UBR5 mRNA expression (%) when all treated (siUBR5) myotubes were relativised to non-treated (HDM) myotubes at the same timepoint 
(0/3 hrs) within the same condition (CON/INT). (B) UBR5 gene expression when all samples were relativised to 0 hr HDM myotubes only (n = 3 
per condition [CON/INT] and treatment [HDM/siUBR5] at each timepoint [0/3 hrs]). (*) Depicts statistical significant (P < 0.05) reduction in 
mRNA expression in non-loaded (CON), treated (siUBR5) myotubes at 3 hrs (HDM = human differentiation medium only;  siUBR5 =  siRNA 
targeting UBR5; CON = non-loaded ; INT = loaded).
Figure 6.3. UBR5 mRNA expression in human myotubes after loading  
 
 
Figure 6.3. UBR5 mRNA expression in human myotubes after loading and gene silencing 
 
 
Figure 6.3. UBR5 mRNA expression in human myotubes after loading and gene silencing 
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Figure 6.3. UBR5 mRNA expression in human myotubes after loading and gene silencing 
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6.3.2! UBR5 mRNA Expression in Loaded and Non-Loaded Myotubes 
After siUBR5 Treatment  
After determining UBR5 mRNA expression in non-treated (HDM) myotubes after 
loading, the present chapter next wished to ascertain UBR5 expression after dosing with 
siUBR5 at 0 hrs and 3 hrs post-loading. Despite a non-significant change in mean UBR5 
mRNA expression at 0 hrs post-loading (100 ± 0% HDM vs. 90.14 ± 5.38% siUBR5, t4 = 1.83, 
-95% CI -5.09 to 24.81, P = 0.14), treatment of siUBR5 significantly reduced UBR5 
expression at 3 hrs by an average ~78% in non-loaded myotubes (100 ± 0% HDM vs. 22.61 
± 0.74% siUBR5, t4 = 105, -95% CI 75.35 to 79.44, P < 0.001; see Figure 6.3A). 
Interestingly however, mechanical loading partially rescued UBR5 mRNA expression 
back towards baseline levels at 3 hrs post-loading, evidenced by a non-significant 
difference between non-treated (100 ± 0% HDM) and treated (79.68 ± 8.4% siUBR5, t4 = 2.42, 
95% CI -3 to 43.64, P = 0.07) myotubes after loading.   
 
6.3.3! UBR5 mRNA Expression when All Samples were Relativised to Non-
Treated Myotubes at 0 hrs 
After comparing treated (siUBR5) and non-treated (HDM) myotubes for each time point 
(0 /3 hr) and condition (CON/INT), the present chapter next wished to ascertain UBR5 
mRNA expression when the mean expression from each group was relativised to 0 hr 
HDM cells only. Despite an increase in mean UBR5 expression in non-loaded (CON) 
and non-treated (HDM) myotubes at 3 hrs post (220 ± 119%), such changes failed to 
reach statistical significance (t4 = 1.01, 95% CI -450.8 to 210.1, P = 0.37; see Figure 
6.3B). Interestingly however, mRNA significantly reduced at 3 hrs post treatment with 
siUBR5 (-28.33 ± 25.16%) versus 0 hr HDM cells (t4 = 5.1, 95% CI 58.47 to 198.2, P = 
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0.01). As with non-loaded/non-treated myotubes at 3 hrs, mean expression in HDM (100 
± 0% 0 hr HDM CON vs. 328.4 ± 176% 3 hr HDM INT, t4 = 1.3, 95% CI -717.2 to 260.3, P = 0.26)  
and siUBR5 (100 ± 0% 0 hr HDM CON vs. 238.2 ± 152.6% 3 hr siUBR5 INT, t4 = 0.91, 95% CI -
561.9 to 285.5, P = 0.26) treated myotubes displayed a non-significant increase after 
loading (see Figure 6.3B). 
 
6.3.4! Global Muscle Protein Synthesis After Mechanical Loading in 
Human Myotubes 
After reporting UBR5 mRNA expression in response to loading and transfection of 
myotubes, the present chapter next wished to determine changes in global MPS after 
loading/transfection via incorporating puromycin into human myotubes. Unfortunately 
however, quantification of changes of MPS was not possible, potentially due to the very 
low total amount of protein loaded for each sample (see Figure 6.4).  
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Western blots demonstrating that very limited protein is present in the ‘total protein’ blots 
(left) prior to incubating with puromycin targeting antibodies shown in the ‘anti-
puromycin’ blots (right), therefore preventing quantification of MPS. Total protein was 
detected using stain-free technology (ChemiDoc system, Bio-Rad Laboratories) whereas 
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Figure 6.4. Puromycin western blots for assessment of total muscle protein synthesis  
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Figure 6.4. Puromycin western blots 
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puromycin was detected using anti-puromycin (1:10000, Merck Millipore) and rabbit 
anti-mouse IgG (1:1000, Abcam) antibodies (HDM = human differentiation medium 
only;  siUBR5 =  siRNA targeting UBR5; CON = non-loaded ; INT = loaded). 
 
6.4!Discussion 
The present chapter aimed to determine the mechanistic role of UBR5 in response to 
mechanical loading in human myotubes. To achieve this, synthetic siRNAs were 
transfected into differentiated human myotubes cultured in monolayer which were 
subsequently loaded using the Flexcell® FX-5000™ Tension system.  
 
6.4.1! Transfection of Human Myotubes Induces Sufficient UBR5-Specific 
Knockdown at 3 hrs Post-Loading 
In previous chapters of this thesis, C2C12 self-assembling fibrin muscle was loaded in 
attempt to mimic the transcriptional and epigenetic responses to mechanical loading/RE 
in-vivo. In the present chapter however, HMDCs were cultured in traditional monolayer 
to permit sufficient differentiation and transfection of human myotubes, therefore 
enabling the mechanistic role of UBR5 to be determined following mechanical loading 
in-vitro. Using the self-assembling model employed within previous chapters, fabrication 
of a mature human fibrin muscle requires extensive optimisation, alongside the need for 
high seeding densities (with cell quantity originally being limited). Indeed, ~4 × 105 cells 
are required to produce just one mature human self-assembling bioengineered fibrin 
muscle (Martin et al., 2013) which would have proven difficult to conduct the work 
presented herein given the number of timepoints/conditions required and the limited 
stock of HMDCs available prior to experimentation. Despite the simplicity of increasing 
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cell yield via serial passaging, primary cells are also restricted to the number of passages 
they may undergo before experiencing diminished proliferative capacity and DNA 
damage (i.e. cellular senescence). Moreover, separation of myoblasts from mixed 
myoblast:fibroblast populations via pre-plating (Khodabukus et al., 2018a) or 
fluorescence/magnetic cell sorting (Martin et al., 2013) is typically a necessity to improve 
myotube maturation. Taken together, culturing of HMDCs in monolayer within the 
present chapter required less than half the number of cells (1.8 × 105 cells/well) versus 
self-assembling fibrin muscle, making the present experiment more achievable with the 
resources available. Indeed, a total number of ~4.5 × 106 cells for each participant were 
required in the present chapter which would have increased to an approximate 9.6 × 106 
cells if using the fibrin bioengineered SkM model (this is assuming a 100% success rate 
when culturing the engineered muscles which is also unlikely to occur). The use of the 
flexcell/monolayer culture system in the present chapter also permitted sufficient 
knockdown in human myotubes across all samples (see Figure 6.3) which may have 
proven difficult if attempting to transfect cells embedded within a surrounding ECM as 
with bioengineered SkM. Furthermore, previous work by our group also demonstrated 
the efficacy of transfecting SkM cells cultured in monolayer with similar commercially 
available synthetic siRNAs used herein to determine the role of a specific gene during 
myoblast differentiation and hypertrophy (Sharples et al., 2013). Indeed, targeted 
knockdown of the phosphotase and tensin homologue (PTEN) was shown to promote 
myotube hypertrophy, particularly in the absence of IGFBP-2 expression (Sharples et al., 
2013). In regards to transfection in bioengineered SkM, previous research demonstrated 
sufficient lentivirus-induced overexpression of NANOG in collagen type 1 C2C12 
bioengineered SkM (Shahini et al., 2018). To the authors knowledge however, no 
previous research has yet reported sufficient gene-specific knockdown in fibrin 
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bioengineered SkM. In the present chapter, human myotubes were treated with 
HiPerFectTransfection™ reagent containing cationic and natural lipids to facilitate uptake 
of siRNAs into the cell. However, physical methods such as low frequency electrical 
stimulation (i.e. electroporation) may be necessary to effectively deliver siRNAs into 
cells cultured in bioengineered muscle which may in itself induce gene regulatory and 
morphological alterations, therefore suggesting that any changes in UBR5 mRNA 
expression observed would not necessarily be extrapolated to the loading stimulus alone. 
However, gene-specific knockdown in fibrin engineered SkM warrants future 
investigation before the present experiments can be carried out in such systems. At 
present however, the current chapter demonstrates an easy and repeatable (evidenced by 
consistent KD efficiencies between all human samples) in-vitro human SkM model for 
investigating the mechanistic role of a gene of interest in response to mechanical loading.  
 
6.4.2! UBR5 mRNA Expression After Mechanical Loading in Non-Treated 
Human Myotubes  
As discussed extensively in chapter 5, UBR5 is an E3 ubiquitin ligase with a suggested 
opposing role to the well-known SkM atrophy-associated E3 ligases, MuRF-1 and 
MAFbx. Indeed, previous work by our group reported increases in UBR5 following acute 
and chronic loading/RE in human and rodent muscle tissue and C2C12 bioengineered SkM 
(Seaborne et al., 2018a, 2019) and also during recovery from atrophy, where MuRF1 and 
MAFbx did not show similar trends during recovery. Furthermore, UBR5 gene 
expression significantly increased to the greatest extent across all models of loading/RE 
(acute loading/RE in human/bioengineered SkM and chronic exercise in humans/rats) 
and in loaded bioengineered SkM alone in chapter 5. Therefore, the present chapter first 
wished to ascertain UBR5 gene expression in loaded, non-treated myotubes using the 
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flexcell system. Interestingly, the present chapter demonstrated a non-significant increase 
in UBR5 mRNA expression after loading, which is in contrast to that identified in loaded 
C2C12 bioengineered SkM in chapter 5, demonstrating a significant increase (see Figure 
6.2). However, it is important to note the disparities between models employed within 
the present and previous chapters. Firstly, bioengineered SkM constructs in previous 
chapters were fabricated using C2C12 cell line cells where gene expression demonstrated 
greater consistency within groups (CON vs. INT) given these cells are 100% myogenic 
cells from the same source. In contrast, the present chapter investigated the effects of 
loading in human muscle cells which contain additional cell sources (i.e. predominantly 
fibroblasts and others such as a small proportion of mesenchymal stem cells) and display 
greater inter-individual variation in mRNA expression compared to C2C12 cells. In-vivo, 
the morphological and functional responses to RE in SkM also demonstrate inter-
variability between human individuals after chronic training (Erskine et al., 2010). 
Furthermore, UBR5 also displayed a non-significant increase in human SkM after acute 
loading/RE which reached statistical significance following chronic exercise (Seaborne 
et al., 2018a). Present and previous findings therefore suggest that repeated loading may 
be required to induce significant changes in UBR5 mRNA expression in human SkM 
cells and tissue and/or that a larger sample size (>n = 3) may achieve statistical 
significance. 
 
Although myotubes were subjected to a replicative loading regime which was applied to 
bioengineered SkM (10% loading, 4 sets × 10 reps × 5 exercise,  90s between sets, 3.5 
mins rest between exercises), differences in the direction and mode of strain applied to 
myotubes may also explain the inconsistencies in UBR5 mRNA expression observed 
between models of loading. Indeed, the flexcell system utilises vacuum pressure to apply 
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equiaxial strain whereas the bioreactor system induced physical uniaxial strain to 
engineered SkM. Moreover, previous research demonstrated that intracellular signaling 
somewhat differs following 15% equiaxial/multiaxial vs. uniaxial stretch/loading in 
C2C12 cells cultured in monolayer (Hornberger et al., 2005). Finally, the Bioflex culture 
membrane stiffness (~900 kPa) is significantly greater versus the surrounding fibrin 
matrix (~12 kPa) in which SkM cells are cultured in in bioengineered muscle systems. 
Indeed, substrate stiffness has been shown to affect muscle structure and function 
(Romanazzo et al., 2012) whilst myotubes cultured on fibrin substrates which resemble 
native muscle stiffness (~12 kPa) show improved differentiation capacity in engineered 
SkM (Chiron et al., 2012). Taken together, the lack of significance in UBR5 gene 
expression in human myotubes versus the significant increase observed in loaded C2C12 
bioengineered SkM may be a consequence of the different cell sources, culture 
conditions/environment and direction/mode of strain employed between both models. 
 
6.4.3! Mechanical Loading of Human Myotubes Post-Transfection Partially 
Rescues UBR5 mRNA Expression 
As discussed in section 6.4.1, dosing of myotubes with siUBR5 induced sufficient 
(~77%) gene-specific knockdown at 3 hrs post-loading (see Figure 6.3 and Table 6.2). 
Interestingly however, mechanical loading seemed to negate the reduction in UBR5 
mRNA expression following transfection-induced knockdown, evidenced by a non-
significant difference in gene expression between treated and non-treated myotubes at 3 
hrs post-loading (see Figure 6.3A). Therefore, this suggests that mechanical loading 
rescued the siRNA induced reductions in UBR5. Such findings therefore support the 
notion that UBR5 plays a critical role in the adaptive response to acute anabolic 
stimuli/loading in SkM cells as well as SkM tissue in-vivo (Seaborne et al., 2018a, 2019). 
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The data presented herein also suggests that UBR5 is likely a downstream target of 
ERK/p90RSK signaling, a pathway that is responsive to mechanical loading and 
important for translation initiation. Indeed, previous work demonstrated that UBR5 is a 
target substrate for ERK2 in COS-1 fibroblast kidney cell line cells after treatment with 
epidermal growth factor (EGF; Eblen et al., 2003) whilst others have shown that the 
ribosomal S6 kinase, p90RSK phosphorylates UBR5 in HeLa cancer cells at numerous 
sites, specifically at Thr637, Ser1227 and Ser2483 (Cho et al., 2017). Interestingly, 
ERK/p90RSK activity is considerably increased after acute aerobic exercise (60 mins 
cycling at 70% VO2max) in humans (Aronson et al., 1997) and chronic aerobic exercise 
(5 days/week of treadmill running for 7 weeks) in rodent SkM (Osman et al., 2001). 
Furthermore, ERK/MEK/RSK signaling is exponentially increased acute loading in 
humans (after both 8-10 reps at 80-85% 1RM and 18-20 reps at 60-65% 1RM; Taylor et 
al., 2012) and mice (post mechanical overload; (Miyazaki et al., 2011) and also after 
acute (10 and 60 mins) uniaxial and multiaxial loading/stretch (15%) in C2C12 SkM cells 
using the same flexcell system employed herein (Hornberger et al., 2005). In the present 
chapter, the mechanism by which transfected siRNAs, and the resulting RNA-induced 
silencing complex (RISC) degrade targeted complimentary DNA sequences may suggest 
that more sustained gene transcription of UBR5 after loading may counteract siUBR5 
induced-silencing and that the extent to which enhanced UBR5 transcription may 
override transfection-induced degradation of the target sequence(s). However, future 
studies should wish to determine the definitive mechanisms of increased UBR5 
expression via assessing the activity of potential upstream signaling (i.e. ERK/p90RSK) 
and downstream targets in response to loading with and without muscle-specific 
knockdown of UBR5.  
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6.4.4! The Reduction in UBR5 mRNA Expression Post-Treatment is 
Negated Following Mechanical Loading  
In the present chapter, alternative analysis was carried out to determine the temporal 
change in UBR5 mRNA expression when all loaded/non-loaded and treated/non-treated 
myotubes were relativised to non-treated myotubes at 0 hrs as opposed to relativising 
mRNA expression to non-treated myotubes at the same timepoint and condition as 
described in section 6.3.2. Consistent with previous analysis, treatment of siUBR5 in 
non-loaded myotubes displayed a significant reduction in UBR5 mRNA expression at 3 
hrs post-loading (see Figure 6.3B). Furthermore, UBR5 gene expression displayed a non-
significant increase in non-loaded, HDM non-treated cells at 3 hrs which was similar to 
levels of mRNA expression in siUBR5 treated cells at 3 hrs post-loading, further 
suggesting that siRNA-induced silencing of UBR5 is negated following mechanical 
loading in human myotubes (see Figure 6.3B). In summary, the present data suggests that 
UBR5 is sufficiently silenced in siUBR5 treated myotubes, however, upregulation of 
UBR5 after mechanical loading is able to negate the reduction in UBR5 observed in non-
loaded cells.  
 
6.5!Limitations 
It is worth also noting the limitations of the present chapter. As described in section 6.4.2, 
myotubes were cultured and loaded in bioflex plates which have stiffer substrates (~900 
kPa) to those observed in fibrin bioengineered SkM (~12 kPa) which may therefore affect 
subsequent myotube maturation and mRNA expression. In attempt to overcome this 
issue, SkM cells derived from biopsies with the highest myogenic population (72 ± 
2.36%; see Table 2.1) were carefully considered and were differentiated over 10 days 
(rather than the typical 5-7 day period when differentiating C2C12 cells) to ensure 
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formation of mature myotubes (see Figure 2.2). The non-uniform directionality of 
myotubes due to the absence of tension applied to the cells imposes another limitation to 
the model employed within the present chapter. Indeed, the random, swirling formation 
of myotubes observed in monolayer do not resemble the uniaxial alignment of SkM fibres 
in-vivo, suggesting that only a sub-population of myotubes may have actually been 
subjected to the maximal strain applied (10%). Furthermore, the flexcell system induces 
multiaxial strain to cells suggesting that such findings observed in the present chapter 
may not translate to native and/or bioengineered SkM muscle which mainly undergo 
uniaxial strain given previous research demonstrating differences in anabolic signaling 
according to the direction of loading (Hornberger et al., 2005). Given the methodological 
issues encountered during total MPS procedures, the present chapter was not able to 
conclude whether silencing of UBR5 affected the anabolic response to mechanical 
loading. The inability to measure MPS in the present chapter was most likely due to the 
low initial protein concentrations and therefore the subsequent total amount of protein 
loaded for puromycin western blotting (despite attempting to precipitate using the 
acetone method). If initial primary cell quantities are sufficient, future studies should 
consider experimenting with a greater cell number or possibly trypsinise and centrifuge 
cells (rather than mechanical dissociation as employed herein) in attempt to maximise 
cell dissociation and therefore increase protein concentrations. Furthermore, future 
studies should investigate the activity of key anabolic signaling proteins such as ERK 
and p90RSK (that have previously been associated with UBR5 as described in section 
6.4.3) in the presence and absence of siRNA to determine UBR5s mechanistic role in 
SkM anabolism after loading. Despite these limitations, the present chapter demonstrates 
that mechanical loading of UBR5-specific knockdown in human myotubes is able to 
rescue its expression, providing novel mechanistic findings regarding the role of UBR5 
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in response to mechanical loading/RE, adding to exciting recent data suggesting an 
importance of this gene during SkM anabolism/hypertrophy and remodelling. 
 
6.6!Conclusion  
Data reported in the present chapter suggests that muscle-specific knockdown of UBR5 
in human myotubes is rescued in the presence of mechanical loading, further supporting 
present (see chapter 5) and previous (Seaborne et al., 2018a, 2019) work by our group, 
suggesting an important role for UBR5 in SkM anabolism/hypertrophy and remodelling 
after loading/RE. Despite the aforementioned limitations described in section 6.5, the 
present chapter proves a cost effective and repeatable model for determining the load-
induced mechanistic role of a specific gene of interest in human SkM cells.  
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CHAPTER 7 
Thesis Conclusion 
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7.1!Summary of Thesis Aims and Main Findings  
The work conducted in the present thesis aimed to develop and characterise the use of a 
murine fibrin bioengineered SkM model to study the transcriptional and epigenetic 
regulation following mechanical loading in-vitro. Moreover, to determine whether 
mechanical loading of bioengineered fibrin muscle mimics the transcriptional and 
epigenetic responses after loading/RE in-vivo.  
 
The first experimental chapter (chapter 3) demonstrated that intermittently loading fibrin 
C2C12 engineered muscle using a novel bioreactor system induced similar changes in gene 
expression of well-characterised mechano-sensitive genes that have previously been 
shown to be regulated after RE in-vivo and in response to loading in collagen 
bioengineered muscle using previously published bioreactors (Cheema et al., 2005; 
Mudera et al., 2010; Player et al., 2014; Aguilar-Agon et al., 2019). Indeed, gene 
expression profiles following intermittent loading using the TC-3 bioreactor suggested a 
greater anabolic response (i.e. increases in IGF-1, IGF-IEa, MGF and reductions in 
IGFBBP-2/5) and acute SkM remodeling (increases in MMP-9, MuRF-1 and MAFbx) 
versus static loading.  
 
After characterising the culture methods, loading regime and transcriptional response of 
known ‘mechano-sensitive’ genes after loading in fibrin bioengineered muscle, the 
following experimental chapter (chapter 4) carried out extensive bioinformatics analysis 
to determine the most frequently regulated genes across the human transcriptome and 
methylome after acute loading/RE in human SkM, and therefore identify an appropriate 
subset of genes to analyse at the mRNA and DNA methylation level after loading in fibrin 
muscle using the system characterised in chapter 3. Interestingly a number of genes that 
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were frequently regulated across the human transcriptome were also epigenetically 
altered at the DNA level after acute RE in humans. This included genes enriched in 
‘cancer’ pathways which in SkM, are associated with ECM/actin structure and 
remodelling, TGF-ß, calcium, IL-6 and retinoic acid signalling as well as mechano-
transduction.  
 
After identifying regulated genes across the human transcriptome and methylome after 
acute RE in chapter 4, chapter 5 then sought to determine mRNA expression and DNA 
methylation of these genes after loading in fibrin bioengineered using the model 
characterised in chapter 3. Data derived from this work suggests that mechanical loading 
alone is sufficient for inducing changes in mRNA expression in engineered fibrin muscle, 
albeit, the few changes observed in DNA methylation suggested a potential need for 
chronic/repeated loading and/or an electrical input to induce concentric shortening 
contraction and perhaps subsequent epigenetic changes. However, this requires future 
investigation.  In regards to chronic loading, whilst it has been shown that the rates of 
fibrinolysis in C2C12 bioengineered muscle can be regulated via the use of plasminogen 
inhibitors (Khodabukus & Baar, 2009), incubation of fibrin SkM for >24 hrs post-loading 
in our lab has proven difficult, even when kept at resting length without the application 
of additional loading. Furthermore, despite the TC-3 permitting simultaneous mechanical 
loading and electrical stimulation, this method is yet to be fully optimised and future 
work should therefore continue to characterise these methods to explore whether chronic 
loading with and without electrical stimulation is indeed imperative for inducing changes 
in DNA methylation in murine fibrin engineered muscle. Interestingly, the E3-uquitin 
ligase, UBR5, demonstrated the greatest increase in mRNA expression after loading in 
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bioengineered SkM alone and across all additional models of exercise/loading such as 
acute and chronic RE/loading in human and rodent SkM in-vivo. 
 
The final experimental chapter of this thesis (chapter 6) therefore wished to ascertain the 
mechanistic role of UBR5 in response to mechanical loading in human myotubes cultured 
in monolayer using the flexcell system. Interestingly, the results demonstrated that 
mechanical loading was able to rescue siRNA-induced knockdown of UBR5 gene 
expression in human myotubes, further supporting the notion that UBR5 may indeed be 
an important mechano-responsive regulator of SkM anabolism/hypertrophy and 
remodelling after loading/RE. However, as discussed extensively in chapter 6 (section 
6.5), we were unable to conclude whether UBR5-specific knockdown in human 
myotubes was able to affect the anabolic responses to loading due to methodological 
issues with total MPS procedures. Despite this, the results presented herein add to the 
recent body of work suggesting an importance for UBR5 in SkM anabolism and 
hypertrophy (Seaborne et al., 2018a, 2019).  
 
7.2!Thesis Conclusion 
Overall, the work carried out within the thesis has proven an effective bioengineered SkM 
in-vitro model for studying the mechano-transcriptional responses to loading in-vivo. 
Furthermore, the present thesis demonstrates a cost effective, simple and repeatable 
model for inducing gene-specific knockdown in human myotubes during mechanical 
loading to investigate the mechanistic role of a gene of interest in response to loading. 
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Table 5.1. Mouse primer sequences for genes that are significantly regulated 
across the human transcriptome and methylome after acute RE in humans 
Target 
Gene 
Primer Sequence (5'-3') 
Product Length  
(bp) 
Reference Seq.  
Number 
MSN F: GGATGCCTTGGGTCTCAACA 75 NM_010833.2  
  R: ATTTCACTCCACGGGAAGCC     
TIMP3 F: CAAGGGCCTCAATTACCGCT 107 NM_011595.2 
  R: TGTCGGTCCAGAGACACTCA     
WNT9a F: CTGGCCTCCTCAACCCTTTT 75 NM_139298.2  
  R: GCATTACTGCAACGCTCTCG   XM_006532855.2  
CTTN F: AGCATGCCTCCCAGAAAGAC 70 NM_001357116.1  
  R: TCTACACGGTCAGCTTGCAC   XM_006508475.2 
      XM_006508474.2  
      NM_007803.5  
      NM_001252572.1 
GSK3ß F: GAAGACTTGCCTTTGGCGTG 100 NM_019827.7  
  R: TAGTGACCTCCCTGGGCTAC   NM_001347232.1 
      XM_006522426.3 
PAX3 F: TCAACCAGCTCGGAGGAGTA 105 NM_008781.4  
  R: AAATGACGCAAGGCCGAATG   NM_001159520.1 
AGTR1 F: TCGCACTCAAGCCTGTCTAC 98 XM_011244264.2  
  R: ACCTCAGAACAAGACGCAGG   XM_006516534.1 
      NM_177322.3 
FOS F: TACTACCATTCCCCAGCCGA 113 NM_010234.3 
  R: GCTGTCACCGTGGGGATAAA     
THBS1 F: TGTAAAGCCTGAGACCTGCC 71 NM_001313914.1 
  R: TTCGTTAAAGGCCGAGTGCT   NM_011580.4 
 318 
ITPR3 F: TGTCTGACCAGAAGAACGCC 85 XM_006523712.3 
  R: TTGCGGTAGTCCTCCTGAGA   NM_080553.3 
RARA F: ATCTGTGGAGACCGACAGGA 96 NM_001361954.1 
  R: CCGTTTCCGGACGTAGACTT   XM_006532592.3 
      XM_006532597.2 
      XM_006532593.2  
      XM_006532593.2  
      NM_001177302.1 
      NM_001176528.1 
      NM_009024.2  
FLNB  F: AGTGCGATGCCCGAGTTTTA 104 NM_001081427.1 
  R: AGGGGCAGGAGGTACGTATT   XM_006518050.1  
      NM_134080.1 
LAMA5 F: CGGGTATCAACTGTGAGCGT 71 XM_017315832.1 
  R: ATGAGGTGAGTCGAGAGGCT   XM_017315831.1 
      XM_006500575.2 
      NM_001081171.2  
RASSF5 F: TCCATACCCTTTCCTCGGGT 73 NM_001311094.2 
  R: CTGGGCTGGTAGGGAACTTT   NM_018750.4  
      NM_001313731.1 
CRK F: GCGTCTCCCACTACATCATCA 106 XM_006532125.2 
  R: TCTCCTATTCGGAGCCTGGA   XM_006532124.2 
      NM_133656.5 
      NM_001277219.1 
SMAD3 F: CGTGGAGTATGTGTCCTGGG 80 XM_006510821.3 
  R: TACATCAGGGTTGTGGTGCC   XM_006510819.2 
      NM_016769.4 
 319 
STAT3 F: CACATGCCACGTTGGTGTTT 73 XM_017314401.1 
  R: GACTCTTGCAGGAATCGGCT   XM_011248846.2  
      NM_011486.5  
      NM_213660.3 
      NM_213659.3 
COL4A1 F: GGCTCTCCGGGTTCAATAGG 84 XM_017312555.1 
  R: GCCGATGTCTCCACGACTAC   NM_009931.2 
ITGB3 F: CTGCCGGAAGAACTGTCACT 93 XM_006532312.2 
  R: TCCAATCTTGAGGCCCACAC   NM_016780.2 
KDR F: TTTCACCTGGCACTCTCCAC 93 NM_001363216.1  
  R: AACATCTTCGCCACAGTCCC   NM_010612.3  
      XM_011240817.2 
ADCY3 F: TTTATGCGGCTGACCTTCGT 70 XM_006514935.3  
  R: GGCGCTGCCTTTTGAAGTAG   XM_006514934.3 
      XM_006514933.2 
      XM_006514932.2 
      NM_001159537.1 
      NM_001159536.1  
      NM_138305.3 
CD63 F: TTGAAGCAGGCCATTACCCA 71 NM_001282966.1 
  R: GCACCCACTGCAATGATGAC   NM_001042580.1 
      NM_007653.3  
DOT1L F: AAGGGAGAAAGATGGCTGGC 76 NM_199322.2 
  R: TTAGACTTGCGTTCGGCACT   XM_006513432.3  
      XM_011243391.2  
      XM_006513429.3  
      XM_011243390.2  
 320 
      XM_006513431.1 
      XM_006513430.1 
      XM_006504845.2 
      NM_001291248.1  
      NM_001291249.1 
      NM_178576.3 
F2RL3 F: ACGCCTCACTACTGGACTCT 100 NM_007975.4 
  R: GGAGCCAGCTAATCGGAAGG   XM_006530660.3 
ESR1 F: GGTGCCCTACTACCTGGAGA 77 XM_017313797.1 
  R: TAGACCTGTAGAAGGCGGGA   XM_006512434.3 
      XM_011243068.2 
      XM_006512435.2  
      XM_006512433.3  
      XM_011243067.2 
      XM_011243066.2 
      NM_001302533.1 
      NM_001302532.1 
      NM_001302531.1  
      NM_007956.5  
LAMA3 F: AAGCCCAGCTCTTACTGCAC 70 NM_001347461.1 
  R: AGCAGTCCGTTGTTCTCCAC   XM_006525689.3 
      XM_017317841.1 
      XM_006525687.3  
      XM_006525686.3 
      XM_006525685.3 
      NM_010680.1  
NANOG F: CTCCGCTCCATAACTTCGGG 119 XM_011241473.1 
 321 
  R: AAAATGCGCATGGCTTTCCC   XM_006506651.2 
      NM_028016.3  
      NM_001289831.1 
      NM_001289828.1 
      NM_001289830.1 
GADD45G F: GAGCTGGACTTAGCCGACTG 89 NM_011817.2  
  R: AAGCTTCCACGATAGCGTCC     
DROSHA  F: GAAGACCTGAGAGCCGCTAC 78 XM_006520021.3  
  R: TCCTTTCATAGCTGCGGTGG   NM_001130149.1 
      NM_026799.3 
NOS2  F: AGAGCCACAGTCCTCTTTGC 111 XM_006532446.3 
  R: CTGGTCCATGCAGACAACCT   NM_001313922.1 
      NM_001313921.1 
      NM_010927.4  
SMO F: GGATGTGTCCGTTACCCCTG 117 NM_176996.4 
  R: TTTTTCTTCCGGCCCAAACG   XM_006505106.4 
APAF1 F: CAGCGGAGGCTCACAGTATT 109 NM_001282947.1  
  R: CTGAGGTAGTATGCCCAGCG   NM_009684.2  
      NM_001042558.1 
ANK3 F: GTCCAATGGGTACAAGGGGG 114 XM_017313780.1 
  R: AACGTCAGAGGGGTTGTTCC   XM_006513139.3  
      XM_017313779.1 
      XM_017313778.1  
      XM_017313777.1 
      XM_017313776.1 
      XM_017313775.1 
      XM_017313774.1 
 322 
      XM_017313773.1 
      XM_017313772.1 
      XM_017313771.1 
      XM_017313770.1  
      XM_017313769.1 
      XM_006513138.2  
      XM_006513137.2 
      XM_006513136.2 
      XM_006513135.2 
      XM_006513134.2 
      XM_006513133.2 
      XM_011243310.1  
      XM_011243309.1 
      XM_011243308.1  
      XM_006513130.2  
      XM_011243307.1 
      XM_006513129.2  
      XM_006513128.2  
      XM_006513127.2  
      XM_006513126.2  
      XM_011243305.1 
      XM_006513125.2  
      XM_011243304.1  
      XM_011243303.1  
      XM_011243301.1  
      XM_011243300.1 
      XM_006513124.2 
 323 
      XM_011243299.1 
      XM_011243297.1 
      XM_011243296.1  
      XM_011243295.1 
      XM_011243294.1 
      XM_011243293.1 
      XM_011243292.1 
      XM_006513122.2  
      XM_011243291.1 
      XM_011243290.1 
      NM_170729.2 
      NM_170690.2 
      NM_170687.3 
      NM_170730.2  
      NM_146005.3 
      NM_009670.4 
      NM_170688.2  
      NM_170689.2 
      NM_170728.2 
RP-IIß F: GGTCAGAAGGGAACTTGTGGTAT 197 NM_153798.2  
  R: GCATCATTAAATGGAGTAGCGTC   
 
 
Table 5.2. Rat primer sequences for genes that are significantly regulated across 
the human transcriptome and methylome after acute RE in humans  
Target Gene Primer Sequence (5'-3') 
Product Length  
(bp) 
Reference Seq.  
Number 
MSN F: TTCTATGCTCCTCGGCTTCG 96 NM_030863.1 
 324 
  R: AATGGTGTCAGGCTTTCGCC      
TIMP3 F: GGCAAGATGTACACAGGGCT 96 NM_012886.2 
  R: ACCCAGGTGGTAGCGGTAAT    XM_006241162.3  
WNT9a F: TCCTAGAGCCCACCGATGAA 100 NM_001105783.1  
  R: GGCATCTGAAGAGTACGGGG   XM_006246448.3 
CTTN F: TGTGCAAGGGCAGATATGGG 109 NM_021868.2  
  R: ACGCGATGTAGTGTGAACCC   XM_006230889.3 
      XM_017590270.1 
      XM_006230891.3  
GSK3ß F: TGGTGCTGGACTATGTTCCG 70 NM_032080.1  
  R: AGTGTCTGCTTGGCTCGAC   XM_006248373.3  
      XM_006248374.3  
      XM_006248375.3  
PAX3 F: CAACCATCTCATTCCGGGGG 99 NM_053710.1  
  R: TGTGGAATAGACGTGGGCTG   XM_006245131.3  
      XM_008767181.2  
AGTR1a F: CCCACTCAAGCCTGTCTACG 96 NM_030985.4 
  R: CCTCAAAACAAGACGCAGGC   XM_008771594.2  
      XM_008771593.2 
      XM_006253882.3 
AGTR1b F: GGCTGTATGGATTTGGGGGTT 71 NM_031009.2 
  R: ATTGAGAGGGGACTGGAGACA   XM_008760879.2  
      XM_006232187.2 
FOS F: TACTACCATTCCCCAGCCGA 113 NM_022197.2 
  R: GCTGTCACCGTGGGGATAAA     
THBS1 F: TAGCTGGAAATGTGGTGCGT 95 NM_001013062.1 
  R: AGCAAGCATCAGGCACTTCT     
 325 
ITPR3 F: GCCGGCGAGAAGATCAAGTA 75 NM_013138.1 
  R: GTCCAGCTCGAAGAGAGACG   XM_008772710.2 
RARA F: GTGCGAAACGACCGAAACAA 109 NM_031528.2 
  R: CTTTGCGCACCTTCTCGATG   XM_017597010.1  
      XM_017597009.1  
      XM_017597011.1 
      XM_008767945.2  
      XM_017597008.1  
FLNB  F: GAACTGGCAAGACGGCAAAG 105 NM_001107288.1 
  R: GCATTATCCACCGGCTTTCG   XM_006251780.3 
      XM_006251781.3  
        
LAMA5 F: CTTTCCCAGCTGCATCCCTT 110 NM_001191609.1  
  R: AACGAAGTCCTGTCACTCGG     
RASSF5 F: ACTGCCCTCTCTACCTTCGT 99 NM_019365.3  
  R: AGGCATCCCACTCTACGTCT   XM_006249796.3 
      XM_008769494.2 
CRK F: AGTTTCCAGATCAAGGCAGGG 73 NM_019302.1  
  R: AAAGAGGGCCCGCACATAC   XM_006246913.1  
SMAD3 F: CTTACAAGGCGGCACATTGG 110 NM_013095.3  
  R: TTGCAGTTGGGAGACTGGAC   XM_008766216.2 
STAT3 F: CTTGCCAGTCGTGGTGATCT 136 NM_012747.2 
  R: TTGGTCCCAGGTTCCAATCG   XM_006247257.3 
      XM_006247258.3  
      XM_006247259.3 
COL4A1 F: TACCCGGCCCTAAAGGTCTC 77 NM_001135009.1 
  R: GAGCCCTGGTTCTCCTTTGAT     
 326 
ITGB3 F: TGACCCGCTTCAATGACGAA 87 NM_153720.1 
  R: CCTGCATGATGGCGTCAAAG     
KDR F: TGCAAGACACTCACAGTTCCC 74 NM_013062.1  
  R: TCGGTGTCCCGATAGAAGCA     
ADCY3 F: GTCGGTCTGGTGTTGGACAT 117 NM_130779.2  
  R: GATCTGGGCTGTGATGAGCA   XM_006239849.3  
      XM_006239850.3 
      XM_006239847.3  
      XM_006239848.3 
CD63 F: GTATGGCCAAGGACAGGGTC 113 NM_017125.3  
  R: CGCTATAGTTTCCACGCAGC   XM_008765024.2  
      XM_008765025.2 
DOT1L F: GCAGTGCCCGAATTGAGAGA 91 NM_001108733.1 
  R: CCCACTAAGCCACCACCATT   XM_006240961.3 
      XM_006240960.3 
      XM_006240959.3 
      XM_017594910.1  
F2RL3 F: ACCTTCCTATTGGCTGGCTC 78 NM_053808.1 
  R: TCTCCAATGGGAGGTCTGCT   NM_012689.1 
ESR1 F: AGGCGGGATACGAAAAGACC 116 XM_017588795.1  
  R: GGTTGGCAGCTCTCATGTCT   XM_006227832.3 
      XM_008758704.2  
      XM_017588797.1 
      XM_017588796.1 
LAMA3 F: CGCAGTGTACGAATCGAAGG 109 XM_017601153.1  
  R: CTTGGAAAGCAGGCGTTGAG   XM_008774089.2  
      XM_003753026.4  
 327 
NANOG F: AAGACTAGCAACGGCCTGAC 90 NM_001100781.1 
  R: CGCGTTCATCAGATAGCCCT   XM_006237310.2 
GADD45G F: CTACGAGTCCGCCAAAGTCC 91 NM_001077640.1  
  R: GGCTATGTCGCCCTCATCTT     
DROSHA  F: TGGATCCGATGCACACACTC 89 NM_001107655.2 
  R: AGCCTGCTTGTTCCTACGAC   XM_006232050.3  
      XM_006232049.3  
NOS2  F: AACGTGTTCACCATGAGGCT 93 NM_012611.3 
  R: GCCCTCGAAGGTGAGTTGAA     
ANK3 F: AGCAGAAGTGGTGCGGTATT 93 NM_001033984.1 
  R: AGTCGGGCTGAAATGTGGAG   NM_031805.1 
ITGA2 F: AGCTTCGTTCACTCCAGACA 114 XM_001075558.5  
  R: ATGGCCACTTGGTGGTTTTG     
GAB1 F: GCAACACTTACCAGGTCCCA  172 NM_001108444.1 
  R: CTGTCAGTGTCTGATGCCGT      
ATM F: ACTGCTACCGAGGTCTACGA 102 NM_001106821.1 
  R: CAGCTCCACCACGATCTCTG    XM_006243068.1  
      XM_008766222.2 
POLR2a F: GCTGGACCTACTGGCATGTT 102 XM_001079162.5 
  R: ACCATAGGCTGGAGTTGCAC     
 
Table 5.3. Human primer sequences for regulated genes across the human 
methylome after acute and chronic RE in humans  
Target 
Gene 
Primer Sequence (5'-3') 
Product Length  
(bp) 
Reference Seq.  
Number 
UBR5 F: AGGCAACACCTTAGGAAGC 81 NM_015902.6  
  R: GCTCCAGCTGATGACCTAC   XM_024447179.1  
 328 
      XM_024447178.1 
      XM_011517106.3 
      XM_017013534.2  
      XM_017013533.2  
      XM_011517105.3 
      XM_011517104.3  
      NM_001282873.1  
AFF3 F: AACGGGAGCTGAGAGCTGAT 70 NM_002285.3 
  R: GGGTGTCGACTTCAAACTTGC     
ODF2 F: TTGTGGCGCACCCAGTGTAA 71 NM_001242353.2 
  R: GCACATTCACAGTGTCCCCT   NM_001351588.2 
      NM_001351586.2  
      NM_001351584.2  
      NM_001351580.2  
      NM_153433.2 
      NM_001351587.2 
      NM_001351579.2 
      NM_002540.5 
      NM_001351582.2 
      NM_001351583.2  
      NM_001351585.2  
      NM_001351581.1  
      NM_001351578.1  
      NM_001351577.1  
      NM_001242352.1  
      NM_001242354.1 
      NM_153437.2  
 329 
      NM_153440.1  
      NM_153432.1 
      NM_153439.1 
      NM_153436.1 
      NM_153435.1  
AXIN1 F: AAGGTCCCGAGGCTACTCAG 99 NM_003502.4 
  R: GCATTTCTTTTGCACGCCAC   NM_181050.3 
      XM_017023745.2  
      XM_017023746.1 
      XM_011522684.2  
      XM_011522683.2 
      XM_011522682.2  
      XM_011522686.1 
RSU1 F: TGCCGCCAGATATTGGGAAG 78 NM_012425.4 
  R: CCTTAGGCAGCGAGATCAGG   XM_005252552.4 
      NM_152724.2 
HEG1 F: AACGTTCGATCGCTGGGATT 73 NM_020733.2  
  R: TGGTCGCTGGAAGTCCTTTG     
TRAF1 F: GGAAGCTGCGTGTGTTTGAG 97 NM_005658.5  
  R: AGCTGGCTCTGGTGGATAGA   NM_001190947.1 
      NM_001190945.1 
SETD3 F: GACCCATCCTCATGCCAACA 77 NM_199123.2 
  R: CAGAAGAGACTGCCCACCTG   NM_032233.3 
      XM_011537232.3  
      XM_005268127.3 
      XM_017021700.1  
      XM_017021699.1 
 330 
      XM_011537231.2 
      XM_011537235.1  
      XM_011537234.1 
GRIK2 F: CACATACAGACCCGCTGGAA 103 XM_017010782.2  
  R: GGTCTAAAATGGCACGGCTG   XM_017010781.2 
      XM_005266946.4  
      XM_024446411.1 
      XM_011535777.3  
      XM_024446410.1 
      XM_005266945.2  
      NM_001166247.1 
      NM_175768.3 
      NM_021956.4 
PLA2G16 F: GATGACAAGTACTCGCCGCT 81 NM_001128203.1  
  R: CTTGTAGAGCACCTCCTGCC   NM_007069.3  
      XM_006718426.1 
      XM_011544741.1  
RPL35a F: TAACTCGGGCCCATGGAAAC 76 NM_001316311.2 
  R: TGTCCAATGGCCTTAGCAGG   NM_000996.4 
ZFP2 F: TTCCACAGCCAGCATCTCAC 99 NM_030613.4  
  R: TCAGTAATACCCGGCTTCGG     
BICC1 F: GGCCATGTTACAAGCTGCTG 97 NM_001080512.3 
  R: TGGCCAAGCAATCTGCGTAT     
STAG1 F: GCATTTTTAGCAACTTCTACCAGC 115 NM_005862.3 
  R: AACTTGAATTTGGCAGGGCA   XM_017005525.1 
KLHDC1 F: TGGTGGGAGCAAAGATGACT 102 NM_172193.3 
  R: TCAAGGCATGACCTGAGTAGTG     
 331 
RPL13a F: GGCTAAACAGGTACTGCTGGG 104 NM_012423.4  
  R: GGAAAGCCAGGTACTTCAACTT     
 
 
Table 5.4. Mouse primer sequences for regulated genes across the human 
methylome after acute and chronic RE in humans  
Target 
Gene 
Primer Sequence (5'-3') 
Product Length  
(bp) 
Reference Seq.  
Number 
UBR5 F: GTCTGCTGGAGCTCGTGATT 106 XM_006520182.3 
  R: TGCTGGAATAACTGGCTGGG   XM_006520181.3 
      XM_006520180.3 
      XM_006520179.3  
      NM_001081359.3 
      NM_001112721.2  
AFF3 F: TCGCCGCCTCCACTAATAAC 196 XM_011238447.2  
  R: GAAGTCAACAACCCGTTGCC   XM_006495737.3 
      XM_011238446.2  
      XM_011238444.2 
      XM_011238443.2 
      NM_001290814.1 
ODF2 F: TTGCACCGACATCAACACCT 114 NM_001355137.1 
  R: TTGCAGTGCTGTTCCCTCAA   NM_001355136.1  
      NM_001355138.1  
      XM_017316304.1  
      XM_017316300.1 
      XM_017316299.1  
      XM_017316295.1  
 332 
      XM_017316294.1 
      XM_017316293.1  
      XM_017316292.1  
      XM_017316291.1  
      XM_017316290.1 
      XM_017316288.1 
      XM_017316286.1  
      XM_017316285.1 
      XM_017316284.1 
      XM_017316283.1  
      XM_017316281.1 
      XM_017316280.1 
      XM_017316279.1  
      XM_017316276.1 
      XM_017316275.1 
      XM_017316273.1  
      XM_017316272.1 
      NM_001177661.1  
      NM_001177659.1 
      NM_001113214.1 
      NM_001113213.1 
      NM_013615.3 
AXIN1 F: ACAGGATCCGTAAGCAGCAC 111 XM_006523516.2 
  R: CCCGGATCTCCTTTGGCATT   XM_006523515.3  
      NM_001159598.1  
      NM_009733.2  
RSU1 F: AACCCCTAGCAGCCAAGAAC 118 XM_006497405.3 
 333 
  R: GAAAAGTAGGCACCAGCACG   NM_009105.4  
HEG1 F: GAACGTAGAACGGGATGCCT 189 XM_017317159.1  
  R: GCTTGGAAATGAGCACGGAC   XM_006522718.2 
      XM_006522715.3 
      XM_006522716.1  
      NM_175256.5  
TRAF1 F: AGCATGCTGGTTATGGCTGA 193 XM_011239054.2 
  R: GGCTCAATGTCCAAGCCTCA   XM_011239053.2 
      XM_011239052.2 
      XM_017317129.1 
      XM_011239051.2 
      XM_011239050.2 
      NM_009421.4 
      NM_001326601.1 
SETD3 F: GGGTGACCTTGGCTCTGATT 91 NM_001364267.1 
  R: CAGCGGTCATCTTCCAGGTT   NM_001364269.1 
      NM_001364266.1 
      XM_006516078.3 
      NM_028262.3 
      XM_011245945.1 
      NM_001081217.1 
GRIK2 F: CAGCACTGGTCTCATTCGCT 84 NM_001358866.1  
  R: GCTGGCAGCTGACGAATTTT   NM_010349.3 
      NM_001111268.2 
      XM_011243127.2  
      XM_006512545.3 
      XM_011243125.2 
 334 
      XM_011243124.2  
      XM_011243123.2  
      XM_011243122.2 
      XM_011243121.2  
      XM_011243120.2  
      NM_001093749.3  
PLA2G16 F: GAATGACTGCCCAGTTTTTGGG 196 NM_001362425.1 
  R: TGTTATCCAGAACAGAGCCCC   NM_139269.2 
RPL35a F: TATGCCCGAGATGAAACGGAG 171 NM_001130485.1  
  R: GCTTCGGAATTTGGCACGAA   NM_001130484.1 
      NM_021338.3  
ZFP2 F: TGTGGGAAAACCTTCAGGCA 115 XM_017314508.1  
  R: GGGAGGAGCGTTCGATGAAA   XM_017314507.1 
      XM_017314506.1 
      NM_178447.3 
      NM_001044700.2 
      NM_001044698.2 
      NM_001044697.2  
      NM_001294323.1 
BICC1 F: TGGTAGCGGTACCTTCTGGA 75 NM_001347189.1  
  R: TGCAGTGAAGACTGTCCACG   NM_031397.3 
STAG1 F: GGGGTACTGGCAAGAGAGTG 198 NM_001357265.1 
  R: TTTCCATCCGACCTGTGCTG   NM_001357264.1 
      NM_009282.4 
      XM_011242692.2 
      XM_006510925.2  
      XM_006510924.2 
 335 
      XM_006510923.2 
      NM_008636.4  
KLHDC1 F: CACACAGAGACGGGTTTGGA 173 XM_011244121.2  
  R: TGGCTTCTGATCAACGGAGG   XM_011244119.2 
RP-IIß F: GGTCAGAAGGGAACTTGTGGTAT 197 NM_153798.2  
  R: GCATCATTAAATGGAGTAGCGTC     
 
Table 5.5. Rat primer sequences for regulated genes across the human methylome 
after acute and chronic RE in humans  
Target Gene Primer Sequence (5'-3') 
Product Length  
(bp) 
Reference Seq.  
Number 
UBR5 F: GCACCAATCCTGACGACTCT 83 XM_017595225.1 
  R: AATGTGTTCTGCTCCGGTCC   XM_006241570.3 
      XM_008765469.2  
      XM_008765468.2 
      XM_008776462.2  
      XM_006226059.3 
AFF3 F: ATGTCCACTCTAGGCCGTGT 175 NM_001191887.2 
  R: TCTGGATCCGGTTGGAGAGT   
      
      
      
      
ODF2 F: AACATCGAGCGCATCAAGGA 106 NM_017213.2 
  R: CCATTTCAGCCTCCACCAGT   NM_001145005.1 
      XM_017591519.1 
      XM_017591520.1  
 336 
      XM_017591521.1 
      XM_017591522.1  
      XM_017591523.1 
      XM_017591524.1 
      XM_017591525.1 
      XM_017591526.1 
      XM_017591527.1  
      XM_017591528.1 
      XM_017591529.1 
      XM_017591530.1 
      XM_017591531.1 
      XM_017591532.1 
      XM_017591533.1  
      XM_017591534.1 
      XM_017591535.1  
      XM_017591536.1 
      XM_017591537.1 
      XM_017591538.1 
AXIN1 F: GGACCTCGGAGCAAGTTTCA 95 NM_024405.1 
  R: GGTTGACAGGCCTCGAATCA   
RSU1 F: TCGGCAACTTGGACCTAACC 89 NM_001109404.1 
  R: AAGCTGGAACTGGTCAGCAA   
HEG1 F: CACTGCAAGGAACCATTGGC 118 XM_017604360.1  
  R: AGTCTGAGCTGTCACTCCCT   XM_006221159.3 
TRAF1 F: CCACAGGGCTGGTCTCTACT 90 NM_001271240.1  
  R: ACTCGTTTTCATCAGGGGCT    
SETD3 F: GCAGCCATGAACCGAGAGTA 80 NM_001346470.1 
 337 
  R: CCCAGGTCACTCTCCTCGTA   XM_017603284.1 
      XM_002726774.2  
GRIK2 F: AACCTAGCCGCCTTTCTGAC 103 NM_019309.2 
  R: CGTCCTCCACTGCTCCATAC   
PLA2G16 F: TAAACAAAGGCATCCACGGC 84 NM_017060.2  
  R: CTTGGGTTCTGGTATGGGCA   
RPL35a F: CTCCGGAACCAAAGAGAGCA 70 NM_021264.3 
  R: ACTCAGTTTCATCTCGGGCA   XM_017604255.1 
      XM_003752497.4  
      XM_003752496.4  
      XM_017604361.1  
      
ZFP2 F: AGGCAATGGCTGTTGGAACT 97 NM_001127558.1  
  R: TAGCTGCATCACTCCTCCCA     
BICC1 F: GAAGATCGGGGCCAAATCCA 119 NM_001108531.1 
  R: TGACCCGGTTGCTTTTCGT   
STAG1 F: CCTGCCAAAAGTCACGTTA 138 NM_001108179.1 
  R: ATTAGCGGGTTGAGGGGGT   XM_006243631.2  
      XM_008766528.2  
      XM_006243632.3 
KLHDC1 F: ACAGCAATCGCGGACGATAA 152 NM_001108027.1 
  R: TACTTTGGGCCTTACCTGGG   
POLR2a F: GCTGGACCTACTGGCATGTT 102 XM_001079162.5 
  R: ACCATAGGCTGGAGTTGCAC    
 
 
